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INfeCtIOus aGeNts wIth RNa GeNOmes
Ribonucleic acid (RNA) is a conformationally flexible biopolymer composed of nucleotide 
subunits. Each nucleotide consists of a phosphate group and a pentose sugar (ribose), 
together forming the backbone of every RNA chain, and one of four nitrogenous bases 
(adenine, guanine, cytosine or uracil). RNA molecules are characterized by a high degree 
of functional plasticity and are critically involved in fundamental cellular processes, 
including the priming of DNA replication, the transfer of genetic information to the 
translation apparatus, and the posttranscriptional regulation of gene expression. RNA 
can also have catalytic properties. Chemical transformations that can be catalyzed by 
RNA molecules include RNA-processing events, nucleotide synthesis, RNA polymeriza-
tion and peptide bond formation3,13,47,54,62,103,108. The remarkable ability of RNA to serve as 
both a carrier of genetic information and a catalyst for the template-based duplication of 
this information lends credence to the hypothesis that the first self-replicating systems 
that emerged on Earth may have been based on RNA only37,56. The conformational vari-
ability and chemical functionality of RNA is restricted by the fact that RNA polymers are 
composed of just four building blocks with limited chemically reactive groups. These 
properties of RNA, combined with the necessity to respond to arising environmental chal-
lenges, may have led to the invention of protein synthesis templated by RNA sequences. 
The transfer of catalytic “responsibilities” to this novel and more versatile biomolecule 
marked the transition to protein-based metabolism. Subsequently, DNA replaced RNA in 
its role of genetic material due to its greater chemical stability, permitting much larger 
genomes. Today, the only known entities that rely on RNA for the storage of their genetic 
information are RNA viruses, viroids and virus-associated RNAs, suggesting they may be 
“evolutionary relics of the RNA world”.
Phytopathogenic viroids are circular, non-coding RNAs with lengths between 250 and 
400 nucleotides (nt) that are not encased in a protein shell, and their entire replicative 
cycle depends on host factors. viroid RNAs are capable of utilizing cellular DNA-depen-
dent RNA polymerases (DdRp) for their replication, and spread trough infected plants via 
plasmodesmata (reviewed in reference102). A subviral human pathogen, hepatitis delta 
virus (HDv), shares the ability of viroids to use host cell DdRp for amplifying its circular, 
single-stranded RNA genome of 1.6 kb. in contrast to viroids, HDv encodes a protein 
required for replication of its RNA – the HD antigen (HDAg) is expressed from the antig-
enomic transcript and encapsidates HDv genomes. The envelope proteins on the outer 
surface of HDv are entirely provided by hepatitis B virus (HBv), making HDv dependent 
on host cells for RNA replication and on another virus for particle assembly105. 
viruses that replicate only via RNA intermediates encode a viral RNA-dependent RNA 
polymerase (RdRp) to amplify their genomes. Plus-strand RNA (+RNA) viruses carry linear, 
single-stranded genomes of mRNA polarity that can initiate viral gene expression im-
mediately after genome uncoating in infected cells. The genomes of minus-strand RNA 
(-RNA) viruses, by contrast, are complementary to mRNA and need to be transcribed 
into mRNAs before viral genes can be expressed. To this end, -RNA virus particles also 
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deliver a viral “transcriptase” into their host cells. The single-stranded RNA genomes of 
retroviruses, although of positive polarity, also do not function as mRNAs at the onset 
of infection, but are transcribed into DNA intermediates by a virion-associated RNA-
dependent DNA polymerase. 
Although the length of RNA genomes is presumably constrained by the low fidelity of 
their RNA synthesis31,53, +RNA viruses constitute the largest virus group today and com-
prise ubiquitous pathogens of plants and animals. in their most economic form, +RNA 
genomes resemble cellular mRNAs, encoding a single open reading frame (ORF), flanked 
by 5’ and 3’ untranslated sequences. The latter carry signals which ensure the recognition 
and efficient translation of the genomic RNA by the cellular translation apparatus, as well 
as its replication by the viral RNA-synthesizing complex. Polypeptides expressed from 
the viral ORF invariably include an RNA-dependent RNA polymerase (RdRp), the enzyme 
responsible for RNA-templated RNA synthesis, a process which takes place exclusively in 
the cytoplasm of the infected cell. in order to express multiple viral gene products from a 
single ORF, many +RNA viruses rely on proteolytic processing of polypeptide precursors 
into mature protein subunits. in addition, eukaryotic +RNA viruses with polycistronic 
genomes have evolved different ways to encode and express multiple ORFs. Many plant 
and insect +RNA viruses employ bi-segmented and  occasionally tri-segmented ge-
nomes. Several translation regulation strategies, such as “leaky scanning” by ribosomes 
and ribosomal frameshifting, can ensure the translation of adjacent or overlapping viral 
ORFs from the same mRNA molecule. Expression of ORFs positioned internally on the 
genomic RNA can involve the use of internal ribosome entry sites (iRES) for ribosome 
recruitment or the synthesis of subgenomic (sg) mRNAs in which these ORFs occupy a 
5’-proximal position. These strategies are not mutually exclusive, and +RNA viruses may 
utilize several of these mechanisms for the expression of their genetic information. 
in addition to the viral RdRp, +RNA viruses generally encode multiple protein factors 
that support RdRp activity and/or are involved in the spatial and temporal regulation of 
viral RNA synthesis. The presence of one such RdRp co-factor - an RNA helicase, among 
the replicative proteins of +RNA viruses was postulated to have permitted genomic RNA 
expansion to sizes above ~6 kb. This hypothesis is based on the selective absence of this 
domain in +RNA viruses with genome sizes below ~6 kb, and the presumed role of viral 
helicases in unwinding large double-stranded (ds) RNA regions of replicative intermedi-
ates, as well as structured regions present in template RNAs that may hamper RdRp pro-
cessivity39,40. The greater coding capacity, in turn, may have permitted the evolution of 
viral gene products solely dedicated to modulating and evading antiviral host responses, 
allowing for greater plasticity of these viral genomes and increased ability of the virus to 
adapt to different host environments. 
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NIDOvIRuses
Three distantly related families of enveloped +RNA viruses – Coronaviridae, Arteriviridae 
and Roniviridae, have been united in the order of Nidovirales based on similarities in their 
gene organization, expression strategies, and the presumed common ancestry of their 
key replicative enzymes17,38,39. The Coronaviridae family has recently been reorganized 
and now comprises the two subfamilies of Coronavirinae (subdivided into the Alpha-, 
Beta-, and Gammacoronavirus genera) and Torovirinae (genera Bafinivirus and Torovirus) 
(http://www.ictvonline.org/virusTaxonomy.asp?version=2009). 
Nidoviruses infect a wide variety of host, ranging from invertebrates to mammals. 
The ronivirus yellow head virus (yHv) causes significant mortality of farmed prawns, 
resulting in severe economic damage through heavy production losses34. The Arteri-
viridae family also includes economically important animal pathogens, such as the 
porcine reproductive and respiratory syndrome virus (PRRSv), which is associated with 
significant economic losses in the swine industry71. Members of Coronaviridae comprise 
numerous enteric and/or respiratory pathogens of farm and companion animals, and the 
Coronaviridae family is currently the only major nidovirus branch that includes known 
human pathogens. After rhinoviruses, human coronaviruses are the second most com-
mon cause of common cold-like disease in humans. in 2003, however, also a potentially 
fatal, emerging human disease, severe acute respiratory syndrome (SARS), was shown to 
be caused by a coronavirus27,63 (recently reviewed in reference76). Most nidoviruses have 
very restricted host specificity and infect only one or a narrow range of closely related 
species. One of the notable exceptions is SARS-Cov, which has been shown to infect a 
range of mammals45, a property that has been advantageous for the development of 
animal models for research on SARS-Cov pathogenesis81,99.
The different nidovirus groups encode widely different sets of structural proteins and, 
accordingly, have distinct virion architectures. Ronivirus and bafinivirus particles are rod-
shaped and contain tubular helical nucleocapsids84,96. A helical nucleocapsid structure is 
also characteristic of the spherical coronavirus and, presumably, torovirus particle4,70,106, 
while arterivirus nucleocapsids are likely icosahedral (Fig. 1). The lipoprotein envelopes of 
nidovirus particles also differ significantly in morphology, largely due to the dissimilar ar-
rays of viral envelope proteins they contain. The virions of Coronaviridae and Roniviridae 
representatives are characterized by large protrusions from the envelope surface formed 
by membrane-spanning viral proteins, while arterivirus particles carry relatively small en-
velope projections. The viral envelope proteins mediate attachment of nidovirus particles 
to receptors on the surface of host cells and fusion of the viral envelope with cellular 
membranes, an event that can take place either at the plasma or endosomal membranes. 
Following release of the viral nucleocapsid into the host cell cytoplasm, the nidovirus 
genome is uncoated and translated by host cell ribosomes. in the late stages of nidovirus 
infection, newly made genomic RNA molecules associate with nucleocapsid proteins. 
interactions of the resulting nucleocapsid structures with intracellular membranes con-
taining the viral envelope proteins trigger budding of progeny virions into the lumen of 
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the smooth endoplasmic reticulum and/or the Golgi complex, followed by the release of 
progeny particles into extracellular space by exocytosis. The mechanisms of virus entry 
and assembly of infectious progeny employed by representatives of the major nidovirus 
groups are evidently different, which stands in contrast to similarities observed in other 
key viral properties. These include the order in which viral genes are encoded in the poly-
cistronic +RNA genomes of nidoviruses, the mechanisms used to express those genes, 
and the composition of the nidovirus replicative machinery. Collectively, these observa-
tions argue for a common evolutionary ancestry of viruses united in the Nidovirales order.
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figure 1. virion architecture in the order Nidovirales. Characteristic electron micrographs of negatively 
stained particles (left panels) and schematic diagrams (right panels) from representatives of the five main 
nidovirus genera: arterivirus, coronavirus, torovirus, bafinivirus and ronivirus. Scale bars represent 50 nm 
in the arterivirus image and 100 nm in all other images. Note the differences in nucleocapsid symmetry 
and envelope protein composition. Abbreviations: N, nucleocapsid protein; M, membrane protein; S, spike 
protein; E, envelope protein; GP or gp, glycoprotein, HE, hemagglutinin-esterase. GP5 and M are the major 
glycoproteins in arterivirus particles, while GP2, GP3, and GP3 are minor envelope components. Toroviruses, 
bafiniviruses, and roniviruses lack an equivalent of the E protein that is present in corona- and arteriviruses. 
Adapted from Enjuanes et al.32 and Snijder et al.92 
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The single-stranded RNA genomes of nidoviruses are 3’ polyadenylated and carry a 5’ 
cap structure. The genome size of Arteriviridae, ranging between 12.7 and 15.7 kb, differs 
considerably from those of Coronaviridae and Roniviridae - the virus groups with the largest 
and genetically most complex RNA genomes described to date (25-32 kb)39. The nonstruc-
tural proteins (nsps) of nidoviruses are encoded in a large “replicase” gene that occupies the 
5’-proximal two-thirds to three-quarters of the genomic RNA and consists of two ORFs - ORF1a 
and ORF1b. A set of small ORFs, coding for the viral structural proteins and, in some nidovirus 
representatives, “accessory” proteins, are found in the 3’-proximal part of nidovirus genomes. 
The nidovirus replicative cycle starts with translation of the genomic RNA, initiated at 
the ORF1a start codon following ribosomal scanning and resulting in the production of a 
large polyprotein, pp1a. A -1 ribosomal frameshift just upstream of the ORF1a termination 
codon results in the C-terminal extension of a fraction of pp1a with the ORF1b-encoded 
polypeptide, giving rise to pp1ab15. The two large replicase polyproteins are co- and post-
translationally processed by virus-encoded (auto)proteinases into 13-16 individual nsps, 
which assemble into a cytoplasmic RNA-synthesizing complex that is anchored to modi-
fied cellular membranes. The structural protein ORFs, which are inaccessible to host cell 
ribosomes due to their 3’-proximal positions in the genomic RNA (Fig. 2), are expressed 
from a set of sg mRNAs. These molecules are 3’-coterminal with the viral genome, result-
ing in a so-called “nested” set of viral RNA species, a property reflected in the name of the 
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figure 2. The polycistronic nature of nidovirus genomes. The genomic RNA of selected representatives 
of the Arteriviridae, Coronaviridae and Roniviridae families are drawn to the same scale. The 5’-proximal 
replicase open reading frames (ORFs), as well as the downstream ORFs encoding the viral structural 
proteins are depicted. The ORF1a/1b ribosomal frameshift site (RFS) and the 3’ poly(A) tail (An) are also 
indicated. ORFs encoding the viral replicase and viral structural proteins are designated (for abbreviations, 
see Fig. 1). Note the large size difference between the genomes of arteriviruses and other nidovirus families 
and subfamilies. EAv, equine arteritis virus; SARS-Cov, severe acute respiratory syndrome coronavirus; BTov, 
bovine torovirus; GAv, gill-associated virus.
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virus order (“nidus” is the Latin word for nest). The sg mRNAs of corona- and arteriviruses 
also contain a short sequence identical to the genomic 5’ end5,22,64,95. 
the NIDOvIRus RePlICase: aN eNzyme tReasuRe Chest 
Despite the large size difference between the replicase pp1ab polyproteins, ranging 
from 3175 amino acids (aa) for the arterivirus equine arteritis virus (EAv) to ~7200 aa for 
the coronavirus murine hepatitis virus (MHv), the conserved array of replicative domains 
and their sequential arrangement in the large nidovirus replicase gene formed the basis 
for nidovirus unification (Fig. 3). The ORF1a-encoded replicase subunits include the 
“main” viral proteinase, an enzyme with a chymotrypsin-like fold and narrow substrate 
specificity. This enzyme mediates limited proteolysis of the C-terminal half of pp1a and 
the ORF1b-encoded portion of pp1ab at a number of sites1,6,24,42,66,94. Up to three ORF1a-
encoded “accessory” proteinases are responsible for the (auto)catalytic processing of 
the N-terminal part of the nidovirus replicase polyproteins (reviewed in reference111). 
The replicase gene portion upstream of the ribosomal frameshift site also specifies a 
number of hydrophobic domains flanking the main proteinase. Transmembrane domain-
containing nidovirus nsps have presumed or established roles in the rearrangement of 
host cell membranes into virus-induced compartments and the anchoring of nidovirus 
RNA-synthesizing complexes to these modified membranes in infected cells2,20,36,60,72-74,78,93. 
RdRp and helicase
ORF1b is the most conserved part of nidovirus genomes. The central viral enzymatic ac-
tivities for RNA-templated RNA synthesis - the RdRp and helicase, are encoded in ORF1b, 
and phylogenetic analyses provided strong evidence for a common ancestry of these key 
enzymes in the different nidovirus groups21,24,41,42,48,91. The RdRp domain is found in the 
C-terminal portion of a larger replicase subunit whose size differs considerably among 
nidoviruses (Fig. 3). Recombinant forms of the RdRp-containing nsps from EAv (nsp9) and 
SARS-Cov (nsp12) have been recently produced, and their initial biochemical characteriza-
tion revealed important functional differences. For example, EAv nsp9 is able to initiate 
RNA synthesis de novo but SARS-Cov nsp12 is a primer-dependent RdRp8,100. Although 
both proteins could catalyze RNA polymerization in vitro in the absence of other viral or 
cellular proteins, the recombinant EAv RdRp could not utilize sequences derived from the 
3’ end of the viral genome as a template, suggesting additional requirements for its activity 
in vivo. it is interesting to note that coronavirus nsp8 has been proposed to act as an “RNA 
primase”, based on its ability to synthesize short oligoribonucleotides in vitro49. No func-
tional counterpart of this protein in the arterivirus replicase has been identified to date. 
The availability of recombinant nidovirus RdRps provides a solid basis both for the de-
tailed functional characterization of their enzymatic activities that should yield valuable 
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mechanistic insights into nidovirus RNA synthesis. Of particular interest would be the 
significance of the nidovirus helicase for viral RNA synthesis. RNA helicases are a diverse 
class of enzymes that unwind RNA duplexes using the energy of ATP hydrolysis. in ni-
doviruses, the helicase domain, much like the RdRp domain, is part of a larger replicase 
subunit (Fig. 3), which also contains an N-terminal predicted zinc-binding domain with 
13 conserved Cys and His residues42,104. Recombinant forms of the arteri- and coronavirus 
nsps comprising the helicase domain (nsp10 and nsp13, respectively) have ATPase ac-
tivities and can unwind RNA and DNA duplexes in a 5’-to-3’ direction in vitro51,52,86,88. The 
helicase activity of coronavirus nsp13 is remarkably processive, permitting strand sepa-
ration of long stretches of double-stranded nucleic acids, and the protein also exhibits 
RNA 5’-triphosphatase activity in vitro51,52. The zinc-binding domains of arterivirus nsp10 
and coronavirus nsp13 are also critical for the in vitro ATPase and helicase activities of the 
proteins87. Although residues from this domain are unlikely to be involved in catalysis, 
zinc coordination might assist the proper folding of the entire replicase subunit and/or 
mediate interactions of the protein with substrate RNA molecules. Notably, the 5’-to-3’ 
amino acids
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figure 3. Organization and composition of nidovirus replicases. Currently mapped functional domains 
in the pp1ab replicase polyprotein of the Arteriviridae, Coronaviridae and Roniviridae representatives 
listed in Fig. 2 are shown schematically to scale. The border between amino acids encoded in ORF1a and 
ORF1b is indicated as RFS (ribosomal frameshift). Arrowheads represent cleavage sites processed by 
virus-encoded proteinases. Sites cleaved by papain-like (PL) accessory proteinases are shown in grey, while 
those processed by the 3C-like main proteinase (3CLpro) are depicted in black. The resulting nonstructural 
proteins (nsp) are numbered where cleavage site maps of pp1ab proteins are available. in addition to the 
proteinase domains, the location of putative transmembrane domains (TM) and the major viral enzymatic 
domains are shown: RNA-dependent RNA polymerase (RdRp), helicase (Hel), exoribonuclease (ExoN,) 
endoribonuclease (Ne, NendoU in the main text), N7-methyltransferase (N7), 2’ O-methyltransferase (2’O), 
ADP-ribose-1”-phosphatase (X) and cyclic phosphodiesterase (CPD). 
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polarity of nidovirus helicases has not been reconciled so far with their presumed role in 
unwinding local double-stranded RNA structures that might hinder the progress of the 
RdRp during viral RNA synthesis, which proceeds in the opposite direction.
the nidovirus endoribonuclease (Nendou)
in addition to the core viral enzymes, the replicative machinery of nidoviruses includes 
several subunits with rather unusual RNA-processing activities that have few or no known 
counterparts in the RNA virus world. The majority of these enzymes are encoded only 
by nidoviruses with large genomes, but one of them - the nidovirus endoribonuclease 
(NendoU) domain, is conserved throughout the nidovirus order39,89. To date, no NendoU 
counterparts have been identified in other RNA viruses, and this domain is thus considered 
a genetic marker of Nidovirales. The NendoU domain is encoded in ORF1b, downstream of 
the RdRp and helicase, and is N-terminally fused to another domain in a larger replicase 
subunit - nsp11 in arteriviruses and nsp15 in coronaviruses (Fig. 3). its endoribonuclease 
function was originally predicted based on distant sequence homology between the 
NendoU domain and a small family of prokaryotic and eukaryotic proteins prototyped by 
XendoU, an endoribonuclease from Xenopus laevis89. Several coronavirus nsp15 orthologs 
were shown to cleave RNA 3’ of uridylates in vitro, and the enzyme’s critical role in the coro-
navirus replicative cycle was established using recombinant coronaviruses that expressed 
mutant forms of nsp1550,59. Biochemical and structural studies have provided some insights 
into the catalytic activity of coronavirus NendoU domains and the determinants of the 
enzyme’s substrate specificity10-12,46,50,55,80. The cognate substrate of NendoU in infected cells 
has not been identified, however, and the molecular details of the role of NendoU in the 
nidovirus replicative cycle, as well as the mechanism(s) to protect viral (and possibly cel-
lular) RNA molecules in infected cells from rapid degradation, remain unexplored thus far. 
exoribonuclease, 2’ O-methyltransferase and N7- methyltransferase
Apart from NendoU, members of the Coronaviridae and Roniviridae encode two ad-
ditional conserved enzymatic domains in the 3’-proximal region of ORF1b – a 3’-to-5’ 
exoribonuclease (ExoN) and a (nucleoside-2’ O)-methyltransferase (2’ O-MTase), mapping 
to coronavirus nsp14 and nsp16, respectively23,39,68,89. A role of ExoN in improving the low 
fidelity of RdRp-mediated RNA synthesis, and thus contributing to the maintenance of 
the large genomes in these two nidovirus families, was postulated39,89. ExoN inactivation 
by substitution of active-site residues correlates with severe defects in coronavirus RNA 
synthesis28,68. MHv ExoN mutants were shown to accumulate 15-fold more mutations than 
the wild-type virus28, but rigorous experimental proof of an ExoN role in proofreading is 
currently lacking. interestingly, a (guanine-N7)-methyltransferase (N7-MTase) activity of 
nsp14 was recently identified in a yeast genetic screen for cap-forming enzymes of coro-
naviruses. The ExoN and N7-MTase activities of nsp14 seem to be functionally separated 
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in the protein’s primary structure18. Nidoviruses with large genomes thus possess at least 
two enzymes that could participate in the formation of 5’-terminal cap 1 structures. 
Recently, mRNA cap methylation was reconstituted in vitro using recombinant nsp14 
and nsp16 from SARS-Cov. This study also reported a surprising role of nsp10 as a critical 
factor for the 2’O-MTase activity of nsp16 in vitro14. The coronavirus helicase was also 
suggested to play a role in viral mRNA capping due to its RNA 5’-triphosphatase activity, 
since removal of the 5’ γ-phosphate is the first step in cap formation52. By contrast, no 
RNA capping functions have been identified in the arterivirus replicase to date.
aDP-ribose-1”-phosphatase and cyclic phosphodiesterase
The repertoire of known and/or predicted nidovirus RNA-processing enzymes is com-
pleted by two domains - a cyclic phosphodiesterase (CPD) and an ADP-ribose-1”-phos-
phatase (ADRP), which are encoded by a smaller subset of nidovirus groups in genomic 
regions other than ORF1b89. Both domains are not unique to nidovirus representatives 
– an ADRP domain is found in the replicase polyproteins of all mammalian viruses of the 
alphavirus-like supergroup43, while a distantly related CPD domain can be found in the 
genomes of some dsRNA viruses89. The CPD domain-coding sequence is found in the 
3’ end of ORF1a just upstream of the ribosomal frameshift in Torovirus representatives, 
while in a subset of Betacoronavirus members it is not encoded in the replicase gene, but 
expressed from a sg mRNA and called the ns2 protein90 (see Fig. 3). None of the other cur-
rently known nidoviruses encodes a CPD homolog. Cyclic phosphodiesterase activity of 
this domain has not been demonstrated so far, and deletion of the ns2-coding sequence 
from the MHv genome does not affect virus replication in cell culture85. However, a 
number of amino acid substitutions in ns2, including replacements of predicted catalytic 
CPD residues, were found to attenuate virus growth in mice, particularly in the livers of 
infected animals82,97. 
A similar phenotype has been reported for an MHv mutant with a substitution in 
the ADRP active site, which replicated efficiently both in cultured cells and in the liv-
ers of infected mice, but did not induce liver disease33. The ADRP domain was originally 
identified as X domain89 and, subsequently, macro domain, as it is evolutionarily related 
to a conserved domain found in the C-terminal region of the histone macroH2A75. All 
representatives of the Coronaviridae family harbor a macro domain in the N-terminal 
region of pp1a/pp1ab, and in coronaviruses this domain is part of the largest replicase 
subunit – nsp3. The biochemical characterization of coronavirus macro domains was 
initially focused on its ability to convert ADP-ribose-1”-phosphate, a by-product of 
cellular pre-tRNA splicing, to ADP-ribose79. Recombinant coronavirus macro domains 
exhibited specific, but poor ADRP activity in vitro, and recent reports have suggested 
these domains bind efficiently to poly(ADP-ribose) - a unique post-translational protein 
modification involved in multiple cell signaling pathways, among which those related to 
cell survival83. it is unclear, however, whether ADP-ribose binding is a conserved property 
of coronavirus macro domains, since a recombinant form of this domain from the group 
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3 coronavirus infectious bronchitis virus (iBv) failed to bind ADP-ribose in vitro77. Curi-
ously, this was a property only of the macro domain derived from iBv strain Beaudette, 
while the iBv strain M41 macro domain has been successfully crystallized in complex 
with ADP-ribose107. Taken together, the properties of the CPD and ADRP domains are 
most consistent with roles of these enzymatic activities in the modulation of host cellular 
responses to viral infection30,33,79,82.
ORf1a-encoded replicase subunits
in contrast to the clear evolutionary relationship among ORF1b-encoded domains, 
the N-proximal parts of pp1a/pp1ab are very poorly conserved among nidovirus fami-
lies21,24,90,110. Aside from the identical sequential arrangement of membrane-associated 
nsps and the main viral proteinase, another discernible common feature is the presence 
of one to three “accessory” proteinases that direct the autocatalytic processing of the 
N-proximal replicase polyprotein regions in which they reside (reviewed in 111). The 
papain-like cysteine proteinase domains residing in nsp2 of arteriviruses and nsp3 of 
coronaviruses reportedly can hydrolyze ubiquitin and interferon-stimulated gene prod-
uct 15 (iSG15) from covalently modified proteins. These activities are due to the narrow 
substrate specificities of these proteinases, which match closely those of known cellular 
deubiquitinases. Consequently, papain-like proteinases of arteri- and coronaviruses have 
been proposed to play a role in counteracting ubiquitin- and iSG15-dependent cellular 
antiviral responses7,35,65. Elegant biochemical studies on SARS-Cov nsp1, a protein with 
no known enzymatic activities, have suggested this replicase subunit could also be 
involved in suppressing antiviral signaling pathways by inhibiting host translation and 
promoting host mRNA degradation57,58,69. This function of nsp1, however, is dispensable 
for SARS-Cov replication in cultured cells69 and might only be important for pathogenic-
ity in the natural host, as demonstrated for its ortholog in MHv112.
in contrast to the apparent expendability of coronavirus nsp1 and nsp2 for viral RNA 
replication in cell culture16,25,44, the similarly positioned region of the arterivirus replicase 
polyprotein contains a protein factor – nsp1, which is critical for viral RNA synthesis. EAv 
nsp1 is not essential for genome replication, but absolutely required for the synthesis 
of sg mRNAs, and a similar function has been proposed for nsp1α from PRRSv61,101. 
interestingly, PRRSv nsp1α and nsp1β have recently been reported to function as in-
terferon antagonists9,19. Multiple ORF1a-encoded nsps from different nidoviruses thus 
may contribute to the evasion of innate immunity surveillance mechanisms, a function 
they might be exceptionally well suited for, considering they are the first viral proteins 
produced upon infection. 
The ORF1a gene products thus seem to play diverse roles in viral RNA synthesis, provid-
ing subunits that modify the intracellular environment for this process to take place and 
ensure the regulated proteolysis of replicase polyproteins. it is clear that ORF1a replicase 
gene products can also have key regulatory functions in viral RNA synthesis, as demon-
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strated for arterivirus nsp161,101 and proposed for the nsp7 to nsp10 replicase subunits of 
coronaviruses26,29,67,98,109,113.
sCOPe aND OutlINe Of thIs thesIs
The functional analysis of nidovirus replicase subunits, both in vitro and in the context 
of viral infection, is imperative for addressing fundamental questions about the com-
position of nidovirus RNA-synthesizing complexes and the regulation of their different 
activities. This information is also of significance for the design of selective inhibitors of 
nidovirus replication. The availability of full-length cDNA clones greatly facilitates the in-
tegration of results derived from biochemical studies on nidovirus replicase subunits and 
their functional analyses in the context of viral replication. The development of a reverse 
genetics system for EAv, which has the smallest nidovirus genome and also replicates 
robustly in a variety of cell lines without the need for extreme safety measures, has made 
this virus exceptionally suited for functional dissection of the nidovirus replicase. Part of 
the work described in this thesis involved the characterization of the conserved NendoU 
domain, mapping to arterivirus nsp11, and its significance for the EAv replicative cycle. 
Another part of this thesis focused on nsp1, previously identified as a candidate “molecu-
lar switch” between genome replication and sg mRNA synthesis in EAv, and was aimed 
at gaining more insight into the regulatory role of the protein in the poorly-understood 
process of discontinuous minus-strand synthesis. 
Chapter 2 explores the inherent multifunctionality of +RNA virus genomes. Well-doc-
umented control mechanisms that determine the use of these molecules as templates 
for translation, minus-strand synthesis or encapsidation, as well as the high degree of 
integration between these processes in different +RNA virus families are discussed. The 
current knowledge on such regulatory events in the replicative cycle of nidoviruses is 
summarized.
Chapter 3 establishes the biological importance of the conserved NendoU domain by 
a site-directed mutagenesis approach. Deletion of the NendoU domain from EAv nsp11 
and certain amino acid replacements rendered viral RNA accumulation undetectable 
when engineered in the full-length EAv cDNA clone. Substitutions of proposed catalytic 
residues, however, resulted in viable mutants with greatly reduced infectious progeny 
titers and small-plaque phenotypes. A more detailed analysis of the latter mutants 
revealed defects in viral RNA accumulation and identified a potential link between the 
NendoU domain and viral sg mRNA synthesis. 
Chapter 4 describes the biochemical characterization of nsp11 from two distantly 
related arteriviruses, EAv and PRRSv. Bacterially expressed nsp11 proteins were found to 
efficiently hydrolyze RNA 3’ of pyrimidines in vitro, with a modest preference for cleavage 
at uridylates. Comparative analysis of arterivirus nsp11 and coronavirus nsp15 purified 
under identical conditions revealed common and distinct features of the endoribonu-
cleic activities of these nidovirus replicase subunits that carry distantly related NendoU 
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domains. The biological significance of this remarkable RNA-processing activity, likely 
common to all nidoviruses, is discussed.
Chapter 5 addresses the significance of nsp1’s autoproteolytic release from the 
replicase polyproteins and the importance of the protein’s ZF domain in the context 
of the complete replicative cycle of EAv. Cleavage of the nsp1/2 site was found to be 
a prerequisite for EAv RNA synthesis. By contrast, several substitutions of predicted 
zinc-coordinating residues selectively blocked sg mRNA accumulation, while genome 
replication was either not affected or even increased. Other mutations of predicted zinc-
binding residues, however, did not affect viral RNA synthesis considerably but severely 
reduced the production of infectious progeny particles. Apart from playing key roles in 
replicase maturation and sg mRNA synthesis, nsp1 was thus also found to have a critical 
function in virion biogenesis.
Chapter 6 presents a study in which both reverse and forward genetics were employed 
to gain more insight into the multiple regulatory roles of EAv nsp1. Alanine replacement 
of non-conserved clusters of polar residues found throughout the nsp1 sequence was 
used as an approach aimed at expanding the repertoire of viable EAv nsp1 mutants with 
discernible defects in one or more of the protein’s functions. The analysis of mutant and 
pseudorevertant phenotypes revealed that the relative abundance of EAv mRNAs is 
tightly controlled by an intricate network of interactions involving all nsp1 subdomains. 
Moreover, nsp1 was implicated in modulating the accumulation of full-length and 
subgenome-length minus-strand templates for viral mRNA synthesis. The quantitative 
balance among viral mRNA species was also found to be critical for efficient production 
of new virus particles. These data establish nsp1 as a major coordinator of the EAv repli-
cative cycle. 
Chapter 7 describes a protocol for the expression and purification of recombinant EAv 
nsp1 from E. coli. The initial difficulties encountered in attempting to obtain recombinant 
nsp1 were found to be largely related to the protein’s poor solubility, and a range of 
fusion tags and expression conditions were explored in order to overcome this problem. 
Expression of the protein from a construct that allowed its autoproteolytic release from a 
precursor polypeptide in E. coli was found to be critical for the successful purification of 
soluble, stable recombinant nsp1. 
Chapter 8 discusses the main results described in this thesis and their implications. 
Potential approaches for future research are also outlined. 
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Chapter 2 
Regulation of the plus-strand RNA virus 
replicative cycle: putting it together by 
taking it apart
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INtRINsIC multIfuNCtIONalIty Of Plus-stRaND RNa vIRus GeNOmes
Plus-strand RNA (+RNA) viruses with linear nonsegmented genomes and no DNA stage 
in their replicative cycle store their genetic information in a single molecule of mRNA 
polarity. This genome RNA is readily translated upon its release into the cytoplasm of the 
infected cell to produce a set of viral proteins which always includes an RNA-dependent 
RNA polymerase. Consequently, during virion assembly there is no need to package a viral 
“transcriptase” along with the genome, a fundamental difference between +RNA viruses 
and those that have minus- or double-stranded RNA genomes. The ability to express 
viral genes directly from the genomic RNA determines the flow of the major steps in the 
+RNA virus replicative cycle. Amplification of the messenger-sense genomic RNA typi-
cally follows its translation and requires the synthesis of a genome-length minus-strand 
RNA intermediate. Some groups of plant and animal +RNA viruses with polycistronic 
genomes also use the genomic RNA as a template for the generation of subgenome-
length minus strands, from which subgenomic (sg) mRNAs are transcribed (reviewed in 
reference 126). Moreover, viral genomes need to be incorporated into progeny particles 
in order to ensure viral propagation. This inherent multifunctionality of +RNA virus 
genomes might provoke “competition” for genomic RNA molecules among translation, 
minus-strand RNA synthesis, and encapsidation. Accordingly, +RNA viruses have evolved 
various control mechanisms to coordinate these processes and prevent such potential 
conflicts. Elucidating the molecular details of these regulatory mechanisms is technically 
challenging, as it entails the use of experimental approaches that separate the intercon-
nected processes outlined above. in this manner, the viral and cellular players important 
for each step can be defined and characterized. 
The entire replicative cycle of +RNA viruses takes place in the cytoplasm of infected 
cells. Specific template recognition and use in an environment where cellular mRNAs 
are abundant is thus required, and could be accomplished in several ways. Temporal 
separation of +RNA genome translation, amplification, and packaging into progeny 
particles would make switching between these steps well defined in time and, possibly, 
easier to achieve. However, the widespread use of this strategy is certainly not obvious, 
since all these processes occur simultaneously in cells infected with most +RNA viruses. 
Plus-strand RNA viruses induce profound membrane rearrangements in the cytoplasm 
of infected cells, which, among other functions, may allow sequestration of viral RNA 
and the compartmentalization of the different steps of the +RNA virus replicative cycle 
(reviewed in references115,125,145). Recruitment of viral and/or cellular proteins to regula-
tory RNA motifs in the viral genome may also determine its commitment to translation, 
minus-strand RNA synthesis, or encapsidation. increase in local concentration of viral 
gene products could favor one of these processes in a subcellular site. The regulated 
in cis usage of genomic RNA templates could also serve as a mechanism to maximize 
the incorporation of translation- and replication-competent genomes in progeny virus 
particles by coupling those two processes with encapsidation. 
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This review focuses on the interplay between replication and three other genome-
based processes: translation, sg mRNA synthesis, and encapsidation, in the replicative 
cycle of +RNA viruses. The current knowledge on the molecular mechanisms that inter-
connect these different steps is very fragmentary and derives mostly from studies of a 
few very dissimilar +RNA viruses with both mono- and polycistronic genomes, though 
only the latter employ the full spectrum of these processes. As an illustration of the pos-
sible strategies that +RNA viruses can employ to regulate differential use of the genomic 
RNA template, three relatively well-studied model systems from different +RNA virus 
clades are discussed below. Special emphasis has been placed on the regulatory roles of 
viral nonstructural proteins. 
The switch between genome translation and replication has been studied extensively 
for the monocistronic picornavirus poliovirus (Pv). integration of data from in vitro and 
in vivo systems has led to a detailed model, in which the fate of the Pv genome as a 
template for translation or minus-strand RNA synthesis is determined by the differential 
association of viral and host cellular proteins with regulatory RNA signals in the genomic 
RNA. 
During replication of Tombusviridae, and several other groups of +RNA viruses with 
polycistronic genomes, subgenomic (sg) mRNAs are produced from complementary sub-
genome-length minus-strand templates126,240. The determinants of viral RdRp attenuation 
during minus-strand synthesis therefore govern the use of genomic RNAs as templates 
for genome amplification or sg mRNA production, an additional aspect of +RNA genome 
multifunctionality. The RNA signals in particular, as well as the viral proteins involved 
in the “premature termination” of minus-strand RNA synthesis, have been extensively 
characterized for members of the Tombusviridae. 
Recent studies on the spatial and functional coupling of genome replication and encap-
sidation in the monocistronic Flaviviridae family have revealed significant involvement of 
viral nonstructural proteins in coordinating these two processes and “channeling” newly 
synthesized viral RNA from replication to packaging. These data have effectively chal-
lenged the canonical dividing line often drawn between virion components and replica-
tive proteins, demonstrating that apart from their “conventional” functions in ensuring 
viral RNA amplification, nonstructural proteins of Flaviviridae members are extensively 
involved in the late phases of the viral replicative cycle important for the generation of 
infectious progeny virions. 
Lastly, considering the focus of this thesis on the regulatory roles of nonstructural 
proteins in the replication of a prototypic nidovirus, our current and mostly rudimen-
tary knowledge on regulation of the replicative cycle in Nidovirales is summarized. The 
implications of recent progress made in research on other +RNA viruses for advancing 
our understanding of the molecular mechanisms governing nidovirus replication are 
discussed.
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CONCeRteD aCtIONs Of vIRal aND hOst Cell PROteINs meDIate the 
swItCh BetweeN tRaNslatION aND RePlICatION Of PICORNavIRus 
GeNOmes
Picornaviridae: an introduction
The Picornaviridae family of nonenveloped +RNA viruses belongs to the recently estab-
lished order of Picornavirales and consists of 12 genera: Enterovirus, Hepatovirus, Pare-
chovirus, Kobusvirus, Erbovirus, Cardiovirus, Aphtovirus, Teschovirus, Sapelovirus, Seneca-
virus, Tremovirus, and Avihepatovirus. The picornavirus group includes several important 
pathogens of humans and farm animals, such as Pv and foot-and-mouth disease virus 
(FMDv), which are also the best-studied representatives of the Enterovirus and Aphtovirus 
genera, respectively. 
Picornavirus genomes are single-stranded RNA molecules that vary between 6.7 and 
8.8 kb in length and contain a single, long open reading frame (ORF), flanked by 5’- and 
3’- untranslated regions (UTRs). The picornavirus genomic RNA lacks a 5’ cap structure 
and contains a poly(A) tail at its 3’ end143,249. in addition, a viral protein, vPg, is covalently 
linked to the 5’ terminus of the genome due to its role as protein primer for genome 
replication54,101. The picornavirus capsid proteins are encoded in the 5’ one-third of the 
genomic ORF, with the 3’ two-thirds coding for the viral nonstructural proteins (shown 
for Pv in Fig. 1A). Picornavirus genome translation is initiated by an internal ribosomal 
entry site (iRES), which is located in the 5’ UTR. Translation of the genomic RNA yields a 
polyprotein that is co- and post-translationally cleaved by virus-encoded proteinases to 
generate the mature viral protein subunits and a number of processing intermediates 
with essential functions in viral replication. The viral proteolytic activities reside in 3CPro 
and, in some viruses, also in the 3CDPro, the 2APro and/or L proteins92. The picornavirus 
RdRp domain maps to 3D, but only the fully processed protein, and not its long-lived 3CD 
precursor, has this catalytic activity221. Picornavirus replication takes place exclusively 
in the host cell cytoplasm, where it induces extensive rearrangements of intracellular 
membranes into characteristic vesicular structures. viral RNA synthesis likely occurs in 
association with these virus-induced vesicles19 and, following encapsidation of newly 
synthesized genomes, the nonenveloped progeny virus particles are released upon lysis 
of the infected cell.
Many studies on picornavirus replication have been performed using Pv as a model 
system. Research on the regulation of Pv replication has greatly benefitted from the de-
velopment of systems that reconstitutes the complete Pv replicative cycle in vitro13,14,131. 
Addition of Pv RNA to cell-free extracts from uninfected HeLa cells results in efficient 
translation of the viral polyprotein, its correct proteolytic autoprocessing, as well as de 
novo Pv RNA synthesis and particle assembly131. This in vitro assay effectively bypasses the 
need for multiple rounds of replication of the incoming genomic RNA that are required in 
infected cells13. A similar uncoupling of translation from the initial rounds of replication 
was achieved in an assay for Pv replication in Xenopus oocytes. These cells do not support 
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Pv RNA translation, but, when a HeLa cell extract is co-injected, microinjection of Pv 
RNA initiates a complete replication cycle, allowing the investigation of host cell factors 
important for viral RNA translation in the context of intact cells58. The availability of in 
vitro systems uncoupling Pv translation from replication, and in particular the system 
based on HeLa cell extracts, has greatly facilitated mechanistic studies on these two key 
steps of the Pv replicative cycle. Combined with complementary reverse and forward 
genetic approaches, in vitro analyses have yielded important insights into the regulation 
of these two interconnected processes. 
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figure 1. A model for genome circularization and initiation of minus-strand RNA synthesis during 
poliovirus replication. (A) Schematic representation of the poliovirus (Pv) genome. A viral peptide (vPg) 
encoded in the 3B region of the genome is covalently attached to the 5’ end of the genomic RNA. The 
5’ cloverleaf (5’ CL) and internal ribosomal entry site (iRES) structures in the 5’ untranslated region (UTR) 
of the Pv RNA, and the 3’ poly(A) tail (An) are shown. The single open reading frame (ORF) in the Pv 
genome encodes a polyprotein, which is cleaved by proteinase activities residing in 2A, 3C and/or 3CD. 
The structural genes, depicted in white, are found in the 5’-proximal region of the genomic ORF and 
the nonstructural genes, shown in gray, are found in its 3’-proximal region. (B) Binding sites for poly(rC)-
binding protein (PCBP) and 3CDPro in the 5’ UTR of the Pv genome (see text for details). (C) Model for 
circularization of the Pv genome. A protein-protein bridge consisting of PCPB, 3CDPro and the poly(A)-
binding protein (PABP) has been proposed to bring the viral polymerase (3DPol) in close proximity of the 3’ 
poly(A) tail and allow for initiation of minus-strand RNA synthesis72(see text for details). 
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Poliovirus genome translation as a prerequisite for its amplification: the clash 
between ribosomes and the RdRp
Potential coupling between genome translation and replication during Pv infection was 
initially suggested based on results obtained using an elegant genetic approach that re-
lied on the insertion of amber termination codons in the Pv ORF. The replication capacity 
of Pv genomes with amber mutations in the 2APro and 3DPol-coding regions was assessed 
in amber-suppressing cell lines, and rescue of mutation-specific defects by providing a 
wild-type (wt) helper Pv genome in trans was also examined144. Surprisingly, 3DPol provid-
ed in trans functioned almost as efficiently as in cis, while no trans-complementation of 
amber nonsense mutations in 2APro was observed144. Consequently, this study identified a 
region in the 2A-coding portion of the Pv genome whose translation in cis is required for 
Pv replication, and the authors suggested a number of scenarios that would necessitate 
coupling translation to replication. An interaction of a newly synthesized viral protein 
with the Pv RNA, for example, could be required for its establishment as a template for 
minus-strand synthesis, or this protein might be unable to diffuse to another template 
RNA due to its restricted localization, e.g. in the membrane-associated replication com-
plex (RC). 
in accordance with the latter hypothesis, formation of Pv RCs has been shown to 
require coupled viral translation, virus-induced membrane modification, and viral RNA 
synthesis44. Modification of ER membranes in HeLa cells prior to Pv infection, by expres-
sion of cellular or viral membrane-binding proteins, resulted in a markedly decreased 
capacity of these cells to support Pv replication. Furthermore, previously altered 
membranes were not used for RC formation irrespective of their morphology44. Even 
the presence of membrane structures induced by translation of all Pv proteins from 
replication-incompetent RNAs decreased the fraction of Pv-susceptible cells, indicating 
that RNA synthesis is necessary for the formation of Pv RCs and that once formed, these 
membrane-associated complexes do not readily exchange components. 
The tight coupling between Pv translation and replication implies the existence of 
regulatory mechanisms that prevent both processes from occurring on the same RNA 
template, and thus avoid potential collisions between translating ribosomes proceed-
ing in a 5’ to 3’ direction, and minus-strand RNA-synthesizing complexes copying the Pv 
genome in the opposite direction. inhibition of Pv minus-strand synthesis by translating 
ribosomes was indeed observed in HeLa S10 in vitro translation-RNA replication reac-
tions15. Clearing Pv RNA of ribosomes by addition of puromycin specifically stimulated 
minus-strand RNA synthesis, while addition of cycloheximide, which “freezes” ribosomes 
on mRNAs, had a negative effect on minus-strand production. A mechanism must 
therefore have evolved to coordinate initiation of minus-strand Pv RNA synthesis with 
clearance of translating ribosomes from the viral genome during Pv infection15, and 
differential interactions of viral and host cell proteins with RNA signals in the 5’ and 3’ 
UTRs of the Pv genome have been suggested to ensure the sequential translation and 
replication of Pv RNA. 
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formation of a ribonucleoprotein complex at the 5’ utR of poliovirus: a 
molecular switch?
Cis-acting RNA signals required both for Pv genome translation and replication have 
been mapped to the UTRs of the Pv genome. A cis-replication element (CRE), which 
overlaps with the 2C-coding region of the Pv ORF, templates the uridylylation of vPg in 
a process catalyzed by 3DPol and required for Pv RNA synthesis 65,66,134,138. The 5’ UTR of Pv 
is 743 nt long, and nt 134 to at least 556 forms the Pv iRES that is required for allowing 
ribosomes to efficiently translate the Pv genome without scanning it from the 5’ end23 
(Fig.1A). While the Pv iRES is crucial for viral RNA translation, it is dispensable for both 
minus-strand and plus-strand Pv RNA synthesis139. By contrast, the 5’-proximal 90 nt of 
the 5’ UTR fold into an RNA cloverleaf structure (5’ CL) that exists only in the plus strand 
and is critically involved in both translation and replication of the Pv genome6,7,60 (Fig.1A). 
A 4-nucleotide insertion in stem-loop D of the 5’ CL severely impaired viral RNA synthesis, 
and this defect could be rescued by suppressor mutations in a highly conserved amino 
acid stretch in the Pv main protease 3CPro, suggesting that a genetic interaction between 
the 5’-UTR and a 3CPro-containing viral protein is important for Pv RNA synthesis7. in vitro 
studies indeed demonstrated the formation of two 5’ CL-containing ribonucleoprotein 
complexes in Pv-infected cells - one of which composed exclusively of cellular factors 
and another including the viral protein 3CDPro 6. Accordingly, the 4-nucleotide insertion 
in stem-loop D of the CL structure inhibited formation of the 3CDPro-5’ CL complex, but 
did not interfere with interaction of cellular proteins with the 5’ CL sequence. Also, only 
uncleaved 3CDPro, but not 3CPro, 3DPol, or a combination of these two subunits in a cleaved 
form, bound to the 5’ CL sequence in vitro. These data suggested that autoproteolytic 
processing of 3CDPro reduces the affinity of the resulting proteins for RNA and could thus 
induce disassembly of the 5’ CL ribonucleoprotein complex5. 
The amino acid determinants of RNA binding and proteolytic activity in the 3CPro 
protein region were mapped to opposite faces of the protein surface. Mutations in 3CPro 
affecting RNA binding caused specific defects in replication, without disturbing transla-
tion or stability of a Pv replicon, or the proteolytic activity of 3CPro 5,136. The interaction 
between 3CDPro and the Pv 5’ UTR was not direct, however, since formation of the 3CD-
Pro-5’ CL complex in extracts from Pv-infected cells required the presence of a cellular 
protein5. Two widely expressed isoforms of the poly(rC)-binding protein (PCBP) ,PCBP1 and 
PCBP2, were shown to selectively bind the top of stem-loop B of the Pv 5’ CL structure59. 
PCBPs are abundant cellular proteins that contain a triple repeat of the K homology 
(KH) motif, present in multiple RNA-binding proteins, and can bind to 3’ UTRs of cellular 
RNAs, thereby influencing their stability (59,160 and references therein). PCBP1 and PCBP2 
interacted with the 5’ CL and stimulated 3CDPro-CL complex formation in vitro. Notably, 
both proteins bind specifically also to stem-loop iv of the Pv iRES and are required for Pv 
translation21,22,59 (Fig.1B), suggesting trans-acting cellular factors may be bifunctional and 
serve to coordinate Pv translation and replication.  
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More detailed biochemical analyses of the interactions of PCBP2 and 3CDPro with the 
5’ UTR of Pv have proposed that PCBP2 can form RNA complexes with different affinities 
depending on the presence of 3CDPol 61. The 5’ CL on its own was a poor competitor of 
PCBP2 binding to stem-loop iv of the iRES. Simultaneous addition of 3CDPro and 5’ CL, 
however, effectively reduced the binding of PCBP2 to the Pv iRES in vitro. By contrast, 
in the presence of PCBP, 3CDPro associated very efficiently with the Pv 5’ UTR sequence 
in vitro, but not with the iRES region only61. The presence of 3CDPro was hence proposed 
to promote dissociation of PCBP2 from stem-loop iv of the Pv iRES and to stabilize its 
interaction with the 5’ CL structure, providing a possible mechanism for modulating the 
switch between translation and replication of the Pv genome. 
A set of elegant experiments using the cell-free Pv translation/replication assay dem-
onstrated that active translation of a Pv replicon inhibits 3DPol elongation activity, while 
addition of S100 extracts from Pv-infected cells negatively affects Pv RNA translation. 
Fractionation of the inhibitory activity identified 3CDPro as a repressor of Pv RNA transla-
tion, and binding of 3CDPro to the 5’ CL was shown to be required for Pv minus-strand 
synthesis, providing additional support for a role of the interplay between 5’ CL, PCBP2 
and 3CDPol in mediating the switch between Pv translation and replication60. 
Circularization of the poliovirus genome driven by cellular proteins: a critical 
determinant of viral RNa synthesis?
Poliovirus minus-strand RNA synthesis initiates within the poly(A) tail at the 3’ end of 
the genome100. For that reason, its requirement for a 3CDPro - 5’ UTR interaction was 
considered unusual, until a protein-protein bridge was proposed to circularize the Pv 
genome and thus bring the 5’ and 3’ RNA termini in each other’s immediate proximity72. 
The cellular poly(A)-binding protein 1 (PABP1), an important factor controlling the stabil-
ity and translation of cellular mRNAs172, interacts with the Pv poly(A) tail in vitro with an 
affinity increasing as a function of the poly(A) tail length. This interaction is mediated by 
the N-terminal region of PABP1, while the C-terminal domain of the protein mediates as-
sociation of PABP1 with PCBP2 and 3CDPro in vitro, also when the two proteins are bound 
to the 5’ CL sequence. Synergistic actions of protein-RNA and protein-protein complexes 
could thus mediate Pv genome circularization (Fig. 1C). A mutant PABP1 with a deletion 
of its C-terminal domain was able to bind the Pv poly(A) tail efficiently, but acted as a 
dominant-negative mutant when added to the cell-free Pv translation/replication sys-
tem. it abrogated viral RNA replication without affecting translation, providing evidence 
for the functional significance of the proposed genome circularization72. 
Collectively, these data suggest an intricate regulatory mechanism for coordinating 
translation and replication of Pv genomes, which relies on established intracellular 
protein-protein and protein-RNA interactions. Translation of input Pv RNA was postu-
lated to occur in association with cellular factors (e.g. PCBP2) until a critical concentration 
of viral proteins in the host cell has been reached, which is followed by shutdown of viral 
translation by 3CDPro. The formation of a ribonucleoprotein complex around the 5’ CL 
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containing PCBP2 and 3CDPro, and subsequent interaction of this complex with PABP1 
bound to the 3’ poly(A), may then serve to deliver the viral RdRp precursor 3CDPro to the 
initiation site for minus-strand RNA synthesis. Self-processing of 3CDPro would then result 
in release of catalytically active 3DPol and disassembly of the 5’-3’ protein-RNA bridge5,60,72. 
According to this model, the specificity of Pv minus-strand synthesis would be conferred, 
somewhat paradoxically, by interaction of 3CDPro with the 5’ CL structure in the genomic 
plus strand, since PABP1 likely associates with the poly(A) tails of cellular mRNAs as well234. 
As synthesis of Pv proteins in infected cells continues for several hours after the onset of 
viral RNA synthesis246, genome translation and replication do not seem to be temporally 
distinct steps in the Pv replicative cycle. The local concentration of 3CDPro in a particular 
cellular compartment might therefore be crucial for determining the fate of Pv RNAs60.
interestingly, both PCBP2 and PABP1 are cleaved by 3CPro/3CDPro in Pv-infected 
cells98,160, suggesting a mechanism for modulating the roles of these host proteins in the 
Pv replicative cycle. PCBP proteins have three RNA-binding KH domains. KH1 was shown 
to bind both the 5’ CL, as well as stem-loop iv of the Pv iRES194, while KH2 mediates the 
PCBP multimerization that is important for RNA binding and translation initiation at the 
Pv iRES16. The KH3 domain, on the other hand, interacts with SRp20, a cellular protein 
involved in mRNA splicing and nucleocytoplasmic trafficking. The association of PCBP2 
with SRp20, which co-fractionates with ribosomal subunits, was proposed to mediate ri-
bosome recruitment to the Pv iRES160. Partial and specific cleavage of endogenous PCBP2 
in the linker region between the KH2 and KH3 domains was observed in Pv-infected cells 
from 3 hours post-infection on. In vitro analyses showed this reaction can be mediated 
by both 3CPro and 3CDPro, and that cleaved PCBP2 lacking the KH3 domain supported Pv 
replication, but did not function in Pv translation. These results suggest that, instead 
of relocating PCBP2 from the Pv iRES to the 5’ CL, as initially proposed61, 3CDPro could 
cleave iRES-bound PCBP, thereby releasing the KH3 domain and, consequently, SRp20 
from the protein complex around stem-loop iv of the iRES. Due to a subsequent lack of 
new initiation events, the Pv genome is eventually cleared from ribosomes and becomes 
available for minus-strand synthesis after genome circularization.  
Other results also argue against recruitment of PCBP from the Pv iRES to the 5’ CL by 
accumulating 3CDPro. Both PCBP1 and PCBP2 co-fractionate with Pv polysomes isolated 
from cell-free translation-replication reactions, and a mutation in 5’ CL that inhibits PCBP 
binding also interfered with the formation and stability of nascent Pv polysomes87. The 
association of PCBP with the Pv 5’ CL is therefore likely required at a very early step dur-
ing Pv infection, before viral proteins such as 3CDPro could alter its properties or affinity 
for viral RNA structures. The partial cleavage of PABP1 observed during Pv infection is 
also mediated by 3CPro and occurs in the linker region between its N-terminal RNA bind-
ing portion and the C-terminal domain interacting with PCBP298. Besides contributing to 
the shut-off of cap-dependent (i.e. host mRNA) translation observed during Pv infection, 
PABP1 cleavage could also alter the ability of the cleaved protein to mediate Pv genome 
circularization. Since not all PCBP or PABP1 molecules are cleaved during infection, the 
shift in the balance of Pv replication and translation could occur within localized environ-
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ments surrounding specific templates in which large amounts of 3CDPro are present160. 
it is worthy of note that a recent report has questioned the requirement of PABP for Pv 
RNA synthesis in cell-free extracts by observing efficient Pv replication and virus produc-
tion in HeLa S10 fractions depleted from a large portion of PABP203. The remaining PABP 
molecules, however, could still be sufficient to support efficient Pv replication, given that 
the stoichiometry and dynamics of the protein complex proposed to circularize the Pv 
genome72 has not been examined in detail.
in conclusion, mechanistic studies of the Pv replicative cycle have uncovered the exis-
tence of a complex regulatory circuit which involves the differential recruitment of viral 
and cellular proteins to RNA signals in the Pv genome. The nature of the RNP formed may 
thus ultimately determine whether the messenger-sense RNA molecule will serve as a 
template for translation or minus-strand synthesis, and may also ensure the specificity of 
Pv RNA amplification. Remarkably, functional coupling seems to exist not only between 
Pv translation and replication, but also between Pv replication and packaging of viral RNA 
into progeny particles. A requirement for active replication of Pv RNAs for their subse-
quent encapsidation was elegantly demonstrated using a genetic approach that utilized 
specific inhibitors of Pv RNA synthesis and virion morphogenesis146. Efficient replication 
of Pv RNA might therefore be a prerequisite for its productive association with capsid 
precursors, a mechanism that would not only confer specificity to Pv packaging, but also 
ensure that only translation- and replication-competent genomes are incorporated into 
progeny virus particles. A recent study has demonstrated that Pv genome replication 
and encapsidation are discrete steps in the viral replicative cycle147, raising intriguing 
questions about the molecular mechanisms of coupling between these two processes.
lONG-DIstaNCe RNa-RNa INteRaCtIONs aRe maJOR DeteRmINaNts Of 
suBGeNOmIC RNa syNthesIs IN the TomBuSvIRIdAE famIly
Tombusviridae: an introduction
The Tombusviridae, a large family of plant viruses with monopartite +RNA genomes, includes 
members of the genera Aureusvirus, Avenavirus, Carmovirus, dianthovirus, machlomovirus, 
Necrovirus, Panicovirus and the prototype genus Tombusvirus. The majority of studies on 
tombusvirus replication and gene expression have been carried out with the prototype vi-
rus tomato bushy stunt virus (TBSv). The 4.8-kb messenger-sense TBSv genome is neither 
5’-capped nor 3’-polyadenylated, and contains five ORFs. The two 5’-proximal overlapping 
ORFs are translated directly from the viral genome into the proteins p33 and p92, both of 
which are indispensable for TBSv RNA synthesis171 (Fig.2A). The production of p92 requires 
translational read-through of the p33 amber termination codon. Consequently, p92 is 
N-coterminal with p33 and accumulates at a ~20-fold lower level compared to p33 during 
TBSv infection. Both p92 and p33 are membrane-associated182 and viral RdRp signature 
motifs are found in the C-terminal domain of p92, which is therefore likely the catalytic 
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subunit for viral RNA synthesis. No known functional motifs have been identified in the 
sequence of the critical accessory replicative protein p33, but the N-terminal half of p33 
has been shown to contain transmembrane segments and peroxisomal targeting signals 
that likely aid the anchoring of tombusvirus replicases to peroxisomal membranes122. 
Expression of the three ORFs encoded 3’-proximally in the TBSv genome is mediated 
by the production of two sg mRNAs. Subgenomic mRNA1 encodes the TBSv capsid 
protein (CP), and sg mRNA2 serves as a template for the translation of the overlapping 
ORFs encoding the p22 and p19 proteins, which are involved in cell-to-cell movement 
and suppression of virus-induced gene silencing in infected plants. Leaky scanning, a 
process in which scanning ribosomes bypass the upstream start codon of the p22 ORF 
and initiate translation at the second start codon and in an alternative reading frame, 
mediates expression of p19. Although p22 is encoded 5’-proximally in sg mRNA2, transla-
tion of p19 is more efficient both in vitro and in vivo 181,182. Tombusvirus sg mRNAs are 
presumably transcribed from 3’-truncated subgenomic minus strands that are produced 
by premature termination of minus-strand RNA synthesis on the genomic RNA template 
by the tombusvirus RdRp complex240.
Regulatory RNa elements in the tombusvirus replicative cycle
Higher-order RNA structures and long-distance RNA-RNA interactions have been impli-
cated in the orchestration of virtually all major steps in the tombusvirus replicative cycle, 
including replicase assembly, genome replication and translation, and subgenomic 
mRNA production. The cap- and poly(A)-independent translation of the TBSv genome 
is facilitated by a 5’-3’ RNA-RNA base-pairing interaction that does not require protein 
factors and effectively circularizes the molecule50,51. Disruption of the 5’-3’ interaction by 
the RdRp complex during initiation of minus-strand synthesis at the genomic 3’ end is 
thus an attractive candidate switch between genome translation and RNA replication, 
since it would inhibit translation and clear the RdRp path of oncoming ribosomes50. 
The core promoters for TBSv plus-strand and minus-strand synthesis are found at 
5’ and 3’ termini of viral RNA molecules, but other important elements are located in 
protein-coding regions and can function by modulating promoter activity or influencing 
replicase assembly, template recruitment, or primer synthesis. One such internal RNA el-
ement, Rii(+), is found in the p92-coding sequence and is required for TBSv replication132 
(Fig.2A). The core Rii region folds into an extended hairpin structure (Rii(+)-SL) that was 
proposed to direct the recruitment of the TBSv genome from translation to replication. 
Accordingly, selective binding of TBSv p33 protein to the Rii sequence was demonstrated 
in vitro. interestingly, p92 could not efficiently recognize the Rii element in vitro, implying 
that template selectivity is not a function of the TBSv RdRp166. The proposed mechanism 
of recruitment of a Rii(+)-SL -p33 complex to membranes via the hydrophobic N-terminal 
domain of p33 would allow the specific retention and/or amplification of the TBSv ge-
nome in RCs, since TBSv sg mRNAs lack the Rii(+)-SL sequence. The Rii(+)-SL element has 
also been suggested to assist viral replicase assembly153,243. 
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an intricate network of RNa signals guides the production of tombusvirus 
subgenome-length RNas
A number of well-characterized long-range intragenomic RNA–RNA interactions are 
critical for the generation of the subgenome-length minus-strand templates for sg 
mRNA production. These associations presumably induce premature termination of 
minus-strand synthesis by the tombusvirus RdRp complex 28,29,104,240. TBSv sg mRNA1 ac-
cumulation is mediated by base-pairing between a 7-nt long “receptor sequence” (RS1), 
found just 3 nt upstream of the sg mRNA1 initiation site, and a complementary “activator 
sequence” (AS1) located ~1000 nt upstream, in the loop of a hairpin29 (Fig. 2, A and B). 
This interaction is formed in the genomic plus strand only, and disturbing it decreases 
both plus- and minus-strand sgRNA1 levels. Likewise, activation of sg mRNA2 production 
requires two sets of interactions between noncontiguous RNA elements28,104,252. A portion 
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figure 2. Regulation of subgenomic mRNA 
synthesis by a network of RNA signals in 
tombusviruses. (A) The organization of the 
polycistronic genome of tomato bushy stunt 
virus (TBSv) is depicted schematically. The 
viral replicase proteins, p33 and p92, are 
amino-coterminal and are expressed from the 
viral genome, the latter by read-through of 
the p33 amber termination codon. The ORFs 
located 3’-proximally in the TBSv genome are 
expressed from two subgenomic (sg) mRNAs. 
The relative positions of the Rii(+)-SL RNA 
motif, important for TBSv replicase assembly, 
and RNA elements involved in long-distance 
interactions mediating sg mRNA synthesis are 
indicated (see text for details). (B-C) Models 
for the synthesis of TBSv sg mRNA1 (B) and sg 
mRNA2 (C). Long-range RNA-RNA interactions 
constitute “RNA attenuation signals” that 
mediate termination of minus-strand RNA 
synthesis by the TBSv RdRp complex. The 
resulting subgenome-length minus strands 
serve as templates for the synthesis of sg 
mRNAs. The AS1, AS2 and RS1 sequences are 
found in the p92-coding region of the TBSv 
genome. The CE and DE sequences are located 
in the p41 gene, while the RS2 motif is present 
in an intergenic region. The 5’ and 3’ UTRs of 
the TBSv genome are shown in light gray.
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of a distal element (DE) located ~1100 nt upstream of the sg mRNA2 start site must base-
pair with part of a core element (CE) located immediately 5’ to the start site for efficient 
sg mRNA2 synthesis to occur252. The DE-CE interaction, similar to AS1-RS1 base-pairing, 
also occurs in the plus-strand genomic RNA, where it likely serves to reposition the sub-
elements mediating a second long-range interaction between RNA elements spanning 
~2100 nt28 (Fig. 2, A and C). A region in the p92-coding sequence just upstream of AS1, 
termed AS2 and, like AS1, found in the loop of a hairpin structure, is complementary to 
and must base-pair with a subsection of CE termed RS2 for efficient sg mRNA2 synthesis 
to take place104.
interestingly, despite the positional coupling of AS1 and AS2 in the TBSv genome, 
these elements do not seem to operate as a functional unit, given that sg mRNA1 ac-
cumulation is not affected by mutations decreasing sg mRNA2 levels104. The 5’-proximal 
location of AS1 and AS2, however, allows the genomic RNA to maintain strict control over 
the launching of primary sg mRNA transcripts. Since both AS1 and AS2 elements reside in 
the ORF of p92, their function would be negatively affected by translation, which might 
have to be downregulated in order for efficient sg mRNA synthesis to occur. interestingly, 
the AS2-RS2 interaction could be functionally replaced by a local hairpin structure in the 
genomic plus strand, but this delayed accumulation of all viral RNAs and reduced the 
relative levels of sg mRNA2. A hairpin RNA element engineered into a TBSv defective 
interfering (Di) RNA could also mediate the production of a Di RNA-derived subgenomic 
mRNA in a sequence-independent manner. However, a minimum stability of the hairpin 
stem was required for RdRp attenuation, and at least one cryptic transcriptional element 
was found to be present in the TBSv genome. its activity appeared to be downregulated 
by destabilization of the hairpin stem, likely to avoid production of superfluous and pos-
sibly deleterious viral RNAs104. 
Recognition of RNA-based signals by protein factors in the tombusvirus RdRp complex 
is, without a doubt, a key determinant of their regulatory activities. Furthermore, compo-
nents of the viral RNA-synthesizing complex might also modulate formation or disruption 
of these RNA-RNA interactions to ensure the temporal and quantitative regulation of the 
different steps they mediate. Accordingly, C-terminal modifications of p92 specifically 
disrupted TBSv sg mRNA production without affecting genome amplification, suggest-
ing these two processes can be effectively uncoupled via the viral RdRp244. Due to the 
overlap of RNA signals that mediate sg mRNA1 production with the region coding for 
the C-terminal part of p92, a TBSv clone with translationally silent mutations in RS1 was 
engineered first. As a result, sg mRNA1 synthesis was inactivated, and therefore only the 
effects of RdRp sequence modifications on sg mRNA2 accumulation could be studied. Re-
verse genetics analyses of the C-terminal domain of p92 revealed a progressive decrease 
in sg mRNA accumulation levels upon removal of up to 4 residues, while genomic RNA 
levels were not affected. Deletion of six or more C-terminal residues, however, resulted in 
nonviable phenotypes244. The TBSv RdRp was found to function primarily at an early step 
during premature termination of TBSv minus-strand synthesis, which is important for 
the accurate and efficient production of subgenome-length minus-strand templates. The 
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ability of C-terminally truncated p92 to recognize different RNA attenuation signals, and 
their base-paired components in particular, seemed compromised in the mutant RdRps. 
These results identified the tombusvirus RdRp-containing replicase subunit as the key 
protein factor mediating recognition of attenuating RNA signals that control subgenome-
length minus-strand production, arguing against differences in protein composition of 
RNA-synthesizing complexes producing genome-length and subgenome-length minus 
strands, in contrast to what has been proposed for arteriviruses212. 
Regulation of the relative abundance of tombusvirus mRNa species
Tombusvirus sg mRNAs serve as templates for translation of the viral structural proteins. 
Subgenomic mRNA accumulation levels in tombusvirus-infected protoplasts are roughly 
proportional to the amounts of their translation products, suggesting transcriptional 
control as a mechanism to regulate viral protein expression levels233. Since the sg mRNA 
promoters and the genome plus-strand promoter are similar linear sequence elements104, 
tombusvirus mRNA abundance is likely determined by the accumulation levels of minus-
strand templates, and thus (also) by the stability of the different RNA signals that mediate 
attenuation. Extending the complementarity region between AS2 and RS2 sequences, 
however, did not result in increased sg mRNA2 levels104. 
The critical role of higher-order RNA structure in attenuation of minus-strand synthesis 
by the tombusvirus RdRp, on the other hand, was elegantly demonstrated by introduc-
tion of theophylline-binding RNA aptamers as the RNA attenuation components for sg 
RNA2 synthesis233. Addition of the ligand for the aptamer stabilized its structure and 
induced efficient sg mRNA2 production, arguing against a fundamental requirement for 
a particular protein factor to specifically bind to the attenuation signal in order for it to 
function, or for induction of a conformational switch in the RdRp. These data imply that 
the activity of tombusvirus RNA attenuation signals is primarily structure-independent, 
and they might instead act as physical barriers impeding the progress of the RdRp on 
the genomic plus-strand template. in line with this hypothesis, destabilizing the stem 
of the AS2-containing hairpin structure stimulated sg mRNA2 production, suggesting 
a potential mechanism for transcriptional regulation of p19 and p22 expression105. Sub-
optimal attenuation of minus-strand synthesis in the sg mRNA2 promoter region might 
serve to ensure that a sufficient number of RNA-synthesizing complexes will reach the 
sg mRNA1 promoter region located upstream, and therefore sufficient mRNA templates 
for CP translation will be produced. The lack of increased sg mRNA1 accumulation in the 
absence of sg mRNA2 production, however, argues against this hypothesis104.  
Alternatively, the suboptimal levels of sg mRNA2 might be related to specific proper-
ties of the proteins they encode, as has been suggested for cucumber leaf spot virus 
(CLSv), member of the genus Aureusvirus. Subgenomic mRNA2 of aureusviruses encodes 
two proteins - p17 (suppressor of gene silencing) and p27 (movement protein). The 
suppressor protein of CLSv has been shown to induce extensive tissue necrosis during 
plant infection, which can adversely affect optimal virus spread. Accumulation levels of 
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sg mRNA2 in aureusvirus-infected cells are significantly lower than those of sg mRNA1, 
suggesting a specific downregulation of the abundance of this transcript to minimize 
suppressor protein-associated toxicity to the host. Functional counterparts of the TBSv 
AS2 and RS2, but not of the DE and CE sequences were identified in CLSv245. The CLSv 
AS2-RS2 interaction was extremely sensitive to destabilization. Replacements stabilizing 
the higher-order component of the CLSv sg mRNA2 attenuation signal or optimizing the 
sg mRNA2 promoter sequence resulted in elevated sg mRNA2 levels, suggesting that 
both the AS2-RS2 interaction and the sg mRNA2 promoter are operating suboptimally in 
CSLv and thus contribute to the consistently lower levels of sg mRNA2 observed. 
Experimental evidence suggests that tombusvirus replicative proteins are also involved 
in controlling the relative abundance of viral mRNAs. Mutations in the RS1 sequence 
that alter the C-terminal residues of p92 had a negative impact on the accumulation 
of both sg mRNA1 and sg mRNA2. While introduction of complementary substitutions 
in AS1 partially restored accumulation of sg mRNA1, no restoration of sg mRNA2 levels 
was observed29, suggesting that the C-terminal domain of the TBSv RdRp is less criti-
cal for sg mRNA1 production. A function in modulating the relative abundance of viral 
mRNAs was also proposed for an arginine/proline-rich RNA-binding motif (RPR), found 
in the sequence encoding the common part of p33 and p92 of the carmovirus cucumber 
necrosis virus (CNv)152. Reverse genetics revealed that certain mutations in the RPR motif 
considerably altered the molar ratios at which CNv RNAs accumulate relative to each 
other, though this was mostly observed for mutants in which overall viral RNA accumula-
tion was severely decreased152. Mutagenesis of a phosphorylation site adjacent to the 
p33/p92 RPR motif also had an effect on the molar ratios of sg mRNA1 and sg mRNA2 in 
CNv-infected cells189. Using a two-component system, in which p92 is expressed from the 
CNv genomic RNA and p33 from a CNv Di RNA, an essential role for the RPR motif of p33 
in CNv replication was demonstrated. in the same system, replacements in this motif had 
little effect on p92 function, possibly due to the presence of two additional RNA-binding 
domains in its central and C-terminal portion169. This experimental set-up unfortunately 
did not allow the definite assignment of a role in controlling the relative abundance of 
CNv mRNAs to either p33 or p92, since only a single RNA molecule was amplified.
host proteins involved in tombusvirus RNa synthesis 
Reconstitution of key steps of tombusvirus replication in tractable model hosts and 
cell-free in vitro systems have provided valuable tools for studying the roles of viral 
and host replication proteins in tombusvirus RNA synthesis. Highly active, template-
dependent CNv replicase complexes have been purified from Saccharomyces cerevisiae, 
taking advantage of the ability of p92 and p33 proteins to direct the amplification of a 
cognate Di RNA template when co-expressed in this host153. TBSv replication has also 
been reconstituted in yeast cells and, notably, also in cell-free yeast extracts151,164. TBSv 
replication was shown to occur in a membranous compartment in the cell extract, where 
the viral RNA is protected from nuclease degradation164. Proteomics analysis of the highly 
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purified tombusvirus replicase complex revealed the presence of a number of host pro-
teins, among which the yeast orthologs of glyceraldehyde-3-phosphate dehydrogenase 
and heat-shock protein 70 - Tdh2p/3p and Ssa1p/2p165,232. The presence of Ssa1p/2p is 
required for the in vitro assembly of a functional TBSv replicase, possibly to facilitate re-
folding of replicase components required for the formation of an active RC165. By contrast, 
a specific and significant reduction in TBSv plus-strand RNA accumulation was observed 
in yeast cells lacking Tdh2p and its ortholog Tdh3p. Consequently, these proteins were 
implicated in promoting efficient use of minus-strand genomic RNA as a template by its 
retention in the RC232. Since this “RC retention signal” is only present in genome-length 
minus-strand RNA, it would be interesting to determine whether the subgenome-length 
minus-strand templates for the synthesis of sg mRNA1 and sgmRNA2 are also retained in 
active RCs by a Tdh2p/3p–mediated mechanism. Despite that a number of host proteins 
affecting tombusvirus RNA synthesis and recombination have been identified83,185, no 
host factors have been implicated in promoting tombusvirus sg mRNA synthesis so far. 
Active tombusvirus replicase complexes purified from yeast or plant cells do not mediate 
sg mRNA production in vitro, however, suggesting their functionality might be perturbed 
by the isolation procedure or the fact that important cofactors for this process are miss-
ing244. 
in summary, local and long-distance RNA-RNA interactions and higher-order RNA 
structures are extensively involved in coordinating of the use of tombusvirus genome 
as a template for the production of genome-length and subgenome-length minus 
strands. These interactions are mainly thought to mechanistically promote termination 
of minus-strand synthesis by the tombusvirus RdRp at sg promoter regions, and have 
been fine-tuned to guarantee the optimal accumulation levels of tombusvirus sg mRNAs 
and their translation products233,245. How is formation of the mutually interfering RNA 
attenuation signals regulated, however (Fig. 2, B and C), remains a question that is largely 
unexplored. Protein factors may assist in bringing together RNA motifs separated by 
large distances in the tombusvirus genome, and both viral replicase subunits have been 
implicated in the specific recognition of the RNA signals critical for the production of 
subgenome-length minus strands. Taking into account the small coding capacity of the 
tombusvirus genome and the significant involvement of host cell proteins in crucial steps 
of tombusvirus replication outlined above, a role for host proteins in the temporal and/
or qualitative modulation of tombusvirus “RNA attenuation signal” formation certainly 
merits further investigation. 
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NONstRuCtuRal PROteINs aRe Key ReGulatORs Of flavIvIRus GeNOme 
eNCaPsIDatION aND vIRION assemBly
Flaviviridae: an introduction
The Flaviviridae family is a group of small, enveloped +RNA viruses that consists of three 
genetically distinct genera - Flavivirus, Pestivirus and Hepacivirus, with members of the 
latter two genera being more closely related to each other than to Flavivirus representa-
tives123. The Flavivirus genus comprises more than 80 members and includes a number of 
vector-borne viruses, such as yellow fever virus (yFv), dengue virus (DENv) and West Nile 
virus, which are associated with severe human diseases. The prototype of the Hepacivirus 
genus, hepatitis C virus (HCv), is a blood-borne human pathogen that frequently estab-
lishes chronic infection and can lead to significant liver damage, while members of the 
genus Pestivirus, such as bovine viral diarrhea virus (BvDv) and classical swine fever virus 
(CSFv), are economically important animal pathogens. 
The single-stranded RNA genome of Flaviviridae members varies between 9.5 and 12.5 
kb in length. it contains a single ORF, with the viral structural proteins encoded in the 5’ 
one-third and the nonstructural proteins in the 3’ two-thirds (Fig. 3). The genomic RNA 
of Flavivirus representatives contains a 5’ cap structure, but lacks a 3’ poly(A) tail and the 
genomic 3’ UTRs contains a number of highly conserved RNA secondary structure ele-
ments that are important determinants of genome translation and replication. HCv and 
pestivirus genome translation, on the other hand, is mediated by an iRES found in the 5’ 
UTR of the viral genome, and the 3’ UTR is much shorter and less structured 210. 
The viral proteins are translated from the flavivirus genome in the form of a polyprotein 
that is processed by cellular and viral proteinases to yield the individual viral gene prod-
ucts. Proteolysis of the flavivirus structural proteins, which consist of the capsid protein 
(C; called core in HCv) and envelope glycoproteins, is mediated predominantly by host 
cell peptidases. The nonstructural proteins are processed by virus-encoded (auto)pro-
teinases and form the viral replication complexes, which mediate viral RNA synthesis in 
close association with modified membranes in the host cell cytoplasm (reviewed in 107,133). 
The principal functions of +RNA virus nonstructural proteins are related to modification 
of the intracellular environment to accommodate viral RCs and orchestration of the syn-
thesis of progeny viral genomes. increasing evidence, however, suggests the existence 
of a high degree of “cross talk” between nonstructural and structural viral gene products 
that is critical for the late stages of the replicative cycle, such as selective genome en-
capsidation, infectious particle assembly, and release. Much of this evidence has been 
obtained for nonstructural proteins of Flaviviridae. The key enzymes required for genome 
expression and replication - the viral protease and helicase (residing in NS3) and the 
RdRp (found in NS5) are conserved in the entire Flaviviridae family (105). The Hepacivirus 
and Pestivirus viruses share an additional conserved domain – a protease which maps to 
NS299. The remaining replicase domains of Flavivirus and Hepacivirus members are not 
evolutionary related, and the molecular details of virus particle formation in these two 
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genera also differ. Therefore, the nonstructural protein determinants of virion biogenesis 
in Flavivirus and Hepacivirus representatives are discussed separately below. 
enzymatic and regulatory activities of Flavivirus nonstructural proteins in virion 
production 
The Flavivirus polyprotein organization is schematically depicted in Fig. 3A. The N-
terminal third of NS3 contains a trypsin-like serine protease domain, the folding and 
protease activity of which require the noncovalent association with a hydrophilic do-
main in NS2B48,52. The C-terminal portion of NS3 has helicase (Hel) and NTPase activity239, 
while NS5 has both 2’-O-methyltransferase and RdRp activities46,204. NS2A, NS2B, NS4A 
and NS4B are highly hydrophobic proteins with small hydrophilic segments and poorly 
understood roles in the flavivirus replicative cycle. Kunjin (KUN) virus NS2A co-localizes 
with dsRNA, NS3 and NS5117, and also binds the KUN 3’ UTR in vitro, while both NS2A and 
NS4A has been implicated in inducing the membrane alterations with which flavivirus 
RCs are associated in infected cells102,124.
Flavivirus progeny particles are formed by envelopment of nucleoprotein complexes 
by ER-derived membranes that contain the viral glycoproteins, and the newly formed 
virions are transported to the cell surface via the secretory pathway118. Subgenomic fla-
vivirus replicons lacking the structural proteins replicate efficiently and can be packaged 
by expression of the structural proteins in trans89. Packaging signals, however, have not 
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figure 3. Multiple nonstructural proteins of Flaviviridae are involved in particle assembly. (A) Schematic 
representation of the genomes of yellow fever virus (yFv, genus Flavivirus, panel A) and hepatitis C virus 
(HCv, genus Hepacivirus, panel B). The yFv genomic RNA carries a cap structure at its 5’ end, whereas 
HCv employs a 5’-proximal iRES element. The single ORF in the yFv and HCv genomes is translated into 
a polyprotein, which is proteolytically processed by host cell and virus-encoded proteinases. Structural 
proteins are shown in white and nonstructural proteins are shown in gray. The nonstructural proteins 
required for viral RNA synthesis and implicated in infectious virus production are highlighted.
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been identified in flavivirus genomic RNAs to date, and the lack of an ordered nucleocap-
sid interior that is characteristically observed in electron microscopy reconstitutions of 
flavivirus particles has led to the suggestion that the C protein interacts electrostatically 
with the viral RNA to aggregate and condense it into particles. Moreover, co-expression 
of flavivirus prM and E is sufficient for secretion of “subviral particles” that mimic the 
major properties of the mature virion envelope178. These observations suggest that flavi-
virus membrane glycoproteins play major roles in orchestrating virion morphogenesis, 
although the determinants of the highly selective packaging of flavivirus RNAs89 remain 
poorly understood. 
The majority of regulatory functions of nonstructural proteins in virion morphogenesis 
described to date are largely independent of their known enzymatic activities. A direct 
enzymatic role of flavivirus nonstructural proteins in the regulation of the process of 
virion formation has been shown only for the main protease from the Flavivirus genus, 
NS3, and its cofactor, NS2B. An NS3-NS2B complex mediates the proteolytic release of 
the viral C protein from its membrane anchor, which occurs on the cytoplasmic side of 
the ER membrane. This cleavage is necessary for the subsequent processing of the viral 
envelope protein, prM, by the host enzyme signal peptidase in the ER lumen. Sequential 
processing of two major virion components initiated by a viral protease was proposed to 
delay virus budding until sufficient genomic RNA has accumulated in infected cells, and 
to reduce secretion of immunogenic subviral particles110. 
Recent biochemical and imaging studies have suggested the existence of virus-induced 
microenvironments in infected cells that allow the coupling of genome amplification to 
its incorporation into progeny particles via specific interactions among structural and 
nonstructural proteins. Ultrastructural studies of DENv-infected cells have indeed sug-
gested a possible topological link between DENv replication and assembly sites238. DENv 
replication induces various modifications of host cell membranes, such as convoluted 
membranes (CMs), thought to be the sites of viral polyprotein processing, and vesicle 
packets, which are likely associated with viral RNA synthesis116. Examination of DENv-
infected cells by transmission electron microscopy showed that virus particles could be 
found in the ER lumen and occasionally in the immediate proximity of vesicles and CMs. 
Three-dimensional reconstruction of cellular volumes containing DENv-induced mem-
brane alterations revealed the presence of a continuous ER-derived membrane network 
containing the virus-induced vesicles and CMs. Moreover, the vesicles likely represented 
invaginations of the ER membrane that are connected to the cytosol via neck-like chan-
nels, which in turn could serve as exit sites for the transport of newly-synthesized viral 
RNA to the cytosol for translation or encapsidation238. Accordingly, ER cisternae contain-
ing virus particles could be found in association with this network and in close proximity 
to the pores of replication vesicles, suggesting spatial coupling of DENv genome replica-
tion and its subsequent incorporation into progeny particles. 
Coupling of genome replication to packaging has also been proposed for Kunjin (KUN) 
virus based on data obtained with a replicon system, in which KUN replicon RNAs are 
produced by RNA polymerase ii-driven system from plasmids containing their cDNA 
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sequence88. viral replication is thus effectively uncoupled from protein production and 
genome encapsidation, allowing the investigation of the importance of KUN replicon 
RNA translation and replication for its incorporation into virus particles. Using a construct 
with a deletion in the viral RdRp active site227, it was shown that replication-incompetent 
KUN virus RNA was only packaged into secreted virions when it was produced in cells 
where it could be replicated via complementation88. in addition to establishing replica-
tion of KUN virus RNA as a prerequisite for its incorporation into progeny virions, these 
data also suggest that the establishment of virus-induced membrane-associated replica-
tion sites might be essential for its relocation to virion assembly sites.
Consistent with the spatial coupling of flavivirus replication and particle formation, a 
number of reports have described essential roles for flavivirus NS2A and NS3 in virion 
morphogenesis. NS2A of yFv is found in two forms in infected cells– a full-length pro-
tein (224 aa) and a C-terminally truncated form (NS2Aα; 190 aa) resulting from partial 
processing by the main viral protease at K190. A K190S substitution in the full-length 
yFv clone blocked NS2Aα cleavage and selectively inhibited production of infectious 
particles in the absence of defects in viral RNA synthesis96,141. Detailed characterization of 
NS2Aα cleavage site mutants revealed that secretion of nucleocapsid-containing virions, 
but not of subviral particles, was impaired. Expression of NS2α in trans from an alphavirus 
replicon could complement the defect in infectious virus production of the K190S mu-
tant96. interestingly, plaque-forming viruses recovered after electroporation of an NS2Aα 
cleavage site mutant defective in infectious progeny release contained compensatory 
second-site mutations in the Hel domain of NS3 (D343 to v, A or G) that restored infectiv-
ity to near wildtype levels without rescuing the NS2Aα cleavage. Taken together, these 
data provide genetic evidence for an interaction of NS2A with the Hel domain of NS3 that 
is critical for infectious virus productions. They also imply that a downstream effect of the 
NS2A internal cleavage which could be also brought up by a mutation in NS3, rather than 
NS2A cleavage per se, is important for this process. 
An essential role in virus assembly has also been demonstrated for NS2A from KUN 
virus108. KUN RNA transcribed from a full-length cDNA clone carrying a NS2A i59N muta-
tion did not support virus particle release108. Analogous to the defects in virus production 
associated with the K190S mutation in yFv NS2A, secretion of KUN subviral particles was 
not affected by the i59N substitution102. Complementation analyses was used to demon-
strate that KUN RNAs with the i59N mutations could be packaged into virions by the KUN 
virus structural proteins produced in cis from the same RNA molecule, but the presence 
of wild-type NS2A produced either in cis or in trans was absolutely essential for packaging 
RNA into virions or virus-like particles108. immunofluorescence and electron microscopy 
analyses revealed an intriguing phenotype of the NS2A-i59N replicon-expressing cells. 
virus-induced membrane structures normally present in cells expressing wild-type rep-
licon RNA were essentially lacking in the i59N mutant, while a compensatory mutation 
in NS2A restored their induction to a level similar to those observed during wt KUN virus 
replication. These results not only implicated NS2A in the biogenesis of virus-induced 
membrane structures, but lent further support to the hypothesis that these structures 
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play a critical role in flavivirus assembly88,238. Combining the data from biochemical and 
imaging studies thus favors a model in which flavivirus NS2A is directly involved in trans-
porting RNA from sites of RNA replication to adjacent sites of virion assembly that could 
very well be part of the same virus-induced membrane network102. 
The role of flavivirus NS3 in the production of infectious particles is still poorly under-
stood, although a recent report suggests it does not depend on the protein’s helicase/
NTPase function158. Mutations of D343 in the Hel domain of NS3 rescued a block in infec-
tious virus production caused by a substitution in NS2A96, and an alanine replacement 
of W349, neighboring D434 in a flexible solvent-accessible loop in the NS3 Hel domain 
structure, resulted in a specific block of infectious virus production158. Similarly to the de-
fects in assembly upon NS2A mutagenesis, the W349A mutation in NS3 did not hamper 
the release of subviral particles, and wild-type NS3 produced from a yFv replicon could 
complement, although very inefficiently, the virion assembly defect of the W349A mu-
tant. By contrast, NS3 is required in cis for KUN virion assembly109,163. Using a dual replicon 
complementation system, Liu and colleagues showed that defects in KUN RNA replica-
tion upon deletion of the Hel/NTPase domain-coding sequence can be complemented 
in trans, while the N-terminal 178 codons (coding for the protease domain) are required 
in cis for KUN RNA synthesis. A complete block of virus production occurring at the stage 
of virus assembly was associated with both deletions in NS3, however, and could not be 
complemented in trans109. RNA structures in the KUN virus NS3 coding sequence do not 
seem to play a role in RNA replication and virion morphogenesis, effectively ruling out 
the presence of RNA packaging signals in this genomic region163. By contrast, NS3 transla-
tion in cis is strictly required for subsequent KUN genome encapsidation. Co-translational 
association of NS3 with a progeny viral genome exiting the RC might thus be one of 
the determinants for specific packaging of replication- and translation-competent KUN 
RNAs. The less strict requirement for yFv NS3 in cis 86,158, on the other hand, suggests that 
important differences in the virion assembly process might exist among members of the 
Flavivirus genus.
Nonstructural proteins of hepatitis C virus coordinate the assembly of infectious 
particles
Over 130 million individuals are estimated to be persistently infected with HCv, the pro-
totype (and so far sole member) of the Hepacivirus genus. Based on genetic differences, 
naturally occurring HCv variants are classified into six major genotypes (1-6) with several 
subtypes within each genotype (represented by letters). HCv-related liver disease fre-
quently progresses to cirrhosis that can lead to hepatocellular carcinoma. Development 
of effective therapies and a vaccine against this major human pathogen were initially 
greatly hindered by the inability of HCv to grow efficiently in cell culture. Subgenomic 
RNA replicons encoding HCv NS3 to NS5B have been adapted for efficient RNA replica-
tion in the human hepatoma cell line Huh-7112, but for a long time studies of the entire 
HCv replicative cycle were not feasible, because full-length genomes containing cell 
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culture-adaptive mutations did not produce infectious virus particles in cell culture20. 
This major obstacle was overcome by construction of full-length chimeric genomes in 
which the HCv “replicase” (NS3-NS5B) and UTRs were derived from the unique genotype 
2a patient isolate JFH1, which can replicate efficiently in cell culture without adaptive 
mutations106,161. The full-length chimeric HCv RNAs, as well as that of the complete JFH-1 
genome231,253, are competent for RNA replication and also direct the efficient production 
of infectious progeny particles. The availability of this experimental system has greatly 
facilitated research on the mechanisms underlying HCv entry, as well as virion assembly 
and egress, in the context of the full HCv replicative cycle. 
The gene organization within the HCv polyprotein (Fig. 3B) is similar to that of mem-
bers of the Pestivirus genus, which will be discussed only briefly here. NS3 to NS5B are 
essential for and sufficient to support HCv RNA replication. NS3 has Hel/NTPase activities 
and, together with its key cofactor NS4A, comprises the main viral proteinase. NS5B 
has RdRp activity 111, while NS4B is a hydrophobic protein with numerous predicted 
membrane-spanning domains that is implicated in the formation of the “membranous 
web”, a virus-induced membrane structure derived from the host cell ER and presum-
ably harboring the HCv RCs45,70. NS2 and p7 also contain hydrophobic regions, but have 
no documented role in RNA replication and are not incorporated into HCv particles to 
detectable levels. ion channel activity has been demonstrated for p730,71, while NS2 is an 
integral membrane protein that is tightly associated with intracellular membranes via a 
highly hydrophobic N-terminal domain. The cytosolic portion of NS2 contains a cysteine 
protease domain that, in association with the N-terminal portion of NS3, mediates the 
autoproteolytic processing of the NS2-NS3 junction113. While NS2 itself is dispensable for 
HCv replication, processing of the NS2/NS3 site is crucial for viral RNA synthesis236. The 
crystal structure of the post-cleavage form of NS2 revealed a dimeric cysteine protease 
with two composite active sites, a peculiar feature essential for the autoproteolytic 
release of NS2113. 
A number of recent reports suggest that, as for distantly related members of the Fla-
vivirus genus, nonstructural proteins are also critically involved the morphogenesis and 
secretion of HCv particles. A report analyzing the stoichiometry of HCv protein and RNA 
molecules estimated that only a minor fraction of the HCv nonstructural proteins (<3%) 
is actively involved in RNA synthesis at a given time point, and a large excess of viral 
proteins over viral RNAs is produced during HCv infection168. This study was carried out in 
a system allowing only transient replication of full-length HCv genomes with replication-
enhancing mutations, which, in addition, did not support virus particle production. it 
would be thus necessary to address this issue in the context of the complete HCv 
replicative cycle, and assess the effects (if any) of active particle morphogenesis on the 
stoichiometry of viral proteins and RNA molecules. Notably, a recent report confirmed 
the hypothesis that replication-enhancing mutations in HCv replicase proteins interfere 
with the production of infectious HCv particles in cell culture, arguing that enhanced 
replication triggered by these mutations occurred at the expense of genomic RNA en-
capsidation and particle formation93,162. 
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infectious HCv virions are likely assembled at ER membranes as high-density particles 
and undergo subsequent transformation to lower-density particles before or during their 
export to the extracellular milieu62. The lipid droplet, a cellular organelle involved in the 
storage of neutral lipids, plays a central role in HCv assembly128. Utilizing lipid droplets 
as assembly organelles is presumably linked to their contribution to the formation of 
very-low-density lipoproteins in hepatocytes, since HCv particles circulating in infected 
patients are associated with lipoproteins. interestingly, an interaction of DENv C protein 
and lipid droplets that is critical for efficient virus production was recently reported173, 
suggesting the involvement of this ubiquitous cellular organelle in virion morphogenesis 
might be a common property in the Flaviviridae family.  
Recruitment of core protein and NS5A to the lipid droplet is a major determinant of 
infectious HCv particle assembly128,190. NS5A is a phosphoprotein found in a hypo- and hy-
perphosphorylated form in HCv-infected cells205 and the majority of mutations conferring 
enhanced replication to HCv subgenomic replicons in cell culture map to the NS5A-coding 
region. The protein is presumably anchored to membranes via an N-terminal α-helix. Three 
subdomains, separated by low-complexity regions, have been indentified in NS5A so far. 
Domain i, located immediately downstream of the α-helix, is the most conserved across 
HCv genotypes and binds RNA in homodimeric NS5A75,208. The region required for NS5A as-
sociation with lipid droplets is also located within domain i128. The roles of the less conserved 
domains ii and iii of NS5A in the HCv replicative cycle are less well understood, although at 
least part of domain ii was shown to be essential for HCv RNA synthesis8. Domain iii is likely 
involved in basal phosphorylation of NS5A, and while it is dispensable for RNA replication, 
residues from this domain are critically involved in infectious progeny production. On the 
basis of these observations, NS5A was proposed to act as a phosphorylation-dependent 
switch between genome replication and particle assembly179,207. An assessment of the 
influence of deletions in domain ii and domain iii on the phosphorylation status of NS5A, 
however, revealed that deletion of residues in domain ii of NS5A important for its hyper-
phosphorylation had little effect on HCv replication and particle assembly8. in contrast, 
deletions in domain iii strongly interfered with virion morphogenesis. This phenotype was 
not related to lack of NS5A at lipid droplets, but rather to a disturbed association between 
NS5A and core protein on the same lipid droplet. An interaction between NS5A and core 
protein, mediated by a Ser cluster in the C-terminal region of NS5A, was shown to be a 
prerequisite for infectious particle production121. interestingly, substitutions of Ser residues 
from this cluster impaired the basal phosphorylation of NS5A, suggesting this posttrans-
lational modification might play a role in NS5A-core association, which is also seemingly 
required for the interaction between core and the HCv genome121. The defects in virus pro-
duction associated with deletions in domain iii of NS5A could be complemented in trans by 
wt NS5A expressed from a subgenomic HCv replicon, i.e. in the context of a replicase, but 
not when expressed on its own. Overall, NS5A seems to play a key role not only in genomic 
RNA amplification, but also in its recruitment from the membrane-associated RCs to lipid 
droplets via a core-NS5A association, implying that protein-protein rather that protein-RNA 
interactions are responsible for the specificity of HCv RNA encapsidation121.
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in addition to NS5A, both p7, NS2 and NS3 are critically involved in the morphogenesis 
and release of infectious HCv particles85,202,247. p7 promotes virus assembly in a genotype-
specific manner, suggesting that interactions with other viral factors are important for 
this function202. Also, the assembly defects of HCv genomes with certain mutations in 
p7 could be rescued by providing p7 in trans26. The NS2 protease domain is important 
for the protein’s role in virion assembly, but both its catalytic activity and uncleaved 
NS2 precursor forms are nonessential84,85, in contrast to a documented critical role for 
uncleaved NS2-3 in the assembly or egress of the pestivirus BvDv particles1. The amino 
acid determinants for the protease activity and post-cleavage functions of NS2 seem to 
differ. C-terminal truncations of NS2 interfere both with virus assembly and RNA replica-
tion, while replacement of the C-terminal Leu residue or fusion of additional amino acids 
to the C -terminus of NS2 abolish infectious virus production while preserving full RNA 
replication capability39. in addition, results from analyses of intra- and intergenotypic chi-
meric HCv genomes have shown that the highest HCv infectivity titers are achieved with 
chimeric genomes in which the junction is positioned in the loop region connecting the 
two transmembrane segments of NS2161. The first hydrophobic region of NS2 is therefore 
also important for HCv virus production, and consequently, full-length NS2 was shown 
to be required for particle assembly. Structural and biochemical analyses have identified 
a Gly residue located in the N-terminal transmembrane region of NS2 that is critical for 
virion assembly and might be involved in intra-membrane protein-protein interactions84. 
Moreover, Arg-to-Lys substitutions in the transmembrane regions of NS2 reduced infec-
tious particle production by decreasing the specific infectivity of secreted virions237. 
NS2, when expressed on its own, is rapidly degraded via the proteasome and NS2 sta-
bility was proposed to be regulated by phosphorylation at S168 55. This highly conserved 
residue, however, does not seem to affect NS2 stability in the context of a replicating HCv 
genome, but S168A and S168G replacements severely decrease infectious virus produc-
tion84,248. The S168G mutation did not prevent the assembly of high-density virus-like 
particles, suggesting NS2 mediates the “maturation” of noninfectious intracellular HCv 
particles to infectious particles that can be released from infected cells. NS2 might thus 
mediate a rearrangement of viral envelope proteins subsequent to particle assembly and 
be required for infectivity. Accordingly, NS2 strongly co-localized with E2 and partially 
with NS5A, but not with core protein in infected cells, and substitutions of S168 do not 
alter the NS5A-core association at lipid droplets248. Pseudorevertant analysis mapped 
second-site mutations to NS2 and domain iii of NS5A that can compensate the S168G-
mediated defects in infectious particle production, and this genetic interaction suggests 
that NS5A acts at different, temporally distinct steps in the generation of infectious HCv 
virions. 
Finally, a role for NS3 in the assembly of infectious intracellular HCv particles was 
discovered by the isolation of an adaptive mutation (Q221L) in the NS3 Hel domain. This 
mutation was required for virion assembly in cells transfected with an intergenotypic 
chimeric HCv genome containing the core to NS2 region of genotype 1a H77c in the 
JFH-1 background247. The Q221L compensatory mutation did not affect the recruitment 
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of NS3, core, or NS5A to lipid droplets, and had no effect on the known enzymatic activi-
ties of NS3 or viral RNA synthesis114. The Q221L substitution enhanced infectious virus 
production by the JFH1 construct as well, suggesting it might be a cell-culture adaptive 
mutation and, consequently, interaction of NS3 with a host protein might be important 
for its function in assembly. However, expression of NS3 containing the Q221L muta-
tion from an alphavirus replicon did not result in trans complementation of the virus 
assembly defects displayed by the original chimeric HCv, implicating NS3 in an early step 
of virion morphogenesis. 
in conclusion, interplay between replicase subunits with catalytic activities important 
for viral RNA synthesis (such as NS3) and those responsible for inducing membrane rear-
rangements to accommodate the viral RCs (such as flavivirus NS2A) appears critical for 
virus production in Flaviviridae. Nonstructural proteins seem to be involved in multiple 
steps of the virion assembly process – from selection of replication- and translation-com-
petent RNA molecules for encapsidation109,163 to “chaperoning” capsid-RNA interactions121 
and the subsequent association of nucleocapsids with viral glycoproteins, and even in 
events conferring infectivity to assembled intracellular particles248. Functional studies 
of nonstructural proteins, as well as recent advances in determining the ultrastructure 
of virus-infected cells, have collectively challenged the view of a spatial and temporal 
segregation between +RNA virus genome replication and encapsidation. They have also 
suggested the existence of intimate connections between intracellular compartments 
for RNA replication and encapsidation, as well as among the protein factors directing 
both processes. Such a “network” would be exceptionally well suited for ensuring the 
selective packaging of replication- and translation-competent messenger-sense viral 
RNA genomes.
whICh vIRal aND CellulaR faCtORs DRIve the PROGRessION Of the 
NIDOvIRus RePlICatIve CyCle? 
The Nidovirales order comprises the distantly related families Arteriviridae, Coronaviridae 
(subfamilies Coronavirinae and Torovirinae that include three and two genera, respec-
tively), and Roniviridae (http://www.ictvonline.org/virusTaxonomy.asp?version=2009). 
The messenger-sense single-stranded nidovirus genomes are polycistronic. Members of 
Coronaviridae and Roniviridae have the largest genomes among RNA viruses known to 
date (25-32 kb), while genome size varies between 12.7 – 15.7 kb in Arteriviridae67. A 
multidomain replicase, which contains an array of evolutionarily related core replicative 
enzyme domains34,37,68,69,73,183,197, is encoded in two large 5’-proximal ORFs in nidovirus 
genomes, while the viral structural genes are located in the 3’-proximal genomic regions. 
Translation of the 5‘-capped, 3’-polyadenylated nidovirus genomic RNA results in two 
multidomain replicase polyproteins - pp1a and pp1ab, with expression of the latter 
requiring a -1 ribosomal frameshift. The replicase polyproteins are processed into 13 
to 16 nonstructural proteins (nsps) by up to four virus-encoded proteases residing in 
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figure 4. Expression of the polycistronic genomes of Nidovirales involves the production of an 
extensive set of sg mRNAs. The genome organization and expression of the arterivirus EAv (A) and the 
coronavirus SARS-Cov (B) are diagrammed. The 5’-proximal replicase ORFs are designated, as well as the 
downstream ORFs encoding the viral structural proteins envelope (E), membrane (M), nucleocapsid (N), 
and glycoproteins (GP) 2-5 for EAv, and E, M, N and spike (S) for SARS-Cov. The 3’ poly(A) tail (An) is also 
shown. An overview of viral mRNA species produced in infected cells is depicted below each schematic 
representation of genome organization. The ORFs translated from the respective mRNAs, the 5’ leader (L) 
and the positions of transcription-regulating sequences (TRS) are shown. The gel hybridization images 
on the right are representative of the wild-type accumulation levels of the seven EAv mRNAs (A) and 
the nine SARS-Cov mRNAs (B) around the peak of viral RNA synthesis in infected cells. The SARS-Cov gel 
hybridization image was reproduced from van Hemert et al. 223 (C) Model for nidovirus replication and 
transcription. Continuous minus-strand RNA synthesis yields a genome-length minus strand template 
for genome replication (left panel). Discontinuous minus-strand RNA synthesis175 results in a nested 
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pp1a. Nidovirus replicase subunits direct the formation of a membrane-anchored 
RNA-synthesizing complex that mediates viral genome replication and the synthesis 
of a 3’-coterminal nested set of subgenomic (sg) mRNAs, the latter being required for 
expression of the viral structural proteins. Depending on the virus species, a set of 2 to 10 
sg mRNAs are produced in nidovirus-infected cells by a process commonly referred to as 
“transcription” to distinguish it from genome amplification (“replication”). Most of these 
molecules are structurally polycistronic, but generally serve as templates for translation 
of only the 5’-proximal ORF, which is not found in the next smaller sg mRNA. Arteri- and 
coronavirus sg mRNAs have a unique “chimeric” structure, since they contain a common 
“leader” sequence representing a 5’-proximal fraction of the genome, linked to different 
“body” segments co-linear with the 3’-proximal part of the genome (Fig. 4, reviewed in 
154,176). By contrast, sg mRNAs produced by members of the Roniviridae family and Torovi-
rus genus lack a common leader sequence, with the exception of the largest torovirus sg 
mRNA35,195,226. 
how are active nidovirus RNa-synthesizing complexes assembled and what is 
their composition? 
Research on the nidovirus replicative cycle has been largely carried out with a number 
of prototype members that are easily propagated in cell culture, and, more recently, for 
which full-length cDNA clones have been constructed4,32,42,217,250,251. Arguably the best-
studied nidovirus prototype, in terms of molecular biology, is the one with the smallest 
genome (12.7 kb) – the arterivirus prototype equine arteritis virus (EAv), although coro-
navirus representatives such as murine hepatitis virus (MHv), transmissible gastroenteri-
tis virus (TGEv), and human coronavirus 229E (HCov 229E) have also been extensively 
characterized. 
initially, comparative sequence analysis was instrumental in assigning putative func-
tions to the numerous nidovirus nsps. Combined with the isolation of a coronavirus as 
the etiological agent of severe acute respiratory syndrome (SARS)43,95, it has spurred nu-
merous biochemical and structural studies of the core viral enzymes as potential targets 
for antiviral compounds. Consequently, a wealth of information has been obtained on 
the properties of individual replicative proteins. in vitro assays for RNA synthesis by re-
combinant forms of the RdRp domain-containing nsps of arteri- and coronaviruses have 
recently been developed17,206. Along with the availability of enzymatically active, recom-
set of subgenome-length minus strands that serve as templates for sg mRNA synthesis in arteri- and 
coronaviruses. This process is likely carried out by an RdRp complex with a different composition, and is 
guided by a base pairing interaction between the TRS complement [(-)TRS] at the 3’ end of the nascent 
minus-strand and the genomic leader TRS, present in a RNA hairpin structure (LTH). Subgenomic mRNAs 
produced by members of the Roniviridae family and Torovirinae subfamily lack a common leader sequence, 
with the exception of the largest Torovirus sg mRNA35,226. The minus-strand templates for sg mRNAs lacking 
a common leader are thought to be produced via a “premature termination” mechanism similar to that 
employed by TBSv (see Fig. 2 and main text for details).
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binant Hel domain-containing nidovirus nsps81,188, these assays will constitute important 
tools for unraveling the fundamental aspects of nidovirus RNA synthesis. Also, apart from 
the “core” viral enzymes, various nsps were predicted and/or found to contain unusual 
RNA-processing enzymes that are rare or lacking in other RNA viruses, such as an RNA 
primase, an exoribonuclease and an endoribonuclease (78,80,127,196 and chapter 4 of this 
thesis). Advances have also been made in characterizing the architecture of membrane-
anchored nidovirus RCs, as well as the roles of membrane-spanning nsps in inducing the 
extensive membrane alterations characteristic of nidovirus infection9,31,56,91,148,149,159,167,198. 
Our understanding of the assembly and composition of the nidovirus RNA-synthesizing 
complex, the regulation of its different activities, and the connection of viral RNA synthe-
sis to assembly of infectious particles is, by contrast, only fragmentary. 
Nidoviruses employ translational and post-translational control to ensure the tempo-
rally and quantitatively regulated expression of the viral replicase subunits, which are 
produced from two large translation products. The efficiency of the programmed –1 
ribosomal frameshifting required for translation of ORF1b25, as well as the temporally 
regulated proteolytic processing of the pp1a and pp1ab precursors, are part of an elabo-
rate mechanism aimed at controlling the relative abundance of nidovirus replicative 
proteins in infected cells199,218,220,235,254,255 (for a review see reference255). Regulated prote-
olysis of larger polypeptides, presumably determined by accessibility of cleavage sites 
and enzyme substrate specificity, may serve to trigger or inhibit specific replicase func-
tions at certain stages of the viral replicative cycle255. Although the critical importance 
of polyprotein processing for nidovirus replication has been well established90,213,218, 
the significance of the numerous (alternative) processing intermediates generated in 
infected cells for the different stages of the viral replicative cycle is poorly understood.
A classical genetic approach involving detailed analysis of conditional-lethal, tem-
perature-sensitive mutants of MHv has provided valuable insights into the functions of 
individual viral replicase proteins in viral RNA synthesis. By complementation analysis, 
this method has also allowed the identification of potential protein–protein interactions 
that may regulate the activity of MHv RNA-synthesizing complexes177. Consequently, 
ORF1a-encoded replicase subunits were proposed to be cis-active, while ORF1b gene 
products were postulated to function in trans following their proteolytic release from 
pp1ab177. Better understanding of the results from such genetic experiments, however, 
requires rigorous characterization of all steps of the viral replicative cycle. This is exempli-
fied by a temperature-sensitive mutation in MHv nsp10 that implicated this protein in 
minus-strand RNA production, but was later shown to abrogate polyprotein processing 
by the main viral proteinase, which is required for viral RNA synthesis41,90,177. Numerous 
pair-wise associations between SARS-Cov proteins have also been identified in large-
scale studies using methods such as yeast two-hybrid screens, GST pull-down assays and 
co-immunoprecipitation79,150,230. Whether these interactions indeed occur in the complex 
intracellular environment of the infected cell, and if so, what their significance is for viral 
replication, however, remains to be established. 
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The dynamic associations of viral and/or cellular proteins with regulatory viral RNA 
sequences, which are likely necessary to ensure the progression of the nidovirus repli-
cative cycle, are slowly emerging. RNA structure probing and reverse genetics studies 
of cis-acting replication signals in the 3’ UTRs of arteri- and coronavirus genomes have 
suggested roles for pseudoknot interactions composed of overlapping RNA elements as 
regulatory “molecular switches”18,63,229,241,257. interestingly, the severe replication defects 
associated with a six-nucleotide insertion in a loop of the pseudoknot located in the 
MHv 3’ UTR were suppressed by mutations in nsp8 (the putative viral primase78), nsp9 (a 
presumed RNA-binding protein47), and the last nucleotide of the MHv genome upstream 
of the poly(A) tail257. Based on these genetic data, interactions between RNA signals in 
the 3’ UTR of the MHv genome were postulated to form the site of assembly of a complex 
that includes at least nsp8 and nsp9. Upon substrate recognition, initiation of minus-
strand synthesis at the 3’ end of the genomic RNA by the nsp8 primase would disrupt the 
“replicase assembly” RNA signal, thereby allowing formation of the pseudoknot, which 
may serve to recruit the viral RdRp and Hel and thus trigger elongation of the nascent 
minus strand. Although appealing, this model does not provide a mechanism for copying 
sequences from the 3’ poly(A) tail, and coronavirus minus-strand RNAs have been shown 
to contain short poly(U) stretches at their 5’ ends74,174. The proposed model would also 
not allow for differentiating between plus strands of genome- or subgenome-length, 
and the latter presumably do not serve as templates for minus-strand synthesis. 
it is worthy of note that circularization of nidovirus genomes has been postulated to 
facilitate both genome replication and sg mRNA synthesis103,201,256. The poly(A) tail was 
identified as an important cis-acting replication element in bovine coronavirus (BCov), 
and a specific interaction of PABP with the BCov 3’ UTR, mediated largely by the poly(A) 
tail sequence, has been described. BCov Di RNAs with shortened poly(A) tails had vir-
tually identical stabilities in the absence of viral infection, but exhibited weaker PABP 
binding in vitro and also replicated poorly in vivo201. in analogy to the model proposed 
for poliovirus72, PABP binding to the poly(A) tail of nidovirus genomes might coordinate 
its amplification, especially in view of the shared dependency of isolated viral replication 
complexes from poliovirus, EAv, and SARS-Cov on host factors for in vitro activity13,222,223. 
So far, experimental support for genome circularization in nidoviruses is scarce, although 
a recent report provided genetic evidence for an interaction between the leader se-
quence and the 3’ UTR of the MHv genome103. in addition, a number of host proteins 
have been shown to specifically bind to sequences in the plus- and minus-strand RNAs of 
MHv, though the mechanistic details and significance of these interactions need further 
investigation57,64,76,77,191-193,201. 
   
Nidovirus transcription: stop-or-go during minus-strand synthesis?
Regulation of nidovirus sg mRNA production is one of the most-studied steps of the 
nidovirus replicative cycle, largely due to the unique mosaic nature of arterivirus and 
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coronavirus sg mRNAs. According to the now widely supported model proposed by 
Sawicki and Sawicki175, the structure of the arterivirus and coronavirus sg mRNAs derives 
from a discontinuous step during minus-strand RNA synthesis, which is guided by con-
served, AU-rich transcription-regulating sequences (TRS)156,224,256. “Body TRS” motifs are 
found preceding almost all structural protein ORFs, and a “leader TRS” is present at the 3’ 
end of the genomic leader sequence. Minus-strand RNA synthesis, initiated at the 3’ end 
of the viral genome, is presumably attenuated at one of the body TRS regions and the 
nascent minus strand, carrying the body TRS complement at its 3’-end, is translocated 
to the 5’-proximal region of the genomic template. This step is guided by base-pairing 
between the genomic leader TRS and the copy of the body TRS present in the 3’ end of 
the nascent minus strand. Nascent strands are subsequently extended with the comple-
ment of the genomic leader sequence, yielding a nested set of subgenome-length 
minus-strand templates that can be directly copied into the various sg mRNAs (reviewed 
in references154,176). Alternatively, the successive body TRS motifs can all be ignored dur-
ing minus-strand RNA synthesis, resulting in a full-length complement of the genome 
which serves as a template for genome amplification. 
The switch between “continuous” and “discontinuous” minus-strand RNA synthesis is 
therefore crucial for the production of viral structural proteins. Moreover, the amounts 
of structural proteins are presumably determined by the abundance of their mRNA 
templates, since the diverse viral mRNA species are produced in nonequimolar amounts, 
and their relative molar ratios are largely constant both in coronavirus- and arterivirus-
infected cells12,38,174. in the model of discontinuous extension during minus-strand 
synthesis, the relative abundance of a sg mRNA would be determined by the degree of 
“attenuation” of RNA synthesis at the corresponding body TRS, and consequently, by the 
abundance of its minus-strand template.  
Extensive research on the TRSs in arterivirus and coronavirus genomes has yielded 
important insights into the primary and higher-order structure determinants of sg mRNA 
production. The base-pairing potential between conserved “core” motifs in the leader TRS 
and the body TRS complement in the nascent minus strand is a key determinant of sg 
mRNA production, but also the sequence context of body TRS motifs and their proximity 
to the genomic 3’ end, reflected in a “gradient” of sg RNA sizes, can influence the accu-
mulation of viral mRNA species (155-157,200,224,256, reviewed in references154,176). Moreover, a 
leader TRS hairpin (LTH), containing the leader TRS in its loop, is essential for EAv sg mRNA 
synthesis214,214,215. The LTH likely serves as a transcription-guiding element, since it could 
still direct the production of leader-containing sg mRNAs even when placed at another 
position in the 5’-proximal region of the EAv genome215. Although important, sequence 
identity between the leader TRS and body TRS can be insufficient for directing sg mRNA 
production156. 
The role of higher-order RNA structures in attenuation of minus-strand synthesis at 
body TRS regions remains unclear. Recent evidence suggests a long-range RNA-RNA in-
teraction enhances production of the N-coding sg mRNA of TGEv135. A mode of regulation 
of minus-strand attenuation by a network of RNA signals, similar to the one described for 
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TBSv104, might therefore have evolved in arteriviruses and coronaviruses, although it is 
probably even more sophisticated, since it likely includes the LTH and needs to direct 
the balanced synthesis of a larger set of sg transcripts. Physical association between the 
5’ and 3’ ends of the coronavirus genome has been proposed to position nascent minus 
strands in the proximity of the leader sequence, facilitating base-pairing between the 
leader TRS and the body TRS complement and thus strand transfer during minus-strand 
synthesis256. Apart from the recently described genetic interaction between the 5’ and 
3’ UTRs of MHv103, however, there is currently no other evidence in support of genome 
circularization and its potential importance for sg mRNA synthesis in arteriviruses and 
coronaviruses. 
The protein factors governing the production of subgenome-length minus strands by 
interactions with the transcription-regulatory RNA networks are, with a few prominent 
exceptions, largely unexplored. A serendipitous discovery of a mutation in nsp10, the Hel 
domain-containing replicase subunit, revealed that sg mRNA synthesis can be function-
ally uncoupled from genome replication in EAv217. The S2429P substitution (amino acid 
position in EAv pp1ab) did not interfere with replicase polyprotein processing or genomic 
RNA accumulation, but resulted in a more than 100-fold reduction of subgenome-length 
minus-strand and plus-strand levels225. S2429 is located just downstream of a predicted 
zinc-binding subdomain in nsp10 and upstream of the conserved Hel motif, and the 
S2429P mutation had no detectable effect on the in vitro helicase activity of recombi-
nant EAv nsp10. Moreover, despite extensive mutagenesis of EAv nsp10, substitutions of 
other residues resulting in similar specific defects in sg mRNA production have not been 
described, while deletion of the entire nsp10-coding sequence or mutations in the Hel 
active site abolished all viral RNA synthesis187,219. 
By contrast, deleting the coding sequence of another replicase subunit, nsp1, from 
the EAv genome specifically reduced the accumulation of subgenome-length viral 
RNAs of both polarities to levels undetectable by RT-PCR, while genome replication 
was largely unaffected212. Subgenomic mRNA production could be partially restored by 
iRES-mediated expression of nsp1 from an alternative region in the EAv genome or by 
plasmid-driven nsp1 expression (212, D.D. Nedialkova, unpublished observations), dem-
onstrating the protein is able to function in trans. Substitutions of amino acids in the 
zinc finger subdomain, but also in the two papain-like cysteine proteinase subdomains 
of nsp1 selectively abolished sg mRNA accumulation (Chapters 5 and 6 of this thesis). 
Evidence for a specific role in sg mRNA production was also obtained for an arterivirus 
ortholog of EAv nsp1 - nsp1α of porcine reproductive and respiratory syndrome virus 
(PRRSv)94. 
Most notably, EAv nsp1 was found to modulate the accumulation of viral minus-strand 
templates to control the relative abundance of both genome-length and subgenome-
length mRNAs in EAv-infected cells. Balanced EAv mRNA accumulation, in turn, was 
demonstrated to be critical for efficient production of infectious progeny particles 
(Chapters 5 and 6). These data provided evidence not only for transcriptional regulation 
as a genuine mechanism for controlling the relative abundance of viral proteins, but for 
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the importance of this control for the later stages of EAv infection, i.e. virion assembly. 
interestingly, certain mutations in nsp1 were also found to affect virus production, but 
without significantly disturbing viral RNA synthesis (Chapters 5 and 6 of this thesis). Also, 
although nsp1 itself is dispensable for EAv genome replication, blocking the autoproteo-
lytic release of the protein from the nascent replicase polypeptide reduced the synthesis 
of all viral RNAs to undetectable levels (chapter 5). A single arterivirus protein thus plays 
a decisive role in the integral control of replication, sg mRNA synthesis, and virus produc-
tion, and studies on EAv nsp1 have provided the most substantial evidence to date for 
coupling of these processes in the nidovirus replicative cycle. 
A specific role in controlling sg mRNA production has not been assigned to any coro-
navirus protein so far, and uncoupling of “continuous” from “discontinuous” coronavirus 
RNA synthesis has only been achieved by mutating TRS motifs256. Unlike the EAv reverse 
genetics system, however, currently available reverse genetics systems for coronavi-
ruses suffer from low transfection efficiencies, likely stemming from difficulties to obtain 
high-quality in vitro-synthesized coronavirus full-length RNAs due to their large sizes. 
Coronavirus phenotypes are thus frequently analyzed after passaging of the mutant 
viruses, an experimental setup that precludes the identification and characterization of 
replication-competent, transcription-negative mutants.
how is nidovirus particle assembly orchestrated?
Mechanisms of virion biogenesis employed by the different nidovirus groups probably 
differ, due to their dissimilar virion morphologies and the widely different sets of struc-
tural proteins they encode. For example, arteriviruses capsids are probably icosahedral, 
while those of coronaviruses have a helical structure11,142, and the membrane-spanning 
structural proteins of nidoviruses are also very divergent. Nevertheless, the nucleocapsid 
(N) proteins of both EAv and MHv partially co-localize with viral replicase subunits at 
the presumed sites of viral RNA synthesis, especially in the early stages of infection, sug-
gesting a topological connection between the sites of genome replication and packag-
ing211,216. 
RNA motifs in the genomes of MHv, BCov and TGEv have been proposed to mediate 
the specific encapsidation of genomic RNAs. insertion of those “packaging signals” into 
nonviral transcripts led to their specific incorporation into viral particles, although with 
variable efficiency33,49,119,242. A selective interaction between the membrane (M) protein 
of MHv and RNA molecules containing the packaging signal was proposed to be critical 
for the specificity and selectivity of RNA encapsidation140 and interactions between the 
M protein and the envelope (E) protein of coronaviruses were implicated in determining 
the intracellular sites of virus assembly and budding228. 
Finally, although a number of studies have examined the sequence requirements for 
packaging of nidovirus Di RNAs33,36,49,82,129, a link between genome translation, replication, 
and encapsidation, similar to those described for Pv and KUN virus88,146 has not been 
systematically investigated for any nidovirus. Likewise, the significance of nidovirus 
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replicase subunits for infectious particle production remains largely unexplored, and to 
date a role in virion assembly has been demonstrated only for EAv nsp1 (Chapters 5 and 
6 of this thesis). it is interesting to note that the N protein was shown to facilitate coro-
navirus genome replication by an as yet uncharacterized mechanism3,180,209. This unusual 
role of a structural protein in RNA synthesis might not be a general feature of nidovirus 
replication, since all structural proteins were shown to be dispensable for EAv genome 
replication and sg mRNA synthesis130.
taking nidovirus replication apart: lessons learned from other +RNa viruses
in the past two decades, research on the spatio-temporal regulation of the eukaryotic 
+RNA virus replicative cycle has led to the emergence of several regulatory strategies 
commonly employed by virus families with diverse genetic plans and gene expression 
modes. A considerable degree of integration between translation, replication, and encap-
sidation of the genomic RNA seems to have evolved in diverse +RNA virus groups88,144,146. 
Plus-strand RNA viruses from different families seem to utilize remarkably analogous 
“molecular switch” mechanisms to regulate the use of the genomic RNA as a template 
for translation or minus-strand RNA synthesis. Circularization of the viral genome has 
been implicated in ensuring the switch between these two processes in virus families as 
diverse as Picornaviridae, Flaviviridae and Tombusviridae51,53,72,170. The importance of long-
distance RNA-RNA interactions, often spanning thousands of nucleotides in +RNA viral 
genomes, for the formation of a variety of functional regulatory RNA elements is slowly 
emerging40,104,184,243. These findings have major consequences for research on regulatory 
RNA motifs, which are traditionally viewed as “localized” sequences or structures. in addi-
tion, studies on +RNA virus replication in genetically tractable model hosts have provided 
ample evidence for essential roles of cellular proteins in many of the fundamental steps 
of the viral replicative cycle2,10,27,72,97,120,165,186,232. Finally, recent data have revealed that the 
intracellular sites of viral RNA synthesis and virion assembly are interconnected, and have 
also implicated common viral protein factors into governing these processes137,238. 
The emergent common themes in +RNA virus replication should undoubtedly be 
reckoned with in future studies on regulatory events in the nidovirus replicative cycle. 
For example, nidovirus RdRp attenuation during minus-strand RNA synthesis at body TRS 
regions may mechanistically resemble the “premature termination” step in tombusviruses 
and may also be controlled by a network of long-distance RNA-RNA interactions135. Long-
range RNA-RNA interactions playing a role in the generation of subgenome-length minus 
strands during nidovirus infection may be the reason that no conserved “local” higher-
order structures have been identified in the body TRS regions of nidovirus genomes so 
far. This possibility should be accounted for when designing in vitro assays to examine 
the possible stalling of nidovirus RdRps at body TRS motifs, as well as in experiments 
aimed at identifying protein factors interacting with TRS networks. Recent reports on the 
characterization of arteri- and coronavirus RNA-synthesizing complexes isolated from 
infected cells have shown they require cytoplasmic host factor(s) for activity in vitro222,223, 
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confirming a key role of host proteins in nidovirus replication. The identity of these fac-
tors and the mechanisms of their action remain to be identified, but they may be part of 
a larger pool of cellular proteins recruited to facilitate nidovirus replication. Pinpointing 
the step(s) of nidovirus RNA synthesis regulated by cellular factors will require an expan-
sion of the current set of experimental approaches with assays that allow the analysis of 
viral RNA translation and minus-strand RNA synthesis at a level of detail that is currently 
not attainable. Lastly, research on the determinants of nidovirus particle assembly may 
benefit from exploring a potential connection between nidovirus genome replication 
and encapsidation. Such a link could ensure the efficiency of RNA incorporation into 
progeny particles, for which the presence of a packaging signal is seemingly insufficient24, 
and may shed more light on the possible roles of nidovirus replicative proteins in virion 
biogenesis. 
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abstract
aBstRaCt
The highly conserved NendoU replicative domain of nidoviruses (arteriviruses, coronavi-
ruses, and roniviruses) belongs to a small protein family whose cellular branch is proto-
typed by XendoU, a Xenopus laevis endoribonuclease involved in nucleolar RNA process-
ing. Recently, sequence-specific in vitro endoribonuclease activity was demonstrated 
for the NendoU-containing nonstructural protein (nsp) 15 of several coronaviruses. To 
investigate the biological role of this novel enzymatic activity, we have characterized a 
comprehensive set of arterivirus NendoU mutants. Deleting parts of the NendoU domain 
from nsp11 of equine arteritis virus was lethal. Site-directed mutagenesis of conserved 
residues exerted pleiotropic effects. in a first-cycle analysis, replacement of two con-
served Asp residues in the C-terminal part of NendoU rendered viral RNA synthesis and 
virus production undetectable. in contrast, mutagenesis of other conserved residues, 
including two putative catalytic His residues that are absolutely conserved in NendoU 
and cellular homologs, produced viable mutants displaying reduced plaque sizes (20 to 
80% reduction) and reduced yields of infectious progeny of up to 5 log units. A more 
detailed analysis of these mutants revealed a moderate reduction in RNA synthesis, with 
subgenomic RNA synthesis consistently being more strongly affected than genome 
replication. Our data suggest that the arterivirus nsp11 is a multifunctional protein with 
a key role in viral RNA synthesis and additional functions in the viral life cycle that are as 
yet poorly defined.
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INtRODuCtION
Nidoviruses are enveloped, positive-strand RNA viruses that have been grouped to-
gether on the basis of similarities in genome organization, the use of similar strategies 
for nonstructural and structural protein expression, and the presumed common ancestry 
of key replicative enzymes2,3,8,12,24. The order Nidovirales currently includes the families 
Arteriviridae, Coronaviridae, and Roniviridae. Notwithstanding their taxonomic unifica-
tion, important differences between nidovirus subgroups exist at the levels of genome 
size, virion architecture, biology of virus-host interactions, and pathogenesis.
Nidovirus RNA synthesis in infected cells entails both amplification of the viral genome 
and the production of an extensive set of subgenomic (sg) mRNAs, presumably each 
from their specific negative-stranded intermediates17-19. RNA synthesis is driven by a 
set of nidovirus enzymes commonly referred to as “replicase”, which includes several 
activities that are rare or lacking in other RNA viruses23. The replicase is expressed from 
the incoming genome by translation of the large open reading frames (ORFs) 1a and 
1b into polyproteins pp1a and pp1ab. The latter polypeptide is a C-terminally extended 
version of pp1a and is derived from a –1 ribosomal frameshift from ORF1a into overlap-
ping ORF1b. The core of the nidovirus replicase polyprotein is formed by a conserved 
array of enzymatic domains consisting of (from N- to C-terminus) one or more papain-
like “accessory proteinases”, a chymotrypsin-like “main proteinase”, the RNA-dependent 
RNA polymerase (RdRp), a helicase that contains a N-terminal zinc-binding domain, 
and an endoribonuclease called NendoU (for Nidovirus-specific endoribonuclease; see 
below)11,24,39. For nidovirus replicase polyproteins of over 6,500 amino acids, encoded 
by Coronaviridae and Roniviridae which have genomes of over 25 kilobases, several 
additional enzymatic activities have been predicted9,23,35,37. The fact that these enzymes 
have not been found in the proteome of the Arteriviridae, which have smaller genomes 
of between 12 and 16 kilobases, was linked to the postulated functional hierarchy of 
the predicted nidovirus “RNA-processing enzymes”, with the nidovirus-wide conserved 
domain (NendoU) playing a key role in the initiation of a cascade of reactions23. 
The replicase polyproteins of equine arteritis virus (EAv), the arterivirus prototype, are 
autocatalytically cleaved into nonstructural proteins (nsps) 1 to 12 by three proteinases 
residing in nsp1, nsp2, and nsp4 (for a review, see reference40). The EAv structural proteins 
are encoded by seven ORFs in the 3’ proximal quarter of the genome and are expressed 
from a nested set of sg mRNAs. These are not only 3’ coterminal with the genome but also 
carry a common 211-nucleotide (nt) 5’ leader sequence, which is identical to the 5’ proxi-
mal region of the genome5. The sg mRNAs are produced via a unique mechanism that 
presumably involves discontinuous extension of minus strand RNA synthesis to produce 
sg-length minus strand templates for the synthesis of sg mRNAs17-19,22. The discontinuous 
step in minus-strand RNA synthesis, during which sequences that are noncontiguous in 
the antigenome are fused to give the sg-length minus strand RNAs, is guided by a base-
pairing interaction between complementary transcription-regulating sequences (TRSs) 
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figure 1. Nidovirus replicase comparison and sequence alignment of the EAv NendoU domain. (A) The 
replicase gene organization of the arteriviruses EAv and porcine reproductive and respiratory syndrome virus 
(PRRSv) and coronaviruses HCov-229E and SARS-Cov are depicted in the form of the polyprotein pp1ab. 
The border between ORF1a- and ORF1b-encoded residues is indicated as RFS (ribosomal frameshift). Gray 
and black arrows represent the sites that are cleaved by accessory papain-like proteinases (AP) and the main 
(“3C-like”) proteinases (MP), respectively. The proteolytic cleavage products are numbered, and within the 
cleavage products, the location of domains that have been identified as structurally or functionally related 
are indicated in black boxes. These include the four nidovirus-wide conserved domains encoded by ORF1b 
(RdRp, zinc-binding domain [Z], helicase [HEL], and NendoU [N]), putative transmembrane domains (TM), 
coronavirus-specific conserved domains (Ac, X, y, ExoN, and MT), and one SARS-Cov specific insertion (SUD). 
For details, see references11, 23, 24, 39 and references therein. Note that the arterivirus and coronavirus polyproteins 
are drawn to different scales. (B) Sequence alignment of the most conserved regions of the NendoU domain of 
several nidoviruses with cellular proteins from the XendoU family. Subdomains A (present in all proteins) and B 
(nidovirus-specific) are indicated. Key conserved residues are shown in bold. in the EAv sequence (bottom line), 
arrows indicate the amino acids targeted in this study by site-directed mutagenesis; amino acid numbers refer 
to their position in EAv pp1ab. Abbreviations and accession numbers are as follows: Npun 0562, hypothetical 
protein of Nostoc punctiforme, ZP_00106190; Poliv smB, pancreatic protein of Paralichthys olivaceus, 
BAA88246; Celeg Pp11, placental protein 11-like precursor of Caenorhabditis elegans, NP_492590; Xlaev 
endoU, endoU protein of Xenopus laevis, CAD45344; SARS-Cov, NC_004718; HCov-229E, human coronavirus 
229E, NC_002645; TGEv, transmissible gastroenteritis virus, NC_002306; MHv-A59, mouse hepatitis virus A59, 
NC_001846; BCov-LUN, bovine coronavirus LUN, AF391542; iBv-B, avian infectious bronchitis virus Beaudette, 
NC_001451; ETov, equine torovirus, X52374; LDv-C, lactate dehydrogenase-elevating virus type C, NC_002534; 
PRRSv-Lv, porcine reproductive and respiratory syndrome virus, strain Lelystad, M96262; PRRSv-vR, porcine 
reproductive and respiratory syndrome virus, strain ATCC vR2332, AAD12125; SHFv, simian hemorrhagic fever 
virus, NC_003092; and EAvB equine arteritis virus strain Bucyrus, NC_002532.
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present at the 3’ end of the nascent minus strand (anti-body TRS) and in the leader region 
of the genomic template (leader TRS)17,27,32. 
Four conserved domains, residing in proteins currently known as nsp9 to nsp11, 
were originally identified when the EAv ORF1b-encoded polypeptide was compared 
to its coronavirus and torovirus counterparts8 (Fig. 1A): the RdRp in nsp9, a putative 
multinuclear zinc-finger and RNA helicase domain that are combined in nsp1020,21, and 
a nidovirus-wide conserved domain in the C-terminal part of nsp11 (between His-2961 
and Phe-3039, using the pp1ab amino acid numbering). This latter domain has no known 
homologs in other groups of RNA viruses and thus it can be regarded as a genetic marker 
of the Nidovirales. A distant relationship between this nidovirus-specific domain and a 
family of cellular proteins prototyped by a Xenopus laevis endoribonuclease (XendoU)15, 
was recently identified23. XendoU is a Mn2+-dependent RNase that cleaves at U stretches 
and releases 2’-3’-cyclic phosphodiester products upon the processing of intron-encoded 
small nucleolar RNAs15. its nidovirus homolog was dubbed “NendoU”13 and using SARS-
coronavirus and three other coronaviruses, two groups independently verified the in vitro 
endoribonuclease activity of the coronavirus nsp15 replicase subunit, which contains the 
NendoU domain1,13. Also, coronavirus NendoU was shown to be Mn2+ dependent, pro-
duce molecules with 2’-3’ cyclic phosphate ends, and cleave upstream and downstream 
of uridylates in GU or GUU sequences. ivanov and colleagues13 reported a preference of 
NendoU for double-stranded over single-stranded RNA molecules, but a slight prefer-
ence for single-stranded RNA was claimed by Bhardwaj and colleagues1. Three residues 
(His-162, His-178, and Lys-224 in XendoU) that are absolutely conserved in proteins 
of the XendoU/NendoU family were implicated in catalysis10,23. Their replacement was 
not tolerated in coronavirus NendoU13 and XendoU10. Using an infectious cDNA clone 
of human coronavirus 229E (HCov-229E), a single substitution of a conserved NendoU 
Asp (Asp-6408; Fig. 1B), which also abolished endonuclease function in the in vitro assay, 
was found to completely block viral RNA synthesis and virus production13. This amino 
acid and a second conserved Asp residue (Asp-6435 in HCov-229E; Fig. 1B) reside in the 
C-terminal part of the NendoU domain, which is well conserved in all nidoviruses, but 
cannot be confidently aligned with the corresponding region in the cellular homologs 
(see below). 
To obtain more information on the role of NendoU in the life cycle of nidoviruses 
in general and of arteriviruses in particular, we performed an extensive site-directed 
mutagenesis study. Using our EAv reverse genetics system, the domain was partially or 
completely deleted and a variety of point mutations were introduced at the position of 
key conserved residues, including those presumably involved in catalysis. Mutants were 
tested for genome and sg RNA synthesis and, when viable, production of progeny virus. 
Whereas deletions and certain point mutations blocked all detectable viral RNA synthe-
sis, other substitutions resulted in attenuated but viable virus mutants. A more detailed 
analysis of the latter mutants suggested a specific link between the NendoU domain and 
viral sg mRNA synthesis.
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mutagenesis of nsp11 in the eav full-length cDNa clone
Mutations in the EAv nsp11 NendoU domain were introduced in an appropriate shuttle 
vector by standard site-directed PCR mutagenesis as described by Landt et al.14. Restric-
tion fragments containing the desired mutations were transferred to pEAv211, a wild-
type (wt) EAv full-length cDNA26, after which all PCR-derived sequences were verified 
to exclude the introduction of unwanted additional nucleotide changes. The mutations 
engineered in the nsp11-coding region are listed in Table 1. pEAv211 was used as the wt 
control in all experiments. The NendoU deletion mutant was constructed by mutagenesis 
PCR, using a sense primer in which nucleotide 9091 was fused to nucleotide 9338 of the 
EAv genome, thereby making an in-frame deletion of the sequences encoding pp1ab 
residues His-2963 to Asp-3038. Similarly, mutants lacking the N-terminal part (His-2963 
to Lys-3007) or the C-terminal part (Ser-3011 to Asp-3038) of the NendoU domain were 
constructed. The PCR products containing the deletions were transferred to pEAv211 
using appropriate restriction sites.
RNa transfection, eav infection, immunoprecipitation and immunofluorescence 
analysis
Baby hamster kidney (BHK-21; ATCC CCL10) cells were electroporated with in vitro derived 
RNA transcripts of wt and mutant EAv full-length cDNA clones, as described previously29. 
infection of BHK-21 cells with EAv-containing supernatants harvested after transfec-
tion, 35S-labeling of protein synthesis, and immunoprecipitation analysis of transfected 
cells were performed by using the methods of de vries and colleagues6. To ensure the 
quantitative nature of the immunoprecipitation, lysate and antiserum were titrated and 
it was confirmed that all of the target protein had been precipitated by performing a 
control reimmunoprecipitation on the supernatant of the primary immunoprecipitation. 
immunofluorescence analyses with EAv-specific antisera against nsp3 (98E3) and N (Mab 
3E2) were performed according to van der Meer and colleagues28. To monitor and com-
pare transfection efficiencies, cells were labeled with anti-nsp3 serum 98E3 and Hoechst 
33258 (1 μg/ml final concentration) to stain nuclei17. For plaque assays, subconfluent 
monolayers of BHK-21 cells were infected with 10-fold serial dilutions of wt or mutant 
EAv. Following a 1-h incubation, a 1% agar overlay was applied and cells were incubated 
at 39.5°C. Plaques were stained with 0.75% (w/v) crystal violet 4 days postinfection. To 
test nonviable mutants for a possible temperature-sensitive phenotype, plaque assays 
were also performed at 34°C.
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RNa isolation and analysis
intracellular RNA was isolated by using the acidic phenol method as described by van 
Marle and colleagues32. RNA was separated in denaturing agarose-formaldehyde gels and 
detected by hybridization to a 32P-labeled probe E154 (5’-TTGGTTCCTGGGTGGCTAATA-
ACTACTT-3’), which is complementary to the 3’ end of the EAv genome and recognizes 
the genome and all sg mRNAs. Phosphorimager screens were exposed to the hybridized 
gels and scanned with a Personal Molecular imager FX (Bio-Rad). Band intensities were 
quantified with Quantity One v4.2.2 software (Bio-Rad).
The presence of the original NendoU mutation(s) in progeny virus was verified in the 
following way: supernatant harvested at the indicated time point was used to infect 
fresh BHK-21 cells. At 24 h post infection, total RNA was isolated and used in reverse 
tra,scription (RT)-PCR experiments with E533 (5’-CAATCACAGAAATAGCAAAATCAGC-3’; 
nt 9799-9823) as antisense primer for the RT and PCR and E519 (5’-CGAGGAAAAGTTT-
GCCGCCGC-3’; nt 9082-9102) as sense primer for PCR. The PCR-products were purified 
and sequenced directly using standard protocols. 
Results
Deletion of the eav Nendou domain is lethal
The boundaries of EAv nsp11 are Ser-2838 and Glu-3056 (using pp1ab numbering)30, with 
residues His-2961 to Phe-3039 forming the conserved 78-residue core of the NendoU 
domain. An alignment of the EAv NendoU domain with cellular and nidovirus homologs 
is shown in Fig. 1B. As explained in the introduction, the N-terminal part (His-2963 to 
Ser-3011; subdomain A) is conserved across the XendoU/NendoU family and contains 
the EAv equivalents (His-2963, His-2978, and Lys-3007) of the putative catalytic residues 
identified in XendoU (His-162, His-178, and Lys-224)10 and HCov-229E nsp15 (His-6345, 
His-6360, and Lys-6401)13. However, the C-terminal 30 residues (subdomain B) of the 
NendoU domain appear to be specific for nidoviruses and include two conserved Asp 
residues (Asp-3014 and Asp-3038), which were found to be equally indispensable for in 
vitro endoribonuclease activity13. Moreover, a reverse genetics experiment showed that 
an Asp-6408→Ala substitution completely blocked Hcov-229E RNA synthesis13. 
 As an initial test of its importance for EAv replication, in-frame deletion mutants 
of the EAv NendoU domain were engineered and transferred to the infectious cDNA 
clone29. Either the complete NendoU-coding sequence was deleted from the nsp11-
coding region or the sequences roughly corresponding to subdomain A (deletion from 
His-2963 to Lys-3007) or subdomain B (Ser-3011 to Asp-3038) were deleted. Electropora-
tion into BHK-21 cells of in vitro-transcribed RNA from these constructs and subsequent 
immunostaining showed that, in all three cases, the virus was no longer viable (data not 
shown), suggesting that the complete NendoU domain is essential for EAv replication. 
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table 1. Overview of the genotype and first-cycle phenotype of EAv NendoU mutants used in this studya
Construct mutation
wt 
codon
mutant 
codon
Nsp3 
Ifab
N
Ifab
Infectious 
progeny 
(Pfu/ml)C
summary of phenotyped
pEAv211
none 
(wild type)
+ + + (~107) Wild type
H2963A His-2963Ala CAU GCA + + + (~102) Small plaque size
H2963Q His-2963Gln CAU CAG + + + (~103) Small plaque size
H2978A His-2978Ala CAU GCC + + + (~103) Small plaque size
H2978Q His-2978Gln CAU CAA + + + (~102) Small plaque size
H2963A/
H2978A
His-2963Ala
His-2978Ala
CAU
CAU
GCA
GCC
+ + + (~102) Small plaque size
S2982A Ser-2982Ala UCC GCC + + + (~107) Wild type
D2992A Asp-2992Ala GAC GCA - - - Nonviable
D2992N Asp-2992Asn GAC AAC + + + (~107) Wild type
D2992G Asp-2992Gly GAC GGC + + + (~107) Wild type
K3004A Lys-3004Ala AAA GCA + + + (~106-107) Wild type
K3004H Lys-3004His AAA CAU + + + (~106-107) Wild type
K3004R Lys-3004Arg AAA AGA + + + (~107) Wild type
K3007A Lys-3007Ala AAA GCC + + + (~102-103) Small plaque size
K3007H Lys-3007His AAA CAU + + + (~102-103) Small plaque size
K3007R Lys-3007Arg AAA CGG + + + (~103) Small plaque size
S3011A Ser-3011Ala AGC GCC + + + (~105) intermediate plaque size
S3011T Ser-3011Thr AGC ACC + + + (~107) Wild type
S3011C Ser-3011Cys AGC UGC + + + (~105) intermediate plaque size
D3014A Asp-3014Ala GAU GCU - - - Nonviable
D3014E Asp-3014Glu GAU GAG - - - Nonviable
D3014N Asp-3014Asn GAU AAC - - - Nonviable
S3030A Ser-3030Ala AGU GCC + + + (~106) intermediate plaque size
S3030T Ser-3030Thr AGU ACG + + + (~105) intermediate plaque size
S3030C Ser-3030Cys AGU UGC + + + (~106) intermediate plaque size
D3038A Asp-3038Ala GAU GCU - - - Nonviable
D3038E Asp-3038Glu GAU GAA - - - Nonviable
D3038N Asp-3038Asn GAU AAU - - - Nonviable
a Data from two independent transfection experiments are summarized. +, positive; - , negative.
b Transfected cells were analyzed after one cycle of replication at 19 h posttransfection. iFA, 
immunofluorescence assay.
c Results indicate the detection of infectious progeny (plaque assays) in medium from transfected cells 
harvested at 19 h posttransfection; approximate virus titers
are shown between brackets.
d Nonviable indicates that no replication detected in immunofluorescence assays for nsp3 and N protein 
(see Fig. 4), and no infectious progeny were detected at 19 h
post-transfection; small plaques were approximately 20% of the wt plaque size. The diameter of 
intermediate-size plaques ranged from 30 to 80% of the wt plaque size.
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Formally, detrimental effects of these deletions (and other lethal mutations; see below) 
at the level of pp1ab proteolysis cannot be excluded even though their C-terminal border 
was relatively distant from the nsp11/12 cleavage site. Unfortunately, straightforward 
analysis in a trans-cleavage assay of the replicase processing event at the nsp11/12 junc-
tion was previously found to be impossible30.
On the basis of the alignment presented in Fig. 1B, both absolutely and less-conserved 
residues of EAv NendoU were targeted by site-directed mutagenesis and reverse genet-
ics (Table 1). Each of the five invariant residues was replaced by Ala and one or two ad-
ditional conservative substitutions. Also some less conserved and variable residues were 
replaced as a control for the alignment and to confirm that amino acid substitutions in 
general could be tolerated in this part of the polyprotein. Mutations were introduced 
into an EAv infectious cDNA clone and, after electroporation of in vitro-transcribed RNA, 
virus viability was analyzed at different time points after transfection. The initial screen-
ing was done on the basis of a double immunofluorescence assay for replicase subunit 
nsp3 and the nucleocapsid (N) protein, which can be used as markers for the synthesis of 
genome and sg mRNA7, respectively31. Cell culture supernatants were harvested around 
the end of the first replication cycle (19 h posttransfection) and tested in a plaque as-
say for the production of infectious virus progeny. Table 1 summarizes the mutations 
that were tested and the results of the first-cycle analysis that were obtained from two 
independent transfection experiments.
Both conserved asp residues in Nendou subdomain B are critically involved in 
arterivirus RNa synthesis
We first probed the importance of the pair of Asp residues (Asp-3014 and Asp-3038) in 
subdomain B that are fully conserved in the NendoU domain of all known nidoviruses. 
Both conservative (Asp→Asn or Asp→Glu) and non-conservative (Asp→Ala) substitu-
tions were tested, but none of these were tolerated. in a first-cycle analysis, no sign of 
nsp3 or N protein synthesis was detected in immunofluorescence assays of transfected 
cells and the production of infectious progeny virus could not be demonstrated in 
plaque assays (Table 1). Ser-3030 of EAv NendoU is the third subdomain B residue that 
is fully conserved in all nidoviruses. Also, this amino acid was replaced with Ala and, 
more conservatively, with Thr and Cys. in all three cases, replication of the mutant virus 
was significantly reduced, with a plaque size that was 30-60% compared to that of the 
wt control (termed “intermediate size” in Table 1) and virus titers being 10- to 100-fold 
reduced. Another Ser residue that was probed, Ser-3011 of EAv NendoU, is located at 
the border between subdomains A and B. A Thr residue is found at this position in some 
cellular proteins of the XendoU family and in all nidovirus homologs, with the exception 
of SARS-Cov (Fig. 1B). To probe the importance of this residue and to corroborate the 
quality of the alignment in Fig. 1B, Ser-3011 was replaced by Thr. This indeed produced a 
mutant virus with a phenotype that could not be discriminated from that of the wt con-
trol, both in terms of virus titer that was obtained and in terms of plaque size. in contrast, 
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substitutions of the Ser-3011 residue by Ala or Cys were less well tolerated: replication 
of these mutant viruses was delayed, plaques were 60-80% of the wt size, and virus titers 
were ~100-fold reduced. Taken together, our data confirmed and extended the general 
importance for nidovirus RNA synthesis of NendoU subdomain B, and in particular its 
pair of conserved Asp residues.
substitution of putative catalytic residues in Nendou subdomain a is not lethal
Obviously, the EAv equivalents (His-2963, His-2978, and Lys-3007) of the three residues 
previously implicated in XendoU/NendoU catalysis (see above) were primary targets for 
site-directed mutagenesis of subdomain A. Both His residues were replaced with Ala or 
Gln, whereas Lys-3007 was substituted with Ala, His, or Arg. However, none of these seven 
substitutions was lethal, although all mutant viruses were severely impaired compared 
to the wt control. irrespective of the replacement used, plaque sizes were reduced to 
approximately 20% of the wt plaque size and virus titers in the order of 102 to 103 PFU/
ml were measured in transfected cell culture supernatant harvested at 19 h posttrans-
fection, a reduction of 4 to 5 log compared to the wt virus. The reduced plaque size is 
illustrated in Fig. 2 for mutants His-2963→Gln and His-2978→Ala. There was no apparent 
synergistic effect of combining the Ala substitutions of both conserved His residues into 
a double mutant (mutant H2963A/H2978A): this virus displayed a similar small plaque 
size phenotype, and also produced ~102 PFU/ml by 19 h posttransfection. 
To verify the presence of the original mutations in the progeny of the mutants, fresh 
BHK-21 cells were infected with transfection supernatants harvested after 46 to 72 h. 
intracellular RNA was isolated from these infected cells after 24 hours, and the direct se-
quence analysis of RT-PCR products derived from this material confirmed that reversion 
to the wt residue had not occurred for any of the mutants with small plaque sizes. in fact, 
the two His→Ala mutations in this double H2963A/H2978A mutant were found to be 
stable for up to 10 passages in BHK-21 cells (data not shown). in conclusion, although the 
substitution of equivalent residues in both XendoU and coronavirus NendoU reduced in 
vitro endoribonuclease activity to undetectable levels10,13, our in vivo data revealed that 
His-2963→Gln His-2978→Ala wild-type
figure 2. Plaque morphology of selected EAv NendoU mutants. The plaque sizes from mutants carrying 
mutations at the position of the putative catalytic residues His-2963 and His-2978 were approximately 
fivefold smaller than those of the wt virus. Plaque sizes of mutants carrying other substitutions at the 
positions of His-2963 and His-2978 or replacements of Lys-3007 were comparable to the plaque sizes 
depicted in this figure.
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EAv mutants carrying such mutations are capable of a consistently low but significant 
level of replication.
in addition to the replacement of the conserved subdomain A residues, several ad-
ditional EAv NendoU residues were targeted, mainly as controls for the alignment and 
the substitutions described above. Replacement of Lys-3004, serving as a control for Lys-
3007 mutagenesis, did not have any effect on virus viability, irrespective of whether Ala, 
His, or Asn was introduced. Also, substitution of a Ser residue (Ser-2982→Ala) that is fully 
conserved in Arteriviridae but not in Coronaviridae proved to be neutral with regard to vi-
rus replication. A final control substitution, replacement of the charged Asp-2992 by Ala, 
resulted in a nonviable virus. However, upon closer inspection of the alignment (Fig. 1B), 
we decided to also replace this residue with Gly (present in the mouse arterivirus lactate 
dehydrogenase-elevating virus) and Asn (which is more conservative compared to the 
Glu or Gln present at this position in most other nidoviruses). Both the Asp-2992→Gly 
and the Asp-2992→Asn mutant proved to have wt phenotype. Since, in contrast to Ala, 
both Gly and Asn frequently reside in β-turns, this result suggests that this property may 
be important for the residue at this position.
in summary, the EAv system was found to tolerate the substitution of three (putative) 
active site residues of NendoU which have been absolutely conserved throughout ni-
dovirus evolution. Although replication of these mutants was profoundly impaired, as 
evident from reduced progeny titers and smaller plaque sizes, this phenotype was in 
clear contrast with that described above for the mutants carrying substitutions of the 
pair of conserved Asp residues in subdomain B.
selective reduction of subgenomic RNa synthesis in mutants with a reduced 
plaque size
The intracellular RNA synthesis of selected mutants was analyzed by isolating total RNA 
from transfected BHK-21 cells at 13 h post electroporation, which, in electroporation 
experiments, approximately equals the peak of RNA synthesis during the first cycle of 
replication. The viral genome (RNA1) and sg mRNAs (RNAs 2 to 7) were separated in aga-
rose gels and visualized by hybridization. No virus-specific RNAs were detected for the 
nonviable or quasi-viable Asp-3014 and Asp-3038 mutants (data not shown). in line with 
its previously described wt phenotype, an RNA pattern very similar to that of wt virus 
was observed for the Ser-3011→Thr mutant. All other mutants analyzed, including those 
with substitutions at the positions of His-2963, His-2978, and Lys-3007, showed a modest 
but significant reduction of viral RNA synthesis compared to the wt control (Fig 3A). 
The relative amounts of genomic RNA and the three most abundant sg mRNAs (mRNAs 
2, 6 and 7) were quantified by phosphorimager analysis. When the amount of genome 
RNA in each lane was set at 100%, the usual value of between 2:1 and 3:1 was obtained 
for the ratio of sg mRNAs versus genome RNA in the wt control and mutant S3011T, 
which has a wt phenotype (Fig. 3B). However, in all other mutants, a specific reduction 
of sg mRNA synthesis was detected. This effect was most prominent in the mutants that 
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produced the smallest plaques, i.e. those with substitutions of His-2963, His-2978, Lys-
3007, and the His-2963/His-2978 double mutant. The reduction of sg mRNA synthesis 
was less striking but still consistently observed for the Ser-3011 and Ser-3030 mutants, 
which had an intermediate plaque size (Table 1).
To make it possible to monitor viral RNA synthesis beyond the end of the first replica-
tion cycle, and without virus spreading to initially untransfected cells, we engineered 
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figure 3. Analysis of intracellular RNA synthesis for selected EAv NendoU mutants. (A) Hybridization 
analysis of intracellular RNA isolated from transfected BHK-21 cells at 13 h post-transfection. The RNA 
was hybridized to an oligonucleotide complementary to the 3’ end of the genome, recognizing both the 
genomic (RNA1) and sg mRNAs 2 to 7. (B) Reduced sg mRNA synthesis by nsp11 mutants with a small or 
intermediate plaque size phenotype. Using the gel depicted in Fig. 3A, the signals for the genomic RNA 
and the most abundant sg mRNAs (2, 6, and 7) in the same lane were quantified. The graph shows the ratio 
(RNA2 + RNA6 + RNA7)/RNA1 for each mutant and the wt control and illustrates the selective reduction of 
sg mRNA synthesis in NendoU mutants with a small or intermediate plaque size phenotype.
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mutants that were negative for virus production. These constructs were based on the 
previously described ORF6 knock-out mutant (ΔORF6)16, which lacks membrane (M) pro-
tein expression and therefore is unable to produce progeny virus36,38. We transferred the 
NendoU His-2963→Ala/His-2978→Ala double mutation and the Lys-3007→Ala single 
mutation to the ΔORF6 backbone and compared RNA synthesis to that of the parental 
ΔORF6 mutant, which contains a wt replicase gene. viral RNA synthesis was analyzed at 
15, 18, 21, and 24 h post transfection and a selective reduction in sg mRNA synthesis was 
again observed for both NendoU mutants at all four time points (data not shown). This 
indicated that the earlier measurements (Fig. 3B) were not likely to be compromised by 
the possibility that sg RNA synthesis of these generally impaired NendoU mutants simply 
lagged behind. Compared to the wt control, these mutants consistently underproduced 
sg mRNAs, suggesting the direct or indirect involvement of NendoU in a process that is 
relatively more important for sg mRNA production than for genome RNA synthesis. 
figure 4. Analysis of structural protein expression of selected 
EAv NendoU mutants. The top panel shows a hybridization 
analysis of sg RNA6 and RNA7 isolated from transfected BHK-21 
cells at 13 h post-transfection (also see Fig. 3). On the right side, 
the corresponding immunoprecipitation data are shown for 
the viral structural proteins M and N, which were 35S-labeled 
from 9 to 13 h post-transfection. The bottom panel shows an 
immunofluorescence analysis (also at 13 h post-transfection) of 
cells transfected with small plaque size mutant Lys-3007→Arg, 
intermediate plaque size mutant Ser-3011→Ala, or the wild-
type control. Cells were double-labeled for replicase subunit 
nsp3 and structural protein N. All images were recorded with the 
same exposure time and contrast/brightness settings. Whereas 
cells transfected with the wild-type control were double positive 
for replicase and N protein, many cells transfected with the 
mutants were fully positive for replicase but either still negative 
or only weakly positive for the N protein.
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Structural protein synthesis was studied in more detail for a selection of mutants (Fig. 4). 
immunofluorescence analysis confirmed that N protein expression of mutants with small 
and intermediate plaque sizes was reduced and lagged behind. Whereas all cells in the 
wild-type control were double-positive for replicase and N protein at 13 h post transfec-
tion, many cells transfected with the mutants were fully positive for replicase, but either still 
negative or only weakly positive for the N protein (Fig. 4). Only at 20-24 h posttransfection 
all cells had become clearly double-positive for both marker proteins (data not shown). in 
a combined RNA and immunoprecipitation analysis at 13 h posttransfection (Fig. 4) using 
samples from equal numbers of transfected cells, the amounts of sg RNA 6 and 7 accumu-
lated by the small plaque mutants His-2963→Ala and Lys-3007→Arg and intermediate 
plaque size mutant Ser-3011→Ala was compared to the synthesis of the corresponding 
structural proteins M and N. Proteins were 35S-labeled from 9 to 13 h post transfection and 
immunoprecipitated with monospecific rabbit antisera6. Compared to the wild-type con-
trol, the structural protein synthesis of the three mutants was clearly reduced but not to an 
extent that would readily explain the large differences (up to 5 log) in infectious progeny 
titers. When comparing mutants with small and intermediate plaque sizes (showing differ-
ences of 2 to 3 log units in infectious progeny titers), sg RNA and structural protein levels of 
the latter were found to be threefold higher at most. Finally, an anti-nsp11 serum was used 
to confirm that small and intermediate plaque size mutants produced similar amounts of 
cleaved nsp11 compared to the wild-type control (data not shown), making it unlikely that 
an nsp11 processing defect is the explanation for the phenotypes of these mutants.
DIsCussION
Pleiotropic effects upon eav Nendou mutagenesis 
in the wake of the 2003 SARS outbreak, the increased interest in the giant and poorly 
characterized coronavirus replicase triggered an in-depth (re)analysis of the nonstructur-
al proteins of SARS-Cov, other coronaviruses, and other nidoviruses. As a direct result, the 
domain previously referred to as “conserved C-terminal nidovirus-specific domain”8 was 
predicted and proven to have endoribonuclease activity1,13,23. Using a HCov-229E reverse 
genetics system, ivanov and colleagues13 showed that a single Asp→Ala mutation in the 
nidovirus-specific subdomain B of NendoU completely blocked viral RNA synthesis. Thus, 
they provided the first experimental evidence for the expected key role of the highly 
conserved, though nidovirus-specific, NendoU domain in the viral life cycle.
in the present study, using the reverse genetics system for the arterivirus EAv, we have 
considerably extended and refined the in vivo analysis of NendoU function. As previously 
concluded by ivanov and colleagues, the results obtained with NendoU deletion mu-
tants and certain subdomain B point mutants indicated that NendoU is critically involved 
in general nidovirus RNA synthesis. Although the replacement of one of three putative 
catalytic residues in subdomain A also exerted a major effect on general virus viability, 
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it was somewhat surprising that only a modest effect on viral genome and sg mRNA 
synthesis was observed for these mutants (Fig. 3), raising new questions on the role of 
the NendoU domain in the nidovirus life cycle.
Formally, we cannot exclude (fundamental) differences between the role of NendoU in 
coronaviruses and arteriviruses and the possibility that equivalent mutations may produce 
different phenotypes in different systems. Reverse genetics data on coronavirus NendoU 
mutants carrying replacements of the conserved His and Lys residues in subdomain A have 
not yet been described. Nevertheless, the result obtained with the single HCov-229E Asp 
mutant that was tested13 was identical to that obtained with the corresponding mutant in 
the EAv system. On the arterivirus side, it is unfortunate that we have not yet succeeded in 
establishing an in vitro NendoU assay for EAv. This is due to complications during protein 
expression in E. coli, which apparently tolerates the expression of large amounts of an Asp-
3014→Ala mutant protein, but not of the wt EAv nsp11 (data not shown). Although the 
experimental proof that EAv nsp11 indeed possesses endoribonuclease activity is lacking, 
all residues reported to be important for the in vitro NendoU activity of its coronavirus 
ortholog are conserved in arteriviruses (Fig. 1B). Thus, we consider it unlikely that this 
activity would ultimately turn out to be lacking in arterivirus nsp11.
Is the function of Nendou uniform in the life cycle of different nidoviruses?
it is perhaps remarkable that replacements of the most conserved residues in the Xen-
doU/NendoU protein family fully blocked the in vitro endonuclease activity but were not 
lethal for EAv in the reverse genetics approach used in this study. Arguably, this apparent 
contradiction may reflect the higher sensitivity of the in vivo assay compared to the in 
vitro system as employed by ivanov and colleagues13. in the latter assay, replacement 
of the pair of His residues and the Lys in subdomain A and the pair of Asp residues in 
subdomain B yielded equally inactive enzymes. However, it is highly unlikely that Ne-
ndoU (or XendoU) mutants with very low, but different residual activities (e.g. 1% or 
less of the wt activity) can be discriminated using this type of experiment. in contrast, 
our biological assays, and in particular the quantification of infectious progeny virus 
produced by the mutants, allowed us to establish differences of up to 5 log (Table 1) 
and can thus be considered to be more sensitive. Consequently, one explanation for the 
phenotypic differences between the Asp mutants and the His/Lys mutants would be a 
higher residual endoribonuclease activity of the latter, which would suffice to support 
a certain reduced level of virus replication. This explanation would imply that the Asp 
residues in subdomain B, which are lacking in the cellular branch of the XendoU/NendoU 
family, play a more important role in NendoU function than the fully conserved His and 
Lys residues in subdomain A, which were proposed to have a catalytic role on the basis 
of experimental data and theoretical considerations relating to the reaction mechanisms 
of other ribonucleases10.
Despite the common ancestry of arterivirus and coronavirus replicases, the polypro-
tein of coronaviruses is considerably larger and in addition to NendoU harbors a series 
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of other putative RNA-processing activities with possibly interconnected functions23. 
it should also be noted, as observed previously by de vries and colleagues7, that the 
NendoU domain is associated with a different N-terminal domain when coronavirus 
nsp15 and arterivirus nsp11 are compared. Within the currently defined NendoU domain, 
the role of subdomain B and its pair of conserved Asp residues is intriguing. Gioia and 
coworkers10 suggested that the two NendoU Asp residues might be the equivalents of 
two XendoU Glu residues (Glu-161 and Glu-167) which were proposed to participate in 
catalysis on the basis of mutagenesis studies. However, these two amino acids more or 
less flank the first conserved His residue (His-162 in XendoU) and thus occupy a com-
pletely different position in the primary structure of the protein compared to the pair of 
conserved Asp residues in NendoU subdomain B. Clearly, structural information for both 
cellular and nidoviral representatives of this novel endoribonuclease family will be re-
quired to understand the domain composition and catalytic mechanism of the enzyme, 
and the specific role of subdomain B in the viral subgroup. At present, it should even be 
considered that the latter domain, although structurally adjacent to NendoU, could be 
functionally separated and fulfill a different role that might be the basis for some of the 
phenotypic differences observed in our collection of EAv mutants. 
Dissecting the role of Nendou in the eav life cycle
The pleiotropic effects observed upon EAv NendoU mutagenesis and their analysis using 
the complex system of a replicating RNA virus in its host cell make it difficult to assess at 
how many levels NendoU may actually influence EAv replication. Clearly, specific dele-
tions and mutations in NendoU can abolish all viral RNA synthesis, supporting a general 
and critical role in this process. Furthermore, we observed a stronger reduction of sg 
mRNA synthesis compared to genome synthesis in a subset of the mutants, but these 
findings could also be attributed to the former process being more sensitive to a general 
debilitating effect of NendoU mutagenesis on virus viability. Still, it appears that the His-
2963/His-2978/Lys-3007 mutants form a separate group and that these mutations exert 
a consistently stronger effect on sg RNA synthesis than e.g. substitutions of Ser-3011 or 
Ser-3030 (Fig. 3B). Also in terms of the production of infectious virus progeny (virus titers 
and plaque size) these mutants appear to segregate into two clusters (Table 1). 
When comparing the wt virus, the intermediate plaque size mutants (replacements of 
Ser-3011 and Ser-3030), and the small plaque size mutants (replacements of His-2963, 
His-2978, and Lys-3007), it appears that relatively small differences in RNA synthesis 
(certainly not more than 10-fold; Fig. 3) are translated into unexpectedly large differences 
in virus production (up to 5 log units) (Table 1). These findings could be interpreted to 
imply that NendoU has an additional function downstream of viral RNA synthesis, for 
example, in a pathway leading to virion assembly. However, it should also be noted that 
little is known about the process in which the seven EAv structural proteins, expressed 
from six sg mRNAs that are each made in constant but different quantities, interact 
to encapsidate the viral genome and form a virus particle36. in particular, it is unclear 
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whether the availability of any of these proteins is a rate-limiting factor for the assembly 
process. Therefore, it certainly cannot be excluded that a relatively small reduction in the 
synthesis of one or multiple sg mRNAs and a corresponding change in structural protein 
expression (Fig. 4) could actually cause a disproportional, much larger reduction in the 
production of infectious progeny.
in view of its conservation in and specificity for the order Nidovirales, the NendoU 
domain was proposed to be involved in a nidovirus-specific, conserved function. The 
synthesis of sg mRNAs, a hallmark of nidoviruses, is an example of such a function4,17-19,34 
and, based on the consensus sequence of the regulatory TRS motif, ivanov and col-
leagues13 proposed a role for the enzyme in the attenuation step during discontinuous 
sg minus-strand RNA synthesis. However, the EAv data presented in this study do not 
support a critical role for NendoU in sg RNA synthesis. Only a relatively small effect on 
RNA synthesis was observed for the putative active site mutants of EAv NendoU (Fig. 3B). 
Although, admittedly, sg RNA synthesis was affected to a greater extent than genome 
synthesis (see above), a much more pronounced effect would have been expected if 
NendoU were a key factor in nidovirus sg RNA production. Previous studies on other 
EAv replicase functions have shown that such specific effects can indeed be induced. 
For instance, deletion of the N-terminal replicase subunit nsp1 completely abolished 
EAv sg mRNA production without affecting genome replication25. Also, a Ser-2429→Pro 
mutation in the so-called “hinge region” of EAv nsp10, which connects the N-terminal 
(putative) zinc finger domain and the C-terminal helicase, resulted in an approximately 
100-fold reduction of sg mRNA synthesis, while again genome replication was not af-
fected29,33. Compared to these examples, the defects in RNA synthesis observed for the 
viable NendoU mutants described in this study should be classified as relatively minor 
and less specific for the process of sg mRNA synthesis.
in conclusion, notwithstanding the viability of many mutants, the EAv NendoU motif 
in nsp11 is an important replicase domain, although the consequences of replacement 
of some of its core residues were less black and white than expected beforehand. Since 
specific NendoU mutants were found to be replication competent and genetically stable, 
it will be interesting to analyze their long-term evolution both in BHK-21 cells and in more 
natural settings like equine cell lines, in which such mutants may have a more pronounced 
phenotype. in addition, identification of the natural substrates of coronavirus and arteri-
virus NendoU and structural information on members of the XendoU/NendoU family will 
be essential for a better understanding of the mutant phenotypes described in this study.
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abstract
aBstRaCt
Nidoviruses (arteriviruses, coronaviruses, and roniviruses) are a phylogenetically compact 
but diverse group of positive-strand RNA viruses that includes important human and 
animal pathogens. Nidovirus RNA synthesis is mediated by a cytoplasmic membrane-
associated replication/transcription complex that includes up to 16 viral nonstructural 
proteins (nsps), which carry common enzymatic activities, like the viral RNA polymerase, 
but also unusual and poorly understood RNA-processing functions. Of these, a conserved 
endoribonuclease (NendoU) is a major genetic marker that is unique to nidoviruses. 
NendoU activity was previously verified in vitro for the coronavirus nsp15, but not for 
any of its distantly related orthologs from other nidovirus lineages, like the arterivirus 
nsp11. Here, we show that the bacterially expressed nsp11 proteins of two arteriviruses, 
equine arteritis virus and porcine respiratory and reproductive syndrome virus, pos-
sess pyrimidine-specific endoribonuclease activity. RNA cleavage was independent of 
divalent cations in vitro and was greatly reduced by replacement of residues previously 
implicated in catalysis. Comparative characterization of the NendoU activity in arterivi-
ruses and severe acute respiratory syndrome coronavirus revealed common and distinct 
features of their substrate requirements and reaction mechanism. Our data provide 
the first biochemical evidence of endoribonuclease activity associated with arterivirus 
nsp11 and support the conclusion that this remarkable RNA-processing enzyme, whose 
substrate in the infected cell remains to be identified, distinguishes nidoviruses from all 
other RNA viruses.
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INtRODuCtION
The replication of single-stranded RNA viruses with genomes of positive polarity (+RNA) 
relies on a process of RNA-templated RNA synthesis that takes place in the cytoplasm 
of the infected cell. Following translation of their genomes, +RNA viruses establish 
membrane-associated replication/transcription complexes that direct amplification 
of the viral genome and, in several cases, transcription of additional viral mRNAs. The 
key replication/transcription complex component in these processes is a virus-encoded 
RNA-dependent RNA polymerase (RdRp), but in addition, +RNA viruses generally encode 
multiple protein factors that support RdRp activity and/or are involved in the spatial 
and temporal regulation of viral RNA synthesis. Many of these enzymes were initially 
identified by comparative sequence analysis, subsequently supported by biochemical 
and molecular biological experiments. in nidoviruses, arguably the genetically most 
complex +RNA viruses12, examples of such accessory enzymes are a second, low fidelity 
RdRp15, as well as an unusual set of “RNA-processing enzymes”33, which are all geneti-
cally segregated in the viral replicase gene and were implicated in various steps of the 
nidovirus life cycle8,16,21,24.
The order Nidovirales comprises the distantly related families Arteriviridae, Corona-
viridae (genera Coronavirus and Torovirus) and Roniviridae and includes the virus groups 
with the largest RNA genomes known to date12. The host range of Nidovirales extends 
from crustaceans to mammals, and the order includes pathogens associated with human 
respiratory infections, with diseases that can vary from common cold to fatal pneumo-
nia. Despite major differences in virion size and morphology, as well as pathogenesis, 
the evolutionary relationship among nidoviruses is evident from the organization and 
composition of the large replicase gene, which consists of the two 5’-most open reading 
frames (ORFs) – ORF1a and ORF1b, of the polycistronic genome (Fig. 1A). Translation of 
the 5’-capped and 3’-polyadenylated nidovirus genomic RNA results in two large precur-
sor polyproteins (pp1a and pp1ab) that are cleaved into 13 to 16 non-structural proteins 
(nsps) by virus-encoded proteases. The relative abundance of nidovirus nsps is intricately 
regulated by the proteolytic processing of the pp1a and pp1ab precursors (references35,39 
and references therein), as well as the efficiency of the -1 ribosomal frameshift required 
for the translation of ORF1b6. The nsps direct the formation of a membrane-anchored 
replication/transcription complex that mediates viral genome replication, as well as the 
synthesis of a 3’-coterminal nested set of subgenomic (sg) mRNAs23,31, from which the 
viral genes located downstream of the replicase gene are expressed. 
The core enzymatic activities commonly required for viral RNA synthesis, such as the vi-
ral RdRp and helicase functions, are encoded in ORF1b of the nidovirus genome, together 
with an additional conserved domain that has no counterpart in the RNA virus world and 
is thus considered a genetic marker of the nidovirus order12,16. Bioinformatics revealed a 
distant relationship between this domain and a small family of prokaryotic and eukaryotic 
proteins, of which XendoU, an endoribonuclease derived from Xenopus laevis that plays 
a role in the production of intron-encoded small nucleolar RNAs19, is the prototype. 
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figure 1. Conservation of the NendoU endoribonuclease across the order Nidovirales. (A) Genome 
organization of the arteriviruses EAv and PRRSv, as well as SARS-Cov. The ORFs, as well as the ORF1a/1b 
ribosomal frameshift site (RFS) and the 3’ poly(A) tail (An), are indicated. The ORFs encoding the viral 
structural proteins envelope (E), membrane (M), nucleocapsid (N), and glycoprotein 2 (GP2) to GP5 for 
EAv and PRRSv and E, M, N, and spike (S) for SARS-Cov are designated. The organization of the respective 
replicase gene products is depicted in the form of pp1ab. The arrowheads represent sites cleaved by virus-
encoded proteases, and the resulting nsps are numbered. The locations of the viral RdRp, helicase (Hel), 
ExoN, NendoU (Ne), and ribose-2’-o-methyltransferase (MT) domains (see the text) are indicated. Note that 
the SARS-Cov genome is drawn to a different scale than the EAv and PRRSv genomes. (B) Phylogenetic tree 
of the NendoU domains of arteriviruses, coronaviruses, toroviruses, and bafiniviruses. For clarity, species 
names are given only for coronaviruses, for which NendoU activity was previously documented (HCov 
229E, human coronavirus 229E; SARS-Cov; MHv; iBv, infectious bronchitis virus), as well as the arteriviruses 
whose NendoU activities were analyzed in this study (EAv and PRRSv). The sequence alignment used for 
construction of the tree, as well as the complete version of the tree, is included as supplemental material 
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XendoU cleaves U stretches in the RNA substrate in vitro in a Mn2+-dependent manner, 
releasing 2’-3’-cyclic phosphodiester products19, and a similar endoribonuclease activity 
was recently shown for a mammalian homolog of XendoU, human placental protein 11 
(PP11)20. in coronaviruses, the proposed endoribonuclease activity maps to the C-terminal 
domain of nsp15, and uridylate-specific cleavage of RNA was demonstrated in vitro for 
several nsp15 orthologs3,16,38. The enzyme was termed NendoU (nidoviral endoribonucle-
ase specific for u), and its crucial role in the coronavirus life cycle was established using 
recombinant coronaviruses that expressed mutant forms of nsp1516,18. Biochemical stud-
ies have provided some insights into the catalytic activity of coronavirus NendoU’s, such 
as their ability to process both single-stranded RNA (SSRNA) and double-stranded RNA 
(dsRNA) 3’ of uridylates and to release 2’-3’cyclic phosphodiester products5,16. The crystal 
structures of nsp15 from mouse hepatitis virus (MHv) and severe acute respiratory syn-
drome coronavirus (SARS-Cov) were recently solved29,38, revealing an active site with two 
histidines and a lysine as likely catalytic residues. The spatial arrangement of the putative 
catalytic residues was strikingly similar to that found in RNase A, a feature also proposed 
for the catalytic site of XendoU28. The critical roles of these three highly conserved residues 
(see Fig. S1 in the supplemental material) in catalysis was supported by the results of 
site-directed mutagenesis studies11,16,38, and the importance of the two His residues for 
optimal viral RNA synthesis during MHv infection was established18. Coronavirus nsp15 
proteins form hexamers via intermolecular interactions that are mediated by their N-
terminal domains13,29,38. Hexamerization has been proposed to be required for optimal 
enzyme activity, most probably by stabilizing the catalytic site in its active conformation17 
and promoting substrate binding38, and a recent study identified numerous residues of 
SARS-Cov nsp15, mapping both to the N-terminus and the catalytic domain of the protein, 
as contributing to RNA binding by the hexamer4. Lastly, the presence of Mn2+ was shown 
to enhance coronavirus NendoU activity in vitro16,38, but its precise role in RNA cleavage 
remains unclear, since it appears to be dispensable for catalysis38 and no metal-binding 
sites have been identified in any of the coronavirus enzymes characterized to date29,38. 
The coronavirus NendoU domain has poorly characterized orthologs in other nidovirus 
lineages, like arteriviruses, toroviruses and white bream virus, the prototype bafinivirus32, 
which are all separated by large evolutionary distances (Fig. 1B; see Fig. S2 in the supple-
(see Fig. S1 and S2 in the supplemental material). The numbers at branching points indicate the support of 
at least 600 out of 1,000 bootstraps, and the branch lengths of the tree represent the average numbers of 
substitutions per residue. (C) Domain organization of SARS-Cov nsp15, PRRSv nsp11, and EAv nsp11. Note 
the difference in size between the respective N-terminal domains. The homologous EAv and PRRSv nsp11 
N-terminal domains (A.E. Gorbalenya, unpublished) are hatched. The partial sequence alignment shows 
the most conserved regions in the NendoU domains of the three viral proteins used in this study and was 
extracted from the alignment presented in Fig. S1 in the supplemental material. For EAv, the amino acid 
numbers given reflect the positions in EAv nsp11 (top row; used in this study) or in replicase polyprotein 
pp1ab (bottom row; used in previous studies). Conserved residues mutated in this study are highlighted. 
The asterisks indicate residues in EAv nsp11 NendoU that were replaced with Ala. The asterisks indicate 
proposed active-site residues, and nidovirus-wide conserved aspartic acid residues are indicated with 
triangles.
106
4
mental material). For example, the NendoU domains of coronavirus nsp15 and arterivirus 
nsp11 share only 26-27% of identical residues and are fused to a family-specific N-termi-
nal domain (Fig. 1C). Clearly, the biochemical characterization of arterivirus nsp11 and 
its counterparts in other nidoviruses is a prerequisite to understanding the functional 
consequences of the observed sequence variation. The prior analysis of arterivirus nsp11 
was limited to a reverse genetics study of NendoU mutants using the arterivirus proto-
type, equine arteritis virus (EAv)24, which revealed a key role in the EAv life cycle for the 
complete nsp11 subunit, as well as the specific importance of the NendoU domain and 
its catalytic residues for viral RNA synthesis. Characterization of the putative EAv nsp11 
endoribonuclease activity in vitro, however, was previously hampered by the fact that 
recombinant nsp11 is extremely toxic to a variety of hosts (C.C. Posthuma, E. van den 
Born, and E. J. Snijder, unpublished observations). The use of a tightly regulated bacterial 
expression system has now enabled us to express and purify recombinant nsp11 for EAv 
and porcine reproductive and respiratory syndrome virus (PRRSv), two distantly related 
arteriviruses whose NendoU domains share ~52% amino acid identity. This technical 
advance allowed us to initiate the protein’s functional characterization and here we 
provide the first direct evidence for the in vitro endoribonuclease activity of arterivirus 
nsp11. Furthermore, we have studied the enzyme’s biochemical requirements for opti-
mal RNA processing and the contribution of proposed active site residues to catalysis. 
Our comparative approach allowed us to identify biochemical properties common to 
the arteri- and coronavirus endoribonucleases, as well as distinct characteristics of the 
arterivirus NendoU, suggesting that it is able to process RNA efficiently in the absence 
of divalent cations by using a cleavage reaction mechanism resembling that of RNase A.
mateRIals aND methODs
Bioinformatics analyses
Complete genome sequences of corona-, toro-, bafini- and arteriviruses available on 
16 April 2008 at the National Center for Biotechnology information GenBank/RefSeq 
databases were downloaded into the viralis platform (A.E.Gorbalenya, unpublished). An 
amino acid alignment of the NendoU domain was produced using the MUSCLE program9 
and alignment of poorly conserved columns was further manually refined to produce a 
final alignment (174 positions). A selection of 25 sequences representing virus species 
diversity (C. Lauber and A.E. Gorbalenya, unpublished) was used for phylogenetic analy-
ses. The following genome sequences were used: bovine torovirus Breda-1 (NC_007447); 
equine torovirus Berne (X52374); white bream virus (NC_008516); infectious bronchitis 
virus strain Beaudette (NC_001451); Beluga Whale coronavirus SW1 (EU111742); human 
coronavirus NL63 (NC_005831.2); human coronavirus 229E (NC_002645); miniopterus bat 
coronavirus 1B (NC_010436); miniopterus bat coronavirus HKU8 (NC_010438); Rhinolo-
phus bat coronavirus HKU2 (NC_009988); Scotophilus bat coronavirus 512/05 (DQ648858); 
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porcine epidemic diarrhoea coronavirus (NC_003436); feline coronavirus (NC_007025); 
mouse hepatitis virus A59 (NC_001846); human coronavirus HKU1 (NC_006577.2); hu-
man coronavirus OC43 (NC_005147); Tylonycteris bat coronavirus HKU4 (EF065505); Pip-
istrellus bat coronavirus HKU5 (EF065509); Rousettus bat coronavirus HKU9 (EF065513); 
severe acute respiratory syndrome coronavirus (Ay291315); porcine respiratory and 
reproductive syndrome virus, strain vR-2332 (Ay150564); porcine respiratory and repro-
ductive syndrome virus, strain Lelystad (Ay588319); lactate dehydrogenase-elevating 
virus neuro-virulent type C (L13298); simian hemorrhagic fever virus (NC_003092) and 
equine arteritis virus (NC_002532.2). Utilizing the PhyML program14, a maximum likeli-
hood phylogenetic tree was compiled using the WAG model of amino acid substitution37 
and rate heterogeneity among sites (gamma distribution with 8 categories). Support for 
internal nodes was measured by bootstrap analysis (1,000 replicates).
Plasmid construction 
Nucleotides 8735 to 9391 of the wild-type EAv infectious cDNA clone pEAv21136, encoding 
EAv nsp11, were PCR-amplified with oligonucleotides E780 (5’-CATGCCATGGGCCATCAC-
CATCACCATCACTCCAACAAAATTTCGTGCCTCCCG-3’), introducing a start codon followed 
by sequences specifying a (His)6 tag, and E584 (5’-CCGGAATTCGCATGCTAGCTCACTCTTG-
GACATAAAAGGTCGCG-3’), providing a stop codon. The fragments were cloned between 
the Ncoi and EcoRi restriction sites of Gateway entry vector pENTR11 (invitrogen, Carls-
bad, CA, USA), and, after sequence verification, placed downstream of the T7 promoter 
in Gateway expression vector pDEST14. Translation of the resulting construct, pDEST14-
EAv nsp11HN, produced a protein corresponding to amino acids Ser-2838 to Glu-3056 
of replicase pp1ab of the EAv-Bucyrus strain (NCBi genome database accession number 
NC_002532), preceded by an N-terminal Met-Gly-His6 tag. Mutant pEAv211 plasmids en-
coding alanine substitutions in the EAv nsp11 region24(with the exception of Tyr-216 Ala) 
were used as templates for the generation of expression constructs encoding mutant 
derivatives of EAv nsp11. The Tyr-216 Ala substitution was newly engineered by using 
primers E780 and E1020 (5’-GGAATTCTCACTCTTGGACAGCAAAGGTCG-3’). The PRRSv 
nsp11-coding sequence (strain vR-2332; accession number Ay150564) was PCR-amplified 
from a full-length cDNA clone22 using oligonucleotides HN-fwd (5’-GGGGACAAGTTTG-
TACAAAAAAGCAGGCTTCGAAGGAGATGCCACCATGAAACATCACCATCACCATCACGGGTC-
GAGCTCTCCGCTCCC-3’) and HN-rev (5’- GGGGACCACTTTGTACAAGAAAGCTGGGTCT-
TATTATTCAAGTTGGAAATAGGCTGTTTTG-3’). The corresponding PCR fragment was 
recombined into Gateway entry vector pDONR201, the entry clone was sequenced, and 
the fragment was transferred to pDEST14. Nsp11 expressed from the resulting construct, 
pDEST14-PRRSv nsp11HN, corresponded to amino acids Gly-3585 to Glu-3807 of PRRSv-
vR2332 replicase pp1ab, fused to an N-terminal Met-Lys-His6 tag. The pDEST14 vector 
encoding wild-type nsp15 from SARS-Cov (Frankfurt-1 strain) was described previously29.
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Protein expression and purification 
Escherichia coli BL21-Ai cells (invitrogen) were transformed with pDEST14-EAv nsp11HN, 
pDEST14-PRRSv nsp11HN and pDEST14-SARS-Cov nsp15HN, respectively, and plated 
on LB-agar containing 100 µg/ml ampicillin and 0.2% D-glucose. Subsequently, liquid 
cultures were inoculated by scraping colonies of freshly transformed cells into LB 
supplemented with 100 µg/ml of ampicillin and 0.2% D-glucose and grown at 37°C until 
the OD600 equaled 0.6. The growth medium was exchanged with LB containing 100 µg/
ml of ampicillin, the culture temperature was lowered to 16°C and protein expression 
was induced by addition of 0.2% L-arabinose (Sigma-Aldrich, St. Louis, MO, USA) for 5 
h. Cells were then harvested by centrifugation and lysed in 20 mM Tris-HCl pH 8.0; 500 
mM NaCl; 5% glycerol; 12.5 mM imidazole; 0.1% Triton-X100, supplemented with 50 U/
ml DNase i (invitrogen) and 1 mg/ml lysozyme (Sigma-Aldrich) for 1 h at 4°C. The Triton-
X100 concentration was adjusted to 0.5%, lysates were incubated at 4°C for additional 
30 min and subsequently clarified by centrifugation at 20,000g for 45 min. Recombinant 
proteins were purified from supernatants using Talon metal affinity resin (Clontech, 
Mountain view, CA, USA). The resin was washed extensively with 20 mM Tris-HCl pH 8.0; 
500 mM NaCl; 5% glycerol; 12.5 mM imidazole, and the proteins were eluted in 20 mM 
HEPES, pH=7.4, 100 mM NaCl, 150 mM imidazole. The protein yield and purity of the 
preparations were assessed by SDS-PAGE and Coomassie Blue staining using bovine 
serum albumin (Bio-Rad, Hercules, CA, USA) as a concentration standard. The purified 
proteins were dialyzed against buffer containing 20 mM HEPES, pH 7.4; 100 mM NaCl; 
50% glycerol, and stored at -20°C. 
RNa and DNa substrates 
RNA and DNA oligonucleotides were chemically synthesized by Eurogentec (Seraing, 
Belgium). Substrate RNA2 (5’-CGCAGUGAGCUCCUAAUCGCCC-3’) and markers RNAm2 
(5’-CGCAGUU-3’), RNAm3 (5’-CGCAGU-3’) and RNAm4 (5’-CGCAG-3’) were described 
previously16. dsRNA substrates were generated by annealing labeled RNA2 and 
unlabeled RNA13 (5’-GGGCGAUUAGGAGCUCACUGCG-3’) at equimolar concentra-
tions. Oligoribonucleotides RNAsGUA (5’-AAAAAAAGUAAAAA-3’) and RNAsGCA 
(5’- AAAAAAAGCAAAAA-3’) were used to assess the preference of the enzymes for 
cleavage after uridylate or cytidylate. DNA oligonucleotides MHv324 (5’-GATCCAATT-
GTCGACGCGTG-3’) and MHv325 (5’-AATTCACGCGTCGACAATTG-3’), which are partially 
complementary, were used to determine the activity of arterivirus nsp11 on ssDNA and 
dsDNA templates. RNA and DNA oligonucleotides were 5’ end labeled using T4 poly-
nucleotide kinase (PNK) (invitrogen) and [γ-32P]ATP (PerkinElmer, Waltham, MA, USA) and 
were purified using RNase-free Micro Bio-spin 30 columns (Bio-Rad) prior to being used 
as substrates. 
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endoribonuclease assays 
Proteins were incubated with the indicated concentration of 5’-32P-labeled substrate in 
25 mM HEPES, pH 7.4; 50 mM NaCl, 1 mM DTT, 0.2 mM EDTA at 30°C. When MnCl2 was 
present, EDTA was omitted from the reaction buffer. EAv nsp11 and SARS-Cov nsp15 
were used at a final concentration of 0.3 μM, and PRRSv at 0.8 μM, unless otherwise 
indicated. Cleavage assays with SARS-Cov nsp15 were performed in the presence of 5 
mM MnCl2. The reactions were stopped by the addition of an equal volume of Gel Load-
ing Buffer ii (95% formamide, 18 mM EDTA, 0.025% SDS; Ambion, Austin, TX, USA) and 
incubation for 3 min at 95°C. The reaction products were separated by electrophoresis in 
20% polyacrylamide/7 M urea/1x TBE gels, supplemented with 0.1% SDS for the analysis 
of double-stranded substrate processing. The gels were exposed to phosphorimager 
screens, which were subsequently scanned using a Typhoon variable Mode imager 
(GE Healthcare, Chalfont St Giles, UK). images were analyzed and quantified using im-
ageQuant TL software (GE Healthcare).
analysis of 3’ termini of cleavage products 
The analysis of the nature of the 3’ ends of 5’ cleavage products derived from NendoU-
mediated RNA processing was performed essentially as previously described16. Unlabeled 
RNAsGUA substrate was incubated with recombinant EAv nsp11 or SARS-Cov nsp15. The 
reaction was stopped by heat denaturation for 4 min at 95°C and the cleavage products 
were incubated with T4 PNK buffer alone (70 mM Tris-HCl, pH 7.6; 10 mM MgCl2; 100 
mM KCl; 1 mM 2-mercaptoethanol), T4 PNK buffer in the presence of 5 U of T4 PNK, or 
calf intestine alkaline phosphatase (CiAP) buffer (10 mM Tris-HCl, pH 7.5; 10 mM MgCl2) 
in the presence of 0.5 U CiAP (Fermentas, Burlington, ON, Canada), for 30 min at 37°C. 
The phosphatases were subsequently heat-inactivated at 95°C for 5 min. The RNAs were 
phenol-extracted, ethanol-precipitated using 10 µg glycogen (Roche, Basel, Switzerland) 
as a carrier, and ligated to [5’-32P]pCp using T4 RNA ligase (Fermentas) as previously de-
scribed16. The reaction products were then resolved in denaturing polyacrylamide gels 
and visualized as described above.
Results
arterivirus nsp11 has mn2+-independent endoribonuclease activity 
Previous attempts to express and purify recombinant EAv nsp11 had been unsuccessful 
due to the high toxicity that the wild-type protein displays in prokaryotic and eukaryotic 
cells (Posthuma, van den Born, unpublished). We have now used the BL21-Ai strain of E. coli 
as host for the T7 RNA polymerase-driven expression of N-terminally His6-tagged nsp11. 
The regulation of T7 polymerase expression in this BL21-derived strain is controlled by the 
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araBAd promoter, whose generally low basal expression was further repressed by the ad-
dition of glucose to the bacterial growth medium prior to induction of nsp11 expression. 
The combination of maximally repressed T7 RNA polymerase expression and induction of 
nsp11 expression at low temperature allowed us to produce and purify wild-type nsp11 
from EAv, as well as PRRSv (Fig. 2A). Nevertheless, the yield of wild-type nsp11 remained 
extremely low, and its toxicity was again illustrated by the fact that mutagenesis of puta-
tive catalytic residues dramatically improved expression levels under otherwise identical 
conditions (data not shown). We have used the same protocol for the expression and pu-
rification of SARS-Cov nsp15, whose endoribonuclease activity was previously character-
ized in some detail3,5,13,16. This allowed us to perform comparative functional studies of the 
arterivirus and coronavirus NendoU-containing nsps purified under identical conditions.
in order to assess their ability to process RNA in vitro, recombinant EAv and PRRSv 
nsp11 proteins were incubated with a 5’-32P-labeled synthetic oligoribonucleotide, RNA2 
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figure 2. Purification and endoribonuclease activity of arterivirus nsp11. (A) Purified recombinant EAv 
nsp11 (0.5 µg and 1 µg), PRRSv nsp11 (2 µg and 4 µg), and SARS-Cov nsp15 (0.5 µg and 1 µg), each 
carrying an N-terminal His6 tag, were analyzed by SDS-PAGE and subsequent Coomassie brilliant blue 
staining. (B) Activity assays using recombinant protein and 2 µM of 5’-32P-labeled (indicated with an 
asterisk) RNA2 substrate were performed at 30°C for 2 or 20 min. The cleavage products were separated by 
electrophoresis in a 20% polyacrylamide/7 M urea gel and were visualized by phosphorimager analysis. A 
nucleotide ladder prepared by alkaline hydrolysis of RNA2 (AH marker), as well as 5’-32P-labeled synthetic 
short oligoribonucleotides (m2, m3, and m4), were included as size markers. Reactions without enzyme 
served as negative controls. The sequence of RNA2 is shown above the gel, and cleavage sites 3’ of the 
cytidylates present in the first () and third (•) positions and 3’ of the uridylate in the sixth position (), and 
the corresponding cleavage products, are indicated.
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(5’-CGCAGUGAGCUCCUAAUCGCCC-3’), that was shown to be efficiently cleaved by coro-
navirus NendoU proteins16. Both arterivirus proteins were able to cleave the substrate in 
the absence of divalent cations, and the resulting products were similar to those derived 
from cleavage of RNA2 by SARS-Cov nsp15 (Fig. 2B). The size of the major cleavage prod-
uct of the SARS-Cov enzyme was consistent with processing 3’ of the uridylate present 
at the sixth position, although its migration in denaturing PAGE was altered due to the 
presence of an additional phosphate group at the 3’ end that is lacking in the synthetic 
marker with the same nucleotide composition, RNA m316,29. A product of identical size 
was generated by cleavage of RNA2 by both EAv and PRRSv nsp11 (Fig. 2B). The arterivi-
rus enzymes also generated products consistent with processing at the two cytidylates 
present at the first and third positions in RNA2, which were detectable in the SARS-Cov 
NendoU-driven reaction, as well, albeit to a lesser extent. An RNA ladder of fragments 
produced by alkaline hydrolysis of RNA2, and therefore containing 3’ phosphates, was 
used to verify the sizes of the cleavage products (Fig. 2B). These results indicated that 
arterivirus nsp11 possesses endonuclease activity and, in cleaving 3’ of pyrimidines, 
exhibits an in vitro substrate specificity similar to that of SARS-Cov nsp15. interestingly, 
the arterivirus enzymes seem to cleave at cytidylates more efficiently than the SARS-Cov 
NendoU, shown by the higher efficiency of processing at the cytidylate present at the 
first position in RNA2 (Fig. 2B), suggesting a less strict preference for uridylate than previ-
ously reported for the coronavirus endoribonuclease 4,16.
Prior studies had established that Mn2+ ions enhanced the NendoU activity of 
coronavirus nsp15 in vitro5,16,38 and were strictly required for RNA cleavage by XendoU11,19. 
The stimulating effect of Mn2+ ions on SARS-Cov nsp15-mediated processing of RNA2 was 
confirmed in our assay (Fig. 3). in contrast, both EAv and PRRSv nsp11 proteins were able 
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figure 3. influence of Mn2+ ions on arterivirus endoribonuclease activity. Recombinant proteins were 
incubated with 5 µM of 5’-32P -labeled (*) RNA2 at 30°C in the absence of Mn2+ or in the presence of 1 mM or 
5 mM of Mn2+, as indicated above the gel. The reactions were stopped after 2 or 20 min, and the cleavage 
products were separated by denaturing PAGE. For size markers and cleavage products, see the legend to Fig. 2.
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to process RNA2 efficiently in reaction buffers lacking divalent cations (Fig. 2B), suggesting 
that metal ions are not required for catalysis. To address this potential discrepancy, we 
investigated the role of Mn2+ ions for arterivirus NendoU activity. Addition of Mn2+ ions 
at concentrations previously shown to stimulate coronavirus NendoU activity in fact 
inhibited the cleavage of RNA2 by both EAv and PRRSv nsp11, as was evident from the 
increase of remaining full-length substrate, as well as the accumulation of processing 
intermediates (Fig 3). inhibition of arterivirus nsp11-mediated RNA cleavage in the 
presence of Mn2+ ions was consistently reproduced with a range of substrates (data not 
shown). These results led us to conclude that Mn2+ ions are not required for optimal 
NendoU activity of arterivirus nsp11 in vitro, and consequently, the subsequent functional 
characterization of the arterivirus enzymes was performed in the absence of Mn2+.
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figure 4. Substrate requirements of the arterivirus 
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arterivirus Nendou cleavage: substrate requirements and preference for 
uridylate 
To gain more insight into the substrate requirements of the arterivirus NendoU, we exam-
ined its ability to cleave ssRNA and dsRNA molecules in vitro. Both ssRNA2 and dsRNA2 
were cleaved by the arterivirus NendoU. ssRNA molecules were processed more efficiently 
by both arterivirus nsp11 and SARS-Cov nsp15 (Fig. 4, A and B). Neither ssDNA nor dsDNA 
were hydrolyzed by the enzymes (Fig. 4C), confirming their specificity for RNA substrates. 
Recent studies of SARS-Cov and MHv nsp15 have shown that they can both process RNA 
at cytidylates, although much less efficiently than at uridylates4,18. The data we obtained 
using RNA2 as a substrate confirmed the strong preference of the SARS-Cov NendoU for 
uridylate and indicated that the EAv endoribonuclease is able to process RNA efficiently at 
pyrimidines (Fig. 2B). The large number of uridylates and cytidylates present in our initial 
substrate complicated the assessment of (potential) low efficiency cleavage events. There-
fore, in order to establish whether EAv NendoU prefers uridylate or cytidylate substrates, 
we used two additional oligoribonucleotides, both containing a single pyrimidine in an 
identical backbone: 5’-AAAAAAGUAAAAA-3’ (RNAsGUA) and 5’-AAAAAAGCAAAAA-3’ 
(RNAsGCA). incubation of these substrates with EAv nsp11 or SARS-Cov nsp15 yielded 
a single cleavage product, consistent with the pyrimidine specificity of these enzymes 
(Fig. 5A). Quantification of the processing efficiency of these molecules under identical 
reaction conditions showed that both the EAv and the SARS-Cov NendoU proteins hydro-
lyzed the RNAsGUA substrate more efficiently than RNAsGCA (Fig. 5B). However, a larger 
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figure 5. Arterivirus nsp11 cleaves RNA preferentially at uridylates. (A) One micromolar 5’-32P -labeled 
synthetic oligoribonucleotide containing a single uridylate (RNAsGUA) or a single cytidylate (RNAsGCA) 
was incubated with 0.3 µM SARS-Cov nsp15 or 0.6 µM EAv nsp11 at 30°C under standard reaction 
conditions. Aliquots were taken at different time points, and the reaction products were analyzed 
by denaturing PAGE and phosphorimager analysis. Cleavage sites and the corresponding products 
are indicated with arrows. (B) The amount of full-length substrate remaining was quantified, and the 
percentage of cleaved substrate was plotted as a function of the reaction time. The data points represent 
mean values from three independent experiments, and the error bars denote standard deviations.
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fraction of the RNAsGCA substrate was cleaved by EAv nsp11 than by SARS-Cov nsp15 
during the course of the reaction (Fig. 5B). These results suggest that EAv NendoU exhibits 
pyrimidine specificity with a clear preference for cleavage at uridylates, which neverthe-
less seems to be less pronounced than that of the SARS-Cov enzyme.
substitution of conserved amino acids in the eav Nendou domain: effects on 
RNa cleavage and substrate specificity 
Functional studies of both XendoU and coronavirus NendoU proteins have confirmed the 
critical role of two His and a Lys residue in catalysis11,16,38. These three amino acids were ini-
tially proposed to form a catalytic center based on their conservation across the entire pro-
tein family33. Structural studies substantiated this hypothesis, showing that these residues 
cluster in a positively-charged groove of the SARS-Cov enzyme29 and form a phosphate-
binding site in XendoU28. Superimposing the spatial arrangements of the catalytic triads of 
SARS-Cov NendoU and RNase A revealed that two additional residues in SARS-Cov NendoU, 
Tyr-342 and Ser-293, interact with the substrate and possibly confer uridylate specificity to 
the enzyme29. To address the importance of the corresponding residues (indicated in the 
alignment in Fig. 1C) for the NendoU activity of EAv nsp11, they were replaced with Ala. 
The N-terminally His-tagged mutant proteins were expressed and purified under conditions 
identical to those used for purification of the wild-type nsp11 (Fig. 6A). A double replace-
ment of His-126 and His-141, as well as single Lys-170- or Tyr-216 to Ala substitutions re-
duced cleavage of RNA2 to undetectable levels (Fig. 6B). Processing of this substrate was not 
observed even at enzyme concentrations 5-fold higher than those optimal for the wild-type 
protein (Fig. 6C), except for the Tyr-216 to Ala mutant, for which trace amounts of cleavage 
products were observed upon longer reaction times. Taken together, these data confirmed 
the critical role of the mutated residues in arterivirus NendoU-mediated RNA processing. 
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figure 6. Catalytic activities of EAv nsp11 mutants. (A) Purified N-terminally His6-tagged EAv nsp11 proteins 
containing the indicated amino acid substitutions were electrophoresed on an SDS-polyacrylamide gel, 
which was subsequently stained with Coomassie brilliant blue. (B and C) Reaction mixtures containing 0.3 
µM (B) or 1.5 µM (C) of mutant recombinant proteins and 2 µM of 5’-32P -labeled RNA2 were incubated at 
30°C. The reactions were stopped at the indicated time points, and the cleavage products were separated in 
a 20% polyacrylamide/7 M urea gel. For size markers, see the legend to Fig. 2. WT, wild type.
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The Ser-174 to Ala substitution also impaired EAv NendoU activity, although not as dra-
matically, since cleavage of RNA2 was clearly detectable at a protein concentration similar 
to that used for wild-type EAv NendoU (Fig. 6B). Comparing the processing efficiency of 
RNAsGUA versus RNAsGCA revealed that the Ser-174 to Ala substitution had rendered the 
EAv NendoU unable to discriminate between uridylates and cytidylates, since the mutant 
protein was able to cleave at both nucleotides with a similar efficiency (Fig. 7A and B). We 
also replaced Ser-174 with Thr, a residue that is present at this position of the NendoU align-
ment in all other nidovirus homologs, with the exception of SARS-Cov and closely related 
bat coronaviruses (see Fig. S1 in the supplemental material). This substitution resulted in 
somewhat impaired in vitro RNA processing in comparison with the wild-type EAv NendoU, 
as well (Fig. 6B), but it had no effect on the uridylate preference of the enzyme (Fig. 7A and 
B). These results strengthen the view that Ser-174 is important for substrate recognition and 
is involved in determining the substrate specificity of the EAv NendoU. 
Our previous analysis of the impact of NendoU mutagenesis on the EAv life cycle 
revealed that substitution of His-126, His-141, Lys-170 or Ser-174 with Ala caused major 
defects in viral RNA synthesis and production of infectious progeny24. in addition, the 
critical role of two nidovirus-wide conserved aspartic acid residues, Asp-177 and Asp-201 
(Fig. 1C) in viral RNA synthesis was established. Non-conservative (to Ala) or conservative 
(to Glu or Asn) substitutions of those residues rendered viral replication undetectable. 
Examining the effect of these mutations on the in vitro endonuclease activity of EAv 
NendoU could therefore provide valuable insight into the basis of this nonviable 
phenotype. Our attempts to purify recombinant EAv nsp11 containing an Asp-177 to 
Ala or Asp-201 to Ala substitution, however, were unsuccessful, since both mutations 
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figure 7. Mutagenesis of Ser-174 influences EAv nsp11 substrate specificity. (A) One micromolar of 
RNAsGUA or RNAsGCA was incubated with 0.6 µM EAv nsp11 S3011A or 0.6 µM EAv nsp11 S3011T at 
30°C under standard reaction conditions. Aliquots were taken at different time points, and the reaction 
products were analyzed by denaturing PAGE and phosphorimager analysis. (B) The amount of full-length 
substrate remaining was quantified, and the percentage of cleaved substrate was plotted as a function of 
the reaction time. The data points represent mean values from three independent experiments, and the 
error bars denote standard deviations.
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rendered the protein insoluble. Similar results were reported following mutagenesis of 
the Asp-177 counterpart in SARS-Cov NendoU13 and the Asp-201 equivalent in the MHv 
enzyme18. The crystal structure of SARS-Cov nsp15 revealed that these residues are part 
of an extensive hydrogen bond network in close proximity to the active site and that 
replacing them could have an indirect effect on the activity of the protein by disturbing 
its secondary structure29, a notion supported by the insolubility of the recombinant 
mutant proteins.
eav Nendou RNa cleavage: reaction mechanism 
A number of parallels have been drawn between the active sites of RNase A, XendoU28, 
coronavirus NendoU29 and, in this report, arterivirus NendoU. RNase A is a remarkably 
well characterized enzyme that has been proposed to cleave the P-O5’ bond in RNA via 
general acid-base catalysis, involving the side chains of the active site His-12 and His-119 
residues (reference26 and references therein). in a first reaction, transphosphorylation of 
the RNA results in the accumulation of 2’,3’-cyclic phosphodiesters, which can be subse-
quently hydrolyzed to 3’-phosphomonoesters in a separate process34 (Fig. 8A). 2’,3’-Cyclic 
phosphates have been detected at the 3’ ends of cleavage products generated by both 
XendoU19 and coronavirus NendoU16, suggesting similarities to RNase A in terms of cleav-
age chemistry. To investigate the chemical nature of the 3’-termini of cleavage products 
generated by the EAv NendoU, the products derived from cleavage of RNAsGUA after 
short (2-min) or prolonged (40-min) reaction times were treated with T4 PNK or CiAP. Fol-
lowing phenol extraction and ethanol precipitation, the cleavage products were ligated 
to [5’-32P]pCp in a T4 ligase-mediated reaction. As expected, pCp could be readily ligated 
to the hydroxyl group present at the 3’ end of the unprocessed substrate (Fig. 8B), and 
this reaction was used as an internal control for determining the efficiency of pCp liga-
tion. in contrast to the uncleaved substrate RNA, efficient transfer of the [32P] label to the 
3’ terminus of the 5’ cleavage product obtained after incubation with EAv nsp11 required 
phosphatase treatment prior to the pCp ligation reaction, suggesting the presence of a 3’ 
phosphate group. After a short EAv NendoU reaction, the 5’ cleavage products could be 
efficiently ligated only after dephosphorylation with T4 PNK (which is capable of remov-
ing both 2’,3’ as well as 3’ phosphates) but not after CiAP treatment (that can remove only 
3’ phosphates), which suggests that the 5’ cleavage products contained predominantly 
2’,3’-cyclic phosphates. Upon longer incubation of substrate and enzyme, however, CiAP 
treatment was sufficient for efficient ligation of a portion of the 5’ cleavage products to 
[5’-32P]pCp, indicating that nsp11-mediated hydrolysis of part of the cyclic phosphodies-
ters had occurred (Fig. 8B). in the SARS-Cov nsp15-mediated reaction, the fraction of 5’ 
cleavage products whose cyclic phosphate ends had been hydrolyzed was even larger, 
as illustrated by the higher efficiency of [5’-32P]pCp ligation after dephosphorylation with 
CiAP (Fig. 8B). These results suggest that the EAv and SARS-Cov NendoU’s are able to 
catalyze both transphosphorylation of RNA to form a 2’,3’-cyclic phosphodiester, as well 
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as its subsequent hydrolysis to a 3’-phosphomonoester, which would be consistent with 
an RNase A-like reaction mechanism.
DIsCussION
the Nendou activity is common to arteri- and coronaviruses, and likely all 
nidoviruses.
This report describes the in vitro endoribonuclease activity of nsp11 from two quite 
distantly related arteriviruses, EAv and PRRSv, and expands the short list of characterized 
XendoU/NendoU superfamily members with representatives of a new, deeply separated 
phylogenetic lineage. The sizes and domain compositions of the nidovirus replicase sub-
units harboring NendoU domains vary considerably among nidoviruses, which might be 
linked to differential catalytic properties and functions of the enzymes in the life cycle of 
different nidoviruses. The biochemical characterization of arterivirus nsp11 documents 
its ability to hydrolyze RNA 3’ of pyrimidines, with a preference for uridylates, and re-
vealed that this endoribonuclease activity is not dependent on the presence of divalent 
cations. Mutagenesis of predicted active site residues abolished the protein’s ability 
to cleave RNA and provided insights into the determinants of the enzyme’s uridylate 
preference. Our comparative analysis of arterivirus nsp11 and coronavirus nsp15 purified 
under identical conditions established important parallels between the ribonucleolytic 
activities of these enzymes, such as the identity of key residues in their catalytic site 
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figure 8. Analysis of the 3’ termini of EAv and SARS-Cov NendoU products. (A) Proposed mechanism for 
the transphosphorylation (1) and hydrolysis (2) reactions catalyzed by RNase A. (B) Cleavage products 
obtained after incubation of 1 µM unlabeled RNAsGUA with 0.6 µM EAv nsp11 or SARS-Cov nsp15 for 2 
min (1) or 40 min (2) at 30°C under standard reaction conditions were subsequently ligated to 5’-[32P]pCp 
without further treatment (lanes a) or after dephosphorylation with T4 PNK (lanes b) or CiAP (lanes c). 
The reaction products were analyzed by denaturing PAGE and phosphorimager analysis. The full-length 
substrate (*) and the 5’ cleavage product () are indicated.
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and their proposed reaction mechanism, which are likely conserved across the entire 
nidovirus order. Our data also revealed differences in their biochemical properties, such 
as the effect of Mn2+ on their in vitro activity, as well as their variable extent of preference 
for cleavage at uridylates, both probably owing to considerable divergence of arterivirus 
nsp11 and coronavirus nsp15, which carry distantly related NendoU’s fused to apparently 
unrelated N-terminal domains (Fig. 1C). 
The endoribonuclease activity of EAv and PRRSv nsp11 seems to be independent of 
the presence of metal ions as cofactors, since both proteins cleaved RNA very efficiently 
in reaction buffers lacking divalent cations and containing EDTA (Fig 2B, 3). This finding 
stands in contrast to the previously documented stimulatory effect of Mn2+ on NendoU 
activity of coronavirus nsp15 in vitro16,38, which was corroborated by the comparative en-
zyme activity studies included in this paper (Fig. 3). Our data show that arterivirus endori-
bonucleolytic activities are inhibited by Mn2+ ions at concentrations that have previously 
been shown to significantly enhance the activities of a number of coronavirus NendoU 
enzymes3,16,38. interestingly, similar Mn2+ concentrations have been reported to inhibit 
RNase A-mediated RNA hydrolysis as well, probably by binding to and blocking of the 
catalytic histidine residues1. The same study showed that low concentrations of Mn2+ may 
enhance RNase A activity, possibly through interactions between the metal ions and the 
phosphates present in the RNA substrate. Due to the fast rate of RNA cleavage by the re-
combinant enzymes and the gel electrophoresis-based activity assays used in this study, 
we have been unable to determine if arterivirus in vitro endoribonuclease activities can 
be further stimulated by low concentrations of Mn2+ or other divalent cations. it should 
be noted that the precise role of Mn2+ in RNA hydrolysis by the coronavirus NendoU and 
its cellular homologs, XendoU and human PP11, remains enigmatic. Although Mn2+ is 
essential for in vitro RNA processing by XendoU and human PP11, the interaction of the 
enzymes with a substrate does not require metal ions11,19,20. The role of Mn2+ for corona-
virus NendoU cleavage is even less clear. Previous studies have implicated Mn2+ ions in 
triggering conformational changes3, as well as affecting RNA binding properties of these 
proteins5. Metal binding sites have not been identified in the currently available crystal 
structures of coronavirus nsp154,17,29,38 or XendoU28. Furthermore, millimolar concentra-
tions of Mn2+ ions are required for enhancing RNA cleavage by coronavirus nsp15 in vitro, 
while the intracellular free Mn2+ concentration is estimated to be in the micromolar range 
(references5,27 and references therein), raising questions about the biological significance 
of this observation. Comparative analysis of both the structure and biochemistry of the 
arteri- and coronavirus enzymes could therefore be used to gain more insight into the 
specific role(s) of divalent cations in coronavirus NendoU-mediated cleavage. 
the eav Nendou active site and mechanism of RNa cleavage
Replacement of the predicted catalytic residues (His-126, His-141 and Lys-170) of EAv 
NendoU with alanine established their importance for in vitro RNA processing (Fig. 6, B 
and C). This observation is consistent with the alignment in Fig. 1C and results of similar 
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experiments with related enzymes of other origins, as well as RNase A. Likewise, the 
substitution of Tyr -216, whose counterpart in the coronavirus NendoU was implicated 
in the proper positioning and orientation of the substrate in the coronavirus NendoU 
active site29, also severely impaired EAv NendoU-mediated cleavage in vitro (Fig. 6B and 
C). interestingly, a replacement of Ser-174 with Ala only moderately affected cleavage by 
the EAv NendoU (Fig. 6B), but rendered the enzyme unable to discriminate between uri-
dylates and cytidylates (Fig. 7). The conservative replacement of Ser-174 with Thr largely 
restored efficient RNA processing, including the preference of EAv NendoU for cleavage 
at uridylates (Fig. 7). Ser-174 of EAv nsp11 is the counterpart of residue Ser-293 in SARS-
Cov nsp1529, which has been proposed to be functionally equivalent to Thr-45 of RNase 
A, a major determinant of this enzyme’s pyrimidine specificity (reference26 and reference 
therein). in a recent study4, the effects of SARS-Cov nsp15 Ser-293 substitutions by Ala 
or Thr were reported to be similar to the ones we describe here for EAv nsp11 Ser-174 
replacements. Two additional residues of SARS-Cov nsp15, Pro-343 and Leu-345, which 
are highly conserved in the C-terminal domain of coronavirus NendoU domains (Fig. 1C), 
were also implicated in determining the substrate specificity of the endoribonuclease. 
Pro-343 was proposed to sterically hinder the access of cytosine to the active site, while 
the side chain of Leu-345 could prevent the access of purines. The extreme C-terminal 
residues of the EAv and SARS-Cov NendoU proteins differ substantially, with the counter-
part residue of Pro-343 being val-217 in EAv nsp11, while the bulky Leu-345 presumably 
has no counterpart (see alignment in Fig. 1C). Structural information on the arterivirus 
endoribonuclease would shed more light on whether the protein’s C-terminal tail is also 
involved in substrate binding and whether the limited conservation of this region could 
account for the more relaxed uridylate specificity we observed for the EAv NendoU in 
comparison to the SARS-Cov enzyme (Fig. 5).
The similarities between the active sites of viral NendoU proteins and RNase A, which 
were previously suggested by others29 and are also outlined in this report, prompted us 
to examine the mechanism of RNA cleavage by the EAv endoribonuclease. The reaction 
products of coronavirus NendoU were shown to possess 2’,3’-cyclic phosphate ends16. 
Analysis of the 3’-ends of cleavage products generated by the EAv NendoU indicated that 
also this reaction proceeds through the formation 2’,3’-cyclic phosphodiesters, a frac-
tion of which appear to be hydrolyzed to 3’ phosphomonoesters upon longer reaction 
times (Fig. 8B). We obtained similar results upon analysis of SARS-Cov NendoU cleavage 
products. These data are consistent with the utilization of an RNase A-like mechanism 
of RNA cleavage by both the arteri- and coronavirus endoribonucleases. The ability of 
the SARS-Cov enzyme to hydrolyze 2’,3’-cyclic phosphodiesters had not been detected 
previously, most likely due to the relatively low activity of the MBP-nsp15 fusion protein 
used in these earlier studies. 
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Role of Nendou in the life cycle of arteri- and coronaviruses
Despite recent advances in our understanding of the biochemical properties of nidovirus 
RNA-processing enzymes, the characterization of their precise roles and mechanisms of 
action in the viral life cycle is still at an initial stage. Reverse genetics-based mutagenesis 
studies of the coronavirus nsps that harbor the exoribonuclease (ExoN) and NendoU 
domains confirmed their importance for coronavirus RNA synthesis7,8,16,18,21, and lent 
support to the involvement of ExoN in the fitness control of coronavirus RNA replica-
tion 8. A site-directed mutagenesis study of EAv nsp11 in the context of the complete 
EAv life cycle suggested that this replicase subunit is a multifunctional viral protein24. 
Substitution of Asp-177 or Asp-201, which in this report were found to render bacterially 
expressed EAv nsp11 insoluble, resulted in a non-viable phenotype. A similar result was 
obtained by deleting the nsp11-coding sequence from the EAv genome. Most notably, 
however, replacement of any of the three putative catalytic residues (His-126, His-141, or 
Lys-170), which were shown in this study to reduce the in vitro EAv NendoU activity to 
background levels, yielded severely crippled, but viable mutant viruses. These substitu-
tions induced a specific defect in viral sg mRNA synthesis, which was accompanied by a 
dramatic reduction of the production of infectious progeny. We cannot formally exclude 
that a basal level of endoribonuclease activity, undetectable in our in vitro assay, may 
be retained by these catalytic site mutants in vivo, which might be sufficient for viral 
replication and production of virus progeny, albeit at a low level. Examination of the role 
of the MHv NendoU in the viral life cycle revealed that mutagenesis of the catalytic His 
residues resulted in severely impaired, but detectable RNA processing activity in vitro, 
and only modest defects in viral RNA synthesis and production of infectious progeny18. 
Furthermore, no specific defects in sg mRNA synthesis were detected. This stands in 
contrast to the observations made upon EAv NendoU mutagenesis by reverse genet-
ics24 and results obtained by replacement of an NendoU active-site His in a SARS-Cov 
replicon. in the latter case, a severe decrease of sg mRNA levels was observed2. Overall, 
these data suggest (partially) different roles of NendoU in the life cycles of arteri- and 
coronaviruses. Alternatively, a potentially higher basal activity retained by the MHv 
NendoU catalytic site mutants, combined with differences in overall replication rates 
between MHv and EAv, might minimize the consequences of these substitutions for the 
MHv life cycle. Moreover, the significance of the uridylate preference observed for arteri- 
and coronavirus endoribonucleases in vitro for viral RNA synthesis is difficult to assess; 
the in vivo substrates of these enzymes are still unknown, and identifying them will be a 
key step in linking the available in vitro and in vivo data mechanistically. in this respect, 
it remains unclear whether the reduction of EAv sg mRNA synthesis and the decrease in 
infectious progeny production seen upon substituting Ser-174 of nsp11 with Ala24 can be 
attributed to the loss of the mutant enzyme’s ability to discriminate between uridylates 
and cytidylates (Fig. 7) or to its overall lower activity (Fig. 6B). in addition, the importance 
of viral determinants of pathogenesis can be difficult to assess in tissue culture, as il-
lustrated by the coronavirus ADP-ribose 1’’-phosphatase (ADRP) and the putative cyclic 
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phosphodiesterase (CPD) domains, which are dispensable for replication in cultured 
cells, but critically involved in viral pathogenicity in vivo10,25,30
irrespective of the exact function of arteri- and coronavirus NendoU proteins in the vi-
ral life cycle, the broad specificity that these endoribonucleases exhibit in vitro suggests 
that their activity in infected cells must be strictly regulated in order to protect viral (and 
possibly cellular) RNA species from rapid degradation. indeed, expression of EAv nsp11 
outside the context of the infected cell is extremely toxic to prokaryotic and eukaryotic 
cells (data not shown). For example, protein-protein interactions or modulation by cofac-
tors might act as allosteric switches to regulate the ribonucleolytic activity of arterivirus 
nsp11 and coronavirus nsp15, and prevent nonspecific cleavage of viral and/or cellular 
RNAs. The hexamerization of coronavirus nsp15, mediated by its N-terminal domain, and 
the presence of Mn2+ have been implicated in ensuring optimal RNA processing activ-
ity5,13,17. By contrast, EAv NendoU activity is inhibited in the presence of Mn2+ (Fig. 3) and 
its quaternary structure may differ as well. Although the yield of bacterially expressed EAv 
nsp11 was unfortunately too low to attempt to analyze its oligomeric state, preliminary 
gel filtration analyses of catalytic site mutants suggest they are present as monomers in 
solution (data not shown). This observation may turn out to be linked to the properties 
of the N-terminal domain of arterivirus nsp11, which is relatively small and apparently 
unrelated to its coronavirus nsp15 counterpart (Fig. 1C) (A.E. Gorbalenya, unpublished). 
in conclusion, the spatial and temporal regulation of EAv NendoU activity is likely en-
sured by coordinated replicase polyprotein cleavage, interactions with other replicase 
subunits or cellular proteins, and/or its compartmentalization in a specifically organized 
membrane-bound replication/transcription complex. The continued biochemical and 
structural characterization of nidovirus NendoU’s, in combination with the functional 
dissection of NendoU-containing ribonucleoprotein complexes in infected cells, should 
provide a basis for the identification of the in vivo target(s) of this replicative endoribo-
nuclease that is unique in the RNA virus world.
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suPPlemeNtal mateRIal
BToV Breda1         [NC_007447]    [1-142] GNGESLRELPETLFSTGRLYN---------LEHDPSKNFNVQQLAI-ETIPKNHHVFAGDFTDVGTDIGGVHHVVALNGYK------
EqToV Berne [X52374]       [1-142] GKGESLFELPDTLFSTGRLYN---------LDHDAAQNFNVKQLAI-ETMPNNHHVFSGDFTEVGTDIGGVHHVVALNGYK------
WBV DF24/00 [NC_008516]    [1-135] -----FVHGQSTPLDLGYTST---------NRLTTKQFIYTPNEDE-YKSKLGHHVSVGDTSNVSWTIGGMHVLTAFQNITN-----
IBV Beaudette [NC_001451]    [1-171] VNGA-FVTLPNTINTQGRSYETFEPRSDIERDFLAMSEESFVERYG-KDLGLQHILY-GEVDK--PQLGGLHTVIGMYRLLRANKLN
BWCoV SW1  [EU111742]     [1-182] -DGK-HVVPTSQLFTEQRSFEDFLPLSVMERDFLNMEAPQFIAKYDCKGLGLEHVLY-GDFSK--KVIGGAHLTIGLARLYIQEKFD
HCoV-NL63  [NC_005831.2]  [1-179] -NGQ-FQDHYDGFYTQGRNLSDFTPRSDMEYDFLNMDMGVFINKYGLEDFNFEHVVY-GDVSK--TTLGGLHLLISQFRLSKMGVLK
HCoV-229E  [NC_002645]    [1-183] -DGK-PVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDIGVFIQKYGLEDFNFEHVVY-GDVSK--TTLGGLHLLISQVRLSKMGILK
Mi-BatCoV 1B [NC_010436]    [1-174] -DGV-FVDQCDGIFTQGRNVSIFEPRSEMESDFLNLDMGLFISKYGLEDYAFEHIVF-GDVSK--NTLGGLHLLISQVRLSKMGVLK
Mi-BatCoV HKU8 [NC_010438]    [1-174] -DGQ-FLDQCDSIFTQGRSAENFVPRTQMETDFLELDMGLFISKYGLENFAFEHIVY-GDVSK--TTLGGLHLLISQVRLSKMGILK
Rh-BatCoV HKU2 [NC_009988]    [1-178] -DGS-FVEPVDGYYSQGRNASTFLPRSQMEKDFLELDTGLFISKYGLEDFNFEHIVY-GDVSK--TTLGGLHLLISQVRLARIGVLK
Sc-BatCoV 512 [DQ648858]     [1-174] -DGA-FVEYPDGYFTQGRVISDFQPRSNMEEDFLNMDMGLFISKYGLEDYGFEHVVF-GDVSK--TTLGGLHLLISQIRLSKIGVLK
PEDV CV777 [NC_003436]    [1-174] -NGK-FEDYPDGYFTQGRTTADFSPRSDMEKDFLSMDMGLFINKYGLEDYGFEHVVY-GDVSK--TTLGGLHLLISQVRLACMGVLK
FCoV VR-2202 [NC_007025]    [1-174] -NGE-YVEQIDSYYTHGRTFETFKPRSTMEEDFLSMDTTLFIQKYGLEDYGFEHVVF-GDVSK--TTIGGMHLLISQVRLAKMGLFS
MHV-A59  [NC_001846]    [1-209] LSGN-EALARGTIFTQSRLLSSFTPRSEMEKDFMDLDDDVFIAKYSLQDYAFEHVVY-GSFNQ--KIIGGLHLLIGLARRQQKSNLV
HCoV-HKU1  [NC_006577.2]  [1-209] VIGN-DALTRFTIFTQSRVLSSFEPRSDLERDFIDMDDNLFIAKYGLEDYAFDHIVY-GSFNH--KVIGGLHLLIGLFRRKKKSNLL
HCoV-OC43  [NC_005147]    [1-210] VGGN-DALSISTIFTQSRVISSFTCRTDMEKDFIALDQDVFIQKYGLEDYAFEHIVY-GNFNQ--KIIGGLHLLIGLYRRQQTSNLV
Ty-BatCoV HKU4 [EF065505]     [1-177] VNNE-FVSFSDTFYTCGRTVGDFTVLTPMEEDFLVLDSDVFIKKYGLEDYAFEHVVY-GDFSH--TTLGGLHLLIGLYKKMREGHIL
Pi-BatCoV HKU5  [EF065509]     [1-186] VNNE-FVQFTDTYYTLGRTVSDFTPVSEMEKDFLALDSDVFIKKYKLEAYAFEHVVY-GDFSR--TTLGGLHLLIGLYKKHQEGHII
Ro-BatCoV HKU9 [EF065513]     [1-175] -DGA-FVQPTDGYFTQSRTVDDFQPRTQLEIDFLDLEQSCFLDKYDLHDLGLEHIVY-GQFD---GTIGGLHLLIGAVRRKRTAHLV
SARS-HCoV Fra1 [AY291315]     [1-181] VDGI-IQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEHIVY-GDFSH--GQLGGLHLMIGLAKRSQDSPLK
PRRSV VR-2332 [AY150564]     [1-92] --GE-AQVLPETVFSTGRIEVDC-------REYLDDREREVAA-------SLPHAFI-GDVKG--TTVGGCHHVTSRY---------
PRRSV LV4  [AY588319]     [1-93] --GE-PQALPETLVSTGRIATDC-------REYLDAAEEEAAK-------ELPHAFI-GDVKG--TTVGGCHHITSKY---------
LDV nv-type-C [L13298]       [1-92] --GK-PVPLPDSLMSTGRIALNV-------REYLDEKEMEFSS-------RCPHAFI-GEVKG--SNVGGCHHVTSRY---------
SHFV LVR-42-0 [NC_003092]    [1-93] --GR-AVPMEDSVYSTGRFEMDI-------RDYLDSAERDFAA-------KHPHAFI-GDTKG--TTVGGCHHITSQY---------
EAV Bucyrus [NC_002532.2]  [1-89] --GK-ARALPDSLFSSGRFETNS-------RAFLDEAEEKFAA-------AHPHACL-GEINK--STVGGSHFIFSQY---------
BToV Breda1 [NC_007447]       -GSIIPNYVKPIATGLI--NVGRSVKR-TTLVDVCANQLYEKVKQQ--IAGVKVSKVIFVNIDFQEVQFMVFAKGEDDIQTFYPQKE
EqToV Berne [X52374]          -GSIIPNYVKPIATGLI--NVGRAVKR-TTLVDVCANQLYEKVKQQ--LEGVKVSKVIFVNIDFQDVQFMVFANGEDDIQTFYPQKD
WBV DF24/00 [NC_008516]       -YQLVSGPANPIMRINV--ALERGNKVETTALDTTLQDYYKIATTN--KVT--VSKTTFFTLDGGQYRMMNFANPDGTIQTSYPVAQ
IBV Beaudette [NC_001451]       AKSVTNSDSDVMQNYFVL-SDNGSYKQVCTVVDLLLDDFLELLRNILKEYGTNKSKVVTVSIDYHSINFMTWFE-DGSIKTCYPQLQ
BWCoV SW1  [EU111742]        VHEISPSSFDVFKSYFVV-THAGAMKQVCTVLDVLLDDFISILKEIKVSHKGVVSEVLHYIVDYQTVDFMLWMG-DNAINTFYPKLQ
HCoV-NL63  [NC_005831.2]     ADDFVTASDTTLRCCTVTYLNELSSKVVCTYMDLLLDDFVTILKSL--DLGV-ISKVHEVIIDNKPYRWMLWCK-DNHLSTFYPQLQ
HCoV-229E  [NC_002645]       AEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKSL--DLTV-VSKVHEVIIDNKPWRWMLWCK-DNAVATFYPQLQ
Mi-BatCoV 1B [NC_010436]       VEDFVSSTDSTLKSCSVTYVNDPSSKMVCTYMDILLDDFVGILKSL--DLSV-VSKVHEVIVDCKVYRWMLWCK-DYKVQTFYPQLQ
Mi-BatCoV HKU8 [NC_010438]       VEEFVHTGDSSLRCASVTYVDNPSSKMVCSYMDILLDDFVTLLKTL--DLSV-VSKVHEVIVDCKVYRWMLWCK-DHKVQTFYPQLQ
Rh-BatCoV HKU2 [NC_009988]       VEDFVDSADDTLHSCSVTYANDPSSKSVCTYMDILLDDFVVILRNL--DLSV-TSKVHDVIVDCKAWRWMLWCK-DSKVATFYPQLQ
Sc-BatCoV 512 [DQ648858]        VEDFVSSSDSTLKSCTVTYVDNPSSKMVCTYVDLLLDDFVNILKSV--DLSV-VSKVHEVVIDCKVWRWMLWCK-DHKVQTFYPQLQ
PEDV CV777 [NC_003436]       IDEFVSSNDSTLKSCTVTYADNPSSKMVCTYMDLLLDDFVSILKSL--DLSV-VSKVHEVMVDCKMWRWMLWCK-DHKLQTFYPQLQ
FCoV VR-2202 [NC_007025]       VQEFMTNSDSTLKSCCITYADDPSSKNVCTYMDILLDDFVTIIKSL--DLNV-VSKVVDVIVDCKAWRWMLWCE-NSQIKTFYPQLQ
MHV-A59  [NC_001846]       IQEFVT-YDSSIHSYFITDENSGSSKSVCTVIDLLLDDFVDIVKSL--NLKC-VSKVVNVNVDFKDFQFMLWCN-EEKVMTFYPRLQ
HCoV-HKU1  [NC_006577.2]     IQEFLQ-YDSSIHSYFITDQECGSSKSVCTVIDLLLDDFVSIVKSL--NLSC-VSKVVNINVDFKDFQFMLWCN-DNKIMTFYPKMQ
HCoV-OC43  [NC_005147]       VQEFVS-YDSSIHSYFITDEKSGGSKSVCTVIDILLDDFVALVKSL--NLNC-VSKVVNVNVDFKDFQFMLWCN-DEKVMTFYPRLQ
Ty-BatCoV HKU4 [EF065505]        MEEMLK-DRATVHNYFITDSNTASYKAVCSVIDLRLDDFVTIIKEM--DLDV-VSKVVKVPIDLTMIEFMLWCR-DGKVQTFYPRLQ
Pi-BatCoV HKU5  [EF065509]        MEEMLK-ERATVHNYFVTESNTASFKAVCSVIDLKLDDFVDIIKAM--DLSV-VSKVVKIPIDLTMIEFMLWCK-DGQVQTFYPRLQ
Ro-BatCoV HKU9 [EF065513]        METVLG-TD-TVTSYAVIDQPTASSKQVCSVVDIILDDFIALIKAQ--DRSV-VSKVVQCCLDFKVFRFMLWCK-GGKISTFYPQLQ
SARS-HCoV Fra1 [AY291315]       LEDFIP-MDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQ--DLSV-ISKVVKVTIDYAEISFMLWCK-DGHVETFYPKLQ
PRRSV VR-2332 [AY150564]      LPRVLP--KESVAVVGVS-SPGKAAKALCTLTDVYLPDLEAYLHPE----TQ--SKCWKMMLDFKEVRLMVWKD-----KTAYFQLE
PRRSV LV4  [AY588319]       LPRSLP--KDSVAVVGVS-SPGRAAKAVCTLTDVYLPELRPYLQPE----TA--SKCWKLKLDFRDVRLMVWKG-----ATAYFQLE
LDV nv-type-C [L13298]         LPPVLV--PGSVVKIGVS-CPGKAAKELCTVTDVYLPELDPYLNPP----TK--SMDYKLLVDFQPVKLMVWKD-----ATAYFH-E
SHFV LVR-42-0 [NC_003092]      LPHVLP--ADSVVKVGVS-KPGVAHKALCTVTDIYLPMLGLYTSPP----TQ--SKVYKVNVDHKACKLMVWRD-----QTMYFQ-E
EAV Bucyrus [NC_002532.2]    LPPLLP--ADAVALVGAS-LAGKAAKAACSVVDVYAPSFEPYLHPE----TL--SRVYKIMIDFKPCRLMVWRN-----ATFYVQ-E
figure s1. Amino acid alignment of the NendoU domain of corona-, toro-, bafini- and arteriviruses. virus 
acronyms are indicated in the first column. NCBi accession numbers of viral genomes and distances of 
the NendoU domain from the N-terminus of the protein (in amino acids) are listed in the second and third 
column, respectively. Conserved residues discussed in the text have been highlighted. Abbreviations are 
as follows: BTov Breda1, bovine torovirus Breda-1; EqTov Berne, equine torovirus Berne; WBv DF24/00, 
white bream virus; iBv Beaudette, infectious bronchitis virus strain Beaudette; BWCov SW1, Beluga Whale 
coronavirus SW1; HCov NL63, human coronavirus NL63; HCov 229E, human coronavirus 229E; Mi-BatCov 
1B, miniopterus bat coronavirus 1B; Mi-BatCov HKU8, miniopterus bat coronavirus HKU8; Rh- BatCov HKU2, 
Rhinolophus bat coronavirus HKU2; Sc-BatCov 512, Scotophilus bat coronavirus 512/05; PEDv Cv777, 
porcine epidemic diarrhoea coronavirus; FCov vR-2202, feline coronavirus; MHv A59, mouse hepatitis 
virus A59; HCov HKU1, human coronavirus HKU1; HCov OC43, human coronavirus OC43; Ty-BatCov HKU4, 
Tylonycteris bat coronavirus HKU4; Pi-BatCov HKU5, Pipistrellus bat coronavirus HKU5; Ro-BatCov HKU9, 
Rousettus bat coronavirus HKU9; SARS-HCov Fra1, severe acute respiratory syndrome coronavirus (referred 
to as SARS-Cov in the main text); PRRSv vR-2332, porcine respiratory and reproductive syndrome virus, 
strain vR-2332 (referred to as PRRSv in the main text); PRRSv Lv4, porcine respiratory and reproductive 
syndrome virus, strain Lelystad; LDv nv-type-C, lactate dehydrogenase-elevating virus neuro-virulent type 
C; SHFv LvR-42-0, simian hemorrhagic fever virus; EAv Bucyrus, equine arteritis virus (referred to as EAv in 
the main text).
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figure s2. Phylogenetic tree of the NendoU domain constructed on the basis of the amino acid alignment 
(174 sites) shown in Figure S1. For virus acronyms, see the legend of figure S1. The scale bar represents 0.1 
substitutions per site on average. Numbers at branching points indicate support from 1,000 nonparametric 
bootstraps.
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abstract
aBstRaCt
Many groups of plus-stranded RNA viruses produce additional, subgenomic mRNAs to 
regulate the expression of part of their genome. Arteriviruses and coronaviruses (order 
Nidovirales) are unique among plus-stranded RNA viruses for using a mechanism of dis-
continuous RNA synthesis to produce a nested set of 5’- and 3’-coterminal subgenomic 
mRNAs, which serve to express the viral structural protein genes. The discontinuous step 
presumably occurs during minus-strand synthesis and joins noncontiguous sequences 
copied from the 3’- and 5’-proximal domains of the genomic template. Nidovirus genome 
amplification (“replication”) and subgenomic mRNA synthesis (“transcription”) are driven 
by 13 to 16 nonstructural proteins (nsp’s), generated by autocatalytic processing of two 
large “replicase” polyproteins. Previously, using a replicon system, the N-terminal nsp1 
replicase subunit of the arterivirus equine arteritis virus (EAv) was found to be dispens-
able for replication but crucial for transcription. Using reverse genetics, we have now 
addressed the role of nsp1 against the background of the complete EAv life cycle. Muta-
genesis revealed that nsp1 is in fact a multifunctional regulatory protein. its papain-like 
autoprotease domain releases nsp1 from the replicase polyproteins, a cleavage essential 
for viral RNA synthesis. Several mutations in the putative N-terminal zinc finger domain 
of nsp1 selectively abolished transcription, while replication was either not affected or 
even increased. Other nsp1 mutations did not significantly affect either replication or 
transcription but still dramatically reduced the production of infectious progeny. Thus, 
nsp1 is involved in at least three consecutive key processes in the EAv life cycle: replicase 
polyprotein processing, transcription, and virion biogenesis.
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INtRODuCtION
The replication of plus-stranded RNA viruses of eukaryotes depends on a unique process 
of cytoplasmic RNA-dependent RNA synthesis that is primarily directed by an enzyme 
complex, always including an RNA-dependent RNA polymerase (RdRp), that is produced 
by translation of the incoming viral genome (reviewed, e.g., in references1, 3, 7). The 
“nonstructural proteins” (nsp’s) or “replicase subunits” of mammalian plus-stranded RNA 
viruses are commonly produced by proteolytic cleavage of larger polyproteins (reviewed 
e.g., in references10,14). This strategy can be supplemented with the synthesis of additional, 
subgenomic (sg) mRNAs, a process referred to as “transcription” for the purpose of this 
article, to express additional proteins (reviewed in reference34). Members of the order Ni-
dovirales of plus-stranded RNA viruses (Arteriviridae, Coronaviridae, and Roniviridae) rely 
heavily on the latter strategy (reviewed in references39, 49,50) to produce their structural 
proteins from genes located in the 3’-proximal third of their genome (Fig. 1).
Nidoviruses have been grouped together on the basis of similarities in genome 
organization and nonstructural and structural protein expression strategies, as well 
as the presumed immediate common ancestry of key replicative enzymes (see our 
recent reviews in references12,56 and references cited therein). The nidovirus replicase/
transcriptase, which will be referred to as “replicase” for simplicity, is expressed from the 
genome RNA by translation of the large open reading frames (ORFs) 1a and 1b (Fig. 1). 
This yields polyproteins pp1a and pp1ab, with the latter being produced via a conserved 
ORF1a/ORF1b -1 ribosomal frameshift mechanism (see reference5 and references cited 
therein). Nidovirus replicases, in particular those of nidoviruses with large genomes 
(corona-,toro-, and roniviruses [25 to 31 kb]), include several enzymatic activities that are 
rare or lacking in other RNA viruses11, 12, 32, 53, 73. Triggered by the 2003 outbreak of severe 
acute respiratory syndrome (SARS)-coronavirus, significant progress has been made in 
the functional and structural characterization of coronavirus replicative proteins4, 32, 73. 
Still, many questions remain regarding the molecular mechanisms that nidoviruses have 
evolved to coordinate the various steps of their replicative cycle.
The arterivirus family is the nidovirus branch that stands out for its much smaller 
genome size (12 to 16 kb). The pp1a and pp1ab replicase polyproteins of the arterivi-
rus prototype equine arteritis virus (EAv)54 are 1,727 and 3,175 amino acids (aa) long, 
respectively (for reviews, see references12, 52, 55) and are cleaved (Fig. 2A) into 13 nsp’s by 
viral proteases contained in nsp1, nsp2, and nsp463, 75. Seven structural protein genes, 
residing in the 3’-terminal quarter of the EAv genome, are expressed from a nested set of 
sg mRNAs (Fig. 1) and are all dispensable for replication and transcription36.
Nidovirus RNA synthesis in infected cells entails both amplification of the viral genome 
and sg RNA production. The “bodies” of arteri- and coronavirus sg mRNAs are 3’-cotermi-
nal, but they also contain a 5’ common leader sequence that is identical to the 5’ end 
of the genome. Replication and transcription are thought to proceed through different 
minus-strand intermediates. Whereas a full-length minus-strand template is used for 
replication, sg mRNAs are assumed to be synthesized from subgenome-length minus 
130
5
strands, generated by a process of discontinuous RNA synthesis (reviewed in references39, 
48–50, 70) involving the 3’-terminal extension of the nascent strands (the complements of 
the sg mRNA bodies) with the complement of the leader sequence. This discontinuous 
step in minus-strand RNA synthesis, which may resemble copy-choice RNA recombina-
tion, is regulated (in part) by conserved transcription-regulating sequences (TRSs). in 
EAv, both sequence elements and higher-order RNA structures have been postulated to 
direct the transfer of the nascent minus strand from the body TRS to the leader TRS in 
the genomic RNA template38, 40, 41, 64, 65. in addition to these RNA-RNA interactions, sev-
eral EAv replicase subunits have been specifically implicated in transcription: the nsp10 
helicase51, 68, 69, the nsp11 putative endoribonuclease45, and nsp162, the most N-terminal 
replicase cleavage product. Previous studies showed that EAv replication can proceed in 
the absence of transcription62, 68, suggesting that the latter process is in part controlled 
by transcription-specific replicase functions. Whereas mutations in nsp10 and nsp11 
affected both genome amplification and transcription45, 68, deletion of the nsp1-coding 
sequence from the replicase gene selectively blocked sg RNA synthesis62, which could be 
partially restored in a replicon RNA that expressed nsp1 from an artificial alternative locus 
in the genome (replicon DiTRAC)62. EAv nsp1 (260 aa) cotranslationally releases itself from 
the replicase polyproteins through a papain-like cysteine protease (PCPβ) activity in its 
C-terminal half58, 59. Comparative sequence analysis identified two other domains in nsp1 
(Fig. 2C), an additional PCP (PCPα), which has become inactivated in the course of EAv 
evolution but is functional in other arteriviruses9, and a potential N-terminal zinc finger 
(ZF) domain (Fig. 2B)62. in the artificial setting of the DiTRAC replicon, the ZF domain and 
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figure 1. Schematic diagram of the genome organization and expression of EAv. The regions encoding 
the replicase polyproteins (pp1a and pp1ab) and structural proteins are indicated on the genome. The 
replication/transcription complex, presumably containing the full-length and subgenome-length minus-
strand templates for replication and transcription, is depicted below the genome. Subgenomic mRNAs, 
with the black boxes representing their common 5’ leader sequence, are shown in the bottom part of the 
scheme.
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the structural integrity of nsp1, but not the proteolytic activity of PCPβ, were important 
for transcription62. The role of nsp1 has now been addressed in the context of the full-
length EAv genome and the complete viral life cycle. We conclude that EAv nsp1 not only 
couples replicase maturation to transcription but also plays a surprising, yet unexplained, 
role in virion biogenesis. Several nsp1 mutations that did not dramatically affect viral 
RNA synthesis were found to severely reduce the production of infectious progeny. Thus, 
EAv nsp1 is a multifunctional protein that is involved in at least three consecutive key 
processes in the EAv life cycle: proteolytic maturation of the replicase, transcription, and 
virion biogenesis. 
mateRIals aND methODs
eav reverse genetics
Site-directed PCR mutagenesis25 was used to engineer mutations in shuttle plasmids car-
rying the nsp1 coding sequence. Following sequence analysis, mutations were transferred 
to EAv full-length cDNA clone pEAv21164, 68. The mutants of the PCPβ active-site cysteine 
EAV replicase pp1ab
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figure 2. (A) Processing scheme of the EAv replicase, depicted in the form of the pp1ab polyprotein. 
The three viral protease domains (the nsp1 PCPβ [β], the nsp2 cysteine proteinase [CP], and the nsp4 
serine proteinase [S]) and their cleavage sites are indicated. Other domain abbreviations are as follows: 
ZF, nsp1 zinc finger domain; α, nsp1 PCPα domain; H, hydrophobic domains; RdRp, RNA-dependent 
RNA polymerase (nsp9); M, metal-binding domain (nsp10); Hel, helicase (nsp10); N, nidovirus-specific 
endoribonuclease NendoU (nsp11). (B) Schematic representation of the putative nsp1 ZF domain, showing 
the four residues that are proposed to coordinate zinc in gray. (C) Comparison of key sequences of the 
three domains identified in the arterivirus nsp1 region, ZF, PCPα, and PCPβ. The putative zinc-coordinating 
residues of the ZF domain and the active-site Cys and His residues of the two PCP domains are indicated. 
Note that EAv PCPα is no longer active due to the loss of its active-site Cys (9). Residues targeted by 
mutagenesis in this study are indicated with an asterisk.
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(Cys-164) and the nsp1/2 cleavage site (Gly-260/Gly-261) have been described before58. The 
amino acid substitutions engineered to generate novel nsp1 mutants are listed in Table 1. 
Following in vitro transcription of full-length cDNA clones by T7 RNA polymerase, BHK-21 
cells were transfected with equal amounts of full-length EAv RNA as described previously68. 
immunofluorescence assays (iFAs)67, 68 were used to monitor transfection efficiencies.
analysis of virus mutants
For an initial assessment of viral phenotypes (in terms of replication and transcription), 
dual-labeling iFAs67 were performed with a rabbit antiserum specific for nsp343, a repli-
case cleavage product expressed from the genome, and a mouse monoclonal antibody 
(MAb) recognizing the nucleocapsid (N) protein (N MAb 3E2)29, which is expressed from 
the smallest sg mRNA. viral RNA synthesis was studied in more detail by isolating total 
intracellular RNA at the end of the first replication cycle (~14 h post-transfection [hpt]) 
using the acidic phenol extraction method, as described previously70. RNA was separated 
in denaturing formaldehyde-agarose gels, and viral mRNAs were visualized by hybridiza-
tion with a radioactively labeled, antisense oligonucleotide probe (complementary to the 
3’ end of the genome), which recognizes both genomic and all sg mRNAs70. Supernatants 
harvested from transfected cell cultures were analyzed for infectious progeny by plaque 
assays36 and infection of fresh BHK-21 cells.
PCPβ activity assay
A vector (pEAvΔH) for testing PCPβ activity in an in vitro transcription and translation 
assay58 was engineered by making an internal Hindiii deletion (removing nucleotides 
[nt] 1506 to 12308 of the EAv genome; NCBi accession no. NC_002532) in the full-length 
cDNA clones for selected mutants. These constructs contained an in-frame fusion of the 
5’ end of ORF1a to the 3’ end of ORF6 and encoded a product of 453 aa (52 kDa) including 
the full-length nsp1 and the nsp1/2 cleavage site. The fusion gene was preceded by a T7 
promoter and the natural genomic 5’-untranslated region and followed by the genomic 
3’-untranslated region and a poly(A) tail. The in vitro PCP assay was performed by transla-
tion of transcripts derived from these vectors in a rabbit reticulocyte lysate (Promega). 
The reaction was performed at 30°C for 90 min in the presence of [35S]methionine, after 
which translation and cleavage products were analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography.
sequence analysis and RNa structure prediction
The RNA structure of the 5’-proximal region of EAv ORF1a was predicted using the 
genetic algorithm of STAR v4.419 and the Zuker algorithm77 on the M-fold web server78. 
Sequence alignments were created using the ClustalW algorithm incorporated in vector 
NTi (invitrogen). The hairpin structure predicted to underlie the ZF-coding region (see 
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Fig. 6) was mutated in full-length cDNA clone pEAv211-RNAko using a combination of 
seven translationally silent mutations in codons specifying residues 22 to 28 of nsp1 
(Fig. 6): C-290→A, C-293→U, U-296→A,U-299→C, G-302→A, U-305→C, and C-308→G 
(numbers refer to positions in the EAv genome sequence).
Results
Design and characterization of eav nsp1 mutants
We have previously reported that nsp1 is dispensable for EAv genome replication but ab-
solutely required for transcription62. in that study, expression of an engineered wild-type 
nsp1 cassette from an artificial internal ribosomal entry site (iRES) inserted in the 3’-termi-
nal part of replicon DiTRAC could complement for the deletion of the natural nsp1-coding 
sequence from the replicase gene62. This resulted in partial restoration of transcription, but 
since the iRES-nsp1 cassette in the DiTRAC replicon replaced five of the seven structural 
protein genes, virus production could not be studied in this system. To address the role of 
nsp1 against the background of the complete EAv life cycle, we have now used a reverse-
genetics approach based on the use of full-length cDNA clones68. Full-length RNA derived 
from cDNA clones containing nsp1 mutations (Table 1) was transfected into BHK-21 cells. 
Replication and transcription were initially monitored using a previously described dual-
labeling iFA62 detecting nonstructural and structural protein expression (data not shown). 
Subsequently, additional assays were used to characterize the phenotypes. The produc-
tion of infectious progeny was investigated by monitoring the spread of the infection in 
transfected cell cultures and/or using cell culture supernatants to infect fresh cells.
the nsp1/2 cleavage is essential for eav genome replication
We first analyzed the importance of cleavage of the nsp1/2 site by the C-terminal PCPβ 
domain of nsp158. in the setting of the DiTRAC replicon, PCPβ activity was dispensable 
for the functionality of nsp1 in transcription62. However, in DiTRAC, nsp1 was expressed 
from a separate iRES-driven cistron and did not have to play its usual role in replicase 
proteolysis. in this replicon, cleavage of the nsp1/2 bond was effectively substituted 
for by translation initiation at the 5’ end of the nsp2 coding sequence and independent 
expression of nsp1 from the 3’-proximal part of the genome. 
Using a full-length cDNA clone, cleavage of the nsp1/2 site was now found to be a prerequi-
site for EAv RNA synthesis. Several mutations that were previously reported to abolish process-
ing of the nsp1/2 site58, 59 rendered the viral RNA noninfectious. These included replacement 
of the PCPβ active-site Cys-164 with Ser and replacement of the P1 (Gly-260) or P1’ (Gly-261) 
residues of the nsp1/2 cleavage site with val (Table 1) (data not shown). The lethal effect of 
these mutations was evident, in several independent experiments, from the complete lack of 
iFA signal in transfected cells and the absence of viral RNA synthesis and infectious progeny. 
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These results are in contrast with our previous observation that deletion of nsp1 selec-
tively blocks transcription but not replication62. We therefore conclude that cleavage of 
the nsp1/2 site by the nsp1 PCPβ domain must be essential to produce a functional EAv 
replication complex. Possibly, the N terminus of nsp2 has to be liberated for this subunit 
to fulfill its role in the formation of the membrane-bound replication complex43, 57. This 
table 1. Overview of the genotype and first-cycle phenotype of EAv nsp1 mutants used in this study
Codona
Construct Mutation
Wild 
type
Mutant Replicationb Transcriptionb
Plaque 
size
Titer
(PFU/
ml)c
Phenotype 
summaryd
pEAv211 NAe NA NA Normal Normal Normal 107-108 Wild-type control
C25A Cys -25Ala UGU GCU Enhanced Negative No 
plaques
<2x101
Transcription 
negative; nonviable
C25H Cys -25His UGU CaU Normal Normal Small 105-106 Transcription 
~normal; attenuated
H27A His-27Ala CAU GCC Normal Normal Small 102-103 Transcription 
~normal; attenuated
H27C His-27Cys CAU uGU Normal Normal Small 102-103 Transcription 
~normal; attenuated
H27R His-27Arg CAU CGU Enhanced Reduced Normal 102-103
Transcription 
impaired; rapid 
reversion
C32A 
C33A
Cys -32Ala
Cys -33Ala
UGC
UGC
GCG
GCC
Normal Normal Normal 107-108 Wild type
C41A Cys -41Ala UGC GCG Enhanced Negative No 
plaques
<2x101
Transcription 
negative; nonviable
C41H Cys -41His UGC Cau Enhanced Negative No 
plaques
<2x101
Transcription 
negative; nonviable
C44A Cys -44Ala UGU GCU Enhanced Negative No 
plaques
<2x101
Transcription 
negative; nonviable
C44H Cys -44His UGU CaU Enhanced Negative No 
plaques
<2x101
Transcription 
negative; nonviable
C164S Cys-164Ser UGC aGC Negative Negative No 
plaques
<2x101
Replication negative; 
nonviable
G260v Gly-260val GGC Gua Negative Negative No 
plaques
<2x101
Replication negative; 
nonviable
G261v Gly-261val GGC Gua Negative Negative No 
plaques
<2x101
Replication negative; 
nonviable
RNAko
7 silent 
mutations
See 
text
See 
text
Normal Normal Normal 107-108 Wild type
a Nucleotide substitutions are indicated in boldface.
b Transfected cells were analyzed by iFA and Northern blot analysis at the end of the first cycle of 
replication (14 to 16 hpt).
c infectious progeny titers in plaque assays of medium from transfected cells harvested at 18 hpt.
d Depending on the mutant, data from two to four independent transfection experiments are summarized.
e NA, not applicable. 
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interpretation is further supported by the nonviable phenotype of an EAv construct, in 
which green fluorescent protein (GFP) was fused to the N terminus of nsp266.
the nsp1 zf domain plays a critical role in transcription
On the basis of site-directed mutagenesis of Cys-25 and Cys-44 (both residues changed 
to Ala) in the DiTRAC replicon, the nsp1 ZF domain was previously implicated in regula-
tion of transcription62. in the context of the EAv full-length clone, the ZF domain was now 
probed more extensively (Table 1). The four putative zinc-coordinating residues (Cys-25, 
His-27, Cys-41, and Cys-44) were targeted, and - as a negative control - two Cys residues 
(Cys-32 and Cys-33) that are not conserved in arterivirus nsp1 sequences (Fig. 2C) were 
also replaced. Nonconservative mutagenesis (to Ala) of the latter two residues resulted in 
a wild-type phenotype, indicating that Cys residues at positions 32 and 33 of the EAv ZF 
domain are dispensable for replication in cell culture. The four putative zinc-coordinating 
residues were replaced both nonconservatively (Cys or His to Ala or Arg) and conserva-
tively (Cys to His and His to Cys). The latter strategy was aimed at maintaining (partial) 
figure 3. (A) Northern blot analysis of genome 
(RNA1) and sg mRNA (RNAs 2 to 7) synthesis 
in BHK-21 cells transfected with EAv nsp1 
ZF mutants (14 hpt) and the RNAko mutant 
designed to probe the role of the RNA structure 
of the ZF-coding region (see text). RNA was 
isolated at 14 hpt, and hybridization was 
carried out using a 32P-labeled oligonucleotide 
probe complementary to the 3’ end of the 
genome and thus recognizing all viral mRNA 
species. Note the upregulation of genome 
synthesis in transcription-negative mutants. (B) 
Phosphorimager analysis of the ratio of sg mRNA 
to genome accumulation, based on the gel 
depicted in panel A. For the transcription-positive 
mutants, the amount of genome was put at 1 
and the relative amounts measured for mRNA7, 
mRNA6, and mRNAs 2 to 5 are shown. With the 
exception of the His-27→Arg mutant, all mutants 
were concluded to maintain fairly normal 
transcription levels. wt, wild type.
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zinc-binding activity. interestingly, a differential effect of the Ala/Arg versus His/Cys ZF 
mutations was indeed observed at some positions (Table 1).
Residues Cys-41 and Cys-44 were both absolutely required for the function of nsp1 in 
transcription (Fig. 3 and Table 1), since their replacement essentially exerted the same 
effect as deletion of nsp1: transcription was reduced to a level that could not even be de-
tected by using reverse transcription-PCR (RT-PCR) (data not shown). Remarkably, these 
transcription-negative mutants also displayed a clear upregulation (2.5- to 3-fold) of 
genome replication (Fig. 3A), suggesting that EAv replication and transcription normally 
compete for common factors.
multiple nsp1 zf domain mutants are transcription positive but severely 
impaired in virus production
in terms of transcription, the role of Cys-25 was found to be somewhat less critical than 
those of Cys-41 and Cys-44. Northern blot analysis revealed that the Cys-25→His mutant 
produced approximately normal amounts of sg mRNAs (Fig. 3B), although replacement 
with Ala completely eliminated transcription. immunoprecipitation analyses and iFAs (D. 
D. Nedialkova et al., unpublished data) confirmed the synthesis of several structural pro-
teins. Remarkably, however, progeny titers were 100- to 1,000-fold reduced and mutant 
C25H displayed a small-plaque phenotype (Fig. 4).
Replacement of the fourth putative zinc-coordinating residue, His-27, with either Ala 
or Cys also yielded a transcription-positive phenotype (Fig. 3). sg RNA synthesis appeared 
somewhat reduced relative to genome synthesis but not more than twofold (Fig. 3B). 
However, the drop in infectivity for these two His-27 mutants was more pronounced (4 
to 5 logs). Signs of probable reversion were occasionally observed in the form of larger 
plaques (Fig. 4). The His-27→Arg mutant, on the other hand, displayed a clear transcrip-
C25→H
H27→C
wild-type
RNA-ko
figure 4. Plaque phenotype of selected mutants from this study. virus was harvested from transfected 
BHK-21 cells at 18 hpt. Plaque assays were also performed on BHK-21 cells and fixed after 3 days. The small-
plaque phenotype of the Cys-25→His and His-27→Cys mutants is illustrated, with the latter showing sign 
of probable rapid reversion (plaques marked R). The fourth photograph illustrates the wild-type plaque 
phenotype of the RNAko mutant.
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tion defect (Fig. 3A and B). Some infectious progeny were produced, but in view of their 
wild-type size, these plaques likely resulted from rapid reversion of the single-nucleotide 
mutation introduced to create the H27R mutant. All other mutants in our data set 
required two replacements to revert to the wild-type codon (Table 1), and they were, 
accordingly, relatively stable.
The characterization of the transcription-positive nsp1 mutants was extended to 
several other time points after transfection (between 11 and 18 hpt) with essentially 
identical results, indicating that these mutants are not merely delayed in terms of virus 
production but fail to produce the normal level of infectious progeny—an observation 
implicating nsp1 in an additional step of the viral life cycle, downstream of transcription. 
Analysis of this phenotype in a longer-time-course experiment was complicated by the 
emergence and spread of revertants, an issue that will be addressed in a follow-up study.
PCPβ proteolytic activity is not affected by mutations in the zf domain
in view of the critical importance of cleavage at the nsp1/2 site for virus viability (see 
above), we selected a number of ZF mutants to investigate whether their nsp1 PCPβ ac-
tivity might have been compromised. PCPβ was previously shown to be highly efficient 
in directing the nsp1/2 cleavage in a rabbit reticulocyte lysate-based in vitro transla-
tion system58. By making an internal deletion in the full-length cDNA clones for these 
mutants, we engineered a vector (pEAvΔH) for in vitro transcription and translation. The 
pEAvΔH product was a 52-kDa (453-aa) fusion protein consisting of the full-length nsp1, 
the N-terminal part of nsp2, and the C-terminal part of the M protein, which is encoded 
by ORF6.
in vitro transcripts derived from these vectors were translated in a reticulocyte lysate in 
the presence of [35S]methionine. Reaction products were analyzed directly by SDS-PAGE 
and autoradiography (Fig. 5). Wild-type nsp1 showed complete cleavage of the 52-kDa 
precursor into nsp1 (30 kDa) and the C-terminal 22-kDa fragment. The same observation 
was made for nsp1 ZF mutants showing (C25H and H27C) or completely lacking (C25A 
and C41A) sg RNA synthesis, strongly suggesting that the transcription defect in the lat-
ter mutants is unrelated to a change in PCPβ proteolytic activity.
analysis of RNa structure of the nsp1 zf-coding region
The 5’-proximal domain of the arterivirus genome is a multifunctional region containing 
RNA signals that are known to be involved in translation, replication, and transcription. 
These signals were previously found to extend into the coding part of the genome, more 
specifically the 5’ end of ORF1a64, 65. This raised the possibility that defects observed in 
our nsp1 ZF mutants could be due to the effect of the introduced mutations on RNA 
sequence or structure, rather than on the nsp1 amino acid sequence. in particular, such 
RNA-specific effects might explain transcription defects, in view of the proximity of the 
leader TRS and leader TRS hairpin64, 65. Also, the production of progeny virus might be 
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affected at the level of genome packaging. The location of encapsidation signal(s) in 
the EAv genome is still unknown, but previous studies with defective interfering RNAs 
implicated sequences in the first ~600 nt of the genome in RNA packaging35.
A comparative analysis of the ZF-coding sequence (nt 285 to 360) of a number of EAv 
isolates revealed that this area is highly conserved (Fig. 6A). RNA structure predictions us-
ing different methods (see Materials and Methods) revealed a prominent and potentially 
stable hairpin structure (predicted ΔG using Mfold is -13.6 kcal/mol [Fig. 6B]), which can 
be formed by nt 285 to 315 of the EAv genome. These nucleotides specify nsp1 aa 22 to 
30, thus including key ZF residues Cys-25 and His-27, for which mutagenesis had yielded 
remarkably variable results (see above). Strikingly, the comparative sequence analysis in 
Fig. 6A provided some additional support for this structure, since four variations found in 
this region were predicted either to maintain the predicted structure (Fig. 6B; C-293→U 
and U296→C), to not affect it due to their position in a bulge (A-292→C and U305→C), 
or to immediately flank the predicted hairpin (A-314→U and U315→C).
in order to address the question whether the defects observed for (some) nsp1 mu-
tants might be due to an effect on the predicted hairpin rather than the nsp1 protein, 
we engineered a mutant (RNAko) in which a combination of seven translationally silent 
mutations was introduced in the codons specifying nsp1 residues 22 to 28 (Fig. 6B). 
Mfold analysis indicated that this combination of mutations in the region of nt 290 to 308 
should destroy the predicted hairpin (data not shown). Also some alternative RNA struc-
tures that can be predicted for the wild-type sequence would be significantly altered by 
this combination of mutations. Nevertheless, in multiple experiments, the phenotype of 
the RNAko mutant was found to be identical to that of wild-type virus, showing normal 
levels of replication and transcription (Fig. 3), wild-type virus titers (Table 1), and a normal 
ZF PCPα PCPβ nsp2 AAAAA
nsp1 C
M 3’5’
pEAVΔH
T7→
kDa
45
30
22
P
nsp1
C
C25Hwild-type H27C C25A C41A
HindIII
figure 5. in vitro assay for PCPβ activity in nsp1 ZF mutants. Expression construct pEAvΔH (see Materials 
and Methods) was used to in vitro translate an nsp1-containing fusion protein in the presence of
[35S]methionine. Reaction products were analyzed by SDS-PAGE and autoradiography. Cleavage of the 52-
kDa precursor (P) yields nsp1 and a 22-kDa C-terminal fragment (C). All nsp1 ZF mutants tested
showed wild-type nsp1 PCPβ activity, thus ruling out that a defect in nsp1/2 cleavage was the basis for 
their phenotype.
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plaque size (Fig. 4). Thus, regardless whether the hairpin depicted in Fig. 6 exists or not, 
it is irrelevant in the context of the results obtained with the Cys-25 and His-27 nsp1 
ZF mutants. in this light, also the phenotype of the H27R mutant is important, since its 
A-304→G mutation is predicted to maintain the RNA hairpin, exchanging a U-A for a U-G 
base pair. Still, H27R transcription is seriously affected (Fig. 3), again suggesting that it 
is the nsp1 amino acid sequence that is important rather than the RNA structure of this 
region.
DIsCussION
Following uncoating, plus-strand RNA virus genomes are first translated by host ribo-
somes to produce the enzymes required for viral RNA synthesis. nsp1 of EAv is the first 
viral protein expressed and thus seems to occupy a strategic position in the viral life 
cycle, which may explain the multifunctionality of this replicase subunit that is now 
emerging. in addition to its critical role in replicase polyprotein processing and sg RNA 
production described before62 and extended here, our new data implicate nsp1 in an 
as-yet-undefined function downstream of RNA synthesis that is ultimately important for 
virion biogenesis.
The data presented in this article, in particular those obtained from mutagenesis of 
the putative zinc-binding residues of the ZF domain, confirm the crucial role of nsp1 in 
C25 C41 C44H27
A
B
Cys-25 His-27
285
290
295
310
305
300
315
ΔG=-13.6 kcal/mol
figure 6. (A) Sequence alignment of the nsp1 ZF-coding domain for a selection of EAv isolates (for details, 
see reference64). The codons for the four key residues of the nsp1 ZF are boxed. (B) Structure of a predicted 
RNA hairpin that can be formed by the sequence specifying nsp1 ZF residues 22 to 28, thus including the 
highlighted codons for Cys-25 and His-27. Natural sequence variations (see panel A) are indicated in gray. 
Residues targeted for mutagenesis in the RNAko mutant (see text) are indicated with asterisks.
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EAv transcription. However, whereas EAv proved to be highly sensitive to replacement of 
Cys-41 and Cys-44, the Cys-25→His substitution was tolerated and the constraints on the 
His occupying position 27 appeared to be even more relaxed. The fact that - compared 
to the distal pair of Zn-binding residues (Cys-41 and Cys-44) - mutations at the proximal 
Cys-25/His-27 pair were relatively well tolerated correlates with (and supports) the align-
ment presented in Fig. 2C, which shows that the position of His-27 is occupied by Cys in 
other arteriviruses.
Zinc binding by the nsp1 ZF domain remains to be verified, an issue currently pursued 
by purification and characterization of recombinant nsp1 from Escherichia coli. Also, we 
cannot formally exclude the theoretical possibility that this region of nsp1 contains, e.g., 
two small adjacent (or even overlapping) domains with different functions. However, the 
results obtained upon mutagenesis of the four putative zinc-coordinating residues lend 
credibility to the hypothesis that they are part of a single ZF domain: e.g., mutations in ei-
ther pair of proposed zinc-binding residues can produce the same transcription-negative 
phenotype (compare C25A with the C41/C44 mutants [Fig. 3]). The three transcription-
positive ZF mutants (C25H, H27C, and H27A) were also the basis for a second important 
observation, which was that nsp1 mutations can result in a major defect in the produc-
tion of infectious progeny, thus implicating the protein in an additional step of the viral 
life cycle, downstream of transcription. The wild-type phenotype of the RNAko mutant 
(Fig. 6) makes it highly unlikely that disruption of RNA structures in the nsp1 ZF-coding 
region played a role in the mixed phenotypes that were observed.
Zinc finger domains are short, independently folded stretches of amino acids that 
require the coordination of one or more zinc atoms to stabilize their higher-order struc-
ture24. These motifs were first identified in TFiiiA of Xenopus laevis and were implicated 
in nucleic acid recognition33. Since then, ZF domains have emerged as one of the most 
prevalent motifs in the mammalian proteome. They are frequently classified according 
to the sequential nature of the zinc-coordinating residues, with the CCHH class being 
the most common one. ZF domains are widely recognized as sequence-specific DNA-
binding motifs, but they have also been shown to bind RNA28, as well as to participate in 
protein-protein interactions27, 30, including dimerization31. Given the versatility and diver-
sity of this structural motif, it is not surprising that many viruses also encode ZF proteins. 
One of the best-characterized examples is the nucleocapsid (NC) protein of onco- and 
lentiviruses, which contains one or two copies of a CCHC zinc-coordinating domain that 
is essential for RNA packaging during virus assembly 8, 31. Upon conservative replacement 
of zinc-binding residues, zinc coordination is maintained and viral genome packaging is 
not affected, but the resulting mutant viruses are almost completely noninfectious15, 16. 
Further analysis implicated these ZF domains in viral RNA synthesis and RNA-protein in-
teractions, thus revealing additional, previously unknown functions of these domains16, 20, 
26. interestingly, a structural study of zinc fingers of the CCHC type in lentiviruses showed 
that an HCHC mutant was no longer able to bind zinc tetrahedrally, while the CCHH form 
could still bind zinc tightly, although this resulted in important structural modifications 
that could be responsible for the loss of infectivity observed for this mutant47.
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Despite clear differences in protein function and origin, intriguing parallels can be 
drawn between these retrovirus NC data and our analysis of EAv nsp1 mutants in which 
putative zinc-coordinating residues were replaced. The transcription-negative phe-
notype of the Cys-25→A and Cys-41/Cys-44 mutants suggests a complete loss of zinc 
coordination. However, the conservative replacements of Cys-25→His and His-27→Cys, 
which in theory may leave the zinc-coordinating potential intact, were both largely toler-
ated in terms of sg RNA production (Fig. 3), although these mutants were significantly 
impaired in a later stage of the viral life cycle, possibly virion biogenesis. The His-27→Ala 
replacement might represent an intermediate that is still able to bind zinc, as described 
for the distal ZF of the Hiv-1 NC (61), in which the same mutant was concluded to retain 
the tetrahedral coordination of the metal ion, with the vacant ligand position presum-
ably occupied by a water molecule. A similar situation has been described for the CCCH 
ZF domain in another viral protease, NS3 of hepatitis C virus22.
very little is currently known about the protein-protein and protein-RNA interactions 
that regulate arterivirus sg RNA synthesis. nsp1 might be involved in the stalling of the 
viral RdRp complex at the body TRSs by interacting with this conserved RNA sequence. 
it could also participate in the targeting of the nascent subgenome-length minus strand 
to the leader TRS in the 5’ end of the template or may facilitate the base pairing between 
body TRS complement and leader TRS - steps that are presumed essential for arterivirus 
sg RNA synthesis. Regardless of the molecular basis of nsp1 involvement in EAv transcrip-
tion, the integrity of the ZF domain was also found to be essential for virus production.
Obviously, in the arterivirus system (Fig. 1), structural protein synthesis and conse-
quently virus production are directly controlled by sg mRNA synthesis. it should also 
be noted that EAv assembly involves a total of seven structural proteins, which are all 
essential for the production of infectious progeny36, 71, 72, and that little is known about 
the molecular interactions between these components and the kinetics of virus assem-
bly. in other words, a small disturbance at the level of sg mRNA synthesis (e.g., affecting 
the ratio at which some of the structural proteins are produced) could in theory have 
major consequences for virus production. Still, three of our mutants (C25H, H27C, and 
H27A) coupled a deviation of not more than twofold in the ratio of genome to sg mRNA 
synthesis to a 2- to 5-log drop in infectious progeny titers (Table 1). We consider it highly 
unlikely, but not impossible, that this is solely due to relatively minor changes at the level 
of sg mRNA production. On the other hand, ostensibly supporting a direct role of nsp1 
in virion biogenesis, there are precedents both for the presence of replicase proteins of 
plus-strand RNA viruses in virions37, 42, 46 and for a link between mutations in replicase 
subunits and the production of infectious progeny23.
A role of nsp1 in translation of viral RNA also needs to be investigated, although a pre-
liminary analysis did not reveal major deviations in structural protein synthesis for mu-
tants like C25H (D. D. Nedialkova et al., unpublished data). As in the case of the function 
of nsp1 in transcription, a better understanding of this phenotype and the role of nsp1 
will require identification of interaction partners, which may be either RNA sequences or 
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other viral proteins. Such studies are currently ongoing using biochemical methods and 
attempting to isolate second-site revertants for selected nsp1 mutants.
Finally, the data in this paper underlines the importance of the nsp1 PCPβ domain in 
the EAv system. This enzyme is a representative of a class of papain-like “accessory prote-
ases” (a term used to discriminate them from the viral “main” protease), which are found 
in evolutionarily distinct lineages of plus strand RNA viruses12, 13, 44. Arteriviruses contain 
an array of two to four of these enzymes in the N-terminal domain of their replicase (9, 
58, 60). Distant homologs of these arterivirus domains are also found in the large nsp3 
product of coronaviruses2, 21, 76, and it has been postulated that, in the course of nidovirus 
evolution, these N-terminal papain-like protease domains may have been optimally 
suited for acquisition and integration of new functions into an expanding replicase12. 
in the case of coronaviruses, engineered deletions and mutations affecting the nsp1 
to -3 region and its proteolytic processing by nsp3 accessory proteinases can induce a 
variety of effects, but, remarkably, a large number of such mutations are tolerated to a 
certain extent6, 17, 18, 74. Thus far, a strictly transcription-specific function, as documented 
here for EAv nsp1, has not been identified in the coronavirus system, suggesting that 
arterivirus evolution may have taken a unique turn, by first acquiring multiple accessory 
PCP-containing replicase subunits and subsequently evolving a key regulatory position 
for these proteins in the viral life cycle.
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abstract
aBstRaCt
The gene expression of plus-strand RNA viruses with a polycistronic genome depends 
on translation and replication of the genomic mRNA, as well as synthesis of subgenomic 
(sg) mRNAs. Arteriviruses and coronaviruses, distantly related members of the nidovirus 
order, employ a unique mechanism of discontinuous minus-strand RNA synthesis to 
generate subgenome-length templates for the synthesis of a nested set of sg mRNAs. 
Non-structural protein 1 (nsp1) of the arterivirus equine arteritis virus (EAv), a multifunc-
tional regulator of viral RNA synthesis and virion biogenesis, was previously implicated 
in controlling the balance between genome replication and sg mRNA synthesis. Here, 
we employed reverse and forward genetics to gain insight into the multiple regulatory 
roles of nsp1. Our analysis revealed that the relative abundance of viral mRNAs is tightly 
controlled by an intricate network of interactions involving all nsp1 subdomains. Distinct 
nsp1 mutations affected the quantitative balance among viral mRNA species, and our 
data implicate nsp1 in controlling the accumulation of full-length and subgenome-
length minus-strand templates for viral mRNA synthesis. The moderate differential 
changes in viral mRNA abundance of nsp1 mutants resulted in similarly altered viral 
protein levels, but progeny virus yields were greatly reduced. Pseudorevertant analysis 
provided compelling genetic evidence that balanced EAv mRNA accumulation is critical 
for efficient virus production. This first report on protein-mediated, mRNA-specific con-
trol of nidovirus RNA synthesis reveals the existence of an integral control mechanism to 
fine-tune replication, sg mRNA synthesis, and virus production, and establishes a major 
role for nsp1 in coordinating the arterivirus replicative cycle.
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INtRODuCtION 
Plus-strand RNA (+RNA) viruses are ubiquitous pathogens of plants, animals, and 
humans. The translation of their messenger-sense RNA genome yields the core viral 
enzymes that always include an RNA-dependent RNA polymerase (RdRp) and assemble 
into a cytoplasmic machinery for viral RNA synthesis. Many +RNA virus groups employ 
polycistronic genomes and different mechanisms to express genes located downstream 
of the 5’-proximal open reading frame (ORF). One of these mechanisms involves the syn-
thesis of subgenomic (sg) mRNAs (referred to as “transcription” in this paper). Although 
the sg mRNAs of +RNA viruses are invariably 3’-coterminal with the viral genome, diverse 
+RNA viruses have evolved different mechanisms for their production18. 
The order Nidovirales comprises several clades of distantly related enveloped +RNA 
viruses, including the arteri- and coronavirus families, which infect a wide variety of 
hosts, ranging from invertebrates to humans. Human coronaviruses are associated 
with respiratory disease (including severe acute respiratory syndrome (SARS), reviewed 
in reference27) and arteriviruses like porcine reproductive and respiratory syndrome 
virus (PRRSv) are important veterinary pathogens. Members of the nidovirus order are 
characterized by their exceptional genetic complexity, and the group includes the virus 
families with the largest RNA genomes described to date (25-32 kb). Nidoviruses share 
important traits in their genome organization and gene expression mechanisms, and 
their key replicative enzymes are presumed to be evolutionarily related (for a review, 
see reference13). Their polycistronic genomes are 5’-capped, 3’-polyadenylated, and the 
two 5’-most open reading frames (ORFs) – ORF1a and ORF1b, encode the viral replicase 
subunits segregated in two large replicase polyproteins, pp1a and pp1ab, the expression 
of the latter controlled by a -1 ribosomal frameshift (Fig. 1A). Autoproteolytic processing 
of these precursors generates between 13 and 16 non-structural proteins (nsps) that 
direct viral RNA synthesis. Besides genome replication, arteri- and coronavirus RdRp-
containing complexes also mediate the synthesis of a distinctive nested set of sg mRNAs 
that are both 5’- and 3’-coterminal with the viral genome and hence consist of sequences 
that are noncontiguous in the genomic RNA (Fig. 1B).
Despite recent advances in the structural and functional characterization of individual 
replicase subunits, the molecular details of nidovirus replication and gene expression 
remain poorly understood. Studies with nidovirus model systems such as equine arteritis 
virus (EAv), the arterivirus prototype, have provided some critical insights about viral 
replicase functions and the regulation of RNA synthesis in infected cells. EAv replicase 
pp1a and pp1ab are co- and post-translationally cleaved into 13 nsps by viral proteases 
residing in nsp1, nsp2, and nsp4. The seven viral structural proteins, which are all dis-
pensable for replication and transcription20, are encoded in a set of overlapping ORFs 
located in the 3’-proximal quarter of the genome (Fig. 1A). in the six sg mRNAs used 
to express these ORFs, a common “leader” sequence representing the 5’-proximal 206 
nucleotides of the genome is linked to different “body” segments that are co-linear with 
the 3’-proximal part of the genome (Fig. 1B). 
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According to the widely supported model proposed by Sawicki and Sawicki30 (Fig. 1C), 
the structure of the arterivirus and coronavirus sg mRNAs derives from a discontinuous 
step during minus-strand RNA synthesis, which is guided by specific RNA signals and 
resembles copy-choice RNA recombination24,47,55. Conserved transcription-regulating 
sequences (TRS; core sequence 5’ UCAACU 3’ in EAv) precede each structural protein ORF 
(body TRSs). The same sequence motif is also present at the 3’-end of the genomic leader 
sequence (leader TRS). Minus-strand RNA synthesis, initiated at the 3’-end of the viral 
genome, is presumably attenuated at one of the body TRS regions (Fig. 1C; reviewed in 
references22,31). Subsequently, the nascent minus strand, carrying the body TRS comple-
ment at its 3’end, is translocated to the 5’-proximal region of the genomic template. 
During this step, the genomic leader TRS serves as a base-pairing target for the 3’ end of 
the nascent minus strand, a role that is facilitated, in the case of EAv, by its presence in 
the loop of an RNA hairpin42. When minus strand synthesis resumes, nascent strands are 
extended with the complement of the genomic leader sequence, yielding a nested set of 
subgenome-length minus-strand templates that are used for the subsequent synthesis 
of the various sg mRNAs. if attenuation does not occur, minus-strand RNA synthesis 
proceeds to yield a full-length complement of the genome, the intermediate required 
for its replication.
Clearly, the protein and RNA factors that determine whether a nidovirus RdRp com-
plex operates in continuous or discontinuous mode, i.e. produces a full-length or a 
subgenome-length minus strand, must be critical for the coordination of the nidovirus 
replicative cycle. As in other nidoviruses, the EAv genomic RNA (RNA1) and sg mRNAs 
(RNA2 – RNA7) accumulate in specific molar ratios (see Fig. 1B) that are essentially 
constant until the peak of viral RNA synthesis is reached11. The relative abundance of 
the transcripts is presumably dictated by the “attenuation rate” at each of the successive 
body TRSs encountered during minus-strand synthesis, which is primarily determined 
by the base-pairing potential between the leader TRS and the body TRS complement 
in the nascent minus strand. Also the sequence context of body TRS motifs and their 
proximity to the genomic 3’ end, which is reflected in the “gradient” of sg RNA sizes, can 
influence the accumulation of viral RNA species. The importance of TRS-driven RNA-RNA 
interactions and the potential for a regulatory role of higher order RNA structures was 
outlined above (reviewed in references22,31). At the protein level, however, only a single 
nidovirus protein specifically involved in transcription was identified thus far: EAv nsp1 
was found to be essential for sg mRNA production, while being dispensable for genome 
replication37,39. Remarkably, nsp1 is also the first protein expressed during infection: it is 
co-translationally released from the nascent replicase polyproteins by a papain-like cys-
teine proteinase activity (PCPβ) in its C-terminal domain (Fig 2). Comparative sequence 
analysis identified two additional conserved domains: a second, proteolytically silent 
PCP domain that is functional in other arteriviruses9 (PCPα), and an N-terminal zinc fin-
ger (ZF) domain36,39 that is critical for transcription and efficient production of infectious 
progeny37,39. Since the accumulation of all sg mRNAs was blocked in the absence of nsp1, 
the protein was proposed to control a switch between replication and transcription39. 
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figure 1. Organization and expression of the polycistronic EAv +RNA genome. (A) Top: EAv genome 
organization, showing the 5’-proximal replicase open reading frames (ORFs), as well as the downstream 
ORFs encoding the viral structural proteins envelope (E), membrane (M), nucleocapsid (N), and 
glycoproteins (GP) 2-5 and the 3’ poly(A) tail (An). Bottom: overview of the pp1a and pp1ab replicase 
polyproteins that result from genome translation, which requires an ORF1a/1b ribosomal frameshift 
(RFS) to produce pp1ab. Arrowheads represent sites cleaved by the three virus-encoded proteases (open 
for autoproteolytically processed ones, closed for sites processed by the main proteinase in nsp4). The 
resulting nonstructural proteins (nsp) are numbered. The key viral enzymatic domains such as the nsp1 
papain-like cysteine proteinase β (PCP), nsp2 cysteine proteinase (CP), nsp4 serine proteinase (SP), nsp9 
viral RNA-dependent RNA polymerase (RdRp), nsp10 helicase (Hel), and nsp11 endoribonuclease (Ne) are 
indicated. (B) Overview of viral mRNA species produced in EAv-infected cells. The ORFs expressed from the 
respective mRNAs are shown in, and the 5’ leader sequence (L) is depicted. The positions of transcription-
regulating sequences (TRS) are indicated. The gel hybridization image on the right is representative of 
the wild-type accumulation levels of the seven EAv mRNAs at the time point used for analysis in the study 
(see text for details). The amount of each mRNA, determined by quantitative phosphorimager analysis, is 
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6 We have now explored the key regulatory roles of nsp1 in the EAv replicative cycle in 
unprecedented detail. Our results indicate that in addition to the ZF region, both PCP 
subdomains of nsp1 are essential for transcription, and suggest an additional role of PCPα 
in virus production. We also established that nsp1 modulates viral RNA accumulation in 
an mRNA-specific manner, and thus maintains the balance among the seven viral mRNAs, 
including the genome. Our data suggests that nsp1 does so by controlling the levels of 
the full-length and subgenome-length minus-strand templates required for viral mRNA 
synthesis. The results we obtained from detailed characterization of nsp1 mutants and 
pseudorevertants provided compelling evidence for a close link between the regulation 
of individual nidovirus mRNA levels and the efficient production of infectious progeny.
mateRIals aND methODs
Cell lines 
Baby hamster kidney cells (BHK-21; ATCC CCL10) were used for all experiments. The cells 
were maintained at 37°C in BHK-21 medium (Glasgow MEM; invitrogen) supplemented 
with 5% fetal calf serum (FCS), 10% tryptose phosphate broth, 100 U/ml of penicillin, 100 
µg/ml of streptomycin and 10 mM HEPES, pH=7.4. Upon transfection or infection with wt 
or mutant EAv, BHK-21 cells were incubated at 39.5°C, since this elevated temperature 
shortens the replication time of the virus substantially without any adverse side effects44.
eav reverse genetics
The substitutions in the nsp1-coding sequence listed in Table 1 and Table 3 were engi-
neered using appropriate shuttle vectors and standard site-directed mutagenesis PCR16. 
Sequence analysis of the cloned fragments was used to verify the introduction of the ap-
propriate nucleotide substitutions and exclude the presence of undesired mutations. The 
mutations in the nsp1-coding sequence were then transferred to pEAv211 or pEAN551, 
both derivatives of EAv full-length cDNA clone pEAv03044 containing some engineered 
restriction sites. viruses derived from either pEAv211 or pEAN551 were previously shown 
to display a wt phenotype28,41. The virus derived from the pEAv211 construct was used as 
a wt control in all experiments. 
indicated as percentage of the total amount of viral mRNA. (C) Model for EAv replication and transcription. 
Continuous minus-strand RNA synthesis yields a genome-length minus strand template for genome 
replication, a process for which nsp1 is dispensable. Discontinuous minus-strand RNA synthesis results in 
a nested set of subgenome-length minus strands that serve as templates for sg mRNA synthesis (see text 
for details). Nsp1 is crucial for this process, which is also guided by a base pairing interaction between the 
TRS complement [(-)TRS] at the 3’ end of the nascent minus-strand and the genomic leader TRS, present in 
a RNA hairpin structure (LTH).
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in vitro RNA transcription from Xhoi-linearized wt or mutant EAv full-length cDNA 
clones was performed using the mMESSAGE mMACHiNE T7 Kit (Ambion). Seven µg of 
in vitro-synthesized EAv RNA were electroporated into 3.5x106 BHK-21 cells using the 
Amaxa Cell Line Nucleofector Kit T and the program T-020 of the Amaxa Nucleofector 
(Lonza) according to the manufacturer’s instructions. Cells were resuspended in BHK-21 
medium and subsequently seeded on coverslips for immunofluorescence analysis or in 
6-well clusters for analysis of intracellular protein and RNA levels, as well as virus produc-
tion. 
eav infection and plaque assays
For EAv infection, subconfluent monolayers of BHK-21 cells were inoculated with trans-
fected cell culture supernatant diluted in PBS-DEAE/2% FCS. Following incubation at 
39.5oC for 1 h, the inoculum was removed, DMEM/2% FCS was added, and the cells were 
incubated at 39.5oC for 16-18 h. For virus titration, BHK-21 cells seeded in 6-well clusters 
were infected with serial 10-fold dilutions of supernatants harvested from transfected 
cells and then incubated under semi-solid overlays consisting of DMEM supplemented 
with 50 mM HEPES, pH=7.4, 2% FCS and 1.2% Avicel (FMC BioPolymer) at 39.5°C for 72 h. 
The overlays were aspirated, cells were fixed with 8% formaldehyde in PBS, and stained 
with crystal violet. For plaque purification, a solid overlay of DMEM containing 50 mM 
HEPES, pH=7.4, 2% FCS and 1% agarose was used.
Immunofluorescence analysis 
immunofluorescence analysis of EAv-transfected cells was performed as described previ-
ously43. Briefly, cells were analyzed at 11 hour post-transfection by dual labeling with a 
rabbit antiserum recognizing EAv nsp325 and an anti-N mouse monoclonal antibody17. 
These proteins are expressed from RNA1 and RNA7, respectively. Nuclei were visualized 
for cell counting by staining with 1 µg/ml Hoechst 33258 (Sigma-Aldrich). Transfection 
efficiencies were determined at 11 h post-transfection by counting cells with the Scion 
image software (Scion Corporation) and calculating the percentage of cells positive for 
EAv nsp3.
RNa isolation and detection of eav mRNas by gel hybridization
Analysis of viral RNA accumulation was carried out before completion of the first rep-
lication cycle. Cells transfected with wt or mutant EAv derivatives were lysed at 11 h 
post-transfection, and total intracellular RNA was isolated by acid phenol extraction as 
previously described48. viral mRNAs were detected by resolving total RNA in denatur-
ing agarose-formaldehyde gels, and equal sample loading was confirmed by ethidium 
bromide staining of ribosomal RNA. The gels were subsequently dried and hybridized to 
a 32P-labeled probe (E154, 5’-TTGGTTCCTGGGTGGCTAATAACTACTT-3’) complementary to 
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the 3’ end of the genome that recognizes both genome and all sg mRNAs48. The gels were 
exposed to phosphorimager screens, which were subsequently scanned using a Typhoon 
variable Mode imager (GE Healthcare). image analysis and quantification of band intensi-
ties were performed with the imageQuant TL software (GE Healthcare).
Detection of eav minus-strand RNas by ribonuclease protection assays
A two-cycle ribonuclease (RNase) protection assay adapted from references21,29 was 
used for the detection of EAv minus-strand RNAs. Total intracellular RNA isolated at 11 
h post-transfection was dissolved in 10 µl of Hybridization Buffer iii (RPA iii Kit; Ambion), 
denatured for 3 min at 95°C and incubated for 16 h at 55°C. Samples were then digested 
with 5 U of RNase T1 (Ambion) per µg total RNA in 10 mM Tris pH=7.5, 300 mM NaCl, 
5 mM EDTA for 60 min at ambient temperature. Following proteinase K treatment and 
phenol:chlorophorm extraction, 0.5 µg of yeast RNA per µg total RNA was added as a car-
rier. After ethanol precipitation, equal amounts of a radiolabelled probe (see below) were 
added to each sample and, following sample denaturation at 85°C for 5 min, hybridization 
was carried out at 55°C for 16 h. RNase digestion of unhybridized RNA was performed 
using the RPA iii Kit according to the manufacturer’s protocol. Protected fragments were 
resolved in 5% polyacrylamide/8M urea gels, which were dried and exposed to phospho-
rimager screens. image analysis and quantification were performed as described above.
To generate probes for minus-strand detection, cDNA fragments derived from the EAv 
genome (nucleotides (nt) 3687 – 4013), RNA6 (nt 68-206 from the leader sequence and 
nt 11,870-12,057 from the body sequence) and RNA7 (nt 68-206 and nt 12,252-12,429) 
were inserted downstream of the T7 promoter in pcDNA3.1 using standard cloning 
procedures. Radiolabelled RNA transcripts were generated by in vitro transcription in the 
presence of [α-32P]CTP (Perkin Elmer) using MAXiscript T7 Kit (Ambion) and purified from 
5% polyacrylamide/8M urea gels by elution for 3h at 37°C in 0.5 M NH4OAc, 0.2% SDS, 
1mM EDTA. The transcript generated for detection of genomic minus strands, pRNA1, 
was 356 nt long and contained 327 nt of (-)RNA1-specific sequence. The transcript and 
EAv-specific sequence length were 382 nt and 327 nt, respectively, for the probe detect-
ing (-)RNA6 (pRNA6), and 372 nt and 319 nt for the probe specific for (-)RNA7 (pRNA7). 
Detection of RNA1(-) was performed using sample RNA corresponding to approximately 
1.25x104 cells and 20 fmol of radiolabelled probe. Levels of (-)RNA6 and (-)RNA7 were 
determined in samples corresponding to 4x104 and 2.5 x104 cells, respectively, using 5 
fmol radiolabelled probe. These conditions ensured that the values obtained were in the 
linear range of the assays (data not shown). 
Protein analysis
Cells transfected with wt or mutant EAv derivatives were lysed at 11 h post-transfection as 
described previously7. The protein concentration in the lysates was determined using the 
Bio-Rad protein assay reagent. Equal amounts of total protein were subjected to SDS-PAGE 
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and transferred to Hybond-P PvDF membrane (GE Healthcare) by semidry blotting. After 
blocking with 5% non-fat milk in PBS containing 0.5% Tween-20, the membranes were in-
cubated with the following antibodies: anti-EAv nsp3 (see above), rabbit anti-M7, anti-N (see 
above), or an anti-β-actin mouse monoclonal antibody (AC-74, Sigma), all diluted in PBS con-
taining 5% non-fat milk, 0.5% bovine serum albumin and 0.5% Tween-20. HRP-conjugated 
secondary antibodies (DAKO) and an ECL-Plus kit (GE Healthcare) were used for detection.
Reverse transcription and quantitative PCR
in order to determine relative specific infectivity, supernatants from BHK-21 cells transfected 
with wt or mutant EAv derivatives were harvested 24 h after transfection and clarified by 
low-speed centrifugation. virions from 1 ml of clarified supernatant were purified by pel-
leting through a 0.4 ml cushion of 20 % sucrose in 20 mM Tris pH=7.5, 100 mM NaCl, 1 mM 
EDTA at 55,000 rpm for 45 min at 4°C using a TLS-55 rotor in a Beckman tabletop ultracen-
trifuge. virion RNA was isolated from pellet fractions by acid phenol extraction as described 
above. Complementary DNAs were synthesized with Thermoscript Reverse Transcriptase 
(invitrogen) using a primer complementary to a region in ORF1a of the EAv genome 
(EAv418as, 5’-AGCCGCACCTTCACATTG-3’). Quantitative PCR (qPCR) was performed es-
sentially as previously described32, 49. Briefly, a cDNA aliquot was amplified with EAv-specific 
oligonucleotides EAv418as and EAv417s (5’ CATCTCTTGCTTTGCTCCTTAG-3’) using HotStar 
Taq Polymerase (Qiagen) and SyBR Green i (Molecular Probes) in an iCycler machine (Bio-
Rad). The data obtained were analyzed with iCycler software, and the specificity of the reac-
tion was confirmed by the melting curve of the amplified products. To generate a standard 
curve, serial ten-fold dilutions of the virion RNA sample derived from cells transfected with 
the wt EAv construct were reverse-transcribed and amplified by qPCR in parallel. The result-
ing standard curve had an R2=0.99 and a 6-log linear range for the EAv ORF1a amplicon 
(data not shown). The relative genomic RNA contents of virions produced by EAv mutants 
were calculated by comparing their threshold cycle (Ct) values against the standard curve 
and the resulting values were normalized to the wt genomic RNA content, which was set at 
1. The relative specific infectivity of each EAv mutant was then determined by dividing the 
respective mutant:wt pfu ratio by the mutant:wt relative genomic RNA content. 
Results
Rationale for mutagenesis of eav nsp1
Previous studies of the role of nsp1 in the EAv replicative cycle focused on the conserved 
amino acids presumed to be essential either for zinc binding by the ZF domain or for 
the catalytic activity of the PCPβ autoprotease37. Mutations that blocked the release of 
nsp1 from the replicase polyproteins were lethal, likely due to their interference with 
downstream polyprotein processing steps that are essential for genome replication28, 
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40, 45. By contrast, replacements of putative zinc-coordinating residues either selec-
tively abolished transcription of all viral sg mRNAs or interfered with virus production 
without affecting viral mRNA accumulation. in an attempt to expand our repertoire of 
viable nsp1 mutants, we now used two approaches: i) alanine scanning mutagenesis 
of non-conserved clusters of polar residues found throughout the nsp1 sequence, and 
ii) a Cys↔His interchange at the positions of residues Cys-25 and His-27, which have 
both been implicated in zinc coordination36,39. The first approach is less likely to perturb 
the protein’s overall stability, since clusters of charged residues are usually found on 
the protein surface, where they may mediate interactions with other biomolecules via 
electrostatic interactions or hydrogen bond formation3,6,51. We reasoned that the second 
approach might preserve zinc coordination but could nevertheless have a subtle effect 
on zinc binding that might be translated in a measurable effect on one or more of nsp1’s 
functions. Moreover, if these substitutions would compromise virus replication, isolation 
of revertant viruses encoding compensatory second-site mutations might reveal poten-
tial regulatory protein-protein or protein-RNA interactions. 
Table 1 lists the nsp1 mutants characterized in this study. in all three subdomains of 
nsp1, clusters of two or three charged amino acids within a five- to seven-amino acid 
stretch were substituted with Ala. Constructs with Ala replacements in the ZF domain 
were designated Z (1 to 3), while those with replacements in the PCPα and PCPβ domains 
were designated A (1 to 4) and B (1 and 2), respectively (see Table 1 and Fig. 2). in addition, 
we swapped the Cys-25 and His-27 residues to generate the ZCH mutant. Full-length RNA 
transcribed from EAv cDNA clones encoding these nsp1 mutations was transfected into 
BHK-21 cells. Analysis of nsp1 mutant phenotypes was performed during the peak of viral 
RNA synthesis and before the bulk of infectious progeny was produced by the wild-type 
aa 1 50 140 260
  ZF PCPα PCPβ
B1 B2
Z1 ZCH Z2 Z3 A1 A2 A3 A4
○ ○
○
○
figure 2. Domain organization of EAv nsp1. The partial sequence alignment shows key regions in the 
three subdomains previously identified in the arterivirus nsp1 region. GenBank accession numbers for the 
full-length arterivirus genomes used for the alignment are as follows: EAv, NC_002532; simian hemorrhagic 
fever virus (SHFv), NC_003092; lactate dehydrogenase-elevating virus (LDv-P and LDv-C), NC_001639 and 
NC_002534; PRRSv-Lv, M96262.2; PRRSv-vR, Ay150564. Zinc-coordinating residues are indicated in bold 
font; the active-site Cys and His of PCPα and PCPβ are indicated with triangles (note the loss of the active-
site Cys in EAv PCPα). The positions of amino acid clusters mutated in this study are indicated with arrows. 
All substitutions were with Ala, with the exception of the ZCH construct, in which Cys-25 and His-27 were 
swapped. The positions of mutations found in pseudorevertants are indicated with open circles. 
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(wt) control (11 h post-transfection; referred to as first-cycle analysis). Previous studies of 
intracellular viral RNA levels had been hampered by the considerable variability in trans-
fection efficiencies of synthetic EAv full-length RNAs. For comparison between mutants, 
these studies used the genomic RNA as an internal standard for each sample to calculate 
relative ratios of viral mRNA accumulation levels24,37. Using an improved electroporation 
protocol (for details, see Materials and Methods), we now achieved very consistent and 
relatively high RNA transfection efficiencies (between 45% and 55% of positive cells at 
11 h post-transfection with replication-competent synthetic EAv RNAs; data not shown). 
This allowed for the comparison of the absolute levels of mRNA accumulation and the de-
tailed first-cycle analysis of EAv nsp1 mutants at a time point at which differences in virus 
production or (pseudo)reversion would not influence the assessment of their phenotype.
all nsp1 subdomains are critical for transcription, while the zf and PCPα 
domains are also important for virus production
The ZF domain of nsp1 is essential for sg mRNA production37,39, but the question of 
whether the PCPα and PCPβ domains also contribute to the protein’s function in tran-
scription has not been previously addressed, partly due to the nonviable phenotype of 
PCPβ mutants in which the nsp1/2 cleavage was impaired37. Consequently, we first ana-
lyzed the impact of clustered charged-to-alanine replacements in nsp1 on viral mRNA 
accumulation. Cells transfected with nsp1 mutants were harvested 11 h after transfec-
table 1. Overview of the genotype and first-cycle phenotype of EAv nsp1 mutants described in this study
Construct Genotype Mutant codonsa Replicationb Transcriptionb
pEAv211 wt NAc +++ +++
Z1 R15A D16A 267-GCG GCC-272 +++++ -
ZCH C25H H27C 297-CAU UGU-305 +++ ++++
Z2 E34A D36A 324-GCA GCC-332 +++ +++
Z3 R46A E49A E52A 360-GCC GCA GCG-380 +++++ -
A1 R80A K83A 462-GCA GCA -474 +++++ ++
A2 R103A D106A R108A 531-GCU GCA GCG-548 +++++ -
A3 E112A E113A 558-GCC GCG-563 +++ +++
A4 K126A R127A 600-GCA GCU-605 ++++ +++
B1 D172A R173A R174A E175A 738-GCU GCA GCU GCG -749 - -
B2 R186A E187 R189A 780-GCC GCA GCG-791 +++++ -
a Nucleotide substitutions are indicated in bold italics; numbers indicate the start and end coordinates of 
the mutated codons in the EAv genome.
b Transfected cells were analyzed by iFA and gel hybridization analysis at 11 h post-transfection. Wild-
type levels of replication and transcription (based on accumulation levels of genomic and sg mRNAs, 
respectively) are indicated with +++. A two- to fourfold increase in genomic RNA levels as compared to 
wild-type is denoted by ++++, while an increase of more than fourfold is shown as +++++. Likewise, a 
more than twofold increase or decrease in accumulation levels of at least two sg mRNA species is shown as 
++++ and ++, respectively (see text for details)
c NA, not applicable.
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tion, intracellular RNA was isolated and resolved in denaturing gels, and viral mRNAs 
were detected by hybridization to a probe complementary to the 3’ end of the genome 
and thus recognizing all viral mRNAs. Substitutions in the ZF domain (mutant Z1), as 
well as in the region connecting the ZF and PCPα domains (Z3), the PCPα domain itself 
(A2) and, notably, also the PCPβ domain (B2) rendered viral sg mRNAs undetectable. in 
addition, all four mutants displayed a noticeable increase in genomic RNA levels (Fig. 3A). 
By contrast, accumulation of all viral mRNAs was blocked in the B1 mutant (Table 1 and 
data not shown), possibly due to the proximity of the charged cluster to the active site 
Cys of PCPβ (Fig. 2). These results demonstrate that all subdomains of nsp1, including 
PCPβ, are important for transcriptional control. This novel role of the PCPβ domain seems 
to be genetically separable from its autoproteolytic activity. 
We previously reported that certain substitutions of proposed nsp1 zinc-coordinating 
residues considerably reduced the yield of infectious progeny without noticeably affect-
ing viral RNA accumulation37. This phenotype was also observed in this study for mutants 
Z2 (ZF domain) and A3 (PCPα domain), in which clusters of alanine substitutions were in-
troduced. These had no apparent effect on viral mRNA levels (Fig.3B), while progeny virus 
titers were reduced by 10- and 200-fold, respectively (Fig. 3C), in supernatants harvested 
24 h after transfection, well beyond the time point of maximum virus production by the 
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figure 3. importance of nsp1 subdomains for transcription and virus production. (A, B). Analysis of EAv-
specific mRNA accumulation by gel hybridization. The domain organization of nsp1 is depicted as in Fig. 
2 and the positions of the clusters of amino acid mutations analyzed are indicated with arrows. BHK-21 
cells were transfected with RNA transcribed from wt or selected mutant EAv full-length cDNA clones. 
Total intracellular RNA was isolated at 11 h post-transfection and resolved by denaturing formaldehyde 
electrophoresis. Equal loading of samples was confirmed by ethidium bromide staining of ribosomal RNA 
(data not shown). EAv-specific mRNAs were detected by hybridization of the gel with a 32P-labelled probe 
complementary to the 3’ end of the viral genome and subsequent phosphorimaging. The positions of the 
EAv genome (RNA1) and the six sg mRNAs (RNA2 to RNA7) are indicated. (C) Plaque phenotype and virus 
titers of the Z2 and A3 mutants. Plaque assays were performed on BHK-21 using cell culture supernatants 
harvested 24 h after transfection. Cells were incubated under a semi-solid overlay at 39.5°C for 72 h, fixed 
and stained with crystal violet. virus titers represent an average of three independent experiments. pfu, 
plaque-forming units.
161
 N
sp1 controls the balance am
ong arterivirus m
RN
A
s 
6
wt control (data not shown). Accordingly, plaques of the Z2 mutant were somewhat 
smaller than those of the wt virus, and those of the A3 mutant were minute (Fig. 3C). 
Titers and plaque phenotypes remained essentially unchanged at 48 h post-transfection, 
arguing against a delay in virus production. Sequence analysis of the A3 progeny re-
vealed reversion of the E113A mutation to the wt sequence at later time points (data not 
shown). These observations imply that both the ZF and the PCPα domains of EAv nsp1 
are involved in a step of the viral replicative cycle that is downstream of transcription and 
is critical for the efficient production of infectious virus particles. 
mutations in nsp1 can differentially affect accumulation of viral mRNa species 
Two mutant phenotypes were previously described upon examination of the role of EAv 
nsp1 in transcription: one in which sg mRNA accumulation was selectively abolished, and 
another in which the levels of all sg mRNAs were uniformly reduced relative to that of the 
genomic RNA37,39. in this study, the ZCH, A1, and A4 mutants displayed a third phenotype, 
demonstrating that replacements in nsp1 can affect EAv RNA levels in an mRNA-specific 
manner. The swapping of two proposed zinc-coordinating residues in the ZCH mutant 
resulted in the upregulation of a subset of sg mRNAs. in comparison to the wt control, 
the accumulation levels of RNA3, 4, 5, 6 and 7 were increased, while those of the viral 
genome and RNA2 remained largely unchanged (Fig. 4, A and B). The increase in mRNA 
levels was not uniform, being more pronounced for RNA5 and RNA6 (4.5-fold and 3-fold, 
respectively) than for RNAs 3, 4, and 7 (~2-fold). Also, the substitution of two positively 
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figure 4. Multiple mutations in nsp1 exert species-specific effects on viral mRNA accumulation. (A, B) Gel 
hybridization analysis and quantification of EAv-specific mRNA accumulation in cells transfected with the 
ZCH, A1, A4 mutant or a wt control. (A) viral mRNA accumulation was analyzed at 11 h post-transfection 
by gel hybridization as described in the legend to Fig. 3. (B) The accumulation levels of each viral mRNA in 
the nsp1 mutants were quantified by phosphorimaging in the linear range of exposure and normalized to 
the level of accumulation of each corresponding viral mRNA in the wt control, which was set at 1. Genomic 
RNA levels are represented as dark grey bars. The relative values correspond to the means from three 
independent transfections and error bars denote standard deviation. 
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charged residues in the PCPα domain of the A1 mutant (see Fig.2) resulted in reduced ac-
cumulation levels of RNA5 and RNA6 (3- to 4-fold), and RNA7 (~30%), but not of RNAs 2 to 
4 (Fig. 4, A and B). in contrast, genomic RNA accumulation was dramatically enhanced in 
the A1 mutant (Fig. 4, A and B). This aspect of the mutant phenotype had been previously 
described in mutants that did not produce any sg mRNAs37, in which it was attributed to 
the increased availability of key factors for viral replication. This explanation does not 
seem likely for the A1 mutant, however, in which accumulation of only two of the six 
viral sg mRNAs was reduced (Fig. 4). Furthermore, another PCPα mutant - A4 (see Fig. 2), 
displayed 4-fold higher levels of genome accumulation without any significant decrease 
in sg mRNA production (Fig. 4, A and B). 
Since EAv mRNAs accumulate to different levels in molar ratios that are maintained 
through most of the replicative cycle (see Fig. 1B), we will refer to these levels in the 
wt control as “balanced”. By contrast, the ZCH, A1, and A4 mutants exerted differential 
effects on viral mRNA abundance, resulting in “imbalanced” viral mRNA accumulation 
profiles. The unusual phenotypes of these mutants implicated nsp1 in the mRNA-specific 
modulation of viral RNA levels, and prompted us to investigate their molecular basis in 
greater detail.
accumulation of viral mRNas and their corresponding minus-strand RNa 
templates are similarly affected by nsp1 mutations
According to the current consensus in the field, minus-strand RNA synthesis in arteri- 
and coronaviruses can operate in either continuous or discontinuous mode, generating 
genome- or subgenome-length templates, respectively22,30,31. The relative abundance of 
the corresponding minus-strand template presumably determines the level to which 
each of the viral mRNAs accumulates1,29. We therefore sought to determine whether the 
differential effects of nsp1 mutations on the accumulation of EAv mRNA species were 
accompanied by changes in the levels of the corresponding minus-strand templates. 
To this end, we developed an RNase protection assay for the detection and quanti-
fication of EAv minus-strand RNA species. We employed a two-step protocol in which 
total RNA extracted from cells transfected with nsp1 mutants was first denatured and 
self-annealed. Due to the large excess of plus strands present in RNA samples extracted 
from EAv-infected cells48, all minus strands are expected to be present in duplexes after 
this annealing step, facilitating their subsequent reliable quantification. The remaining 
single-stranded RNA was then removed by RNase T1 digestion. Following inactivation 
of the enzyme, we added an excess of 32P-labeled transcripts of positive polarity, which 
were derived either from a region unique to the EAv genome, or from the leader-body 
junction regions of RNA6 and RNA7. The samples were then subjected to a second round 
of RNA denaturation, hybridization, and digestion with RNase A and T1, after which the 
protected fragments were analyzed by electrophoresis. 
The minus-strand templates of the most abundant viral mRNAs – RNA1, 6, and 7, were 
selected for quantitative analysis. Accumulation levels of genome-length [(-)RNA1] and 
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figure 5. Minus-strand RNA accumulation is also modulated by mutations in nsp1. (A-D) Analysis and 
quantification of EAv minus-strand accumulation by a two-cycle RNase protection assay. (A) Schematic 
representation of the nested set of viral minus-strand RNA [(-)RNA] species produced in EAv-infected cells. 
The anti-leader sequence is depicted as a grey box. The in vitro-transcribed plus-strand probes used for 
detection of (-)RNA1 (pRNA1), (-)RNA6 (pRNA6) and (-) RNA7 (pRNA7) are shown. pRNA6 and pRNA7 target 
the leader-body junction sequences of (-)RNA6 and (-)RNA7, respectively. Note that hybridization with 
pRNA1 results in the protection of a single fragment, while the probes for (-)RNAs 6 and 7 each protect 
three fragments – one derived from the full-length sg minus strand, and two fragments derived in part from 
partial hybridization of these probes to larger viral (-)RNAs in which the target sequences are noncontiguous 
(exemplified for pRNA6). For simplicity, non-EAv sequences present near the termini of the three probes 
were omitted from the scheme. (B) viral (-)RNA accumulation was analyzed at 11 h post-transfection for 
the ZCH, A1 and A4 mutants, and a wt control. Protected fragments were resolved on denaturing 5% 
polyacrylamide/8M urea gels and visualized by phosphorimaging. The constructs analyzed are labeled 
above the lanes (M, mock-transfected cells; (-), no-RNase control that shows a band corresponding to 0.2 
fmol of the full-length probe). Sizes (nt) of RNA markers have been indicated on the left. The single 327-nt 
protected fragment resulting from hybridization with the positive-sense probe for RNA1(-) is indicated. The 
probes for subgenome-length minus strands protected fragments derived from the full-length (-)RNA6 and 
(-)RNA7 (327 nt and 319 nt, respectively; denoted with LB), as well as from the (-)RNA6 and (-)RNA7 body 
sequences (188 nt and 180 nt, respectively; denoted with B) and the anti-leader sequence (139 nt; denoted 
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subgenome-length minus strands corresponding to RNA6 and RNA7 [(-)RNA6 and (-)
RNA7] were quantified in total intracellular RNA extracted at 11 h post-transfection with 
the ZCH, A1, and A4 mutants, and a wt control. Subgenomic minus- and plus-strand 
levels were similarly affected by the nsp1 mutations in a sg RNA-specific manner (Fig. 5). 
Genomic minus-strand accumulation was increased in the A1 and A4 mutants, albeit to 
a somewhat lesser extent as compared to the increase in genomic plus-strands (Fig. 4). 
These results clearly implicate nsp1 in a regulatory step (or steps) that controls minus-
strand RNA accumulation, and ultimately determines the levels to which both genome- 
and subgenome-length mRNA species accumulate in EAv-infected cells. 
Changes in the accumulation of viral mRNas induced by nsp1 mutations result 
in altered viral protein levels
The relative abundance of nidovirus mRNAs likely serves to regulate the relative concen-
tration of their respective translation products during infection. it was therefore impor-
tant to determine whether viral protein levels indeed mirrored the specific changes in 
viral mRNA levels caused by mutations in nsp1. To this end, we examined the intracellular 
accumulation of the EAv replicase subunit nsp3 and the structural proteins M and N in 
cell lysates harvested 11 h after transfection (Fig.6A). When compared to the wt control, 
nsp3 was more abundant in cells transfected with the A1 and A4 mutants, in line with 
the increased genome levels observed for these mutants at the same time point (Fig. 
4). The intracellular levels of the M and N proteins were also in general agreement with 
the abundance of their corresponding mRNA templates (RNA6 and RNA7, respectively). 
interestingly, even the modest reduction in RNA7 levels detected for the A1 mutant 
(~30%, Fig. 4B) was reflected in a decrease in N protein levels (Fig. 6A). The close correla-
tion between mRNA and corresponding protein levels argues against the possibility that 
the engineered nsp1 mutations might have caused a defect in viral mRNA translation. 
Overall, these data establish that even modest changes in viral mRNA accumulation are 
directly translated into altered viral protein levels during EAv infection. 
with L). The presence of two bands in the size range of the anti-leader fragment has been described 
previously10. (C) The relative levels of minus-strand accumulation were quantified by phosphorimaging. For 
(-)RNAs 6 and 7, only the bands resulting from protection of full-length sg minus strands (denoted with LB in 
panel [B]) were quantified. The values correspond to the means from three independent transfections that 
were normalized to the level of accumulation of each minus-strand RNA in the wt control, which was set at 
1. intracellular RNA from the same transfection samples for which plus-strand accumulation was quantified 
(Fig. 4B) was used. Genomic minus-strand RNA levels are represented as dark grey bars. Error bars denote 
standard deviation. (D) The ratio of plus-strand to minus-strand accumulation for RNAs 1, 6 and 7 was 
calculated using the mean relative values obtained in Fig. 4B and Fig. 5C.
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Production of infectious virus particles is severely impaired in nsp1 mutants 
with imbalanced mRNa accumulation
We next examined whether the production of infectious virus particles was disturbed 
in the three nsp1 mutants with imbalanced mRNA accumulation profiles. EAv assembly 
involves the coordinated interplay of the N protein and six envelope proteins, all of which 
are required for virus infectivity20,53. A critical step in assembly is the heterodimerization 
of the major viral envelope proteins, GP5 and M
8,34, and both the GP5 and M protein levels, 
as well as the levels of their mRNA templates, RNA5 and RNA6, were strongly affected in 
the ZCH and A1 mutants (Fig. 4B and 6A). Furthermore, other documented interactions, 
such as the oligomerization of the minor envelope proteins - GP2b, GP3 and GP4
52, could 
be readily affected by the altered relative abundances of viral structural proteins. The 
decreased ratio of N protein and genomic RNA in the A1 and A4 mutants (Fig. 4B and Fig. 
6A) could also adversely affect the assembly of infectious virions. Analysis of the infec-
tious progeny virus titers in culture supernatants harvested 24 h after transfection with 
the ZCH, A1, and A4 mutants indeed revealed a dramatic loss of infectivity (Fig. 6B). in 
comparison to wt, the infectious progeny yield of the ZCH and A4 mutants were reduced 
by approximately 4 logs and that of the A1 mutant by ~5 logs. 
We subsequently purified virions by sedimentation through a sucrose cushion in 
order to quantify their genomic RNA content by reverse transcription-quantitative 
PCR. virions from medium harvested at 24 h after transfection with the ZCH, A1, and 
A4 mutants were compared with the progeny produced by the wt control. Consistent 
with the reduction in infectious progeny titers, these results showed a decrease in the 
total number of genome-containing virus particles secreted from cells transfected with 
each of the three mutants (Table 2). interestingly, when the relative specific infectivity 
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figure 6. Analysis of viral protein accumulation and virus production by selected nsp1 mutants. (A) 
Western blot analysis of EAv-specific protein accumulation. Cells transfected with wt or mutant viral 
genomes were harvested 11 h after transfection and equal amounts of total protein were analyzed with 
EAv-specific sera detecting nsp3, M and N, which are translated from RNAs 1, 6 and 7, respectively. The 
relative levels of each mRNA template (derived from Fig. 4B) are indicated below the gels. Beta-actin 
was used as a loading control. (B) Plaque phenotype and virus titers of the ZCH, A1 and A4 mutants in 
comparison with wt. Plaque assays were performed on BHK-21 using cell culture supernatants harvested 
24 h after transfection. virus titers represent an average of three independent experiments.
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of each mutant virion preparation was assessed by relating the genomic RNA content to 
the plaque-forming units (pfu), a marked decrease in the pfu per unit of genomic RNA 
ratio of the ZCH, A1, and A4 virion preparations was revealed (Table 2). The ZCH, A1, and 
A4 mutations thus seem to affect both the total number of secreted virions, as well as 
their specific infectivity. Also, even at this relatively early time point post transfection, the 
three mutants exhibited heterogeneous plaque morphology, indicative of rapid rever-
sion (Fig. 6B). These results, together with the RNA and protein analyses outlined above 
(Fig. 4B and 6A), demonstrate that even moderate changes in the accumulation of EAv 
mRNAs and proteins can be associated with a dramatic decrease in the yield of infectious 
progeny. Thus, a previously unnoticed link seems to exist between the fine-tuning of 
the relative abundance of EAv mRNAs (and, consequently, viral protein levels) and the 
efficiency of virion biogenesis.
second-site mutations in nsp1 can restore both the quantitative balance among 
viral mRNa species and efficient virus production 
To gain more insight into the molecular basis of the nsp1 mutant phenotypes described 
above, we attempted to isolate revertant viruses encoding compensatory second-site 
mutations. The mutants in which sg mRNA accumulation was completely blocked, how-
ever, proved to be extremely stable. We were repeatedly unable to detect infectious par-
ticles in supernatants of transfected cells, even after prolonged incubation (up to 70 h) 
at 39.5°C or at a reduced temperature of 35°C, or after using these supernatants to infect 
fresh BHK-21 cells (data not shown). By contrast, the rapid appearance of large plaque 
variants among the prevailing small plaques produced by the ZCH, A1, and A4 mutants 
(see Fig. 6B) suggested genetic heterogeneity. Large plaque clones of these three mu-
table 2. Relative specific infectivities of virus particles from nsp1 mutants with imbalanced mRNA profiles
Construct Relative infectivitya Relative genomic RNA contentb Relative specific infectivityc
Exp. 1d Exp. 2 Exp. 1 Exp. 2 Exp. 1 Exp. 2
pEAv211 1 1 1 1 1 1
ZCH 4x10-4 5x10-4 2.7x10-1 7.9x10-1 1.9x10-3 5.1x10-4
A1 2x10-5 5x10-6 8.5x10-4 6.4x10-3 2.4x10-2 7.9x10-4
A4 4x10-4 4x10-4 1.8x10-2 1.6x10-1 2.2x10-2 2.4x10-3
a virus titers were determined by plaque assays of culture supernatants harvested at 24 h post-transfection 
and normalized to the pfu/ml value of the wt control, which was set at 1.
b EAv genomic RNA levels were quantified in virion preparations obtained from culture supernatants 
harvested at 24 h post-transfection by reverse transcription and quantitative PCR. values for mutant 
virions were obtained by comparing their threshold cycle (Ct) against the qPCR standard curve, and were 
normalized relative to the genomic RNA level in the wt control, which was set at 1.
c Relative specific infectivity values were calculated by dividing the relative infectivity (mutant:wt pfu ratio) 
by the relative genomic RNA content for each construct.
d The data shown are derived from two independent experiments.
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tants were isolated and propagated in fresh cells, and the EAv nsp1 gene was amplified 
by RT-PCR. Sequence analysis of the PCR products confirmed the presence of the origi-
nally engineered mutant codons, and identified additional mutations in the nsp1-coding 
sequence in the majority of the plaques analyzed (data not shown). A pseudorevertant of 
ZCH had acquired a substitution in the vicinity of the original mutations (Ala-29 to Asp). 
interestingly, Ala-29 was also mutated in five independent A1 pseudorevertants, where 
it had been replaced with Lys due to two nucleotide substitutions (Table 3). in addition, 
four clones of the A4 offspring contained a Thr-196 to Lys substitution, and Gly-47 to Ala 
and Glu-112 to Lys replacements were found in one clone each. 
To ascertain these second-site substitutions conferred a replicative advantage, they 
were introduced into their respective parental (mutant) full-length cDNA clones, yielding 
a set of viruses collectively referred to as “nsp1 pseudorevertants”. Cell culture superna-
tants harvested 24 h after transfection with RNA from nsp1 pseudorevertants indeed 
contained between 2 and ~4 log units more infectious progeny than those of the original 
mutants (Table 3), confirming the compensatory nature of the second-site mutations. 
Both virus titer and plaque size of the three viruses carrying a second-site mutation in the 
A4 mutant background were similar to those of the wt control (Table 3; data not shown). 
Replacement of Ala-29 with Asp or Lys in the ZCH and A4 backgrounds, respectively, 
increased virus titers by 2 to ~4 log units, with plaque sizes being intermediate between 
those of the parental mutant and the wt control (Table 3; data not shown). The rela-
tive specific infectivities of virion preparations derived from all nsp1 pseudorevertants 
were also considerably higher in comparison to those of the parental mutants (data not 
shown). Notably, the pseudorevertants showed a partial or complete restoration of the 
mRNA-specific defects that we had observed for the original mutants (Fig. 7). introduc-
table 3. Overview of EAv nsp1 pseudorevertants described in this study.
Construct Second-site mutationa Wild-type codonb Mutant codon Titer (pfu/ml)c Plaque size
pEAv211 NAd NA NA 1x108 wild-type
ZCH A29D (1) 309-GCCe GAC 5x106 intermediate
A1 A29K (5) 309-GCG AAG 5x106 intermediate
A4 G47A (1) 363-GGU GCU 5x107 wild-type
E112K (1) 558-GAA AAA 5x107 wild-type
T196K (4) 810-ACA AAA 5x107 wild-type
a virus clones were isolated from plaque assays of culture supernatants harvested between 20 h and 24 h 
post-transfection. The number of clones containing each mutation is indicated in brackets.
b Numbers indicate the start coordinate of the codon in the EAv genome.
c Pseudorevertants were reconstructed in the wild-type EAv background, and infectious progeny titers 
were determined by plaque assays of culture supernatants harvested at 24 h post-transfection. The 
average titers of three independent experiments are shown.
d NA, not applicable.
e A silent mutation changing the original alanine codon from GCG to GCC was introduced as a marker 
mutation upon construction of the ZCH mutant.
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figure 7. Second-site mutations in nsp1 moderate species-specific defects in mRNA accumulation. (A-D) 
Gel hybridization analysis and quantification of EAv-specific mRNA accumulation. (A) BHK-21 cells were 
transfected with ZCH and A1 mutants, reconstructed pseudorevertants, and wt controls. The positions 
of the originally mutated amino acid clusters are indicated with arrows; the open circle denotes the 
position of second-site mutations. viral mRNAs were analyzed 11 h post-transfection by gel hybridization 
as described above. (B) For ZCH+A29D and A1+A29K, the accumulation levels of each viral mRNA were 
quantified by phosphorimaging and the values were normalized to the wt level of accumulation of 
each corresponding viral mRNA from the same experiment, set at 1. Genomic RNA levels are shown as 
dark grey bars. The relative values correspond to the means from three independent transfections and 
error bars denote the standard deviation. The relative accumulation levels of viral mRNAs at 11 h post-
transfection for the ZCH and A1 mutants are derived from Fig. 4B and are represented here to facilitate 
comparison between mutant and pseudorevertant phenotypes. (C) BHK-21 cells were transfected with 
the A4 mutant, reconstructed pseudorevertants and a wt control. The positions of the originally mutated 
amino acid cluster and the second-site mutations are indicated as in (A). viral mRNAs were analyzed 11 
h post-transfection. (D) For A4+G47A, A4+E112K, and A4+T196K, quantification of relative viral mRNA 
accumulation levels was performed as described in (B). Similarly, the relative accumulation levels of viral 
mRNAs at 11 h post-transfection for the A4 mutant derived from Fig. 4B are represented to facilitate 
comparison.
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tion of the Ala-29 to Asp substitution in the ZCH mutant was accompanied by a consider-
able reduction of the otherwise abnormally high accumulation of RNAs 3 to 7, though 
RNA5 and RNA6 were still present at ~150% of the normal level (Fig. 7B). Likewise, the 
Ala-29 to Lys replacement moderated the effect of the A4 substitutions on the accumula-
tion levels of RNA1, RNA5, and RNA6; those of RNA1 and RNA2 were somewhat reduced 
relative to wt. introduction of G47A, E112K, or T196K in the A4 background in each case 
suppressed the increased ratio of genomic to sg mRNA that was characteristic for the 
parental mutant virus (Fig. 7D). Thus, both the pronounced mRNA-specific accumulation 
defects, as well as the associated drop in virus production observed for the ZCH, A1, and 
A4 mutants (Fig. 4) were considerably alleviated by second-site mutations in nsp1. The 
location of both the original and the second-site mutations in nsp1 revealed multiple 
genetic interactions between all nsp1 subdomains that are important for the protein’s 
role in regulating the relative abundance of EAv mRNAs. in addition, the increased virus 
production by the pseudorevertants was invariably correlated with a distinct shift to-
wards an mRNA accumulation profile that was (more) similar to wt (Fig. 7, B and D). These 
observations provide compelling evidence that efficient virus production depends on 
maintaining “balanced” viral mRNA levels in EAv-infected cells.
DIsCussION
in order to progress through their replicative cycle, +RNA viruses need to orchestrate 
key macromolecular processes that often overlap in time and possibly also in space. 
Multifunctional viral proteins, which can regulate and interlink multiple of these steps, 
may therefore have evolved in order to facilitate this spatio-temporal coordination. EAv 
nsp1 was first identified as a general transcription factor that is also critical for replicase 
polyprotein processing and efficient production of infectious progeny37,39. By employ-
ing forward and reverse genetics, we have now examined the significance of all nsp1 
subdomains for these multiple regulatory roles. Detailed quantitative analyses of viral 
mRNA species and their corresponding minus-strand templates in nsp1 mutants allowed 
us to identify a previously unrecognized function of the protein in the mRNA-specific 
regulation of viral RNA abundance. Nsp1 seems to perform this function by controlling 
the accumulation of the minus-strand templates for viral mRNA synthesis. Together with 
its well-documented general role in transcription, these results place nsp1 at the heart 
of the unique process of discontinuous minus-strand RNA synthesis that is employed 
by arteriviruses and other nidoviruses. Even the modest changes in viral mRNA levels 
we observed in nsp1 mutants with differential deviations in viral mRNA abundance are 
seemingly reflected in altered levels of their translation products. The dramatically re-
duced virus yields of these mutants revealed that the critical fine-tuning of the “balance” 
of EAv mRNA accumulation has major implications for the final stages of the replicative 
cycle. The importance of this balance is greatly emphasized by the rapid emergence of 
pseudorevertant viruses, in which both the mRNA-specific accumulation defects and the 
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impaired virus production were significantly moderated. The mapping of compensatory 
second-site mutations to the nsp1 gene itself implies that multiple physical interactions 
among nsp1 subdomains are essential for the protein’s role in transcriptional control. Our 
findings constitute the first evidence for the involvement of a protein factor in regulating 
the relative abundance of individual mRNA species during nidovirus infection. 
the intricate interplay between nsp1’s subdomains
Previous reports have suggested that the multiple roles of nsp1 during EAv infection 
can (in part) be functionally separated, with the ZF domain being essential for transcrip-
tion and efficient virus production, and the PCPβ protease cleaving the nsp1/2 site, 
irrespective of the ZF integrity37. This study extended and refined the above concept 
showing, first, that the functional repertoire of nsp1 also includes the differential control 
of mRNA accumulation, and, second, that some functions may be based on the interplay 
between two or even all three of the protein’s subdomains. The phenotypes observed 
upon replacing charged amino acid clusters with alanine established the importance of 
all nsp1 subdomains for sg mRNA accumulation (Fig. 3A). The involvement of PCPβ in 
transcription is seemingly unrelated to its autoproteolytic function, whose inactivation 
is detrimental to genome replication37. The co-translational, cis-cleavage of the nsp1/2 
site in the nascent replicase polyproteins35 is probably the sole processing step mediated 
by PCPβ, which becomes rapidly available to exercise any trans-acting, non-proteolytic 
activities it may have. Such secondary non-proteolytic functions have previously been 
reported for several +RNA viral autoproteinase domains, such as those of hepatitis C 
virus NS214 and beet yellow virus L-Pro26.
The previously uncharacterized PCPα domain, a PCPβ paralog that has lost its pro-
teolytic capacity in EAv9, appears to cooperate with the ZF in transcription and virion 
biogenesis (Fig. 3). Likewise, it works in concert with both flanking nsp1 subdomains 
in controlling the relative abundance of viral mRNAs (Fig. 4, Table 3, and Fig. 7). The Lys 
and Arg residues replaced with alanine in the A1 and A4 mutants, and the Lys that had 
evolved in their pseudorevertants are all basic residues. They are found in different nsp1 
subdomains, but could well be spatially juxtaposed to provide a positively charged side 
chain to a functional region that is involved in interactions essential for one or more of 
the protein’s activities. The Gly-47 to Ala reversion, which maps to the junction region 
between the ZF and PCPα, might serve to reposition these subdomains relative to each 
other. A similar readjustment of the protein’s tertiary structure might account for the 
compensatory effect exerted by the Ala-29 to Asp reversion on the ZCH mutant. Despite 
the fact that its orthologs in other arteriviruses have retained their proteolytic activity, it 
is tempting to speculate that the incorporation of the PCPα domain in the arterivirus nsp1 
region can be primarily attributed to the non-proteolytic functions outlined above. On 
the whole, there seems to be considerable cooperation between nsp1 subdomains. This 
interplay appears crucial for coupling the different processes that nsp1 controls and may 
be based on interactions that are either intra- or intermolecular, in view of the protein’s 
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ability to form homo-oligomers38. Notably, a recent paper describing the crystal structure 
of PRRSv nsp1α, an arterivirus ortholog of the EAv ZF and PCPα domains, reported that 
the protein exists in equilibrium between monomers and dimers in solution. Residues 
from both subdomains also contribute both to nsp1α dimerization and the formation of 
a hydrophilic groove at the dimer surface36. 
the quantitative balance among eav mRNa species is critical for efficient virus 
production
Characterization of the three nsp1 mutants with imbalanced viral mRNA accumulation 
profiles showed that the disruption of the balance was due to a reduction of the levels 
of certain viral mRNA species only for the A1 mutant (see Fig. 4B). By contrast, specific 
upregulation of most mRNAs was observed for both the ZCH and A4 mutants and the 
associated dramatic defects in virus production were surprising, also in view of the ap-
parently undisturbed translation of viral mRNAs (Fig. 6A). in an attempt to quantify the 
relationship between virus yield and viral mRNA accumulation, we used the data sets of 
Fig. 4B, 7B, and 7D to calculate the mean relative mRNA accumulation for the ZCH, A1, 
and A4 mutants, as well as their pseudorevertants. Plotting these values versus the corre-
sponding infectivity titers (derived from Fig. 6B and Table 3) revealed efficient production 
of infectious progeny for viruses with mRNA accumulation that was close to that of the 
wt control or modestly decreased (Fig. 8A). in contrast, severely reduced virus yields were 
observed when viral mRNA accumulation was increased, as seen for the ZCH, A1, and A4 
mutants. This somewhat counterintuitive observation was rationalized by assessing the 
importance of the quantitative balance among EAv mRNA species for infectious virus 
production. in order to establish this relationship, for each mRNA species, the absolute 
deviation of its relative accumulation from the mean of the complete nested set of 
mRNAs (Fig. 8A) was calculated. From these seven values, the mean (absolute) deviation 
was calculated for each mutant or pseudorevertant, and these values were also plotted 
against virus titers (Fig. 8B). By definition, the mean deviation is equal to zero for the wt 
virus, whose mRNA levels we refer to as “balanced”. All nsp1 mutants and their pseudor-
evertants have mean deviations larger than zero and these values reflect the magnitude 
of imbalance of their mRNA accumulation profiles. Remarkably, the plot revealed that 
the data nicely fit (R2=0.95) a negative exponential regression between infectious virus 
yield and mRNA imbalance, which is depicted as a negative linear regression in the semi-
logarithmic plot of Fig. 8B. This strong relationship underlines that the magnitude of im-
balance between different mRNA species, rather than the accumulation levels of mRNA 
species per se, is a chief factor affecting progeny yield. it should be noted that several fac-
tors may have affected our analysis of this relationship to a certain extent. For example, 
only a relatively small variety of nsp1 mutants and pseudorevertants was analyzed and 
although some pseudorevertants were recovered repeatedly, they were plotted only 
once. Also, the rapid emergence of pseudorevertants likely contributed to the virus titers 
measured for the ZCH, A1, and A4 mutants a 24 h post transfection, which would thus be 
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overestimated in our analysis. Therefore, an extension of this study with new mutants and 
pseudorevertants may further refine the relationship illustrated by Fig. 8B. it would also 
be interesting to evaluate how virus yields are affected by a general imbalance between 
replication and transcription (A4 mutant) versus sg mRNA-specific changes (ZCH mutant), 
although the latter seem to have an added negative effect (A1 mutant). 
The molecular basis of perturbed infectious particle production in the mutants is 
probably complex, although it is likely related to the altered relative abundances of viral 
structural proteins resulting from the respective changes in the levels of their mRNA tem-
plates (Fig. 4B and 6A). The observation that increased production of infectious progeny 
by the nsp1 pseudorevertants invariably correlated with restoration of balanced viral 
mRNA accumulation (Table 3 and Fig.7) lends further support to this hypothesis. Dif-
ferential changes in structural protein levels might adversely affect their ability to form 
complexes that drive particle assembly, or alter the stoichiometry of these complexes 
when incorporated in virions. The latter option is consistent with the observed decrease 
in relative specific infectivity of virion preparations from the ZCH, A1, and A4 mutants 
(Table 2). Detailed information on the architecture of EAv virions and the molecular inter-
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figure 8. Relationship between viral mRNA accumulation profiles and infectious virus yield. The data 
obtained on the accumulation of genome and sg mRNAs were used for a quantitative assessment of nsp1 
mutant phenotypes in terms of (A) changes in mRNA accumulation compared to wt and (B) the extent to 
which the balance between viral transcripts was disturbed (B). (A) For each mutant and pseudorevertant, 
a value for the accumulation of each of its 7 mRNAs at 11 h post-transfection had been assigned as 
compared to that of the wt control (see Fig. 4B, 7B and 7D). The mean of these seven values (“mean relative 
mRNA accumulation”) was plotted against the corresponding progeny virus titer in culture supernatants 
at 24 h post-transfection (Fig. 6B and table 2). Wild-type is depicted in black. The engineered nsp1 mutants 
and nsp1 pseudorevertants are designated. The three pseudorevertants of mutant A4, displaying very 
similar phenotypes, are indicated as A4+PSR. (B) For each mRNA species, the deviation of its relative 
accumulation from the mean of the complete nested set of mRNAs (see panel A) was calculated. From 
these seven values, the mean (absolute) deviation was calculated for each mutant and plotted against 
virus titers as in (A). For wt, the mean deviation is 0. Engineered nsp1 mutants and their pseudorevertants 
are indicated as in (A). The data fit a negative exponential regression calculated using Microsoft Excel and 
depicted as a gray line (y = 6x106+7e-8.4306x, R2=0.95). The inset shows an expanded view of the upper left 
quadrant of the graph (shaded in gray).
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actions among EAv structural proteins that drive virus assembly is unfortunately lacking. 
Nevertheless, our data clearly establish a previously unknown link between balanced 
EAv mRNA accumulation and efficient virus production. We thus conclude that nsp1 
critically promotes virion biogenesis by modulating viral mRNA accumulation, as well as 
acting at an additional, currently unknown step of the EAv replicative cycle, downstream 
of viral RNA synthesis37 (Fig.3).
Nsp1 modulates a broad spectrum of successive stages in the nidovirus 
replicative cycle
The onset of +RNA gene expression is marked by translation of the viral genome. in 
subsequent stages of infection, this molecule is utilized also as the template for replica-
tion and, in some cases, transcription, as well as packaging into progeny virus particles. 
virtually nothing is known about the temporal coordination of these distinct processes 
in the nidovirus replicative cycle. Non-structural protein expression is extensively regu-
lated at the translational and post-translational level, by ribosomal frame-shifting and 
concerted autoproteolytic processing of replicase polyproteins, which together control 
the production of the core viral replicative enzymes4,40,45,50. By contrast, regulation of 
structural protein expression is presumed to occur mainly at the transcriptional level, 
although the exact significance and control of the relative abundance of the various 
viral mRNAs in infected cells had not been examined for any nidovirus. Prior studies37,39, 
together with our present findings, clearly implicate EAv nsp1 in controlling the balance 
between replication and transcription (Fig. 3 and 4). Mutations in nsp1 were previously 
shown to selectively block or equally reduce the accumulation of all sg mRNA species. 
The pronounced upregulation of genomic RNA levels in nsp1 mutants with a complete 
block in sg mRNA production was also described before37 and suggested to result from 
redirecting a limited pool of RNA-synthesizing complexes, normally engaged in both 
replication and transcription, to the exclusive amplification of the viral genome. 
Some of the mutant phenotypes in this report, however, are poorly compatible with the 
above scenario. Genome RNA levels were increased 4-6 fold in the A1 and A4 mutants, for 
which sg mRNAs synthesis was clearly detectable and even enhanced (Fig. 4). in addition, 
the ZCH and A1 mutations differentially modulated the accumulation levels of a specific 
subset of sg mRNAs and their subgenome-length minus-strand templates (Fig. 4 and 5). 
This effect was accompanied by unchanged genome RNA levels in the ZCH mutant. Taken 
together, these data imply that nsp1 does not only allow the viral RdRp complex to engage 
in discontinuous minus-strand synthesis, but also enables it to differentiate between the 
various body TRS motifs it encounters while traversing the genomic template. This oc-
curs by a currently unknown mechanism that is different from the previously described 
“polar attenuation” caused by the relative position of body TRSs in the array of successive 
attenuation signals that need to be “overcome” by the minus-strand RNA-synthesizing 
complex23. The changes in viral RNA accumulation observed for the A1 and A4 mutants 
could result from partial loss of recruitment of nsp1 to the RdRp complex, or its com-
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promised ability to recognize RNA signals that direct discontinuous RNA synthesis. viral 
RNA synthesis would then be shifted towards replication, but the increased availability 
of template and/or viral enzymes that this causes (Fig. 4B and 6A) might account for the 
relatively high levels of sg mRNA accumulation in these two mutants. This, in turn, would 
imply that the availability of nsp1 is important for its function in transcription. indeed, 
the intracellular distribution of nsp1 is distinct from that of the other EAv nsps – a large 
fraction of the protein is present in the host cell nucleus38, while only ~25% of the cyto-
plasmic nsp1 fraction co-sediments with the membrane-bound viral RNA-synthesizing 
complexes upon their isolation from infected cells46. immunofluorescence analysis did 
not reveal a significant change in intracellular nsp1 distribution for any of the mutants 
we described here (data not shown), but more rigorous biochemical studies are needed 
to ascertain the recruitment of nsp1 to RdRp complexes is completely unchanged. Nsp1 
mutations clearly influenced minus-strand RNA accumulation (Fig. 5), although we cannot 
formally exclude that the protein controls minus-strand RNA stability rather than synthe-
sis. Unfortunately, analysis of the kinetics of minus-strand accumulation in the ZCH and 
A1 mutants was hampered by the rapid emergence of pseudorevertants (Fig. 6B; Table 
3) and the low abundance of these molecules at earlier time points post-transfection, 
which precluded their accurate quantitation (data not shown). Resolving this issue thus 
remains a formidable technical challenge. The recently described protocols for isolation 
of active viral RNA-synthesizing complexes from EAv-infected cells46, as well as in vitro 
activity assays using a recombinant form of the EAv RdRp2 might provide better platforms 
for future research on the mechanistic aspects of nsp1 function.
Nsp1 remains the only known arterivirus protein specifically implicated in the regula-
tion of transcription15,39 and, to date, a functional counterpart has not been identified in 
coronaviruses or other nidoviruses. Species-specific changes in viral mRNA abundance 
were observed upon inactivation of the nsp14 exoribonuclease of human coronavirus 
229E19. However, the major effect of this mutation was a reduction of the accumulation of 
all viral mRNAs by more than 100-fold. in view of the (indirect) dependence of transcrip-
tion on genome replication and translation, the phenotype of the nsp14 mutants should 
be interpreted with caution. Nevertheless, a potential specific role of the coronavirus 
exonuclease in sg mRNA transcription deserves further investigation, although its analy-
sis may be complicated by the multifunctionality of this protein, which was implicated in 
improving the fidelity of viral RNA synthesis12,33 and also includes an N7-methyltransferase 
domain5. Elegant studies of the tombusvirus replicase have shown that genome replica-
tion and sg mRNA synthesis can be effectively uncoupled by mutations in the C-terminus 
of the viral RdRp, which could only be achieved after separation of the protein-coding 
sequence from overlapping regulatory RNA sequences54. This example once again under-
lines the theoretical and technical challenges encountered while dissecting the complex 
mechanisms coordinating +RNA virus replication and transcription. 
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abstract
aBstRaCt
Arteriviruses and coronaviruses, distantly related plus-strand RNA viruses, generate an 
extensive nested set of subgenomic (sg) mRNAs as templates for the translation of viral 
structural proteins. These viral RNA molecules are copied from a complementary set of 
minus-strand templates that are produced via a unique mechanism of discontinuous 
minus-strand extension that is poorly understood. Non-structural protein 1 (nsp1) from 
equine arteritis virus (EAv), the prototype arterivirus, is essential for sg mRNA production 
but dispensable for genome replication. Apart from securing the balance between these 
key viral processes, nsp1 has also been shown to modulate viral RNA accumulation in 
an mRNA-specific manner by controlling the levels of templates required for viral mRNA 
synthesis. The development of in vitro assays to address nsp1 function, combined with 
solution of the protein’s three-dimensional structure, could be instrumental in providing 
mechanistic details of the multiple roles of this protein in the viral replicative cycle. We 
therefore explored different expression conditions and fusion tags for the production 
and purification of soluble recombinant nsp1 in Escherichia coli. We describe the pitfalls 
we encountered upon purification of GST-tagged nsp1 and subsequent tag removal 
by proteolytic cleavage, and initial difficulties in purifying hexahistidine-tagged nsp1. 
We outline a successful approach for nsp1 expression from a construct that allowed its 
autoproteolytic release from a precursor, and which yielded soluble, stable recombinant 
nsp1 purified from bacterial cells that can be used for functional studies. 
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INtRODuCtION
Replication of RNA viruses with single-stranded genomes of messenger RNA polarity 
(plus-strand [+] RNA) is ensured by an RNA-dependent RNA polymerase (RdRp) that is 
produced by translation of the viral genome following its uncoating in the infected cell. 
Plus-strand RNA virus viruses also employ virally-encoded helicases (Hel), presumably to 
unwind local double-stranded RNA structures that might impede RdRp progress during 
viral RNA synthesis. The activities of these two essential enzymes need to be modulated 
to assure the temporal progression of the viral replicative cycle that requires the inte-
gral coordination of genome replication, translation, and packaging. +RNA viruses that 
produce subgenomic RNAs, like arteriviruses and coronaviruses, are challenged with an 
additional regulatory step. intricate circuits involving protein-protein and protein-RNA 
interactions that modulate viral RNA synthesis have therefore evolved. These “molecular 
switches” can require the recruitment of cellular proteins, but are often mediated by viral 
domains that can be covalently linked to the RdRp or Hel, or exist as independent poly-
peptides. An example of such a candidate “molecular switch” is non-structural protein 1 
(nsp1) of the equine arteritis virus (EAv), the prototype arterivirus. 
The EAv genome is translated to produce a multidomain replicase precursor from 
the two 5’-proximal open reading frames (ORFs) in the viral genome, resulting in the 
synthesis of polyprotein (pp) 1a and, after a ribosomal frameshift, pp1ab. The replicase 
polyproteins are proteolytically processed by virus-encoded (auto)proteinases into 13 
nsps that possess enzymatic activities and/or indirect regulatory roles in viral RNA repli-
cation. The viral structural genes are encoded in the 3’-end of the genome and expressed 
from subgenomic (sg) mRNAs. Arterivirus sg mRNAs are 5’- and 3’-coterminal and are 
copied from sg-length minus-strand templates produced by discontinuous minus-strand 
extension13, an unusual process that is also utilized by the distantly related coronaviruses 
and remains poorly characterized. Subgenomic mRNA synthesis and genome replication 
presumably compete for the same template – the genomic plus strand, implying the 
existence of protein and/or RNA signals that serve as regulatory switch(es). 
EAv nsp1 is vital for the quantitative balance between genome replication and sg 
mRNA production, and is the only arteri- or coronavirus protein specifically implicated 
in sg mRNA synthesis to date20 (Chapters 5 and 6 of this thesis). Nsp1 is also the first 
protein expressed during infection, by a co-translational release from the nascent rep-
licase polyproteins by a papain-like cysteine proteinase activity (PCPβ) in its C-terminal 
domain (Fig. 1A); this cleavage is essential for virus viability14 (Chapter 5). Two additional 
conserved subdomains were identified by bioinformatics: a second, proteolytically silent 
PCP domain that is functional in other arteriviruses (PCPα), and an N-terminal zinc finger 
(ZF) domain. interestingly, nsp1 was recently found to modulate the levels at which 
individual viral mRNAs accumulate relative to each other during EAv infection, likely by 
controlling the relative abundance of their minus-strand templates (Chapter 6). Unravel-
ing the molecular mechanisms underlying the regulatory functions of nsp1 could there-
fore provide invaluable insights into the poorly understood process of discontinuous 
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minus-strand synthesis. For that purpose, expression and purification of recombinant 
nsp1 and solving its three-dimensional structure would greatly facilitate its detailed 
characterization. The ability of the protein to form complexes with RNA and specifically 
recognize viral sequences that regulate sg mRNA synthesis, as well as its influence on 
the in vitro EAv RdRp activity could be examined3,22. Also, experiments based on isolated 
active viral RNA-synthesizing complexes from cells transfected with nsp1 mutants and 
addition of recombinant nsp1 could address the importance of timing of nsp1 expres-
sion and whether defects associated with mutations in nsp1 can be complemented by 
the wild-type protein.
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figure 1. Constructs for expression of recombinant EAv nsp1. (A) Domain organization of EAv nsp1. Three 
conserved subdomains were identified by comparative sequence analysis: an N-terminal zinc finger (ZF) 
domain, a papain-like cysteine proteinase activity (PCPβ) in its C-terminal domain which mediates the co-
translational release of nsp1 from the nascent replicase polyproteins, and a second, proteolytically silent 
PCP domain that is functional in other arteriviruses (PCPα). The position of predicted zinc-coordinating 
residues and the active-site amino acids of PCPα and PCPβ are indicated with lines. The lack of PCPα 
proteolytic activity is likely due to a natural loss of the active-site Cys. (B) Schematic diagrams of fusion 
proteins produced from nsp1 expression constructs. Nsp1 was expressed in E. coli fused to the C-terminus 
of GST with a Factor Xa Protease cleavage site (iEGR) and a three-amino-acid spacer. Proteolytic processing 
of the GST-nsp1 fusion protein by Factor Xa yielded nsp1 containing three foreign amino acids (GiP) at 
its N-terminus. Numbers indicate amino-acid positions in EAv pp1a. Nsp1 was also produced as an N- or 
C-terminally His-tagged protein (nsp1-HN and nsp1-HC, respectively). A recombinant protein with an 
N-terminal His tag followed by the nsp1 sequence and 169 residues from nsp2 was used to generate 
bacterially expressed autoprocessed nsp1. This recombinant form of nsp1, whose amino acid sequence is 
identical to that of nsp1-HN, is referred to as nsp1-HN-ap in the text.
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We therefore set out to design a protocol for the expression and purification of stable 
and soluble recombinant nsp1 for crystallization and structure determination via X-ray 
diffraction, as well as functional in vitro studies. Since significant amounts (mg) of protein 
are usually required for structural studies, and nsp1 is a relatively small protein (30 kDa) 
that is not expected to be post-translationally modified, we chose E. coli as the expres-
sion host. Several terminally extended derivatives of nsp1 were produced and a variety 
of conditions for their purification were explored. The nsp-coding sequence was fused to 
the C-terminus of glutathione-S-transferase (GST) via a linker region encoding a Factor 
Xa Protease cleavage site (Fig. 1B). Alternatively, hexahistidine [(His)6] tags were fused 
to the N-terminus or C-terminus of the protein. Lastly, expression of nsp1 with an N-
terminal (His)6 tag from a construct that encoded an amino-acid sequence derived from 
the N-terminal region of nsp2 was used to assess the effect of autoproteolytic cleavage 
on the solubility and stability of recombinant nsp1. We outline the technical difficulties 
encountered upon purification of GST-nsp1 and removal of the affinity tag by proteolysis. 
Furthermore, we show that autoproteolytic release of nsp1 from a precursor polypeptide 
is likely key for the successful purification of stable, soluble nsp1 with an N-terminal (His)6 
tag by metal affinity chromatography. Although the current yield of recombinant nsp1 
obtained following the protocol described here is likely too low for structural studies, 
the purified protein can be used for setting up in vitro assays aimed at elucidating one or 
more of its functions. 
matReRIals aND methODs
Construction of plasmids for recombinant nsp1 expression
in order to generate a plasmid for the expression of EAv nsp1 fused to GST in bacte-
rial hosts, the nsp1- coding sequence (nucleotides 225 to 1004 of the wild-type EAv 
infectious cDNA clone pEAv21121) was amplified by PCR with oligonucleotides E872 
(5’- CGCGGATCCCCATGGCAACCTTCTCCGC- 3’) and E386 (5’-GGAATTCGCATGCCTAGCC-
GTAGTTGCCAG-3’). The fragment was cloned between the BamHi and EcoRi restriction 
sites of the pGEX-5X-3 expression vector (GE Healthcare, Chalfont St Giles, UK), tran-
scription from which is driven by the chemically inducible tac promoter. The resulting 
plasmid, pGEX-5X-3-nsp1, encoded EAv nsp1 (amino acids Met-1 to Gly-260 of replicase 
pp1ab of the EAv-Bucyrus strain, NCBi genome database accession number NC_002532) 
fused to the C-terminus of GST. The two protein moieties are separated by 7 amino acid 
spacer representing a Factor Xa cleavage site (NH2- ile-Glu-Gly-Arg-COOH), followed by 
NH2- Gly-ile-Pro COOH, originating from translation of sequences in the multiple cloning 
site of the vector. 
For the generation of plasmids for bacterial expression of (His)6-tagged EAv nsp1, 
oligonucleotides E777 (5’-CATGCCATGGGCCATCACCATCACCATCACATGGCAACCTTCTCC-
GCTACTGG-3’) and E386 (5’- GAATTCGCATGCCTAGCCGTAGTTGCCAG-3’) were used to 
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amplify the nsp1-coding sequence, introducing a start codon followed by sequences 
specifying a (His)6 tag, and a stop codon, respectively. Amplification with E385 (5’-TATA-
ACGCGTGGTACCATGGCAACCTTCTCC-3’) and E778 (5’-CCGCTCGAGTTAGTGATGGTGATG-
GTGATGGCCGTAGTTGCCAGCAGGCAAAC-3’) was used to introduce the (His)6 tag-coding 
sequence followed by a stop codon, downstream of nt 1004. The fragments were cloned 
between the Ncoi and Xhoi restriction sites of Gateway entry vector pENTR11 (invitrogen), 
and, after sequence verification, placed downstream of the T7 promoter in Gateway ex-
pression vector pDEST14. The resulting constructs, pDEST14-EAv nsp1-HN and pDEST14-
EAv nsp1-HC, mediate the expression of recombinant nsp1 preceded by an N-terminal 
Met-Gly-(His)6 tag (nsp1-HN), or followed by a C-terminal (His)6 tag (nsp1-HC). Lastly, an 
expression construct encoding aa 1 to 429 of EAv pp1a preceded by a Met-Gly-(His)6 
tag, was generated by PCR amplification of nt 255 – 1511 of pEAv211 with E777 and 
E1064 (5’- CCGCTCGAGTTA TGTGGCAAGCTTGGTCCTTGG – 3’), subsequent cloning of the 
fragment between the Ncoi and Xhoi restriction sites of pENTR11 and recombination to 
pDEST14. The resulting plasmid, pDEST14-nsp1-2N-HN, mediates the expression of EAv 
nsp1 fused to 169 aa from the N terminus of EAv nsp2, allowing for the generation of 
autoproteolytically processed nsp1 with an N-terminal (His)6 tag. This recombinant form 
of nsp1, whose amino acid sequence is identical to that of nsp1-HN, is referred to as 
nsp1-HN-ap in the text.
Bacterial strains for recombinant nsp1 expression
The BL21(DE3) strain of Escherichia coli and its derivatives, C41 (DE3) and C43(DE3) were 
used as expression hosts as indicated in the text. The BL21(DE3) strain lacks the OmpT 
and Lon proteases and contains a chromosomal copy of the T7 polymerase gene behind 
a lacuv5 promoter. Expression of T7 polymerase is induced by addition of the lactose 
analog isopropyl b-D thiogalactoside (iPTG). The C41 (DE3) and C43(DE3) strains were 
isolated in a screen for BL21(DE3) derivatives with improved characteristics of toxic 
protein expression12. 
expression and purification of Gst-nsp1
Plasmid pGEX-5X-3-nsp1 was transformed in an expression strain of E. coli and a single 
colony was used to inoculate 2 ml of LB containing 50 µg/ml of ampicillin (LB-Amp). The 
culture was grown overnight, diluted 1:100 in fresh LB-Amp, and subsequently grown at 
37°C to mid-logarithmic phase (OD600 0.6 – 0.8). Recombinant protein expression was in-
duced by addition of iPTG. The duration of induction, temperature at which bacteria were 
cultured during induction, and amount of iPTG, are indicated in the text. After induction, 
cells were harvested by centrifugation at 2,500 x g for 10 min and stored at -20°C. The 
pellets were resuspended in buffer A (10 mM Tris-HCl pH 7.5, 400 mM NaCl, 10% glycerol; 
1 ml of buffer A was used per 10 ml of original culture volume) supplemented with 1 mg/
ml lysozyme (Sigma-Aldrich) and 150 U/ml dNasei (invitrogen), and incubated for 1 h 
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at 4°C with gentle mixing. The lysates were then supplemented with 0.5 % Triton-X100, 
incubated for 30 min at 4°C and clarified by high-speed centrifugation. Pellet fractions 
were resuspended in 1X Laemmli sample buffer (LSB) for SDS-PAGE analysis of insoluble 
proteins. Supernatant fractions were incubated with GST affinity resin (glutathione 
sepharose 4B [GS4B] from GE Healthcare, unless otherwise indicated in the text) for 1 – 2 
h at 4°C with gentle mixing. The affinity resin was then washed extensively with buffer 
A supplemented with 0.5 % Triton-X100, followed by washing with buffer A alone. The 
bound GST-nsp1 was eluted with 10 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0, 
and analyzed by SDS-PAGE and Coomassie Brilliant Blue staining. Alternatively, the resin-
bound fusion protein was equilibrated in Factor Xa cleavage buffer and digested with 
Factor Xa Protease (see below).
factor Xa cleavage of Gst-nsp1
GS4B resin-bound recombinant GST-nsp1 was equilibrated in FXa buffer (50 mM HEPES 
pH=6.5, 100 mM NaCl, 10 % glycerol, 1 mM CaCl2, 50 mM L-Arg pH=9.5; final pH of buffer: 
7.5). Subsequently, Factor Xa Protease (Qiagen) was added to the slurry and proteolytic 
reactions were carried out as specified in the text. Cleaved nsp1, containing three addi-
tional amino acids at the N terminus (NH2- Gly-ile-Pro COOH) as a result from the cloning 
strategy, was recovered from the supernatant of the pelleted GS4B resin. After digestion, 
Factor Xa Protease and traces of GST or uncleaved fusion protein were removed by incu-
bation of the nsp1-containing fraction with Xa Removal Resin (Qiagen; 50 µl per 4 U of 
enzyme) and GS4B. The nsp-containing fraction was then centrifuged at 100,000 x g for 1 
h at 4°C in a Beckman tabletop ultracentrifuge. The supernatant fraction was analyzed by 
gel filtration on a Superdex 75 column (GE Healthcare) in 50 mM HEPES pH=6.5, 100 mM 
NaCl, 10 % glycerol, 50 mM L-Arg. 
expression and purification of his-tagged nsp1
Expression of recombinant nsp1 from pDEST14-EAv nsp1-HN and pDEST14-EAv nsp1-HC 
vectors was performed essentially as described above for GST-nsp1 fusion protein ex-
pression. Supernatants from induced bacterial cultures lysed in buffer B (10 mM Tris-HCl 
pH 8.0, 400 mM NaCl, 10% glycerol supplemented with 0.5 % Triton-X100 were incubated 
with Ni-NTA agarose (Qiagen) or HiS-Select HF Nickel Affinity Gel (Sigma-Aldrich) for 1 h 
at 4°C with gentle mixing. Unbound proteins were washed off with buffer B containing 
10 mM imidazole, and proteins bound to the resin were eluted in buffer B supplemented 
with 250 mM imidazole. 
For expression and purification of autoproteolytically processed recombinant nsp1-
HN-ap, the pDEST14-nsp1-2N-HN expression vector was transformed in C41(DE3) cells 
and a single colony was used to inoculate 5 ml of LB-Amp. After growth for 4 h at 37°C, the 
starting culture was diluted in 1 l pre-warmed LB-Amp and cells were grown at 37°C until 
the OD600 equaled 0.6. The culture was cooled on ice and recombinant protein expression 
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was induced with 1 mM iPTG at 16°C for 16 h. The cells were harvested by centrifugation 
at 2,500 x g for 10 min, pellets were resuspended in buffer C (50 mM 2-(N-morpholino)-
ethanesulphonic acid [MES] pH 7.0, 500 mM NaCl, 10 % glycerol, 5 mM imidazole; 1 ml 
buffer per 50 ml original culture) supplemented with 1 mg/ml lysozyme, 30 U/ml DNasei, 
and 0.1 % Triton-X100, and the cell suspension was incubated for 1 h at 4°C with gentle 
mixing. The Triton-X100 concentration was adjusted to 0.5%, lysates were incubated at 
4°C for additional 30 min and subsequently clarified by centrifugation at 20,000 x g for 30 
min. Recombinant nsp1 was purified from supernatants using Talon metal affinity resin 
(Clontech). The resin was washed twice with 50 resin volumes of buffer C containing 0.5 
% Triton-X100, followed by three washes with 50 volumes of buffer C containing 10 mM 
imidazole. Elution was performed in 20 mM MES pH=7.0, 500 mM NaCl, 10 % glycerol, 
150 mM imidazole in two steps. Eluates were pooled and immediately loaded onto a 
Superdex-75 column, and gel filtration was carried out as indicated in the text. Fractions 
containing nsp1 were pooled, and Ultrafree 10-kDa filter columns (Millipore) were used 
for protein concentration.
Results aND DIsCussION
expression and purification of Gst-tagged nsp1
initial characterization of the proteolytic activity of EAv nsp1 showed that the protein is 
at least partially active as an autoproteinase when increasingly longer N-terminal frag-
ments of pp1a were expressed in as C-terminal GST fusions in bacterial cells14. Autopro-
teolytic processing suggested proper folding of nsp1 (and its PCPβ domain in particular) 
in a fraction of the bacterially produced fusion proteins, although both precursor and 
self-processed GST-containing proteins could only be recovered from the insoluble frac-
tions of cell lysates under the experimental conditions used14. We therefore set out to 
explore expression and purification conditions that would allow us to produce soluble 
GST-nsp1, as well as protocols for the removal of the GST tag to obtain native nsp1. To 
that end, the nsp1-coding sequence (amino acids 1 – 260 from EAv pp1a) was cloned in 
frame with the GST gene in plasmid pGEX-5X-3, and the resulting plasmid was used to 
produce a GST-nsp1 fusion protein under the control of the strong iPTG-inducible tac 
promoter. The two protein moieties in the fusion are separated by a seven amino-acid 
linker containing a Factor Xa Protease cleavage site (ile-Glu-Gly-Arg), followed by three 
residues (Gly-ile-Pro) derived from an in-frame vector sequence (see Fig. 1C).
Lowering expression temperature has been shown to improve recombinant protein 
solubility in E. coli, presumably by allowing enough time for the proper folding of newly 
produced recombinant proteins due to slower metabolic rates10,23. Expression of GST-
nsp1 in BL21(DE3) cells was therefore tested in small-scale bacterial cultures that were 
grown to mid-log phase, and protein production was induced at 30°C by the addition of 
0.5 mM iPTG. Pellet and supernatant fractions of lysates (prepared as described in Materi-
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als and methods) from cells harvested at 2.5 h and 7 h after induction were analyzed 
by SDS-PAGE. Large quantities of a protein with an apparent molecular mass of 55 kDa, 
consistent with the expected mass of GST-nsp1, were produced exclusively in the iPTG 
induced bacterial cultures, and Western blotting with GST- and nsp1-specific antibodies 
confirmed the identity of the fusion protein (data not shown). The majority of recombi-
nant GST-nsp1, however, was present in the insoluble fraction of cell lysates, especially 
after longer induction times (Fig. 2A).
in an effort to increase the fraction of soluble GST-nsp1 produced in bacterial cells, 
the temperature during protein expression was further decreased to 25°C, and the con-
centration of iPTG was lowered to 0.3 mM. These conditions resulted in a slightly higher 
yield of soluble fusion protein, although the bulk of GST-nsp1 still remained in insoluble 
aggregates (Fig. 2B). The fusion protein was purified from the soluble fraction of bacterial 
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figure 2. Expression and purification of GST-nsp1. (A) BL21(DE3) cells transformed with pGEX-5X-3-nsp1 
were cultured until OD600 of 0.7, GST-nsp1 expression was induced by the addition of 0.5 mM iPTG, and the 
cultures were incubated at 30°C. Lysates were obtained from non-induced or iPTG-induced cells harvested 
2.5 or 7 hours post induction. After centrifugation of total cell lysates, obtained as described in Materials 
and Methods, the insoluble pellet (P) fractions were resuspended in 1x LSB and equal volumes of pellet 
and supernatant (S) fractions were separated on a 12.5 % polyacrylamide gel by SDS-PAGE. Proteins were 
visualized by subsequent staining of the gel with Coomassie Brilliant Blue R-250. (B) GST-nsp1 expression 
was induced with 0.3mM iPTG for 5.5 h at 25°C, and the soluble fraction of the total bacterial lysate was 
incubated with Glutathione Sepharose 4B (GS4B). The resin was pelleted by centrifugation, and unbound 
proteins (flow-through, FT) were collected for analysis. impurities were then removed by washing the 
resin twice with buffer A with 0.5 % Triton-X100, followed by a single washing step with buffer A alone (for 
buffer composition, see Materials and Methods). Bound GST-nsp1 was subsequently eluted with 10 mM 
reduced glutathione in 50 mM Tris-HCl pH 8.0 in three steps. Proteins from the pellet (P) and soluble (S) 
fractions of the total bacterial lysates, as well as the FT, wash and elution steps were analyzed by SDS-PAGE 
and Coomassie blue staining. (C) BL21(DE3) cells were transformed with a mutant derivative of pGEX-5X-
3-nsp1 containing a C41H substitution in nsp1. Expression and purification of the mutant recombinant 
protein was performed essentially as described in (B) but protein expression was induced at 20°C. 
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lysates with glutathione sepharose 4B (GS4B) as described in Materials and methods. 
The purity of the fusion protein was more than 90%, and the yield of GST-nsp1 obtained 
under these conditions was ~1 mg/ l culture, as estimated by Coomassie Blue staining 
and comparison to BSA standards (Fig. 2B and data not shown). 
We then attempted to purify a mutant form of the fusion protein - GST-nsp1 C41H, 
carrying a Cys-41 to His substitution of a zinc-coordinating residue in nsp1 that abolishes 
sg mRNA production when introduced into the infectious cDNA clone of EAv (Chapter 
5 of this thesis). The mutant recombinant protein, however, was found exclusively in 
the insoluble fraction of bacterial lysates when expressed using the protocol described 
above, as well as when the protein production temperature was lowered even further, to 
20°C (Fig. 2C). No significant amounts of GST-nsp1 C41H were obtained upon expression 
of the protein in a variety of conditions aimed at promoting protein solubility and/or 
suppressing protein aggregation. The strategies explored included the addition of 3% 
ethanol to the culture medium during protein production, which was shown to mimic 
a heat-shock response in E. coli and enhance solubility of some recombinant proteins, 
likely by inducing overexpression of heat-shock proteins, which can act as chaperones 
and facilitate correct protein folding and assembly17. The increase of osmotic pressure, 
coupled with addition of “osmolytes” (small organic molecules, e.g. betaine and proline, 
which have unfavorable interactions with protein surfaces and therefore stabilize their 
natively folded state) to the culture medium during induction of protein expression has 
been reported to decrease protein aggregation in E. coli4,8. None of these conditions pro-
moted greater solubility of GST-nsp1 C41H (data not shown), and neither did expression 
of the mutant fusion protein in two different strains of E. coli – C41(DE3) and C43(DE3). 
These results suggest the C41H substitution has a significant destabilizing effect on the 
overall structure of nsp1 in E. coli, which can be difficult to overcome, considering the 
predicted zinc-binding role of Cys-41 and the structural importance of zinc coordination 
for the proper folding of ZF domains.
Gst tag removal by factor Xa proteolysis
Due to the large size of GST tag (26 kDa) and its potential to influence the biochemical 
properties of nsp1, tag removal was a prerequisite for subsequent functional studies and 
attempts to crystallize the protein in order to solve its three-dimensional structure. To 
this end, GST-nsp1 was expressed and purified as described above, and was subjected 
to proteolysis with Factor Xa protease while bound to the GST affinity resin (Fig. 3A). 
Addition of increasing amounts of protease resulted in the release of a 30-kDa protein 
in the supernatant when cleavage was performed in buffer conditions recommended 
by the manufacturer (Qiagen FXa buffer; see legend of Fig. 3A) at ambient temperature; 
this protein was absent in the no-enzyme control reaction. Western blotting confirmed 
that the 30-kDa cleavage product was indeed nsp1 (data not shown). Centrifugation of 
cleaved nsp1 at 100,000x g, however, revealed that the protein precipitated in the ab-
sence of the fusion tag (data not shown) in Qiagen FXa buffer. An optimized protocol for 
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the Factor Xa-mediated proteolytic reaction that prevented precipitation of cleaved nsp1 
was then determined empirically. L-Arg, a known aggregation suppressor2, was found to 
be a crucial additive for stabilizing the protein (Fig. 3B), and proteolysis was carried out in 
FXa buffer (for composition, see the figure 3 legend) at 4° to account for potential thermal 
instability of nsp1. in subsequent experiments, 0.1% CHAPS was added during proteolytic 
digestion to decrease non specific association of cleaved nsp1 with the GS4B resin.
Cleaved nsp1 forms dimers in solution
Using the optimized protocols for GST-nsp1 expression, purification and tag removal out-
lined above, a large-scale expression culture (1 l) was grown with the aim of producing 
sufficient recombinant nsp1 for preliminary characterization of the protein preparation’s 
suitability for crystallization trials. Proteolysis of the resin-bound GST-nsp1 in FXa buffer 
resulted in the release of soluble native nsp1, and glutathione elution of GS4B-bound 
proteins following cleavage did not show the presence of remaining unprocessed fu-
sion protein (Fig. 4A). Judging by the intensities of Coomassie-stained protein bands, 
however, the ratio of cleaved nsp1 and eluted GST protein was not 1:1, suggesting loss of 
native nsp1, possibly due to aggregation. in addition, impurities with molecular masses 
consistent with GST-nsp1 and GST remained present in the cleaved nsp1 fraction even 
after it was incubated with fresh GS4B resin. in an attempt to obtain a native nsp1 sample 
of higher purity, as well as to analyze the protein’s aggregation state, the S100 fraction of 
cleaved nsp1 was subjected to size exclusion chromatography. The protein eluted in two 
peaks with estimated molecular masses of 51 kDa and 27 kDa, and SDS-PAGE analysis 
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figure 3. GST tag removal by Factor Xa proteolysis. (A) The soluble fraction of a total bacterial lysate (S, 
left panel) was divided in four samples and each sample was incubated with equal volumes of GS4B. 
Contaminants were washed out as described in the legend to Fig. 2B, and the resin with bound fusion 
protein was equilibrated in 20 mM Tris pH=6.5, 50 mM NaCl, 1 mM CaCl2 (Qiagen Factor Xa buffer). 
Proteolytic cleavage of resin-bound GST-nsp1 was carried out at room temperature by addition of different 
amounts of Factor Xa Protease (1, 0.2, 0.05 or 0 units [U]). Samples were removed from the proteolytic 
digestion mixture at 3 and 6 hours after the start of the reaction and separated by SDS-PAGE on a 12 % 
polyacrylamide gel that was stained with Coomassie blue in order to estimate the yield and purity of 
cleaved nsp1. (B) Digestion of GS4B-bound GST-nsp1 with Factor Xa Protease was performed for 16 h at 
4°C in 50 mM HEPES pH=6.5, 100 mM NaCl, 10 % glycerol, 1 mM CaCl2 supplemented with 50 mM L-Arg. 
Cleaved nsp1 (input, i) was analyzed by ultracentrifugation at 100,000 x g for 1h at 4°C. The pellet (P100) 
fractions were resuspended in 1x LSB, and equal volumes of pellet and supernatant (S100) fractions were 
analyzed by SDS-PAGE and Coomassie blue staining as an indication of cleaved nsp1 solubility. 
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of peak fractions confirmed the presence of nsp1 (Fig.4 B), suggesting that ~90% of the 
protein form dimers in solution under these experimental conditions. The lack of high-
molecular mass peaks in the elution profile argued against the presence of non-specific 
aggregates in the sample. Traces of GST, however, were still found in the nsp1-containing 
column fractions (data not shown), likely due to the small difference in molecular mass 
between the two proteins and GST’s ability to form homodimers9. Finally, the yield of 
native nsp1 obtained in this experiment was estimated to be ~0.2 mg from 1 l of culture. 
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figure 4. Analysis of cleaved nsp1 by gel filtration. (A) One liter of BL21(DE3) cells transformed with 
pGEX-5X-3-nsp1 were cultured until OD600 of 0.7, expression of GST-nsp1 was induced by addition of 0.3 
mM iPTG and the culture was incubated for 5 h at 25°C. Cells were then harvested and lysed, and the 
fusion protein found in the soluble fraction of the total bacterial lysate was bound to GS4B. After washing 
out contaminants, 20 U of Factor Xa Protease were added, and proteolytic digestion was carried out in a 
600-μl volume for 14 h at 4°C in FXa buffer (see Materials and Methods) supplemented with 0.1 % CHAPS. 
Cleaved nsp1 was recovered from the resin supernatant, and GST-containing proteins remaining on the 
resin were eluted with 600μl 10 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0 to check the efficiency 
of proteolysis (fraction E). Factor Xa and GST-containing contaminants were removed from the cleaved 
nsp1 fraction by subsequent incubations with Xa Removal Resin and fresh GS4B. The solubility of cleaved 
nsp1 was determined by ultracentrifugation as in Fig. 3B, and equal volumes of P100, S100 and E fractions 
were analyzed by SDS-PAGE. Half of the S100 fraction (~250 µl) was loaded onto a Superdex-75 column. (B) 
Elution profile of cleaved nsp1. Gel filtration chromatography of the S100 sample in (A) was performed in 
50 mM HEPES pH=6.5, 100 mM NaCl, 10 % glycerol, 50 mM L-arginine (final pH of buffer: 7.5). Blue dextran 
(2,000 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen A (25 kDa) and 
ribonuclease A (13.7 kDa) were used as native molecular mass markers. The elution volumes of the marker 
proteins filtered through Superdex-75 in FXa buffer were fitted to a linear equation (R2=0.98), and the 
standard curve was used to estimate the molecular masses of nsp1 elution peaks.(C) Peak fractions from 
(B) were analyzed by SDS-PAGE and Coomassie Blue staining. 
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substantial protein precipitation during factor Xa proteolysis
The production of soluble GST-nsp1 fusion in bacterial cells and nsp1 aggregation during 
proteolytic cleavage of the GST tag were two obvious major bottlenecks in obtaining suf-
ficient protein material for nsp1 structure determination. Buffer composition during Factor 
Xa digestion of the fusion protein, however, was largely constrained by inherent proper-
ties of the protease, such as its decreased activity at high pH and salt concentrations above 
100 mM. Factor Xa is also active as a disulfide-linked heterodimer, and therefore sensitive 
to the presence of reducing reagents during proteolytic cleavage. Addition of non ionic 
detergents such as Triton X-100 or Nonident P-40 reportedly does not interfere with Factor 
Xa proteolytic activity, although their presence even in trace amounts is poorly compatible 
with crystallization trials, due to their low critical micelle concentration (CMC). We therefore 
attempted to increase the fraction of soluble GST-nsp1 produced in expression cultures by 
using a number of the approaches outlined above that do not employ detergents with low 
CMC. A combination of expression in C43(DE3) cells and addition of 330 mM sorbitol and 
2.5 mM betaine to the culture during protein production was the only condition which 
resulted in an increase in purified GST-nsp1, although the effects were modest at best 
(data not shown). in addition, a number of independent experiments for purification of 
GST-nsp1 from a large-scale culture and subsequent cleavage of the GST tag resulted in 
variable yields of cleaved nsp1 that could be as low as ~0.025 mg per liter of bacterial 
culture, despite high levels of GST-nsp1 in the soluble fractions of bacterial lysates. 
in an effort to identify the basis of the observed variability, GST-nsp1 produced in 1 l 
of bacterial culture was bound to GS4B resin and subjected to Factor Xa digestion essen-
tially as in Fig. 4. Cleaved nsp1 was recovered in the supernatant, and proteins remaining 
associated with the GS4B resin were eluted by boiling in an equal volume of 1x LSB. 
Analysis of the two fractions by SDS-PAGE revealed that by far the majority of cleaved 
nsp1 remained associated with the glutathione resin, as – surprisingly – did GST and a 
large fraction of uncleaved fusion protein (Fig. 5A). The fact that these proteins could 
only be dissociated from the resin by a harsh elution step is indicative of substantial 
protein aggregation that occurred irrespective of whether the GST-nsp1 fusion protein 
was produced in BL21(DE3) or C43(DE3) cells (Fig. 5B). This phenomenon could be due to 
the tendency of recombinant GST to undergo oxidation-induced aggregation, probably 
via disulfide bond formation among surface-exposed cysteine residues found close to 
the C-terminus of the protein1,9. Aggregated GST, however, was shown to retain its abil-
ity to bind glutathione affinity matrix9 and therefore should still be eluted efficiently in 
the presence of excess glutathione, which was not the case for the protein aggregates 
we observed (Fig. 5B). Furthermore, when recombinant GST was expressed on its own 
in BL21(DE3) cells and subjected to Factor Xa proteolysis under conditions identical to 
those used for digestion of GST-nsp1, a large fraction of GST could still be eluted from 
the affinity resin with glutathione (Fig. 5B). The nsp1 moiety is therefore the most likely 
cause of the observed aggregation, which was not related to the presence of the affinity 
resin, since it was also detected upon Factor Xa digestion of GST-nsp1 in solution (data 
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not shown). Taken together, these results prompted us to better characterize the proper-
ties of purified GST-nsp1. The fusion protein was eluted from GS4B and dialyzed against 
a wide range of buffers with different pH and ionic strength, all of which contained 1 
mM CaCl2 and 50 mM L-Arg (essential components of Factor Xa buffer). The aggregation 
state of the fusion protein was then assessed by dynamic light scattering, a method for 
determination of particle size in solution. The hydrodynamic radius of GST-nsp1 particles 
indicated that the fusion protein is largely present as “soluble aggregates” in the majority 
of buffers tested, or completely precipitated under certain conditions (data not shown). 
in view of the limitations on buffer additives compatible with Factor Xa activity outlined 
above, further optimization aimed at improving GST-nsp1 solubility was not pursued.
expression and purification of hexahistidine-tagged nsp1
The difficulties encountered during expression and purification of recombinant GST-
nsp1 were seemingly related to the inherent instability and/or improper folding of nsp1 
when fused to the C-terminus of GST. Taking this into consideration, fusion to another 
large protein tag with solubility-enhancing properties was not tested. instead, a (His)6 
tag was fused to the N- or C-terminus of nsp1. A (His)6 tag allows for convenient one-step 
protein purification by immobilized metal affinity chromatography. in general, this small 
tag has little effect on protein folding or stability, and consequently, it rarely needs to be 
removed from the target protein after purification. However, it does not alter the solubil-
ity properties of the target protein. it was therefore surprising that, upon iPTG induction 
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figure 5. Protein precipitation during Factor Xa cleavage of GST-nsp1. (A) Expression and purification of 
GST-nsp1, followed by on-resin cleavage of the GST tag by Factor Xa Protease were performed essentially 
as in Fig. 4A, apart from the absence of CHAPS from the cleavage buffer. Cleaved nsp1 was recovered from 
the buffer fraction after pelleting of GS4B by centrifugation, and unprocessed and/or resin-associated 
proteins were eluted from GS4B with 1x LSB. Equal volumes of LSB eluate and cleaved (C) protein fractions 
were analyzed by SDS-PAGE and Coomassie blue staining. (B) GST-nsp1 was expressed in BL21(DE3) or 
C43(DE3) cells. GST was expressed in BL21(DE3) cells that were transformed with empty pGEX-5X-3 vector. 
GS4B-bound GST-nsp1 and GST only were subjected to proteolysis with Factor Xa Protease in FXa buffer 
and cleaved proteins (designated with C) were recovered from the buffer fraction. Proteins that remained 
bound to GS4B after the proteolytic digestion were eluted once with 10 mM reduced glutathione in 20 
mM Tris pH=7.5, 150 mM NaCl (E), followed by elution with 1x LSB. Equal volumes of the C, E and LSB 
fractions were analyzed by SDS-PAGE followed by Coomassie Blue staining.
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of (His)6-tagged nsp1 expression in BL21(DE3) cells transformed with pDEST14-nsp1-HN 
or pDEST14-nsp1-HC, robust expression of a 30-kDa protein was detected only in the 
induced cultures, and was present predominantly in the soluble fractions of bacterial 
lysates (Fig. 6A). Western blotting with an nsp1-specific antibody confirmed the identity 
of the recombinant proteins produced in induced cultures (data not shown). Both nsp1-
HN and nsp1-HC bound very poorly to Ni-NTA agarose, however, and the majority of 
both recombinant proteins were found in the flow-through fractions (Fig. 6, B and C). 
Similar results were obtained when a different metal affinity matrix (HiS-Select HF Nickel 
Affinity Gel) was used, and washing out unbound proteins in the absence of imidazole 
did not improve the recovery of nsp1-HN or nsp1-HC neither, but increased the amount 
of contaminants in the elution fractions (data not shown). The PCPβ domain of nsp1 
serves to autoproteolytically release the C-terminus of the protein from the rest of pp1a 
during EAv infection, cleaving a Gly-Gly sequence14, and since the protease domain is 
active in E. coli, it might have cleaved off the C-terminal (His)6 tag in the nsp1-HC protein. 
Expression of an active-site protease mutant (C164S) from pDEST12-nsp1-HC, however, 
did not improve the binding of nsp-HC to metal affinity matrices (data not shown). These 
results suggest that neither the N-terminal nor the C-terminal (His)6 tag is exposed for 
binding metal ligands under the experimental conditions used, while a control (His)6–
tagged protein could be purified efficiently under identical conditions (data not shown). 
Nevertheless, both nsp1-HN and nsp1-HC seemed to be stably folded in bacterial cells 
in the absence of solubility-enhancing fusion tags indicating to importance of authentic 
terminal sequences for folding. The protein’s N-terminal subdomain is a ZF (Fig. 1B), with 
the first of predicted zinc-coordinating residues located relatively close (24 amino acids) 
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figure 6. Expression and purification of His-tagged nsp1. (A) BL21(DE3) cells transformed with pDEST14-
nsp11-HN or pDEST14-nsp11-HC were cultured until OD600 of 0.7, recombinant protein expression was 
induced by the addition of 0.5 mM iPTG, and the cultures were incubated at 30°C. Lysates were obtained 
from non-induced or iPTG-induced cells harvested 18 hours postinduction. After centrifugation of total 
cell lysates, the insoluble pellet (P) fractions were resuspended in 1x LSB, and equal volumes of pellet 
and supernatant (S) fractions were separated on a 12.5 % polyacrylamide gel by SDS-PAGE. Proteins were 
visualized by subsequent staining of the gel with Coomassie blue. (B, C) The soluble fraction of the total 
bacterial lysates from induced cells in (A) was incubated with Ni-NTA Agarose. The beads were pelleted by 
centrifugation, and the flow-through (FT) was collected for analysis of unbound proteins. Contaminants 
were then removed by washing the beads twice with buffer B containing 10 mM imidazole. Bound nsp1-
HN (B) or nsp11-HC (C) was subsequently eluted with buffer B supplemented with 250 mM imidazole in 
two steps. Proteins from the pellet and soluble fractions of the total bacterial lysates, as well as the FT, 
wash (W) and elution (E) steps were analyzed by SDS-PAGE and Coomassie Blue staining.
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to nsp1’s N-terminus which might interact with other residues for folding to proceed 
properly. Also, in view of the lack of in trans PCPβ proteolytic activity, it has been pro-
posed that after co-translational self-processing, the C-terminal residues of nsp1 might 
fold back into the protease active site, thereby blocking subsequent cleavage events24. 
Another viral autoprotease, the alphavirus Sindbis virus core protein, is rendered pro-
teolytically inactive following autocatalytic cis cleavage in this manner5. A C-terminal 
(His)6 tag would thus also be inaccessible for binding to affinity resins. To overcome 
these intrinsic problems with tag accessibility, attempts were made to purify individual 
(His)6-tagged nsp1 subdomains of nsp1. Constructs encoding only the ZF and PCPα 
domains (amino-acids 1 to 140 or 1 to 156 from EAv pp1a) fused to a C-terminal (His)6 
tag expressed very poorly in bacterial cells and were mostly insoluble, while expression 
of an N-terminally (His)6-tagged PCPβ (amino-acids 151 to 260 from EAv pp1a) was not 
detected at all in induced cultures (data not shown).
Importance of nsp1 autoproteolytic processing for recombinant protein 
stability
in the course of this project, the crystal structure of nsp1α from another arterivirus, porcine 
reproductive and respiratory syndrome virus (PRRSv; strain XH-GD) was reported by Sun 
and co-workers16. The N-terminal part of PRRSv pp1a/pp1ab also contains a ZF domain fol-
lowed by two PCP domains. Unlike its ortholog in EAv, PCPα is proteolytically active, medi-
ating the self-release of nsp1α from the viral replicase polyproteins, while the PCPβ domain 
cleaves nsp1β off6. Homology between EAv nsp1 and PRRSv nsp1α is thus limited to the 
first two subdomains of EAv nsp1. Nevertheless, PRRSv nsp1α is also essential for sg mRNA 
production in virus-infected cells11, suggesting similar functions of the two distantly related 
proteins in the replicative cycle of arteriviruses. in the report by Sun and co-authors, PRRSv 
nsp1α was purified after expression of N-terminally (His)6-tagged nsp1α-nsp1β sequence in 
E. coli in order to obtain nsp1α in its self-processed form. interestingly, a number of nsp1α 
C-terminal residues were indeed found to reside in the substrate-binding pocket of the 
protease domain in a well-stabilized form that would preclude further proteolytic reactions. 
Thus, autoproteolytic processing of PRRSv nsp1α might very well be a prerequisite for cor-
rect folding and stability of the protein – a notion further supported by the insolubility of a 
protease active-site mutant, C76S, when expressed in E. coli under a variety of conditions.
Although the problems we encountered while attempting to purify (His)6-tagged EAv 
nsp1 did not seem related to the protein’s solubility but rather to tag accessibility, we 
could not exclude that nsp1-HN and nsp1-HC were also present as soluble aggregates in 
lysates fractions, which could also account for poor binding to metal affinity resins. We 
therefore set out to determine whether bacterially expressed self-cleaved nsp1 could 
be purified with more success. To this end, the N-terminal 429 amino-acids from EAv 
pp1a, fused to an N-terminal (His)6 tag (see Fig. 1C), were cloned in pDEST14, resulting in 
expression plasmid pDEST14-nsp1-2N-HN. Nsp1 expressed from similar constructs was 
previously shown to efficiently mediate its autoproteolysis both in vitro and in vivo14,18, 
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and the difference in molecular mass between the precursor protein (47 kDa) and na-
tive nsp1 (30 kDa) is sufficiently large to be easily seen by SDS-PAGE. Recombinant (His)6 
–tagged nsp1 obtained from this construct is referred to as nsp1-HN-ap to distinguish it 
from nsp1-HN, although the primary structure of the two proteins is identical. 
The wild-type pDEST14-nsp1-2N-HN and a mutant derivative carrying a C44H substitu-
tion in nsp1 (a mutation of a zinc-coordinating residue in nsp1 that renders sg mRNA 
production undetectable when introduced into the infectious cDNA clone of EAv) were 
transformed in C41(DE3) cells, and protein expression and purification were performed 
following a protocol similar to that used by Sun and co-workers for the purification of 
PRRSv nsp1α. Briefly, transformed cells were grown at 37°C to mid-log phase and the 
culture temperature was lowered to 16°C during protein production, which was induced 
by addition of 1 mM iPTG. The levels of recombinant protein in the induced cultures were 
not sufficiently high to be easily detected by Coomassie staining (Fig. 7A, top panels), 
but Western blotting with an nsp1-specific antibody revealed robust expression of both 
nsp1-HN-ap and its mutant derivative, nsp1-HN-ap C44H (Fig. 7A, bottom panels). Both 
proteins were found predominantly in the supernatant fractions of bacterial lysates and 
exclusively in self-processed form, since virtually no precursor proteins were detected. 
These results suggest that nsp1 autoproteolysis with this combination of expression con-
struct and expression conditions is very efficient in E. coli, despite the low temperature 
of protein production. The C44H mutation also does not seem to influence the efficiency 
of nsp1 self-processing, in line with previous results showing that mutations of zinc-
coordinating residues do not affect nsp1 autoprocessing in vitro (Chapter 5 of this thesis). 
Wild-type nsp1-HN-ap could be efficiently purified by metal affinity chromatography 
with Talon resin (charged with cobalt ions), albeit in the presence of a number of abun-
dant protein contaminants (Fig. 6A, top left panel). Also, some of the protein was still 
found in the fraction of proteins that did not bind to the affinity resin. Nevertheless, this 
protocol resulted in the purification of ~0.2 mg recombinant nsp1-HN-ap from 1 l of 
bacterial culture (data not shown). The yield of nsp1-HN-ap C44H, however, was much 
lower (Fig. 7A, top right panel), and immunoblot analysis of fractions obtained during 
purification revealed that most of the mutant recombinant protein did not bind the Talon 
affinity resin (Fig. 7A, bottom right panel). The C44H substitution might interfere with 
zinc binding and thus adversely affect the conformational stability of the N-terminal part 
of nsp1, and possibly of the whole protein, if interdomain interactions are required for 
its correct folding. This might not impede the PCPβ domain-mediated autoproteolytic 
release of nsp1, which most probably occurs co-translationally14,15, but could result in 
protein aggregation that could, in turn, render the (His)6 inaccessible for metal binding.
in order to improve sample purity, gel-filtration chromatography of pooled eluates 
containing recombinant nsp1-HN-ap (Fig. 6A) was performed in 20 mM MES pH=7.0, 
500 mM NaCl, 20 % glycerol, 1 mM DTT. The bulk of wild-type nsp1-HN-ap eluted in a 
single peak with an estimated molecular mass of 63 kDa (Fig. 7B), consistent with a dimer. 
Column fractions from the single elution peak preceding that of dimeric nsp1 contained 
largely a ~75-kDa contaminant (Fig. 7B, lower panel, a-b), and higher oligomeric forms 
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figure 7. Expression and purification of autoproteolytically processed His-tagged nsp1. (A) C41(DE3) cells 
were transformed with wild-type pDEST14-nsp1-2N-HN or a mutant derivative of the plasmid carrying a 
C44H substitution in nsp1. induction of recombinant protein expression and purification of His-tagged 
proteins was performed as described in Materials and Methods. Samples obtained from total lysate of 
non-induced [(-)] cells, pellet (P) and supernatant (S) fractions of total lysates from iPTG-induced cells, and 
fractions obtained during purification (FT, flow-through) were resolved by SDS-PAGE. The gels were stained 
with Coomassie blue (top panels) or blotted onto Hybond-P PvDF membrane (GE Healthcare) by semi-dry 
Western blotting (WB, bottom panels). The membranes were subsequently incubated with an nsp1-
specific monoclonal antibody (12A4), followed by an HRP-conjugated secondary antibody (DAKO) and an 
ECL-Plus kit (GE Healthcare) for detection. The expected position of the unprocessed nsp1-2N-HN protein 
(predicted molecular mass: 46.6 kDa) is indicated with an asterisk. (B, C) Top: Gel-filtration profile of wild-
type nsp1-HN-ap (B) or nsp1-HN-ap C44H (C) obtained upon size exclusion chromatography of the pooled 
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of nsp1 were thus unlikely to be present in solution. The resolution of the gel filtration 
column was, however, insufficient to achieve a substantially improved purity of recombi-
nant nsp1. Despite the low protein yield and purity, the fractions eluted from the Talon 
resin after purification of nsp1-HN-ap C44H (Fig. 7A, left panel) were also analyzed by gel 
filtration, to assess whether the C44H mutation is associated with a change in oligomeric 
state. The elution profile of nsp1-HN-ap C44H was much less symmetric due to the com-
plexity of the sample, but the mutant protein was only detected in fractions from two 
elution peaks with approximately equal areas and estimated molecular masses of 57 kDa 
and 34 kDa (Fig. 7C). The C44H thus seems to destabilize, but not completely prevent 
nsp1 self-association. it is difficult to establish, however, whether this may be attributable 
to an importance of the ZF domain for dimerization, or to a more general defect in the 
overall fold of nsp1 (see above). Nevertheless, recombinant nsp1 purified by two different 
protocols forms dimers in solution (Fig. 4B and 7B), even in the presence of 1 mM DTT and 
high salt concentrations (500 mM NaCl, Fig. 7B). it is therefore unlikely that the observed 
dimerization is caused by tag sequences in the recombinant protein. Also, in view of 
nsp1’s homo-oligomerization in infected cells19, the ability of recombinant nsp1 to form 
dimers might be of functional significance for its role(s) in the EAv replicative cycle.
Though nsp1-HN-ap was efficiently resolved by size-exclusion chromatography in 20 
mM MES pH=7.0, 500 mM NaCl, 20 % glycerol, 1 mM DTT, the protein was unstable in this 
buffer, since precipitation was observed during concentration of nsp1-containing chroma-
tography fractions. The loss of protein was even more pronounced after overnight storage 
at 4°C, or when the sample buffer was exchanged with one of a lower ionic strength (20 
mM MES pH 7.0, 200 mM NaCl, 50% glycerol). in an attempt to obtain a purer and more 
stable preparation of recombinant nsp1-HN-ap, the protein was expressed and purified 
as above, with minor adjustments to the original protocol (described in detail in Materials 
and Methods). Beta-mercaptoethanol was added at 5 mM to buffer C prior to bacterial 
lysis and Talon affinity purification to prevent the formation of disulfide bonds that might 
contribute to the high level of protein contaminants co-purifying with nsp1. Also, elution 
eluates in (A) on a Superdex-75 column. Blue dextran (2,000 kDa) was used to determine the column void 
volume, and the elution volumes of conalbumin (75 kDa), ovalbumin (43 kDa) and chymotrypsinogen 
A (25 kDa) filtered through Superdex-75 in the same buffer conditions were fitted to a linear equation 
(R2=0.97). The standard curve was then used to estimate the molecular masses of nsp1 elution peaks 
that were within the linear range. Bottom: peak fractions from top panels were analyzed by SDS-PAGE 
and Coomassie Blue staining (B) or Western blotting with the nsp1-specific antibody (C). (D) Wild-type 
nsp1-HN-ap was purified as in (A), with the following modifications: addition of 5 mM β-mercaptoethanol 
to buffer C during bacterial lysis and Talon purification, and a single-step elution with 100 mM imidazole, 
followed by three elution steps with 250 mM imidazole in buffer C. Fractions from cell lysis and Talon 
purification analyzed by SDS-PAGE and Coomassie blue staining are denoted as in (A). (E) Eluates 2 – 4 
from (D) were pooled and subjected to size-exclusion chromatography on a Superdex-75 column in 
20 mM MES pH=7.0, 1M NaCl, mM DTT. Nsp1-containing peak fractions were concentrated in the same 
buffer, or in the presence of 0.1 % β-octylglucoside (β-oct). Equal sample volumes obtained immediately 
after concentration (1, 3) or following overnight incubation of the concentrated samples at 4°C (2, 4) were 
resolved by SDS-PAGE and visualized by Coomassie blue staining. 
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of proteins bound to the Talon resin was performed as follows: first, proteins that were 
bound with low affinity were eluted with 100 mM imidazole in buffer C, followed by three 
elution steps with 250 mM imidazole in buffer C. Most of the contaminants were eluted 
in the 100 mM imidazole step, together with a relatively low proportion of recombinant 
nsp1-HN-ap. The nsp1-containing eluate fractions obtained in this way were of higher 
purity (Fig. 7D). The pooled eluates were loaded onto a Superdex-75 column, gel-filtration 
chromatography was carried out in 20 mM MES pH=7.0, 1M NaCl, 20 % glycerol, 5 mM DTT. 
The peak column fractions that contained nsp1 were split in two samples that were subse-
quently concentrated at 4°C by ultrafiltration in the absence of additives, or in the presence 
of 0.1 % β-octylglucoside. There was no detectable protein precipitation during ultrafiltra-
tion in both buffers, and SDS-PAGE showed similar levels of recombinant nsp1 present in 
the two samples immediately after protein concentration, as well as following overnight 
incubation at 4°C (Fig. 7E). The yield of nsp1-HN-ap after Talon affinity purification and after 
gel filtration and was estimated at 0.3 mg and 0.25 mg/ l culture, with the minor loss of 
protein likely due to exclusion of gel-filtration fractions that contained a low level of nsp1 
and high levels of contaminating proteins (data not shown). The inclusion of an additional 
purification step, i.e. ion exchange chromatography, might remove co-purifying proteins 
more efficiently to obtain a sample that is sufficiently pure for structure determination. 
CONCluDING RemaRKs
Despite recent insights into successful strategies for the expression and purification of 
recombinant proteins emerging from large-scale structural genomics studies (see e.g. 
reference7), optimal conditions for each protein still have to be determined empirically. 
Our experience greatly underscores the importance of the choice of fusion tag that can be 
facilitated by at least some prior knowledge about the domain structure and/or biochemical 
properties of the target protein. The extensive aggregation we observed upon expression of 
nsp1 as a C-terminal GST fusion might be due to a number of factors, such as e.g. improper 
folding of the ZF domain when the N-terminus of nsp1 was blocked by its fusion to GST, 
or the formation of GST dimers forcing nsp1 dimerization before the protein has reached 
its stably folded state. Ultimately, successful purification of soluble recombinant nsp1 was 
achieved with nsp1 which was autoproteolytically released from a precursor polypeptide in 
E. coli, an observation that is in line with results of other studies in which soluble viral pro-
teins that are derived from proteolytic processing of longer polypeptides were obtained5,16. 
it is thus tempting to suggest that mimicking the natural way of protein production may 
be a generally applicable approach for obtaining soluble recombinant viral proteins. This 
strategy could also constitute an important addition to the widely-used approaches of 
expressing subdomains and/or truncated proteins for structural and functional studies.
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DIsseCtING the ROles Of RePlICase suBuNIts IN NIDOvIRus RNa 
syNthesIs
Plus-strand RNA virus replication requires cytoplasmic RNA-templated RNA synthesis - a 
process foreign to cells and thus accomplished by a virus-encoded RdRp, which is pro-
duced upon translation of the viral genome following its uncoating in the infected cell. 
As is clear from the in vitro activity assays developed for a variety of recombinant viral 
RdRps3,4,17,54,61,81,85,103, this enzymatic activity can be sufficient for catalysis of RNA polym-
erization. Apart from this critical process, however, +RNA viruses also need to ensure the 
specificity of viral RNA amplification and encapsidation in an environment where cellular 
mRNAs are abundant, as well as to evade cellular defense mechanisms. These require-
ments have necessitated the evolution of complex regulatory circuits that control +RNA 
replication. They are commonly mediated by virus-encoded domains and can also make 
use of cellular proteins. The viral regulators are typically produced as separate protein 
units but may also be part of multidomain proteins. in view of their (usual) absence from 
virions, these proteins are called “nonstructural”, differentiating them from the structural 
components of virus particles. Collectively, they are commonly referred to as “the viral 
replicase”. The coordination of various processes in +RNA replication is directed by repli-
case subunits, via their enzymatic activities and/or non-catalytic modulatory functions. 
The replicase proteins of RNA viruses are often multifunctional, a property likely stem-
ming from the limited coding capacity of RNA virus genomes, which has in turn been 
attributed to the low fidelity of their replication machinery15,27. 
Nidoviruses arguably encode the most complex replicase among RNA viruses known 
to date19, and between 13 and 16 individual viral nonstructural proteins (nsps) are 
produced in nidovirus-infected cells90,96,97,104,107,108. A replicative machinery of such com-
plexity may have been necessitated by the nidovirus gene expression strategy, which 
includes the synthesis of an extensive set of subgenomic (sg) mRNAs, and by the need 
to maintain the exceptionally large genomes characteristic of most Nidovirales represen-
tatives19. Most nsps localize to virus-induced networks of modified membranes found 
in the perinuclear region of nidovirus-infected cells, which are thought to be the sites 
of viral RNA synthesis32,53,56,77. A large fraction of nidovirus nsps have predicted and/or 
demonstrated enzymatic activities. Most of these have distant protein homologs in the 
cellular world, and a smaller subset also among RNA viruses9,18,24,26,42,74. Understanding the 
roles of individual replicase subunits in the nidovirus replicative cycle will undoubtedly 
shed light on how are nidovirus RNA-synthesizing complexes assembled and what are 
the determinants of their diverse activities. This knowledge, in turn, will be instrumental 
in designing strategies to combat known and emergent diseases caused by nidoviruses.
More than a decade ago, a reverse genetics system was developed for equine arteritis 
virus (EAv), the arterivirus prototype and the nidovirus with the smallest genome thus 
far95. This system has greatly benefitted research on the fundamental aspects of nidovirus 
molecular biology. important insights into the unique process employed by arteri- and 
coronaviruses to generate a nested set of 5’- and 3’-coterminal sg mRNAs have been 
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obtained by dissecting the roles of EAv regulatory RNA sequences, like TRSs and leader 
TRS hairpin48,51,52,91,92,100. Having the most “compact” nidovirus replicase, EAv is commonly 
considered as a powerful model system for functional, structural and genetic studies 
of the elaborate nidovirus replicative apparatus. Among the most significant findings 
obtained with the EAv reverse genetics system was the discovery that nidovirus genome 
replication can be uncoupled from sg mRNA production via mutations in replicase sub-
units86,95,101. This observation strongly suggests that these two processes are carried out 
by RNA-synthesizing complexes of (partially) different protein composition. 
The studies described in this thesis focused on the role of nidovirus replicase subunits 
in coupling different processes in the viral replicative cycle. Two very different proteins 
were examined: one encoded in ORF1a and specific for arteriviruses (nsp1), and another 
one encoded in ORF1b and containing a domain that is conserved across a broad spec-
trum of nidoviruses (NendoU). An experimental approach combining mutagenesis of 
replicase subunits (using full-length cDNA clones) with appropriate in vitro biochemical 
assays that address specific functions of individual nsps can yield biologically relevant 
insights into the functions of nidovirus nonstructural proteins. This approach was em-
ployed in the research outlined in Chapters 3 and 4 to gain more insight into the role 
of the conserved NendoU domain in the EAv replicative cycle and to examine, for the 
first time, the in vitro endoribonuclease activity of the arterivirus NendoU-containing 
replicase subunit. in Chapters 5 and 6, we explored the regulatory roles of EAv nsp1, 
so far the sole nidovirus protein with a demonstrated specific role in sg mRNA produc-
tion. Our data, obtained using reverse and forward genetics, revealed that nsp1 is a key 
coordinator of genome replication, sg mRNA synthesis, and virus production. To conduct 
research that could help unravel the molecular mechanisms underlying nsp1 function, 
we have developed a protocol for purification of recombinant nsp1 from E. coli (Chapter 
7). This accomplishment occurred at the final stages of the studies presented in this 
thesis, leaving it to others to fully exploit its potential. in the following sections, our data 
on NendoU and nsp1 are discussed in substantial detail in the framework of relevant 
findings obtained by others, and potential future research directions are outlined.  
 
the NIDOvIRus RePlICatIve eNDORIBONuClease
Endoribonucleases are ubiquitous in both prokaryotic and eukaryotic cells and play im-
portant roles in a diverse set of processes related to the maturation of tRNAs and mRNAs, 
as well as the regulated degradation of cellular transcripts37,44,80. Both DNA and RNA 
viruses employ virus-encoded endoribonucleases to perform various functions, such as 
inhibition of cellular mRNA translation or post-transcriptional regulation of viral gene 
expression82,83,89. Among these is also the sole endoribonuclease other than NendoU 
encoded by +RNA viruses – the pestivirus E(rns), an essential structural component of 
pestivirus particles that also acts as an interferon antagonist23,39,40,70. 
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The NendoU domain is conserved among the different nidovirus groups both at the 
amino acid sequence level, as well as in terms of its relative position in the C-terminal 
part of the pp1ab replicase polyprotein. NendoU was postulated to be involved in a 
nidovirus-specific step of the viral replicative cycle, based on its genetic segregation with 
the core RNA-synthesizing enzymes and the lack of NendoU counterparts in the replicase 
genes of other known RNA virus groups12,74. Also, the replicase genes of nidoviruses with 
large genomes harbor additional RNA-processing domains whose functions may be 
interconnected with that of NendoU19,74. Structural and functional studies on coronavirus 
NendoU5-7,22,26,30,60,105 had initially verified its proposed endoribonuclease activity and 
established several mechanistic aspects of coronavirus NendoU-mediated RNA cleavage 
in vitro. By contrast, the biochemical characterization of NendoU from other nidovirus 
groups lagged behind. We were able to overcome the considerable technical difficulties 
that were associated with obtaining a recombinant form of nsp11, the NendoU-contain-
ing replicase subunit from EAv. The availability of recombinant nsp11 allowed us to initi-
ate the biochemical characterization of the arterivirus NendoU, which was carried out 
in comparison with a coronavirus ortholog (Chapter 4). This in vitro functional analysis 
was complemented by a reverse genetic study of the EAv NendoU domain, the results of 
which underscored the importance of this enzyme for arterivirus replication (Chapter 3).
substrate specificity and regulation of Nendou activity
Recombinant forms of NendoU-containing arteri- and coronavirus replicase subunits 
exhibit broad substrate specificity in vitro, processing both single-stranded and double-
stranded RNA substrates 3’ of pyrimidines. The modest preference for cleavage at single-
stranded uridylates, noted for both arterivirus nsp11 and coronavirus nsp15 by us and 
others, seems to be more pronounced for the coronavirus enzyme. This difference is 
presumably due to amino acid determinants in the C-terminal region of the coronavirus 
NendoU domain that are seemingly not conserved in the corresponding region of the 
arterivirus NendoU (5,6,26,105 and Chapter 4 of this thesis). Whether these enzymes have 
similar substrate specificity in the context of viral infection, however, remains to be 
established.  
NendoU enzymes share certain features with bovine pancreatic RNase A, such as the 
identity of active site residues and mechanism of RNA hydrolysis. Non-catalytic residues 
of RNase A have also been proposed to contribute to RNA cleavage, and the type of 
nucleoside immediately downstream of the cleavage site seems to exert significant influ-
ence on the rate of substrate hydrolysis, with purines being preferred over pyrimidines 
45,58. A systematic investigation of the importance of nucleotides flanking the cleavage 
site for RNA hydrolysis by NendoU has not been performed to date, and might provide 
clues about the natural substrates of this enzyme in infected cells.
Hexamerization of coronavirus nsp15 via intermolecular interactions mediated by its 
N-terminal domain acts to stabilize the NendoU catalytic site in its active conformation 
and promotes substrate binding6,29. The (local) concentration of nsp15 during coronavi-
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rus infection was therefore postulated to act as an allosteric switch in coronavirus Nen-
doU29. Arterivirus nsp11, on the other hand, does not seem to form oligomers in solution 
(Chapter 4 and data not shown) and might thus be similar to its distant cellular homolog 
XendoU, which is active as a monomer59. 
Nidovirus nsps containing the NendoU domain mediate efficient RNA processing in 
vitro in the absence of other viral or cellular proteins (5,26 and Chapter 4). Nevertheless, 
NendoU activity or substrate specificity may be regulated via protein-protein interactions 
during infection, and a number of examples of such regulatory interactions have been 
described for endoribonucleases of both viral and cellular origins. The endoribonuclease 
activity of bacteriophage T4 RegB is enhanced by the E. coli ribosomal protein S1, and 
the presence of S1 also alters RegB cleavage site specificity. This interaction has been 
postulated to play a role in ensuring the targeted degradation of early viral transcripts 
by RegB14,35,63. Similarly, the virion host shutoff endoribonuclease of herpes simplex virus 
1 associates with polyribosomes to selectively degrade mRNAs that are actively trans-
lated84. An example of a negative protein regulator is RraA from E. coli, which binds to 
RNase E and disrupts its multimerization, thereby inhibiting the endoribonucleic activity 
of the enzyme, which is involved in mRNA degradation8,36. 
The potential modulation of NendoU activity by proteins of viral or cellular origins has 
not been addressed to date. Large-scale studies of pair-wise interactions between SARS-
Cov proteins expressed in cells outside the context of infection have demonstrated an 
nsp15 self-interaction in a yeast-two-hybrid screen47. Assays based on pull-down of in 
vitro-translated replicase subunits with GST-tagged viral proteins have also suggested 
SARS-Cov nsp15 might interact with nsp8 (the putative RNA primase), nsp9 (an RNA-
binding protein), the viral RdRp and the protease domain of nsp325. The results of this 
study should be interpreted with extreme caution, however, because it is difficult to 
assess whether proteins derived from in vitro translation or fused to GST are properly 
folded, and GST is also known to impose dimerization on its fusion partners, which may 
also interfere with the native fold of a protein (see Chapter 7). 
it is also unclear how NendoU activity is affected by proteolytic processing of the 
ORF1b-encoded part of nidovirus replicase polyproteins. Analysis of the cleavage kinet-
ics of EAv pp1ab showed processing of the ORF1b-encoded polypeptides is slow and 
occurs in no apparent sequential order, giving rise to many processing intermediates, 
among which nsp10-12 and nsp11-1297. interestingly, cleavage at the nsp9/nsp10 and 
nsp11/nsp12 junctions of EAv pp1ab was found to be essential for virus viability, while 
a mutant with impaired processing of the nsp10/nsp11 cleavage site was viable, though 
severely crippled96. The NendoU domain maps to the C-terminal portion of EAv nsp11, 
and may thus be inactive when fused to downstream nsp12, but capable of processing 
RNA as part of an nsp10-11 polypeptide. Obtaining recombinant EAv nsp11 precursor 
polypeptides and analyzing their RNA processing activities in vitro could therefore yield 
important insights into whether NendoU activity is regulated by polyprotein processing. 
Our attempts to purify recombinant nsp11-12, following the same protocol used for ex-
pression and purification of enzymatically active arterivirus nsp11 (see Chapter 4), were 
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unfortunately unsuccessful, likely due to insolubility or instability of this polypeptide in 
E. coli (data not shown). We have not attempted to obtain recombinant nsp10-11 so far, 
and this might in fact prove challenging, in view of the high toxicity associated with 
heterologous expression of both nsp10 and nsp11 (Chapter 4 and unpublished observa-
tions of L.C. van Dinten, J.C. Zevenhoven, and E.J. Snijder). Analysis of the in vitro duplex 
unwinding and RNA-processing activities of this precursor, however, may reveal potential 
mechanisms of regulating not only NendoU, but also the helicase activity of nsp10. 
Finally, an alternative approach to assess the importance of nsp11 precursor forms for 
the replicative cycle of EAv could involve deletion of the nsp11-coding sequence from 
ORF1b and engineering an EAv cDNA construct that expresses nsp11 from alternative 
locations in the viral genome, such as ORF1a93 or a sg mRNA. This experimental setup 
may also shed light on the significance of the downregulation of expression of NendoU-
containing replicase subunits relative to ORF1a-encoded viral nsps. 
Nendou: a subunit of viral replication complexes?
Heterologous expression of arterivirus nsp11 and coronavirus nsp15 in both prokaryotic 
and eukaryotic cells is extremely toxic (60,105 and Chapter 4). Combined with the lack 
of toxicity of NendoU mutants defective in RNA processing, this observation suggests 
that the enzyme may target essential cellular RNA components when it is expressed 
outside the context of infection. The intracellular localization of NendoU-containing 
replicase subunits in nidovirus-infected cells may therefore determine their access to 
RNA substrates. A rabbit polyclonal antibody that recognizes EAv nsp11 (and likely also 
nsp11-containing precursor polypeptides) was recently raised in our laboratory (D.D. 
Nedialkova and E.J. Snijder, unpublished data) and used to examine the intracellular 
distribution of nsp11 in EAv-infected cells. Our preliminary results suggest the protein 
co-localizes with membrane-anchored replicase subunits at presumed sites of RNA 
synthesis in perinuclear regions (Fig. 1A), and a similar distribution of SARS-Cov nsp15 
has been reported77. 
Remarkably, arterivirus nsp11 is not predicted to contain hydrophobic or transmem-
brane domains (data not shown), but the protein efficiently co-sedimented with isolated 
EAv RNA-synthesizing complexes that are known to be associated with membranes98 
(Fig. 1B). Compartmentalization of NendoU-containing nsps may thus represent a 
regulatory mechanism for sequestering this enzymatic activity, which is potentially 
detrimental to cellular mRNAs, into virus-induced membrane compartments. it will be 
interesting to determine whether nsp11 targeting to the sites of EAv RNA synthesis is 
mediated by interactions with other viral replicase subunits, and what effect perturbing 
nsp11 sequestration would have on the viral replicative cycle. 
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Does Nendou have a conserved function in the replicative cycle of arteriviruses 
and coronaviruses?
A critical role of the NendoU domain-containing nsps in the replicative cycle of both 
corona- and arteriviruses was established by reverse genetics-based mutagenesis of this 
domain in EAv (Chapter 3), MHv, and human coronavirus (HCov) 229E26,30. Deletions in 
the EAv NendoU domain and replacements of conserved Asp residues in NendoU of EAv, 
MHv and HCov 229E rendered viral RNA synthesis undetectable when introduced in the 
corresponding full-length infectious cDNA clones. A more rigorous characterization of 
these mutants, however, is required to rule out defects in polyprotein processing that 
could provide an alternative explanation for the observed nonviable phenotypes. 
Replacement of any of the three predicted active site residues of NendoU reduced the 
in vitro RNA-processing activities of arterivirus nsp11 and coronavirus nsp15 to levels 
close to background without affecting protein solubility (26,30,105 and Chapter 4). The same 
substitutions yielded viable, but severely crippled EAv mutants with a specific defect in 
viral sg mRNA synthesis, accompanied by a dramatic reduction of infectious progeny 
titers by up to 5 logs (Chapter 3). By contrast, mutagenesis of the MHv NendoU active 
site resulted in only modest defects in viral RNA synthesis and an up to 1.5 log decrease 
in progeny titers. Notably, no specific defects in MHv sg mRNA synthesis were observed 
for these mutants30. 
Overall, these data underscore the importance of the NendoU domain for efficient viral 
replication, but also suggest (partially) different roles of NendoU in the replicative cycles 
of arteri- and coronaviruses. A more thorough characterization of the NendoU mutant 
phenotypes, such as the quantitative analysis of viral minus-strand RNA species and ac-
cumulation levels of viral proteins, may aid in pinpointing steps of the viral replicative 
A
B
nsp11 nsp3
M I P10 S16
◄ nsp11
figure 1. eav nsp11: a subunit of viral replication complexes? (A) 
immunofluorescence analysis of nsp11 localization in EAv-infected 
vero E6 cells (8 h post-infection). A dual labeling was performed 
as previously described94, using a rabbit polyclonal antibody that 
recognizes EAv nsp11 (left panels, see text for details) and an Alexa 
488-conjugated rabbit antiserum recognizing EAv nsp3 (right 
panels). (B) Distribution of EAv nsp11 in subcellular fractions from 
EAv-infected cells. Active viral RNA-synthesizing complexes were 
isolated from EAv-infected cells by the method of van Hemert et al.98. 
Post-nuclear supernatants (PNS) of mock-infected (M) or EAv-infected 
(i) BHK-21 cells were prepared, and the PNS from EAv-infected cells 
was fractionated into a 10,000 x g pellet (P10) and supernatant (S10). 
The S10 fraction was clarified further by centrifugation at 16,000 
x g to yield S16. The membrane-associated viral RNA-synthesizing 
complexes are found in the P10 fraction, but require a cytosolic factor 
from the S16 fraction for in vitro activity98. Equivalent amounts of M, i, 
P10 and S16 fractions originating from the same number of cells were 
separated on SDS-PAGE gels, and the distribution of EAv nsp11 was 
analyzed by Western blotting with the anti-nsp11 rabbit antiserum.
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cycle at which NendoU operates. it will also be important to analyze NendoU active-site 
mutants in relevant in vivo infection models, in view of the documented roles of other 
(putative) nidovirus RNA-processing enzymes in viral pathogenicity16,62. Finally, connect-
ing the currently available data from in vitro RNA-processing assays and reverse genetics 
mechanistically requires the identification of the in vivo substrates of these enzymes, 
which will undoubtedly provide clues about the basis for the conservation of this enzy-
matic activity exclusively in nidoviruses.
how can the substrates of Nendou in infected cells be identified?
identifying the substrate(s) of NendoU in nidovirus-infected cells is a daunting task and 
different approaches to tackle it can be envisaged. isolation of protein complexes contain-
ing NendoU either without or in association with its substrates, for example, would open 
up the possibility of characterizing NendoU RNA-processing in vitro and identification of 
the bound RNA molecules, respectively. imperative to the success of both approaches 
and the biological relevance of the obtained results will be the use of infected cells as 
a starting material for purification of NendoU-containing complexes. The availability of 
highly specific antibodies that recognize NendoU-containing replicase subunits will also 
aid both approaches. This requirement, however, could be circumvented by the insertion 
of affinity tags in protein regions that are non-essential for RNA processing and virus 
viability. Such regions might be present in the family-specific N-terminal domains of 
coronavirus 15 and arterivirus nsp11. The available three-dimensional structures of two 
coronavirus nsp15 orthologs could guide the insertion of such tags6,29,60,105. Alternatively, 
random insertion mutagenesis could be employed to explore suitable insertion sites. 
isolation of NendoU-containing complexes may be facilitated by the association of the 
enzyme with membrane-bound viral replication complexes and the available protocols 
for their isolation from SARS-Cov- and EAv-infected cells77,98,99. This approach could not 
only aid the identification of interacting partners of NendoU-containing nsps, but will 
also help establish whether the in vitro substrate specificity of NendoU becomes nar-
rower when in complex with other proteins. Alternatively, methods developed for the 
identification of in vivo RNA-protein interactions in cellular RNPs could be applied in 
the search for NendoU substrates. Briefly, these approaches rely on the irradiation of 
intact living cells or purified complexes with 254-nm Uv light, which primarily cross-links 
proteins to RNA. The introduction of a covalent link between these two moieties permits 
the subsequent affinity purification of protein-RNA complexes under highly stringent 
conditions, ensuring that only specific interactions are detected21,87,88. After isolation of 
an RNP complex, cross-linked RNAs can be identified by RT-PCR and sequencing. Similar 
methods have been used successfully to map numerous RNA-protein interactions in 
small nucleolar RNPs21,88. Naturally, many potential pitfalls can be envisaged when trying 
to apply these methods to the identification of NendoU substrates, the most important 
of which would be the isolation of the enzyme in complex with its substrate or a cleav-
age product. The viability of NendoU active site mutants, together with their apparently 
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unimpaired ability to bind RNA molecules in vitro (Chapter 3 and 6,30) may be exploited in 
pursuing this line of research. 
in conclusion, our data on the arterivirus NendoU (Chapters 3 and 4) and that obtained 
by others on its coronavirus orthologs5-7,22,26,30,105 provide a solid foundation for future 
research aimed at understanding the molecular details of NendoU functions during 
nidovirus replication. Apart from unique insights into the role of a replicative endori-
bonuclease in the life cycle of +RNA viruses, this knowledge will also be an important 
prerequisite for assessing the suitability of NendoU as a target for the development of 
antiviral compounds.
NsP1 Is a Key faCtOR IN the INteGRal COORDINatION Of the 
aRteRIvIRus RePlICatIve CyCle
Nidovirus RNA synthesis in infected cells entails both amplification of the viral genome 
and the production of sg mRNAs, the latter serving as templates for the translation of 
viral structural and accessory protein genes. The process of sg mRNA synthesis is often 
referred to as “transcription”, to distinguish it from genome amplification (“replication”). 
The nidovirus genome and sg mRNAs are 3’-coterminal, while those of arteriviruses and 
coronaviruses also contain a common 5’ “leader” sequence of 170-210 nucleotides (nt) or 
55-92 nt, respectively34,76. 
The majority of recent data on arteri- and coronavirus RNA synthesis supports a model 
proposed by Sawicki and Sawicki67, according to which the unique structure of arterivirus 
and coronavirus sg mRNAs derives from discontinuous extension during minus-strand 
RNA synthesis. This process resembles copy-choice RNA recombination and is guided 
by specific RNA signals termed transcription-regulatory sequences (TRS; core sequence 
5’ UCAACU 3’ in EAv). in the genomic RNA, these RNA motifs are found upstream of each 
structural protein gene in (body TRS) and in the 3’ end of the leader sequence (leader 
TRS) (recently reviewed in 49,68). Minus-strand RNA synthesis is invariably initiated at the 
genomic 3’ end and can presumably be “attenuated” at a body TRS motif. The genomic 
leader TRS serves as a base-pairing target for the body TRS complement present at 3’ 
end of the nascent minus strand, which is translocated to the 5’-proximal region of the 
genomic template and extended with a copy of the leader sequence. A nested set of 
subgenome-length minus-strand templates are thus produced and serve as templates 
for the synthesis of the various sg mRNAs. Therefore, discontinuous minus-strand exten-
sion and the synthesis of a full-length complement of the genome likely “compete” for 
the same template – the genomic plus strand. This reasoning implies the existence of 
regulatory mechanisms that govern the temporal and quantitative control of the use of 
genomic RNA as a template for either full-length or subgenome-length minus-strand 
production.
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eav nsp1 links three key steps of the viral replicative cycle: replicase 
polyprotein processing, subgenomic mRNa production, and virion biogenesis
Arterivirus nsp1 remains the sole nidovirus replicase subunit shown to be dispensable 
for genome amplification but essential for sg mRNA production. Based on the observa-
tion that accumulation of all sg mRNAs was blocked in the absence of nsp1, the protein 
was proposed to control a switch between replication and transcription via a predicted 
zinc finger (ZF) domain in its N-terminal region86. Apart from the ZF, nsp1 contains two 
additional conserved domains - papain-like cysteine protease alpha (PCPα) and PCPβ, 
the former lacking proteolytic activity and the latter mediating nsp1 self-cleavage from 
pp1a/pp1ab11.
The data presented in Chapter 5 identified nsp1 as a multifunctional protein involved 
in three consecutive steps of the EAv replicative cycle: replicase protein proteolysis, 
sg mRNA production, and virion biogenesis. The autoproteolytic release of nsp1 from 
nascent replicase polyproteins was found to be required for EAv RNA synthesis (Chapter 
5), even though replication can proceed in the absence of nsp186. impairing cleavage at 
the nsp1/2 site by the C-terminal PCPβ domain of nsp1 likely hinders the subsequent 
autoproteolytic cleavage of the nsp2/nsp3 site by a cysteine protease located in the N-
terminal region of nsp278. Accordingly, a mutation that blocked the self-release of nsp2 
has been shown to dramatically affect downstream cleavage events in pp1a and result 
in a non-viable phenotype when analyzed in the EAv reverse genetics system55. Hence, 
the first proteolytic event in EAv replicase polyprotein processing – the autoproteolytic 
release of nsp1, may trigger a cascade of downstream proteolytic events that are es-
sential for virus viability. 
The postulated key role for the nsp1 ZF domain in transcription was supported by 
the complete and selective block of sg mRNA accumulation observed upon certain 
replacements of zinc-coordinating residues in the full-length EAv cDNA clone (Chapter 
5). However, this domain is unlikely to be the sole determinant of the protein’s function 
in transcription, because transcription-negative phenotypes were also obtained upon 
replacements of charged residues in the PCPα and PCPβ domains (Chapter 6). These 
results argue against the involvement of a distinct nsp1 subdomain in mediating sg 
mRNA production. The PCPβ-mediated autoproteolytic release of nsp1, on the other 
hand, does not seem to require an intact ZF domain (Chapters 5 and 7). Substitutions of 
zinc-coordinating residues, however, negatively impacted the solubility and presumably 
the folding of recombinant nsp1 expressed in E. coli (Chapter 7).
An intriguing phenotype was obtained upon replacements of residues in the nsp1 
ZF and PCPα domains. These mutations had little effect on the accumulation of EAv 
mRNAs, but greatly decreased the production of infectious progeny particles, suggesting 
functional cooperation between the two domains in mediating a process required for 
efficient virion biogenesis (Chapters 5 and 6). it is still not known which part of the poorly 
characterized multistep process leading to the assembly and release of infectious EAv 
particles is perturbed by mutations in nsp1. 
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Nsp1 modulates minus-strand RNa accumulation to control the relative 
abundance of viral mRNas
The genomic RNA and sg mRNAs of arteri-and coronaviruses accumulate in specific 
relative molar ratios that are essentially constant until the peak of viral RNA synthesis 
has been reached, and it is largely unknown how these ratios are maintained2,13,64,66,69,71. 
Differential defects in the accumulation of EAv sg mRNAs have previously been observed 
upon mutagenesis of the core leader TRS and its flanking nucleotides. Altering the base-
pairing potential between the leader TRS and the body TRS complements in nascent 
minus strands through mutation of either element showed that the size and stability 
of this duplex region is an important determinant of the levels to which the various sg 
mRNAs accumulate51,52. The data presented in Chapter 6 revealed for the first time that 
mRNA-specific modulation of viral RNA levels in EAv-infected cells can be brought about 
by mutations in a protein factor: nsp1. These results, combined with the data presented 
in Chapter 5, provide genetic evidence that balanced accumulation of EAv mRNA species 
is also regulated by nsp1, implying the existence of a functional link between this repli-
case subunit and the TRS network of RNA signals. Unlike the leader TRS, however, nsp1 
is also involved in a process controlling the amount of viral genome that accumulates in 
EAv-infected cells. 
The relative molar ratios of coronavirus mRNAs and their corresponding minus-strand 
templates are similar, implying that coronavirus mRNA abundance is primarily deter-
mined at the level of minus-strand synthesis2,64,71. The quantitative analysis of individual 
minus-strand RNAs produced in nidovirus-infected cells, however, is inherently prob-
lematic due to their colinearity and low abundance, and is further complicated by the 
presence of a large excess (> 100-fold) of plus strands65,101. To meet these challenges, 
we developed a sensitive ribonuclease (RNase) protection assay for the detection and 
accurate quantitation of genome- and subgenome-length EAv minus-strand RNAs 
(Chapter 6). This assay permits the first-cycle analysis of minus-strand accumulation, 
because it requires a relatively small number of EAv-transfected cells, and is therefore 
well-suited for the characterization of minus-strand production by EAv mutants defec-
tive in infectious progeny production. This technical advance allowed us to establish that 
nsp1 maintains the balance among the seven EAv mRNAs, likely by controlling the levels 
of their corresponding minus-strand templates (Chapter 6).  
Expanding the current set of methods available for the analysis of EAv mutant pheno-
types with a protocol for the quantitation of viral minus-strand RNAs will undoubtedly 
assist in pinpointing the mechanisms underlying defects in viral mRNA production. For 
example, the protocol could be used to determine whether substitutions in EAv NendoU 
that negatively impact viral mRNA abundance (Chapter 3) have comparable effects on 
minus-strand accumulation and thus help establish whether NendoU functions dur-
ing plus-strand or minus-strand synthesis. Analysis of the effects of well-characterized 
leader TRS and body TRS mutations51,52,92 on subgenome-length minus strand accumula-
tion would also facilitate the characterization of the roles these RNA motifs play in the 
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discontinuous extension of minus strands. A better understanding of this latter process 
could be facilitated by the characterization of postulated transitory intermediates, such 
as “antileaderless” minus strands that may accumulate when the transfer of the nascent 
minus strand to the leader TRS region is impaired51,52,91,92.
Using the RNase protection assay described in Chapter 6, we attempted to detect 
such intermediates by hybridization of total RNA from EAv-infected cells with a probe 
complementary to the region of the EAv genomic minus strand containing the body TRS 
complement of RNA2. Theoretically, this probe should protect two fragments: a larger 
fragment derived from the genomic minus strand, and a smaller fragment derived from 
the body sequence complement present uniquely in the subgenome-length minus-
strand template of RNA2 [(-)RNA2]. This approach, however, consistently yielded only a 
single protected fragment originating from the genomic minus strand when samples 
from EAv-infected cells were analyzed (data not shown). Our inability to detect a (-)
RNA2-derived fragment in this experimental setup may be related to the lower relative 
abundance of RNA2 (and its minus-strand template) when compared to the genomic 
RNA (see Chapter 6). An entirely different experimental approach, such as e. g. RNA 
ligase-mediated amplification of cDNA ends38 may be better suited to establish whether 
antileaderless subgenomic minus strands accumulate as a result of mutations in regula-
tory proteins or RNA sequences. 
what are the molecular mechanisms of nsp1 function in eav RNa synthesis?
There is ample genetic evidence for the critical role of EAv nsp1 in regulating the balance 
between replication and transcription, as well as in controlling the relative abundance 
of viral mRNAs (86 and Chapters 5 and 6). Examining the interactions of nsp1 with other 
viral proteins and RNA motifs critically involved in viral RNA synthesis, and discontinu-
ous minus-strand extension in particular, is an obvious starting point in dissecting the 
molecular bases of the various regulatory activities of nsp1 in the EAv replicative cycle. 
it will be important to establish whether nsp1 can associate with nsp9 and nsp10, 
the EAv RdRp and helicase, respectively. A single amino acid substitution in nsp10 can 
selectively reduce the accumulation levels of subgenome-length plus and minus strands 
by ~500-fold without affecting the in vitro duplex-unwinding activity of recombinant 
nsp1072,95,101. Perturbation of an nsp1-nsp10 interaction required for the discontinuous 
extension of minus strands would certainly be an appealing explanation for the tran-
scription defect of the nsp10 mutant. Our attempts to isolate an nsp1-nsp10 or an nsp1-
nsp9 protein complex in EAv-infected cells by co-immunoprecipitation under various 
experimental conditions have not been successful so far (data not shown), a result that 
may reflect the dynamic nature of these putative complexes. Experimental verification 
of their formation could be pursued by examining the ability of these proteins to as-
sociate in vitro, which will be facilitated by the available protocols for the purification of 
recombinant nsp1 (Chapter 7), nsp93, and nsp1073 from E. coli. Ultimately, an in vitro assay 
reconstituting RdRp attenuation during minus-strand RNA synthesis should be devel-
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oped to assess the effects of nsp1 and nsp10 on this process. To this end, the currently 
available EAv RdRp assay3 must be advanced to support robust in vitro RdRp activity of 
recombinant EAv nsp9 on viral templates.
in the discontinuous minus-strand synthesis model, the relative abundance of sg 
mRNAs is presumably determined by the “attenuation rate” at each of the successive 
body TRS motifs encountered during minus-strand synthesis, and the data we obtained 
in Chapter 6 can be reconciled with this model. interactions of nsp1 with body TRS motifs 
in the plus strand or their complements in nascent minus strands are therefore obvi-
ous candidates for promoting viral RdRp pausing and/or nascent strand transfer to the 
genomic leader region. Our preliminary data suggest that recombinant nsp1 can interact 
with RNA both as a monomer and a dimer, and exhibits low binding specificity in vitro 
(A.J.W te velthuis and D.D. Nedialkova, unpublished observations). Ongoing experiments 
are aimed at establishing whether nsp1 can operate in a sequence-specific manner, by 
binding to RNA sequences in EAv body TRS regions or their minus-strand complements, 
and discriminate between the various TRS motifs. Considering the apparent ability of 
nsp1 to bind RNA in a dimeric form, it will also be interesting to determine if the protein 
can aid the juxtaposition of sequence elements in the leader TRS hairpin and the na-
scent minus strand, and thereby facilitate base-pairing between the leader TRS and the 
body TRS complement. This base-pairing step presumably ensures the fidelity of strand 
transfer during discontinuous minus-strand synthesis, and the core TRS sequence is thus 
unlikely a (major) determinant of sequence-specific body TRS recognition by protein 
factors51,92,100. in line with this notion, a construct carrying five mutations (5’-UCAACU-3’ 
- 5’-AGUUGU-3’) in the EAv leader TRS and RNA7 body TRS still permitted a certain level 
of RNA7 accumulation100. Also, a recombinant SARS-Cov with a “rewired transcription 
circuit”, carrying a 3-nt substitution in the core sequences of the leader and all body TRSs, 
replicates efficiently in cell culture106. Hence, body TRS motifs are likely recognized based 
on higher-order RNA structure present in the genomic RNA template or the nascent mi-
nus strand, rather than in a (core) sequence-dependent manner. This observation should 
be taken into account when examining the ability of recombinant nsp1 to bind these 
motifs in vitro.
The unique sequence context of each body TRS motif and its proximity to the genomic 
3’ end can also influence the accumulation of cognate sg mRNA species in EAv-infected 
cells. This was established in a prior study with the use of an EAv replicon derived from 
the full-length clone. in this construct, the sequence context of a body TRS motif was 
standardized by inserting several copies of an RNA7 body TRS cassette directly down-
stream of the EAv replicase gene in a head-to-tail fashion50. This cassette contained the 
core body TRS sequence of RNA7, flanked by 21 nt of natural upstream and 388 nt natural 
downstream sequences, including the complete EAv N protein gene. in this setting, all 
but the 5’-proximal TRS motifs have an identical sequence context over more than 400 
nt, but are found at different distances from the genomic 3’ end (Fig. 2A). The number of 
sg mRNAs produced in cells transfected with this construct corresponded to the number 
of (functional) body TRS motifs. Smaller sg mRNAs accumulated to higher levels in this 
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setting, resulting in a gradient of sg mRNA abundance50. Such “polar attenuation” may 
reflect the shorter time period needed for the synthesis of smaller RNAs. Alternatively, 
it can result from the association of a protein factor with the RNA-synthesizing complex 
necessary for commitment of the latter to discontinuous minus-strand extension. 
if this factor is present in a limiting amount or mediates a rate-limiting step, attenua-
tion of minus-strand synthesis would occur more frequently at 3’-proximal body TRS 
regions41,50.  
in an attempt to assess whether mRNA-specific defects associated with nsp1 muta-
tions were related to the proximity of body TRS motifs to the genomic 3’ end, we engi-
neered the ZCH and A1 mutations (Chapter 6) in the construct containing four repeats 
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figure 2. effects of nsp1 mutations on the relative abundance of sg mRNas produced from a 
construct with repeated RNa7 body tRs cassettes. (A) Schematic representation of the mABCD 
construct described by Pasternak et al.50. Four repeats of a sequence cassette containing 417nt from 
the EAv genome (nt 12,229 to 12,645) were inserted in a head-to-tail fashion immediately downstream 
of the EAv replicase gene, replacing the structural protein ORFs. The cassette includes the body TRS of 
RNA7 (indicated with a grey rectangle), flanked by 21 nt and 388 nt of natural upstream and downstream 
sequences, respectively. Consequently, this cassette contains the entire ORF coding for N protein. 
Transfection of BHK-21 cells with RNA transcribed in vitro from the mABCD construct results in the 
amplification of the genomic RNA (RNA1) and the synthesis of four sg mRNAs (RNAs A – D), schematically 
drawn in the lower panel. The body TRS motif of RNA2, located in replicase ORF1b (shown with a black 
rectangle), was inactivated by two nucleotide substitutions. (B) The ZCH and A1 mutations in nsp1 (see 
chapter 6) were introduced into the mABCD background, and BHK-21 cells were transfected with RNA 
transcribed from wild-type or mutant mABCD derivatives. Total intracellular RNA was isolated at 11 h post-
transfection and resolved by denaturing formaldehyde electrophoresis. EAv-specific mRNAs were detected 
by hybridization of the gel with a 32P-labelled probe complementary to the 3’-end of the viral genome. The 
positions of the genomic RNA and the four sg mRNAs are indicated. (C) Accumulation levels of each viral 
mRNA in panel (B) were quantified by phosphorimaging. Dark grey bars denote genomic RNA levels.
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of the RNA7 body TRS cassette (mABCD) described by Pasternak et al. (Fig. 2A). in the 
background of the full-length EAv cDNA clone, the ZCH mutation resulted in ~2-fold 
upregulation of RNA7 accumulation (Chapter 6), but had little effect on the abundance 
of sg mRNAs when introduced in the mABCD construct (Fig. 2, B and C). The observed 
background-specific difference must be linked to the sequence context of TRS elements. 
For instance, an increase in sg mRNA accumulation may require a larger portion of the 
upstream sequence flanking the body TRS of RNA7 than the 21 nt present in each cas-
sette of the mABCD construct. in addition, the size gradient of sg mRNA abundance was 
not affected by the ZCH mutation. By contrast, when the A1 mutation was introduced 
in the mABCD background, all sg mRNAs accumulated to similar levels, irrespective 
of their sizes (Fig; 2, B and C). Also, a pronounced enhancement of genomic RNA ac-
cumulation was seen in the A1 mutant, similar to what we had previously observed in 
the background of the full-length EAv cDNA clone (Chapter 6). The basis for the virtual 
absence of “polar attenuation” in the mABCD construct that contains the A1 mutation 
in nsp1 is not immediately evident. it may be associated with the increased availability 
of viral nonstructural proteins and/or template, both stemming from the higher levels 
of genomic RNA accumulation. A role of viral replicase subunits (and nsp1 in particular) 
as limiting factors in EAv sg mRNA synthesis is thus a tempting hypothesis. in order to 
assess whether nsp1 availability is important for sg mRNA accumulation, however, it will 
be necessary to uncouple the effects of nsp1 mutations on genomic RNA accumulation 
from those on sg mRNA abundance. This may be addressed with the use of an inducible 
cell line, in which nsp1 is supplied in trans and its expression levels can be quantitatively 
modulated. in this setting, the effects of nsp1 abundance on replication and transcription 
of an EAv mutant lacking nsp1 can be examined. Our efforts to generate nsp1-expressing 
stable cell lines have unfortunately been unsuccessful so far, probably due to the high 
toxicity of the heterologously expressed protein (data not shown).
Finally, it should be stressed that evidence for the involvement of a replicase protein 
in the mRNA-specific control of nidovirus RNA synthesis has only been obtained in EAv 
so far. Uncoupling of genome replication from sg mRNA production through mutations 
in nonstructural proteins has also only been observed upon substitutions in nsp1 of EAv 
and PRRSv (Chapters 5 and 6, 33,86), as well as EAv nsp1095,101. it is therefore unclear whether 
the synthesis of full-length and subgenome-length RNAs by members of other nidovirus 
families also require protein complexes with a different composition. Alternatively, the 
viral RdRp-containing replicase subunit of Coronaviridae and Roniviridae representatives 
can contain domains responsible for the recognition of TRS motifs, especially in view of 
the unprecedented size of this protein among viral RdRps20,85. Mechanistic differences 
in replication and transcription among the different nidovirus groups certainly exist, as 
illustrated by the lack of a common leader sequence in sg mRNAs of some nidovirus rep-
resentatives10,75,102. The larger genome size and larger set of replicative proteins encoded 
by viruses belonging to the Coronaviridae and Roniviridae families18,26,42,74 are also likely 
to be manifested in differences among the molecular mechanisms of viral RNA synthesis. 
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Nevertheless, the fundamental aspects of this process are likely shared among nidovi-
ruses, considering the evolutionary relationship among their key replicative enzymes. 
the relative abundance of eav mRNas is fine-tuned to allow efficient virus 
production
The data presented in Chapter 6 allowed us to postulate the existence of a previously un-
known link between the regulation of individual nidovirus mRNA levels and the efficiency 
of infectious progeny production. Mutations in nsp1 that exerted differential effects on 
EAv mRNA and corresponding protein abundance also adversely affected the assembly 
of infectious virions. We isolated numerous nsp1 pseudorevertants with compensatory 
mutations which invariably rescued both efficient virus production and balanced EAv 
mRNA accumulation. A closer inspection of the relationship between infectious virus 
yield and viral mRNA accumulation revealed that the magnitude of imbalance between 
different mRNA species is a principal factor affecting progeny yield in EAv; in fact, there 
seems to be a remarkably linear relationship between virus titers and mRNA species im-
balance (Chapter 6). Collectively, these results reveal that mRNA-specific modulation of 
viral RNA levels is a fundamental mechanism for the quantitative control of viral protein 
expression, which has important implications for the late stages of the EAv replicative 
cycle. Our results also suggest that nsp1 promotes virion biogenesis by acting at differ-
ent stages of the EAv replicative cycle – one connected to the modulation of viral mRNA 
accumulation, as well as an additional, currently unknown step downstream of viral RNA 
synthesis (Chapters 5 and 6).
Altering relative abundances of viral structural proteins by changing the levels of their 
mRNA templates could negatively impact virion assembly by several mechanisms. For 
example, the stoichiometry of protein complexes which drive this process and/or confer 
infectivity to progeny particles can be altered. The decreased ratio between structural 
proteins and genomic RNA we observed in some nsp1 mutants may also adversely affect 
infectious progeny production. Accordingly, virion preparations from nsp1 mutants with 
imbalanced mRNA accumulation profiles contained not only fewer virus particles, but 
also had lower specific infectivity (Chapter 6). it will be interesting to determine whether 
virions produced by nsp1 mutants with defects in progeny production but not in viral 
RNA accumulation are also characterized by low specific infectivity. Elucidating the mo-
lecular basis of nsp1 function in virion biogenesis, however, requires more comprehen-
sive knowledge of the molecular processes that govern genome encapsidation, as well 
as the assembly and secretion of infectious progeny particles from EAv-infected cells.
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uNDeRstaNDING NIDOvIRus RePlICatION: a Case fOR ReDuCtIONIsm
A widely used approach in research on complex biological systems is reducing them to 
a set of fundamental parts, the functioning and interactions of which are subsequently 
characterized separately. This method has been successfully applied in studies on the 
replicative cycle of numerous +RNA viruses. in particular, various strategies have been 
used to uncouple genome replication from its translation and encapsidation in order to 
examine the critical determinants for each process (see Chapter 2). Similar approaches 
could be applied to address some of the fundamental questions about the regulation of 
key steps in the nidovirus replicative cycle, although experimental setups may have to be 
tailored to accommodate the complexity of nidovirus replication. 
in analogy to research conducted with DENv and yFv 1,28, nidovirus replicons encoding 
reporter proteins with enzymatic activities which can be monitored with high sensitivity 
(such as firefly luciferase), could be designed to discriminate between mutations affect-
ing viral genome translation or RNA synthesis. Expression of green fluorescent protein 
from the replicase gene of EAv without major effects on viral replication has already been 
reported, demonstrating that insertion of foreign (reporter) genes in certain regions of 
the EAv replicase is feasible93. Also, generation of nidovirus replicon RNAs lacking struc-
tural protein genes from DNA-based vectors, combined with trans-complementation 
approaches, should help establish whether replication of nidovirus genomes is a pre-
requisite for their incorporation into viral particles, as shown for KUN virus and Pv31,46. 
Constructs containing the EAv replicase gene-coding sequence downstream of the T7 
RNA polymerase promoter are already available and have been instrumental in studies 
on EAv polyprotein processing in the recombinant vaccinia virus/T7 RNA polymerase sys-
tem79,90,96,104. This experimental approach has permitted the analysis of proteolysis defects 
associated with mutations in the main EAv protease that are lethal in the context of the 
complete EAv replicative cycle. EAv genome translation was thus effectively uncoupled 
from its amplification in this system, which may serve as a basis for future experiments on 
the determinants of these two key viral processes.
Apart from genetic approaches, development of a cell-free assay for nidovirus RNA 
synthesis, analogous to the one available for Pv43, would provide an invaluable tool for 
characterization of mutations that block nidovirus replication early in infection. Ulti-
mately, (a combination of ) methods should permit the identification of specific steps in 
genome translation and replication affected by mutations that are now classified simply 
as “nonviable” with conventional reverse genetics. The recently developed assays for the 
isolation of active viral replication/transcription complexes (RTCs) from SARS-Cov- and 
EAv-infected cells98,99, however, can currently only be used to analyze wild-type RTCs, or 
mutant RTCs that support robust RNA synthesis and virus production. Nevertheless, the 
availability of purified active nidovirus RTCs will greatly benefit analysis of the composi-
tion of the nidovirus RNA-synthesizing machinery, as well as identification of the host 
factors shown to be required for nidovirus RC activity in vitro. ideally, the question of 
whether genome-length and subgenome-length are produced by RdRp complexes of 
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different composition, i.e. the existence of a separate “replicase” and a “transcriptase”, 
could also be addressed by attempting to purify the two activities, as has been achieved 
for vesicular stomatitis virus, a minus-strand RNA virus57. This, however, will likely require 
the isolation of complexes that are actively engaged in minus-strand synthesis, and it is 
unclear whether nidovirus RTCs isolated according to the currently available protocols 
can mediate production of minus strands98,99. 
Alternative “bottom-up” approaches relying on recently developed in vitro RdRp 
activity assays3,85 can also be envisaged, where known components (e.g. membranes, 
recombinant nonstructural proteins, viral RNA templates) can be combined to recon-
struct active RNA-synthesizing complexes exhibiting at least some of the properties 
of nidovirus RTCs. The large number of nidovirus replicase subunits and the potential 
critical roles of polyprotein processing intermediates in viral RNA synthesis, however, 
may complicate such approaches. Taking into account also the large size of nidovirus 
genomic RNAs (13–32 kb) and the mounting evidence that long-range RNA-RNA interac-
tions are key players in regulation of the +RNA virus replicative cycle, reconstruction of 
nidovirus RNA-synthesizing complexes from their individual components will certainly 
be a formidable task.
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When outside of host cells, viruses are largely biologically inert entities, barely more 
than pieces of genetic material enclosed in a protein coat and sometimes also wrapped 
in a lipid envelope. Following infection of a suitable host cell, however, expression of 
viral genes endows viruses with a remarkable capacity to enlist cellular molecular ma-
chineries to the task of producing new viruses. The effects of viral replication on host 
cell metabolism can be tremendous and often lead to cell death.  The flow of the key 
steps in the replicative cycle of viruses is primarily determined by the viral genome type. 
The majority of currently known viruses employ RNA genomes, which can be single- or 
double-stranded, and have messenger RNA polarity (plus-strand) or are complementary 
to mRNA (minus-strand).  Plus-strand RNA virus genomes are readily translated upon 
their release into the cytoplasm of the infected cell to produce a set of viral proteins. 
A number of these proteins assemble into membrane-associated RNA-synthesizing 
complexes that direct viral RNA replication. Key to this process is a virus-encoded RNA-
dependent RNA polymerase (RdRp), whose activity is often supported and modulated 
by virus-encoded protein factors. Together, RdRp and accessory factors are commonly 
referred to as “the viral replicase”. Replicase subunits of RNA viruses have enzymatic 
activities and/or nonenzymatic regulatory functions and are frequently multifunctional, 
a property likely stemming from the limited coding capacity of RNA virus genomes.  
One of the most complex RNA virus replicases known to date is encoded by viruses in 
the order Nidovirales. This order comprises three distantly related families of enveloped 
plus-strand RNA viruses: Coronaviridae (subfamilies Coronavirinae and Torovirinae), 
Arteriviridae, and Roniviridae, which can infect a range of hosts from invertebrates to 
mammals, including man. The evolutionary relationship among nidoviruses is evident 
from similarities in gene organization, expression strategies, and the presumed common 
ancestry of their key replicative enzymes. Nidovirus genome sizes vary between 13-16 
kb for Arteriviridae and 25-32 kb for Coronaviridae and Roniviridae, and the latter two 
families possess the largest RNA genomes currently known. The multidomain replicase is 
encoded in two large 5’-proximal open reading frames in nidovirus genomes, while the 
viral structural protein genes are located in the 3’-proximal genomic regions.  Translation 
of the 5‘-capped, 3’-polyadenylated nidovirus genomic RNA results in two large repli-
case polyproteins, pp1a and pp1ab, the latter translated after a -1 ribosomal frameshift. 
Through processing of the replicase polyproteins by virus-encoded proteases, between 
13 and 16 individual viral nonstructural proteins (nsps) are produced in nidovirus-
infected cells. in addition to genome replication, the nidovirus replicative machinery also 
mediates the synthesis of a set of two to ten subgenomic (sg) mRNAs. The production of 
these molecules secures the expression of the structural protein genes.  The sg mRNAs 
of all nidoviruses are 3’-coterminal with the viral genome, and those synthesized by ar-
teriviruses and coronaviruses also contain a common 5’ leader sequence identical to the 
5’-proximal region of the genomic RNA.  This unique mosaic structure of arterivirus and 
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coronavirus sg mRNAs is presumed to derive from discontinuous RNA synthesis during 
the production of the subgenome-length minus-strand templates for sg mRNA synthesis. 
The functional characterization of replicase subunits is a prerequisite for illuminating 
the regulatory mechanisms that govern the diverse activities of nidovirus RNA-synthe-
sizing complexes. Understanding fundamental aspects of viral replication is of critical 
importance for developing strategies to prevent and treat diseases caused by known and 
emergent nidoviruses. The work described in this thesis focused on the roles of replicase 
subunits in coupling different processes in the replicative cycle of equine arteritis virus 
(EAv). This virus, which is the prototype of the Arteriviridae, has the smallest genome 
among nidoviruses and it is recognized as one of the best studied nidovirus models 
in terms of molecular biology. The current knowledge on the numerous enzymatic ac-
tivities found in the nidovirus replicase is largely derived from biochemical and genetic 
studies of viral nsps and is summarized in Chapter 1. in Chapter 2, a literature review on 
strategies for spatio-temporal regulation of the eukaryotic plus-strand RNA virus replica-
tive cycle is presented, focusing on the inherent multifunctionality of plus-strand RNA 
virus genomes as templates for at least three different processes: translation, synthesis of 
minus-strand RNAs, and production of progeny particles.  The implications of emergent 
common themes for our current understanding of and future research on regulatory 
events in the nidovirus replicative cycle are summarized.  
in the following six Chapters of this thesis, experimental work conducted in this study 
is presented and discussed. We examined two different EAv replicase subunits: nsp11, 
containing an enzymatic domain that is conserved across a broad spectrum of nidovi-
ruses (NendoU), and nsp1, a protein specific for arteriviruses having a critical function in 
sg RNA production.  The availability of an EAv full-length cDNA clone greatly facilitates 
functional studies of the elaborate viral replicative apparatus using reverse and forward 
genetics. An experimental approach combining site-directed mutagenesis of the virus 
with in vitro biochemical characterization of a recombinant protein form was employed 
in Chapters 3 and 4 to gain more insight into the role of nsp11 in the EAv replicative 
cycle. A nidovirus-specific conserved domain, mapping to the C-terminus of arterivirus 
nsp11 and coronavirus nsp15, had been identified by comparative sequence analysis. 
Subsequently, bioinformatics uncovered a distant relationship between this domain and 
a family of cellular endoribonucleases, suggesting that nidovirus nsps containing this 
function may be capable of hydrolyzing RNA molecules. The biological importance of 
this proposed enzymatic activity (now called NendoU) for the replicative cycle of EAv 
was probed and established in Chapter 3. Deletion of the NendoU-coding sequence 
from the viral genome rendered EAv RNA accumulation undetectable. Similar pheno-
types were obtained upon a number of single amino acid replacements. Substitutions 
of conserved residues presumed critical for endoribonucleic activity, however, yielded 
viable mutants, albeit with severe defects in infectious progeny production and small-
plaque phenotypes. Upon further analysis of the presumed NendoU active site mutants, 
evidence for the importance of this domain for optimal EAv RNA synthesis was obtained, 
and a potential link between NendoU and viral sg mRNA production was identified. 
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The in vitro endoribonuclease activity of the arterivirus NendoU-containing replicase 
subunit was examined in detail (Chapter 4). in in vitro activity assays, bacterially ex-
pressed nsp11 from EAv and a distantly related arterivirus, porcine respiratory and repro-
ductive syndrome virus (PRRSv), were found to efficiently cleave RNA 3’ of pyrimidines. 
Both enzymes exhibited a modest preference for cleavage after uridylates, an activity 
that was greatly reduced by replacement of residues previously implicated in catalysis. 
Comparative analysis of the distantly related NendoU activity of arterivirus nsp11 and 
coronavirus nsp15, purified and tested under identical conditions, revealed common and 
distinct features. Taken together, the data presented in Chapters 3 and 4 reveal that this 
remarkable RNA-processing activity is common to arteri- and coronaviruses, and provide 
a solid foundation for future research aimed at understanding the molecular details of 
NendoU functions during nidovirus replication.
The regulatory roles of EAv nsp1, the only nidovirus protein to date with a demon-
strated specific role in sg mRNA production, were explored in Chapters 5 and 6 using 
reverse and forward genetics. The autoproteolytic release of nsp1 from the replicase 
polyproteins is mediated by a C-terminal papain-like cysteine proteinase domain (PCPβ), 
and cleavage of the nsp1/2 site was found to be a prerequisite for viral RNA synthesis 
(Chapter 5). Two more subdomains had previously been identified in nsp1 by compara-
tive sequence analysis - a zinc finger (ZF) domain mapping to the N-terminal portion of 
nsp1, and an additional cysteine proteinase domain (PCPα) that is proteolytically inactive. 
Substitutions of proposed zinc-coordinating residues were found to selectively block EAv 
sg mRNA accumulation, or to severely decrease the production of infectious progeny 
without affecting viral RNA accumulation. These data identified nsp1 as a multifunctional 
replicase subunit with critical functions in at least three consecutive key processes in the 
EAv replicative cycle: replicase polyprotein processing, sg mRNA production, and virion 
biogenesis. 
in Chapter 6, alanine replacement of non-conserved clusters of polar residues in the 
nsp1 sequence were tested in the EAv cDNA clone in an attempt to expand the rep-
ertoire of viable EAv nsp1 mutants with defects in the protein’s regulatory functions. 
Detailed analysis of mutant and pseudorevertant phenotypes revealed that the relative 
abundance of EAv mRNAs is tightly controlled by an intricate network of interactions 
involving all nsp1 subdomains. Furthermore, the quantitative balance among viral mRNA 
species was found to be critical for efficient production of new virus particles.  An assay 
was developed for the quantitative detection of viral minus-strand RNA species and 
allowed us to demonstrate that nsp1 likely modulates the accumulation of full-length 
and subgenome-length minus-strand templates for EAv mRNA synthesis. Collectively, 
the data presented in Chapters 5 and 6 identify nsp1 as a key coordinator of genome 
replication, sg mRNA synthesis, and virus production. 
To address the molecular details of nsp1 function, the development of in vitro as-
says and solution of the three-dimensional structure of the protein are of significant 
importance.  The different approaches we explored for the production and purification 
of soluble recombinant nsp1 in Escherichia coli are described in Chapter 7. The pitfalls 
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we encountered upon purification of GST-tagged nsp1 and subsequent tag removal by 
proteolytic cleavage were largely related to the poor solubility of recombinant nsp1. A 
successful approach for nsp1 expression from a construct that allowed its autoproteolytic 
release from a precursor is outlined. This protocol resulted in the purification of soluble, 
stable recombinant nsp1 that can be used in future research.
in Chapter 8, the implications of our data on EAv nsp1 and nsp11 are discussed in 
substantial detail in the framework of relevant findings obtained by others. Potential 
directions for future research are outlined, aimed at identifying the biological substrates 
and significance of NendoU activity for nidovirus replication and unraveling the molecu-
lar mechanisms that underlie the multiple regulatory roles of nsp1.
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virussen zijn buiten hun gastheercel voornamelijk inerte deeltjes, nauwelijks meer dan 
fragmenten genetisch materiaal, ingesloten in een eiwitmantel die soms is verpakt in een 
lipide envelop. Na infectie van een geschikte gastheercel echter verschaft de expressie 
van hun genoom virussen het opmerkelijke vermogen om de moleculaire machinerie 
van de cel in the schakelen bij het produceren van nieuwe virussen. Het effect van virale 
replicatie op het metabolisme van de gastheercel kan enorm zijn en leidt vaak tot de dood 
van de cel. De volgorde van de voornaamste stappen in de replicatiecyclus van virussen 
wordt in de eerste plaats bepaald door het type van het virale genoom. De meerderheid 
van de thans bekende virussen bezit een RNA-genoom, dat enkel- of dubbelstrengs kan 
zijn en van ‘messenger RNA’ (mRNA) polariteit (plusstrengs) of complementair daaraan 
(minstrengs). Plusstrengs RNA-virus genomen worden na hun binnenkomst in het cyto-
plasma van de geïnfecteerde cel direct vertaald in virale eiwitten. De meeste van deze 
eiwitten assembleren tot een membraangebonden RNA-synthetiserend enzymcomplex 
dat de virale replicatie aanstuurt. Sleutelfactor in dit proces is een virus-gecodeerd RNA-
afhankelijk RNA-polymerase (RaRp), waarvan de activiteit vaak wordt ondersteund en 
gereguleerd door virusgecodeerde eiwitfactoren. RaRp en accessoire eiwitten worden 
gezamenlijk doorgaans “het virale replicase” genoemd. De replicase-onderdelen van 
RNA-virussen hebben enzymatische activiteiten en/of niet-enzymatische, regulerende 
taken, en zijn vaak ook multifunctioneel, een eigenschap die waarschijnlijk zijn oor-
sprong vindt in de beperkte coderende capaciteit van RNA-virusgenomen.
Eén van de meest ingewikkelde, tot op heden bekende, RNA-virus replicases behoort 
toe aan de virussen in de orde Nidovirales. Deze groep omvat drie ver verwante families 
van envelop-bevattende, plusstrengs RNA-virussen – Coronaviridae (subfamilies Corona-
virinae en Torovirinae), Arteriviridae, en Roniviridae, die gezamenlijk een scala aan gas-
theren kunnen infecteren, van ongewervelde dieren tot zoogdieren, inclusief de mens. De 
evolutionaire relatie tussen nidovirussen uit zich in vergelijkbare genoomorganisaties en 
genexpressie-strategieën, en de veronderstelde gemeenschappelijke afkomst van hun 
belangrijkste replicatieve enzymen. De grootte van het nidovirusgenoom varieert van 
13 – 16 kb voor Arteriviridae tot 25 – 32 kb voor Coronaviridae en Roniviridae, en daarmee 
bezitten de laatstgenoemde twee families de grootste RNA-genomen die momenteel 
bekend zijn. Het multidomein replicase is gecodeerd in de twee grote, 5’-gelegen open 
leesramen in het nidovirusgenoom, terwijl het 3’-gelegen genoomdeel de genen voor 
de virale structurele eiwitten bevat. vertaling van het 5’-cap-dragende en 3’-gepoly-
adenyleerde nidovirusgenoom resulteert in twee grote replicase polyproteïnen, pp1a 
en pp1ab, waarvan de laatste vertaald wordt na een -1 ribosomale ‘frameshift’. Dankzij 
klieving van de replicase polyproteïnen door virusgecodeerde proteases worden in 
nidovirus-geïnfecteerde cellen tussen de 13 en 16 individuele virale niet-structurele 
eiwitten (‘nonstructural proteins’; nsps) geproduceerd. Naast genoomreplicatie verzorgt 
de replicatiemachinerie van nidovirussen ook de synthese van een set van twee tot tien 
subgenome (sg) mRNAs. De productie van deze moleculen verzekert de expressie van de 
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genen die de structurele eiwitten coderen. De sg mRNAs van alle nidovirussen zijn 3’-co-
terminaal met het virale genoom, en die van arterivirussen en coronavirussen bevatten 
aan het 5’-uiteinde tevens een gemeenschappelijke ‘leader’ sequentie, die identiek is aan 
het 5’-uiteinde van het genoom-RNA. Aangenomen wordt dat de unieke mozaïekstruc-
tuur van arterivirale en coronavirale sg mRNAs voortkomt uit een proces van discontinue 
RNA-synthese, dat plaatsvindt tijdens de productie van de subgenome min-strengen die 
gebruikt worden als matrijs voor sg mRNA-synthese. 
De functionele karakterisering van replicase-onderdelen is essentieel voor het in 
kaart brengen van de regulerende mechanismen die de diverse activiteiten van het 
RNA-synthetiserende enzymcomplex van nidovirussen controleren. Het begrijpen van 
de fundamentele aspecten van virale replicatie is van doorslaggevend belang voor het 
ontwikkelen van strategieën ter voorkoming en behandeling van ziekten, veroorzaakt 
door zowel bekende als onverwacht opduikende nidovirussen. Het werk beschreven 
in dit proefschrift concentreert zich op de functies die specifieke replicase-onderdelen 
hebben in het koppelen van verschillende processen tijdens de vermeerderingscyclus 
van het equine arteritis virus (EAv). Dit virus, het prototype van de Arteriviridae familie, 
heeft het kleinste genoom onder de nidovirussen en wordt gezien als één van de best 
bestudeerde nidovirus-modellen in termen van moleculaire biologie. De huidige kennis 
van de talrijke enzymatische activiteiten die aanwezig zijn in het nidovirus-replicase is 
voornamelijk verkregen door de biochemische en genetische karakterisering van virale 
nsps en wordt samengevat in hoofdstuk 1. Hoofdstuk 2 bevat een literatuuroverzicht van 
de strategieën die eukaryote plusstrengs RNA-virussen gebruiken om hun vermenigvul-
digingscyclus te reguleren in ruimte en tijd. Er is daarbij speciale aandacht voor de in-
trinsieke multifunctionaliteit van plusstrengs RNA-virusgenomen als matrijs in tenminste 
drie verschillende processen: translatie, synthese van minstrengs RNAs, en de productie 
van nieuwe virusdeeltjes. Het belang van de gemeenschappelijke thema’s die zichtbaar 
worden voor ons huidige begrip van en toekomstig onderzoek aan regulerende stappen 
in de vermeerderingscyclus van nidovirussen worden samengevat.
in de volgende 6 hoofdstukken van dit proefschrift wordt het experimentele werk, 
uitgevoerd in dit promotieonderzoek, gepresenteerd en besproken. Twee verschillende 
EAv replicase-onderdelen werden onderzocht: nsp11, dat een enzymfunctie bevat die 
geconserveerd is in een breed spectrum van nidovirussen (NendoU), en nsp1, een eiwit 
specifiek voor arterivirussen met een doorslaggevende functie in sg RNA-productie. 
De beschikbaarheid van een ‘full-length’ cDNA kloon voor EAv bevordert functionele 
studies aan de uitgebreide replicatiemachinerie van dit virus in belangrijke mate, 
gebruikmakend van zogenaamde ‘forward’ en ‘reverse’ genetica. in hoofdstuk 3 en 4 
wordt een experimentele aanpak gebruikt die plaatsgerichte mutagenese van het virus 
combineert met de in vitro biochemische karakterisering van een recombinant eiwit-
product om onze kennis te vergroten van de rol van nsp11 in de EAv replicatiecyclus. 
Een nidovirus-specifiek, geconserveerd domein, gelegen in het C-terminale deel van 
arterivirus nsp11 en coronavirus nsp15, was reeds eerder geïdentificeerd door vergeli-
jkende sequentieanalyse. vervolgens onthulde bio-informatica een verre verwantschap 
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tussen dit domein en een familie van cellulaire endoribonucleases, en suggereerde dat 
nidovirus nsps die dit domein bevatten in staat zouden kunnen zijn RNA-moleculen te 
hydrolyseren. Het biologische belang van deze voorspelde enzymatische activiteit (nu 
NendoU genaamd) voor de vermeerderingscyclus van EAv is onderzocht en bevestigd 
in hoofdstuk 3. Het verwijderen van het NendoU-coderende gebied uit het virale ge-
noom maakte EAv RNA-accumulatie ondetecteerbaar. Gelijksoortige virale phenotypen 
werden verkregen wanneer een aantal specifieke aminozuren werden vervangen. Mu-
tagenese van geconserveerde aminozuren die verondersteld werden essentieel te zijn 
voor de endoribonuclease activiteit leverde echter levensvatbare mutanten op, hoewel 
deze wel ernstige defecten vertoonden op het gebied van de productie van infectieus 
nageslacht en een zogenaamd ‘small-plaque’ fenotype hadden. verdere analyse van deze 
veronderstelde NendoU ‘active site’-mutanten bewees het belang van deze functie voor 
optimale EAv RNA-synthese en onthulde een potentiële connectie tussen NendoU en de 
virale sg mRNA-productie.
De in vitro endoribonuclease activiteit van het arterivirus NendoU-bevattende repli-
case-eiwit werd in detail onderzocht (hoofdstuk 4). Bacterieel geëxpresseerd nsp11 van 
EAv en een ver verwant arterivirus, het ‘porcine respiratory and reproductive syndrome 
virus’ (PRRSv), bleken in in vitro activiteitstesten RNA  substraten efficiënt te klieven  aan 
de 3’ zijde van pyrimidines. Beide enzymen vertoonden een bescheiden voorkeur voor 
klieving na uridines, een activiteit die in belangrijke mate kon worden verminderd door 
mutagenese van aminozuren waarvan al eerder werd aangenomen dat ze van belang 
zijn voor enzymactiviteit. vergelijkende analyse van de ver verwante NendoU activiteit 
van arterivirus nsp11 en coronavirus nsp15, gezuiverd en onderzocht onder dezelfde 
omstandigheden, toonde zowel gemeenschappelijke eigenschappen als verschillen aan. 
Gezamenlijk laten de data gepresenteerd in hoofdstuk 3 en 4 zien dat deze opmerkelijke 
‘RNA-processing’ activiteit een gemeenschappelijke eigenschap is van arteri- en corona-
virussen, en vormen zij een solide basis voor toekomstig onderzoek gericht op het begri-
jpen van de moleculaire details van de NendoU functie in de replicatie van nidovirussen.
De regulerende functies van EAv nsp1, het enige tot nu toe bekende nidovirus-eiwit 
met een aangetoonde specifieke functie in sg mRNA-productie, zijn onderzocht in hoofd-
stuk 5 en 6, gebruikmakend van ‘forward’ en ‘reverse’ genetica. De autoproteolytische 
klieving van nsp1 van de replicase polyproteïnen wordt uitgevoerd door een C-terminaal 
papaine-achtig cysteine proteinase domein (PCPβ), en klieving tussen nsp1 en nsp2 is 
een voorwaarde voor virale RNA-synthese (hoofdstuk 5). Twee andere domeinen van 
nsp1 zijn eerder geïdentificeerd door vergelijkende sequentie-analyse – een ‘zinc fin-
ger’ (ZF) domein in het N-terminale deel van nsp1, en een tweede cysteine proteinase 
domein (PCPα) dat proteolytisch inactief is. Mutagenese van de veronderstelde zink-
coördinerende aminozuren bleek te resulteren in een selectieve blokkade van EAv sg 
mRNA accumulatie, of in een sterke reductie van de productie van infectieus nageslacht 
zonder dat de RNA accumulatie was veranderd. Deze data identificeren nsp1 als een 
multifunctioneel onderdeel van het replicase met kritische functies in tenminste drie op-
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in hoofdstuk 6 werden EAv mutanten getest waarin niet-geconserveerde groepjes 
polaire aminozuren in nsp1 waren vervangen door alanine, dit in een poging de collectie 
levensvatbare nsp1 mutanten met defecten in de regulerende functies van het eiwit uit 
te breiden. Gedetailleerde analyse van mutanten en pseudorevertanten maakte duidelijk 
dat de relatieve hoeveelheden van de EAv mRNAs strikt worden gereguleerd door een 
ingewikkeld netwerk van interacties waarbij alle subdomeinen van nsp1 betrokken 
zijn. verder bleek de kwantitatieve balans tussen de virale mRNAs kritisch te zijn voor 
efficiënte productie van nieuwe virusdeeltjes. Er werd een protocol ontwikkeld voor de 
kwantitatieve detectie van virale minstrengs RNA-moleculen en dit maakte het mogelijk 
om aan te tonen dat nsp1 waarschijnlijk de accumulatie moduleert van de ‘full-length’ 
en subgenome minstrengs RNAs die als matrijs gebruikt worden om de EAv mRNAs 
te maken. Gezamenlijk identificeren de data in hoofdstuk 5 en 6 nsp1 als een centrale 
coördinator van genoomvermeerdering, sg mRNA-synthese en virusproductie.
Om de moleculaire details van de nsp1-functies te kunnen ontrafelen, zullen de 
ontwikkeling van in vitro test systemen en het bepalen van de drie-dimensionale 
structuur van het eiwit van groot belang zijn. De verschillende benaderingen die zijn 
getest voor de productie en zuivering van oplosbaar recombinant nsp1 in Escherichia 
coli zijn beschreven in hoofdstuk 7. Er deden zich problemen voor bij de zuivering van 
GST-gelabeld nsp1, en de daaropvolgende proteolytische klieving van het GST-gedeelte, 
die grotendeels te wijten waren aan de slechte oplosbaarheid van recombinant nsp1. 
Er wordt echter ook een succesvolle aanpak voor nsp1 expressie beschreven, waarbij 
gebruik werd gemaakt van een construct dat autoproteolytische klieving van nsp1 vanaf 
een groter expressieproduct mogelijk maakt. Deze aanpak resulteerde in de zuivering 
van oplosbaar, stabiel recombinant nsp1 dat in toekomstig onderzoek gebruikt kan 
worden.
in hoofdstuk 8 worden de conclusies van onze analyse van EAv nsp1 en nsp11 in detail 
besproken tegen de achtergrond van relevante, door anderen verkregen resultaten. 
Mogelijke richtingen voor toekomstig onderzoek worden besproken, onderzoek gericht 
op de identificatie van de biologische substraten en de betekenis van NendoU activiteit 
voor nidovirusreplicatie, en op het ontrafelen van de moleculaire mechanismen achter 
de diverse regulerende functies van nsp1. 
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